data_1kvj_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1kvj _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.549 ' HB ' HD11 ' A' ' 51' ' ' ILE . 1.7 m . . . . . 0 N--CA 1.508 2.463 0 CA-C-O 120.924 0.392 . . . . 0.0 110.298 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.409 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 0.5 OUTLIER -135.8 165.99 24.32 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.957 -1.089 . . . . 0.0 111.034 -179.827 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.62 ' HA ' ' HA ' ' A' ' 51' ' ' ILE . 38.0 t -114.4 150.68 34.28 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.232 -0.917 . . . . 0.0 111.421 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.434 ' CG1' HD21 ' A' ' 62' ' ' LEU . 0.9 OUTLIER -144.17 130.22 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.783 -0.573 . . . . 0.0 110.559 -179.234 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.568 ' HA ' ' HA ' ' A' ' 49' ' ' THR . 90.2 m -109.22 122.25 46.92 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.538 0.685 . . . . 0.0 110.595 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.648 HG12 ' CG2' ' A' ' 75' ' ' ILE . 45.9 mt -109.61 121.61 62.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.568 -0.707 . . . . 0.0 111.239 -178.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.639 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 1.4 m -70.71 133.28 46.48 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 177.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.485 HG21 ' HB2' ' A' ' 48' ' ' ALA . 2.1 t -127.03 161.06 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.11 -0.994 . . . . 0.0 111.083 -178.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.83 158.65 35.58 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.493 -0.754 . . . . 0.0 110.728 178.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 73.93 20.99 79.71 Favored Glycine 0 N--CA 1.497 2.706 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.591 ' HB3' ' CD1' ' A' ' 71' ' ' PHE . 0.0 OUTLIER -128.87 28.93 5.29 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.891 -1.358 . . . . 0.0 110.806 -179.816 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.8 m -71.59 49.17 0.16 Allowed 'General case' 0 N--CA 1.501 2.114 0 O-C-N 120.918 -1.114 . . . . 0.0 111.243 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.487 ' O ' ' N ' ' A' ' 21' ' ' SER . 0.0 OUTLIER -150.56 118.55 6.27 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.879 -1.138 . . . . 0.0 108.896 178.844 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.487 ' O ' HG13 ' A' ' 23' ' ' VAL . 76.5 m-20 -14.97 -51.55 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.761 0 C-N-CA 123.742 0.817 . . . . 0.0 113.115 -178.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.796 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 3.7 p -52.1 -14.46 0.42 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.399 -0.813 . . . . 0.0 112.973 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.604 ' HB2' HD21 ' A' ' 43' ' ' LEU . 63.8 m -91.63 -24.77 19.44 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 119.121 -2.237 . . . . 0.0 110.65 -179.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.725 ' HB ' ' HG ' ' A' ' 43' ' ' LEU . 1.6 p -87.8 -34.98 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.53 -0.731 . . . . 0.0 109.231 179.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.796 ' CE3' ' HA ' ' A' ' 21' ' ' SER . 0.0 OUTLIER -81.79 -22.67 37.0 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 117.687 -1.605 . . . . 0.0 109.094 178.828 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.633 ' HB ' ' CZ3' ' A' ' 24' ' ' TRP . 0.6 OUTLIER -87.6 -24.68 23.9 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 120.94 -1.1 . . . . 0.0 110.812 178.027 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.562 HD12 ' CB ' ' A' ' 69' ' ' MET . 12.5 mm -92.78 -26.53 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.388 0 O-C-N 120.874 -1.142 . . . . 0.0 109.656 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.621 ' HG2' HD11 ' A' ' 39' ' ' ILE . 4.4 tm-20 -78.83 -40.22 33.37 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 177.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.43 ' HB2' ' O ' ' A' ' 24' ' ' TRP . 68.9 mm-40 -70.44 -33.79 71.73 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 119.361 -0.936 . . . . 0.0 109.287 178.315 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.508 ' HA ' ' OE1' ' A' ' 29' ' ' GLN . 4.3 tp60 -75.89 -62.16 1.68 Allowed 'General case' 0 N--CA 1.496 1.849 0 C-N-CA 119.61 -0.836 . . . . 0.0 110.586 179.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.529 HG21 HG23 ' A' ' 50' ' ' ILE . 51.1 mt -60.85 -50.5 80.26 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 O-C-N 120.994 -1.066 . . . . 0.0 109.841 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -47.73 -44.2 23.33 Favored Glycine 0 N--CA 1.5 2.917 0 N-CA-C 110.849 -0.901 . . . . 0.0 110.849 179.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.01 16.86 24.46 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.98 -1.306 . . . . 0.0 112.447 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -65.79 -42.3 92.04 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.175 0 O-C-N 120.89 -1.131 . . . . 0.0 111.061 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -163.04 -76.75 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.222 -0.924 . . . . 0.0 110.784 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.524 ' O ' ' HA ' ' A' ' 52' ' ' TYR . . . -141.39 75.84 0.33 Allowed Glycine 0 N--CA 1.495 2.567 0 N-CA-C 108.758 -1.737 . . . . 0.0 108.758 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.729 HG12 ' HB ' ' A' ' 39' ' ' ILE . 41.1 t -103.04 91.43 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 CA-C-O 122.665 1.221 . . . . 0.0 108.128 179.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.454 ' HB2' ' CD1' ' A' ' 51' ' ' ILE . 63.2 m-70 -61.67 -14.27 29.82 Favored 'General case' 0 C--N 1.283 -2.325 0 CA-C-N 114.827 -1.079 . . . . 0.0 110.627 -179.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.575 ' HB3' HG22 ' A' ' 51' ' ' ILE . 6.8 t60 -170.83 121.1 0.56 Allowed 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.729 ' HB ' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -122.07 128.8 75.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.268 -0.895 . . . . 0.0 109.565 -179.438 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.457 ' HB3' HG22 ' A' ' 49' ' ' THR . 0.0 OUTLIER -125.19 99.83 6.26 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.599 -1.313 . . . . 0.0 111.445 -179.615 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.467 ' HA ' ' HA ' ' A' ' 48' ' ' ALA . 15.0 p -107.41 153.97 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 177.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.81 ' HB3' ' HB3' ' A' ' 45' ' ' GLU . 0.2 OUTLIER -153.15 94.33 1.82 Allowed 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.103 -0.998 . . . . 0.0 110.763 -178.057 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.725 ' HG ' ' HB ' ' A' ' 23' ' ' VAL . 14.5 mt -46.83 -25.17 0.7 Allowed 'General case' 0 N--CA 1.508 2.436 0 O-C-N 121.923 -0.486 . . . . 0.0 112.016 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.574 ' HG2' ' N ' ' A' ' 45' ' ' GLU . 0.4 OUTLIER -96.92 -38.48 9.8 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 120.4 -1.437 . . . . 0.0 111.332 179.651 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.81 ' HB3' ' HB3' ' A' ' 42' ' ' SER . 0.2 OUTLIER -74.61 -4.2 35.72 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.202 -0.936 . . . . 0.0 108.802 177.476 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.9 mptt 56.66 34.88 25.28 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.271 -0.893 . . . . 0.0 112.961 177.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -148.19 151.32 35.32 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.534 -1.353 . . . . 0.0 112.071 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.485 ' HB2' HG21 ' A' ' 14' ' ' VAL . . . -130.84 103.28 6.48 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.568 ' HA ' ' HA ' ' A' ' 11' ' ' THR . 14.8 t -116.55 134.72 54.51 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.233 -0.917 . . . . 0.0 110.376 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.609 ' CG1' HD23 ' A' ' 62' ' ' LEU . 1.3 pp -144.85 -178.71 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-O 121.621 0.724 . . . . 0.0 110.785 -178.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.62 ' HA ' ' HA ' ' A' ' 9' ' ' SER . 0.0 OUTLIER -121.59 145.38 28.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 177.918 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.586 ' CD1' ' N ' ' A' ' 52' ' ' TYR . 13.7 p90 -149.2 165.82 30.7 Favored 'General case' 0 C--N 1.296 -1.761 0 O-C-N 121.245 -0.909 . . . . 0.0 111.347 -177.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -84.5 107.14 10.09 Favored Pre-proline 0 N--CA 1.49 1.539 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.701 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.516 ' HD3' ' O ' ' A' ' 52' ' ' TYR . 48.2 Cg_endo -75.11 -9.12 20.48 Favored 'Trans proline' 0 C--N 1.319 -1.018 0 O-C-N 123.624 1.328 . . . . 0.0 109.75 178.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 8.8 mtmm -74.18 -35.97 64.01 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.5 pp -121.4 -17.16 7.68 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.523 -0.736 . . . . 0.0 111.44 179.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.482 ' OE1' ' HB ' ' A' ' 61' ' ' THR . 2.7 mm-40 -131.58 -179.39 5.35 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.796 -1.19 . . . . 0.0 110.484 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.516 ' OG1' ' HD2' ' A' ' 59' ' ' PRO . 0.5 OUTLIER -164.22 173.5 3.96 Favored Pre-proline 0 N--CA 1.497 1.914 0 O-C-N 120.874 -1.141 . . . . 0.0 110.01 -179.993 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.516 ' HD2' ' OG1' ' A' ' 58' ' ' THR . 37.9 Cg_endo -62.78 8.32 0.13 Allowed 'Trans proline' 0 N--CA 1.502 1.972 0 C-N-CA 121.227 1.285 . . . . 0.0 113.258 -179.164 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.553 ' HG3' ' N ' ' A' ' 61' ' ' THR . 0.2 OUTLIER -90.68 -28.27 18.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.973 -1.08 . . . . 0.0 108.525 177.773 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.553 ' N ' ' HG3' ' A' ' 60' ' ' LYS . 0.8 OUTLIER -85.85 -27.69 24.91 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 177.953 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.609 HD23 ' CG1' ' A' ' 50' ' ' ILE . 4.5 mp -72.15 -27.62 62.72 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 176.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.454 ' O ' ' HB2' ' A' ' 67' ' ' ASP . 14.2 tp60 -86.65 -20.21 28.14 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 177.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.52 ' HB3' ' O ' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -91.28 -22.15 20.71 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.159 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -85.27 -27.66 25.85 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.515 HG12 ' HB1' ' A' ' 73' ' ' ALA . 2.1 tp -85.17 -32.73 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 177.249 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.454 ' HB2' ' O ' ' A' ' 63' ' ' GLN . 27.8 t70 -74.37 -32.28 62.68 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 177.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.5 -43.39 69.79 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.878 -0.514 . . . . 0.0 109.868 178.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.562 ' CB ' HD12 ' A' ' 26' ' ' ILE . 23.6 mmm -59.86 -46.72 88.38 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.18 -0.95 . . . . 0.0 109.996 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 114.54 51.42 0.46 Allowed Glycine 0 N--CA 1.499 2.846 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.591 ' CD1' ' HB3' ' A' ' 17' ' ' MET . 75.1 m-85 -139.27 130.18 26.29 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.69 -0.888 . . . . 0.0 109.526 179.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.46 ' O ' ' HA ' ' A' ' 14' ' ' VAL . 1.7 m-20 -49.9 111.32 0.49 Allowed 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.433 -0.792 . . . . 0.0 110.045 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.515 ' HB1' HG12 ' A' ' 66' ' ' ILE . . . -109.77 127.26 54.52 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.185 -0.947 . . . . 0.0 111.582 -178.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.639 ' HB ' ' HB2' ' A' ' 13' ' ' SER . 75.5 t -131.67 76.4 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.487 -0.758 . . . . 0.0 109.071 178.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.648 ' CG2' HG12 ' A' ' 12' ' ' ILE . 33.3 pt . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 121.763 0.792 . . . . 0.0 110.861 -179.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.591 HG12 ' CD1' ' A' ' 51' ' ' ILE . 12.9 t . . . . . 0 N--CA 1.506 2.344 0 CA-C-O 121.45 0.643 . . . . 0.0 110.446 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.4 ' O ' HG12 ' A' ' 51' ' ' ILE . 9.8 m120 -124.6 166.3 16.35 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 120.785 -1.197 . . . . 0.0 111.306 -179.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.621 ' HA ' ' HA ' ' A' ' 51' ' ' ILE . 2.5 m -120.29 145.68 46.85 Favored 'General case' 0 N--CA 1.505 2.294 0 O-C-N 121.088 -1.007 . . . . 0.0 111.833 -179.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.405 ' CG2' ' HB3' ' A' ' 59' ' ' PRO . 1.0 OUTLIER -134.24 140.97 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.639 -0.663 . . . . 0.0 110.891 -179.29 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.6 ' HA ' ' HA ' ' A' ' 49' ' ' THR . 2.9 m -118.91 130.35 55.68 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.229 -0.919 . . . . 0.0 110.151 178.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.7 ' HA ' ' HA ' ' A' ' 75' ' ' ILE . 51.9 mt -122.74 133.02 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.363 -0.836 . . . . 0.0 111.553 -178.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.543 ' HB3' ' CG1' ' A' ' 74' ' ' VAL . 0.1 OUTLIER -87.75 117.2 26.42 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.071 -1.018 . . . . 0.0 108.703 178.129 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.592 HG13 ' CE ' ' A' ' 17' ' ' MET . 14.6 p -112.21 108.43 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 O-C-N 121.179 -0.951 . . . . 0.0 110.408 -178.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.506 ' HA ' ' HD2' ' A' ' 46' ' ' LYS . 0.1 OUTLIER -108.34 -32.11 7.58 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.052 -1.03 . . . . 0.0 112.008 -178.6 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -70.03 30.97 0.41 Allowed Glycine 0 N--CA 1.502 3.066 0 C-N-CA 120.423 -0.894 . . . . 0.0 112.255 -179.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.638 ' SD ' ' HA ' ' A' ' 43' ' ' LEU . 13.2 ptp -90.75 -173.21 3.64 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.474 -1.603 . . . . 0.0 109.799 178.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 16.9 p -147.22 -27.65 0.38 Allowed 'General case' 0 N--CA 1.514 2.745 0 O-C-N 121.248 -0.908 . . . . 0.0 112.283 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.428 ' C ' HD12 ' A' ' 43' ' ' LEU . 19.5 p -179.7 176.44 0.78 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.109 -0.994 . . . . 0.0 108.55 -179.048 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.603 ' HB3' ' CZ3' ' A' ' 24' ' ' TRP . 4.3 m120 -43.31 -31.69 0.68 Allowed 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.773 -0.579 . . . . 0.0 110.618 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.553 ' HA ' ' HE3' ' A' ' 24' ' ' TRP . 3.7 p -54.12 -26.29 26.68 Favored 'General case' 0 N--CA 1.506 2.339 0 O-C-N 121.06 -1.025 . . . . 0.0 110.398 178.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.533 ' HB3' ' CE1' ' A' ' 71' ' ' PHE . 80.7 m -91.49 -25.81 19.1 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.701 0.762 . . . . 0.0 108.977 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.568 HG22 ' CD1' ' A' ' 43' ' ' LEU . 12.0 t -79.47 -41.62 22.49 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 176.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.603 ' CZ3' ' HB3' ' A' ' 20' ' ' ASN . 2.1 m0 -60.79 -40.47 92.75 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 176.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 40.2 m -66.7 -31.05 71.47 Favored 'General case' 0 N--CA 1.502 2.127 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.608 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.538 ' HA ' ' SD ' ' A' ' 69' ' ' MET . 2.1 mt -99.07 -17.22 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.225 0 O-C-N 121.142 -0.974 . . . . 0.0 110.902 -179.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.676 ' HG3' HD13 ' A' ' 39' ' ' ILE . 1.1 tt0 -87.67 -31.66 19.63 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 177.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.472 ' HB3' ' O ' ' A' ' 24' ' ' TRP . 1.1 tm0? -80.41 -39.49 28.22 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 178.016 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.406 ' HB2' ' SD ' ' A' ' 69' ' ' MET . 7.2 mm100 -70.6 -60.02 2.5 Favored 'General case' 0 N--CA 1.502 2.154 0 C-N-CA 119.251 -0.98 . . . . 0.0 110.352 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.521 HG12 ' HE3' ' A' ' 69' ' ' MET . 45.4 mm -60.58 -42.38 91.37 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.113 -0.992 . . . . 0.0 110.497 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -51.73 -45.93 54.6 Favored Glycine 0 N--CA 1.5 2.961 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.4 mttt -114.98 27.53 9.34 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.331 -1.099 . . . . 0.0 111.494 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.476 HG21 ' HB1' ' A' ' 65' ' ' ALA . 12.2 p -66.46 -43.26 91.09 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 O-C-N 120.887 -1.133 . . . . 0.0 111.449 -179.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.481 ' HB3' ' HG2' ' A' ' 57' ' ' GLN . 0.7 OUTLIER -178.86 -52.13 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.109 -0.995 . . . . 0.0 110.777 179.847 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.417 ' O ' ' HA ' ' A' ' 52' ' ' TYR . . . -148.24 81.74 0.2 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -179.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.683 HG12 ' HB ' ' A' ' 39' ' ' ILE . 38.8 t -133.07 97.4 2.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.013 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.585 ' HB2' ' CD1' ' A' ' 51' ' ' ILE . 59.5 m-70 -72.1 -29.28 63.94 Favored 'General case' 0 C--N 1.289 -2.063 0 C-N-CA 120.043 -0.663 . . . . 0.0 109.818 -179.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.619 ' HB2' HG23 ' A' ' 51' ' ' ILE . 24.7 m-70 -144.57 117.23 8.66 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.683 ' HB ' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -117.79 126.02 74.52 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 179.391 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.558 ' HB3' HG21 ' A' ' 49' ' ' THR . 2.1 tmtm? -126.52 119.54 27.39 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.616 -1.303 . . . . 0.0 111.01 -179.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.511 HG21 HG21 ' A' ' 26' ' ' ILE . 47.0 t -107.29 170.77 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 178.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.679 ' HB3' ' HB2' ' A' ' 45' ' ' GLU . 0.6 OUTLIER -149.82 85.25 1.42 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.683 -1.261 . . . . 0.0 110.67 -179.51 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.638 ' HA ' ' SD ' ' A' ' 17' ' ' MET . 20.0 tp -42.53 -43.1 3.58 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.2 mp0 -82.92 -44.24 15.58 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.154 -0.966 . . . . 0.0 111.771 -178.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.679 ' HB2' ' HB3' ' A' ' 42' ' ' SER . 5.8 mt-10 -80.03 8.94 6.09 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.195 -0.941 . . . . 0.0 110.344 179.133 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.538 ' HD3' ' SD ' ' A' ' 17' ' ' MET . 8.1 mmtp 37.15 59.47 1.11 Allowed 'General case' 0 N--CA 1.504 2.253 0 CA-C-O 121.528 0.68 . . . . 0.0 110.967 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.402 ' HA ' ' H ' ' A' ' 14' ' ' VAL . 12.5 t-20 -159.08 149.08 19.14 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.031 -1.043 . . . . 0.0 111.202 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.477 ' HA ' ' O ' ' A' ' 40' ' ' LYS . . . -139.41 122.31 16.62 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.4 -0.813 . . . . 0.0 110.745 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.6 ' HA ' ' HA ' ' A' ' 11' ' ' THR . 6.9 t -113.59 151.93 31.01 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.302 -0.874 . . . . 0.0 109.539 178.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.566 HG13 HG23 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -160.13 157.23 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.026 -1.046 . . . . 0.0 111.954 -177.932 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.621 ' HA ' ' HA ' ' A' ' 9' ' ' SER . 0.0 OUTLIER -109.89 152.85 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.587 -0.696 . . . . 0.0 109.27 178.378 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.556 ' CD1' ' N ' ' A' ' 52' ' ' TYR . 33.9 p90 -158.04 160.16 37.11 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.899 -0.72 . . . . 0.0 111.874 -177.056 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -86.61 120.32 71.86 Favored Pre-proline 0 N--CA 1.492 1.669 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 177.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -59.23 -29.68 91.0 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 O-C-N 123.633 1.333 . . . . 0.0 109.73 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.38 -19.18 65.38 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.855 -0.528 . . . . 0.0 110.681 178.174 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -124.65 -36.82 2.55 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.096 -1.003 . . . . 0.0 111.441 -179.173 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.528 ' C ' HG22 ' A' ' 58' ' ' THR . 3.4 mm-40 -130.15 155.05 46.85 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.054 -1.029 . . . . 0.0 110.399 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.603 ' HB ' ' HD2' ' A' ' 59' ' ' PRO . 4.7 p -136.61 172.97 6.09 Favored Pre-proline 0 N--CA 1.5 2.074 0 O-C-N 121.004 -1.06 . . . . 0.0 109.807 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.603 ' HD2' ' HB ' ' A' ' 58' ' ' THR . 42.9 Cg_endo -68.45 -14.36 39.73 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 O-C-N 123.326 1.171 . . . . 0.0 110.896 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.8 -38.37 13.03 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.322 -0.861 . . . . 0.0 109.352 179.042 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.556 ' HA ' ' HB2' ' A' ' 64' ' ' GLU . 0.3 OUTLIER -73.14 -27.01 61.43 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.237 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.445 ' CD2' HD12 ' A' ' 50' ' ' ILE . 16.3 mt -72.18 -28.39 63.18 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 176.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -83.43 -32.24 26.19 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 177.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.556 ' HB2' ' HA ' ' A' ' 61' ' ' THR . 0.1 OUTLIER -71.58 -20.08 62.05 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 177.402 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.476 ' HB1' HG21 ' A' ' 33' ' ' VAL . . . -90.02 -25.18 20.97 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 177.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.504 HG13 HD12 ' A' ' 12' ' ' ILE . 0.4 OUTLIER -88.62 -39.49 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 178.042 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -68.87 -29.62 67.96 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 177.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.45 -44.01 59.05 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.552 -0.717 . . . . 0.0 109.881 178.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.538 ' SD ' ' HA ' ' A' ' 26' ' ' ILE . 28.7 mtm -51.69 -49.82 61.66 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.455 -0.778 . . . . 0.0 110.52 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 111.47 55.24 0.5 Allowed Glycine 0 N--CA 1.498 2.797 0 C-N-CA 119.542 -1.313 . . . . 0.0 110.096 179.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.533 ' CE1' ' HB3' ' A' ' 22' ' ' CYS . 25.4 m-85 -135.89 124.37 23.51 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.637 -0.92 . . . . 0.0 109.357 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -56.62 92.98 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.513 -0.742 . . . . 0.0 109.513 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.469 ' HA ' ' O ' ' A' ' 13' ' ' SER . . . -120.56 178.27 4.74 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 122.188 0.994 . . . . 0.0 112.13 -178.143 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.543 ' CG1' ' HB3' ' A' ' 13' ' ' SER . 3.6 p -159.26 91.68 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 179.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.7 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . 25.1 pt . . . . . 0 C--N 1.302 -1.462 0 CA-C-O 122.362 1.077 . . . . 0.0 111.772 -178.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.467 HG13 HD11 ' A' ' 51' ' ' ILE . 4.8 t . . . . . 0 N--CA 1.499 2.002 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.578 ' HB3' ' CZ ' ' A' ' 52' ' ' TYR . 0.9 OUTLIER -116.35 163.92 15.31 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.89 -1.131 . . . . 0.0 110.392 179.816 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.636 ' HA ' ' HA ' ' A' ' 51' ' ' ILE . 47.5 p -129.37 143.5 50.87 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.237 -0.915 . . . . 0.0 111.247 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.464 ' CG2' ' HB3' ' A' ' 59' ' ' PRO . 0.9 OUTLIER -142.26 142.26 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 CA-C-O 121.674 0.75 . . . . 0.0 110.806 -179.553 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.545 ' HA ' ' HA ' ' A' ' 49' ' ' THR . 20.7 m -106.47 145.99 31.11 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.892 ' HA ' HG12 ' A' ' 75' ' ' ILE . 23.3 mm -126.42 116.13 44.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -177.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.539 ' H ' ' CG2' ' A' ' 75' ' ' ILE . 1.4 t -82.91 111.25 18.62 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 176.089 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.525 HG23 ' HB3' ' A' ' 71' ' ' PHE . 9.8 p -108.91 135.06 48.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 O-C-N 121.538 -0.726 . . . . 0.0 112.325 -176.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -116.57 174.3 6.15 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.455 -0.778 . . . . 0.0 110.348 179.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 81.91 -7.73 62.02 Favored Glycine 0 N--CA 1.499 2.889 0 C-N-CA 120.483 -0.865 . . . . 0.0 111.164 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.674 ' HB3' HD12 ' A' ' 43' ' ' LEU . 12.4 mtm -82.46 112.09 19.08 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.76 -1.436 . . . . 0.0 111.041 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.4 t -139.56 25.14 2.42 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.07 -1.019 . . . . 0.0 111.984 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.456 ' O ' ' N ' ' A' ' 21' ' ' SER . 0.4 OUTLIER -170.07 139.33 1.81 Allowed 'General case' 0 N--CA 1.5 2.073 0 O-C-N 120.991 -1.068 . . . . 0.0 109.075 178.978 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.528 ' HA ' ' CD2' ' A' ' 43' ' ' LEU . 22.6 m120 -23.09 -45.44 0.01 OUTLIER 'General case' 0 N--CA 1.518 2.958 0 CA-C-O 121.453 0.644 . . . . 0.0 112.585 -178.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.815 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 1.5 p -56.46 -14.13 2.81 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.705 ' HB2' HD13 ' A' ' 43' ' ' LEU . 71.8 m -92.91 -26.83 17.43 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 119.808 -1.808 . . . . 0.0 111.678 -178.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.632 ' HB ' ' HB2' ' A' ' 43' ' ' LEU . 7.9 p -88.92 -34.73 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.119 -0.988 . . . . 0.0 108.706 178.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.815 ' CE3' ' HA ' ' A' ' 21' ' ' SER . 0.0 OUTLIER -79.98 -23.59 41.49 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 117.634 -1.626 . . . . 0.0 108.964 178.495 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.591 ' HB ' ' CZ3' ' A' ' 24' ' ' TRP . 1.7 t -84.46 -27.41 27.51 Favored 'General case' 0 N--CA 1.506 2.346 0 O-C-N 120.679 -1.263 . . . . 0.0 110.352 178.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.495 ' CD1' ' CD2' ' A' ' 71' ' ' PHE . 17.8 mm -89.48 -29.91 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 O-C-N 121.142 -0.973 . . . . 0.0 109.532 179.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.705 ' HG3' HG23 ' A' ' 39' ' ' ILE . 9.8 tt0 -81.31 -32.66 33.02 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 178.287 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.537 ' HB2' ' O ' ' A' ' 24' ' ' TRP . 0.9 OUTLIER -80.45 -26.5 38.29 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.281 177.872 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.418 ' O ' ' HB ' ' A' ' 33' ' ' VAL . 4.1 tp60 -71.43 -65.44 0.75 Allowed 'General case' 0 N--CA 1.497 1.92 0 C-N-CA 119.238 -0.985 . . . . 0.0 108.824 179.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.588 HG23 HG12 ' A' ' 50' ' ' ILE . 18.2 mm -59.51 -52.02 65.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.237 -0.915 . . . . 0.0 110.258 179.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -49.18 -39.75 27.94 Favored Glycine 0 N--CA 1.502 3.061 0 N-CA-C 110.404 -1.079 . . . . 0.0 110.404 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.15 26.39 10.51 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.232 -1.158 . . . . 0.0 111.047 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.502 HG12 ' OD1' ' A' ' 34' ' ' ASN . 11.1 p -74.36 -46.81 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 120.455 -1.403 . . . . 0.0 111.331 -179.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.502 ' OD1' HG12 ' A' ' 33' ' ' VAL . 1.0 OUTLIER -173.46 -32.14 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.33 0 O-C-N 120.907 -1.12 . . . . 0.0 111.633 179.259 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.507 ' O ' ' HA ' ' A' ' 52' ' ' TYR . . . -168.97 85.37 0.09 OUTLIER Glycine 0 N--CA 1.496 2.695 0 C-N-CA 119.873 -1.156 . . . . 0.0 110.509 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.755 HG12 ' CD1' ' A' ' 39' ' ' ILE . 42.8 t -130.38 90.34 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 CA-C-O 122.512 1.148 . . . . 0.0 109.307 178.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.562 ' HB2' HD13 ' A' ' 51' ' ' ILE . 42.1 m-70 -65.88 -13.46 59.68 Favored 'General case' 0 C--N 1.286 -2.153 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.926 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.743 ' HB3' HG12 ' A' ' 51' ' ' ILE . 0.2 OUTLIER -152.22 128.52 10.56 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 120.759 -1.213 . . . . 0.0 110.381 179.385 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.755 ' CD1' HG12 ' A' ' 36' ' ' VAL 0.293 2.0 mm -121.19 139.26 48.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.857 -177.906 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.687 ' HB3' HG23 ' A' ' 49' ' ' THR . 0.0 OUTLIER -142.1 83.17 1.83 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.556 -1.34 . . . . 0.0 109.685 176.621 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.505 HG21 ' HB2' ' A' ' 48' ' ' ALA . 17.2 t -107.33 155.94 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.068 -1.02 . . . . 0.0 109.272 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.729 ' HB2' ' HB3' ' A' ' 45' ' ' GLU . 41.5 m -152.33 91.07 1.55 Allowed 'General case' 0 C--N 1.308 -1.21 0 O-C-N 121.112 -0.992 . . . . 0.0 110.1 -178.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.705 HD13 ' HB2' ' A' ' 22' ' ' CYS . 6.9 tp -30.77 -53.38 0.19 Allowed 'General case' 0 N--CA 1.508 2.474 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -179.285 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.566 ' HA ' ' NZ ' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -78.5 -37.13 43.96 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.687 -1.258 . . . . 0.0 112.241 -178.81 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.729 ' HB3' ' HB2' ' A' ' 42' ' ' SER . 27.5 tt0 -59.48 -15.37 17.16 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 119.617 -0.833 . . . . 0.0 109.274 177.35 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.566 ' NZ ' ' HA ' ' A' ' 44' ' ' GLU . 0.1 OUTLIER 53.71 52.83 12.4 Favored 'General case' 0 N--CA 1.503 2.209 0 CA-C-O 121.816 0.817 . . . . 0.0 109.812 -179.813 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.465 ' ND2' ' HA ' ' A' ' 13' ' ' SER . 0.2 OUTLIER -170.75 159.37 6.44 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.579 -0.701 . . . . 0.0 109.716 179.905 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.505 ' HB2' HG21 ' A' ' 41' ' ' VAL . . . -150.7 116.85 5.63 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.302 -0.874 . . . . 0.0 109.492 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.687 HG23 ' HB3' ' A' ' 40' ' ' LYS . 4.8 t -110.13 127.38 54.86 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 120.843 -1.161 . . . . 0.0 109.069 179.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.622 ' HB ' HD13 ' A' ' 39' ' ' ILE . 1.8 pp -140.5 164.04 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.43 -0.793 . . . . 0.0 110.567 -177.155 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.743 HG12 ' HB3' ' A' ' 38' ' ' HIS . 1.5 pp -113.61 172.54 3.4 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 O-C-N 120.936 -1.103 . . . . 0.0 109.734 178.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.578 ' CZ ' ' HB3' ' A' ' 8' ' ' ASN . 11.0 p90 -163.3 167.36 21.98 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.343 -0.848 . . . . 0.0 110.963 -178.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -88.17 121.74 70.28 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.456 -0.778 . . . . 0.0 110.458 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -64.92 -29.58 57.87 Favored 'Trans proline' 0 N--CA 1.488 1.185 0 O-C-N 123.804 1.423 . . . . 0.0 108.784 178.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.1 ptpp? -77.62 -6.48 53.94 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.854 -0.529 . . . . 0.0 110.627 178.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.445 HD21 ' HG2' ' A' ' 57' ' ' GLN . 1.6 tt -117.13 -46.97 2.69 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.089 -1.007 . . . . 0.0 111.16 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.445 ' HG2' HD21 ' A' ' 56' ' ' LEU . 21.1 mm-40 -148.87 -174.05 4.52 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.077 -1.014 . . . . 0.0 110.951 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.581 ' HB ' ' HD2' ' A' ' 59' ' ' PRO . 1.1 p -144.07 176.82 2.05 Favored Pre-proline 0 N--CA 1.499 1.98 0 O-C-N 121.086 -1.009 . . . . 0.0 109.715 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.581 ' HD2' ' HB ' ' A' ' 58' ' ' THR . 40.6 Cg_endo -68.29 -7.04 18.93 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 O-C-N 123.529 1.279 . . . . 0.0 110.791 178.362 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.86 -38.16 58.24 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.092 -1.005 . . . . 0.0 109.333 178.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.664 ' HA ' ' HB2' ' A' ' 64' ' ' GLU . 0.2 OUTLIER -90.74 -19.66 23.27 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 177.832 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.555 ' HB2' ' HA ' ' A' ' 59' ' ' PRO . 0.1 OUTLIER -71.17 -34.02 70.54 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 176.831 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -81.51 -30.82 33.11 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 176.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.664 ' HB2' ' HA ' ' A' ' 61' ' ' THR . 3.2 mt-10 -73.98 -17.98 60.93 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 176.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.464 ' HB2' HG21 ' A' ' 33' ' ' VAL . . . -86.94 -24.71 24.67 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 106.835 -1.542 . . . . 0.0 106.835 176.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.578 HG13 HG21 ' A' ' 12' ' ' ILE . 0.8 OUTLIER -86.57 -41.94 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 177.519 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.82 -31.83 72.91 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 177.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -75.19 -38.73 60.68 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.51 -0.744 . . . . 0.0 109.701 178.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.591 ' SD ' HG21 ' A' ' 25' ' ' THR . 0.0 OUTLIER -53.81 -46.61 71.17 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.54 -0.725 . . . . 0.0 111.396 179.86 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 119.0 35.06 0.98 Allowed Glycine 0 N--CA 1.501 3.028 0 C-N-CA 120.143 -1.027 . . . . 0.0 110.828 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.525 ' HB3' HG23 ' A' ' 14' ' ' VAL . 96.8 m-85 -140.5 136.61 33.11 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.284 -1.127 . . . . 0.0 109.62 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.04 135.02 56.3 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.359 -0.838 . . . . 0.0 111.233 -179.282 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.575 ' HB2' HG23 ' A' ' 66' ' ' ILE . . . -122.45 140.63 52.51 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.367 -0.833 . . . . 0.0 111.748 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.76 ' C ' HG13 ' A' ' 75' ' ' ILE . 4.4 t -155.7 99.02 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 178.329 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.892 HG12 ' HA ' ' A' ' 12' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.629 0 C-N-CA 118.567 -1.253 . . . . 0.0 113.742 -174.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.3 m . . . . . 0 N--CA 1.501 2.096 0 CA-C-O 121.152 0.501 . . . . 0.0 110.165 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.717 ' HB3' ' CZ ' ' A' ' 52' ' ' TYR . 1.9 t30 -129.79 161.8 29.91 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.276 -0.89 . . . . 0.0 110.368 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.572 ' HA ' ' HA ' ' A' ' 51' ' ' ILE . 0.3 OUTLIER -119.99 128.7 53.8 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.382 -0.824 . . . . 0.0 109.351 179.069 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.581 HG21 ' HB3' ' A' ' 59' ' ' PRO . 1.0 OUTLIER -121.14 133.75 66.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.384 -0.822 . . . . 0.0 112.061 -178.222 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.534 ' HA ' ' HA ' ' A' ' 49' ' ' THR . 19.0 m -114.68 121.27 42.86 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.797 ' HA ' ' HA ' ' A' ' 75' ' ' ILE . 13.1 tt -118.43 132.35 68.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 CA-C-O 121.831 0.824 . . . . 0.0 111.348 -179.072 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.548 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 49.1 m -77.17 121.75 24.05 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 178.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.641 ' HA ' ' O ' ' A' ' 72' ' ' ASP . 0.2 OUTLIER -126.43 121.49 58.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.271 -0.893 . . . . 0.0 111.65 -178.055 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.483 ' CD ' ' HG2' ' A' ' 46' ' ' LYS . 10.2 tp10 -109.49 158.07 18.34 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.457 -0.777 . . . . 0.0 110.559 179.458 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.51 10.09 59.56 Favored Glycine 0 N--CA 1.498 2.778 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 179.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.585 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 20.4 mmt -45.31 -41.47 8.77 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.026 -1.279 . . . . 0.0 110.46 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 40.1 m 61.51 -48.5 0.14 Allowed 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.841 -0.537 . . . . 0.0 112.249 178.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.425 ' N ' ' O ' ' A' ' 17' ' ' MET . 14.0 p -170.42 152.14 3.92 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.11 -0.994 . . . . 0.0 111.163 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.545 ' HB2' ' CZ3' ' A' ' 24' ' ' TRP . 3.2 p30 -29.28 -40.97 0.02 OUTLIER 'General case' 0 N--CA 1.511 2.589 0 C-N-CA 123.103 0.561 . . . . 0.0 112.431 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.551 ' HA ' ' HE3' ' A' ' 24' ' ' TRP . 4.2 p -48.28 -23.91 1.03 Allowed 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.257 -0.902 . . . . 0.0 111.374 179.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.698 ' HB3' ' CE1' ' A' ' 71' ' ' PHE . 68.9 m -89.59 -21.11 23.0 Favored 'General case' 0 N--CA 1.503 2.175 0 O-C-N 121.124 -0.985 . . . . 0.0 109.78 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.552 HG23 ' HB2' ' A' ' 43' ' ' LEU . 1.0 OUTLIER -85.74 -38.29 12.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 176.096 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.551 ' HE3' ' HA ' ' A' ' 21' ' ' SER . 4.2 m0 -64.0 -32.57 74.16 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 119.098 -1.041 . . . . 0.0 108.844 177.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.467 ' O ' ' HB2' ' A' ' 29' ' ' GLN . 0.6 OUTLIER -83.84 -24.68 30.83 Favored 'General case' 0 N--CA 1.505 2.28 0 C-N-CA 119.812 -0.755 . . . . 0.0 111.345 179.868 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.501 HG23 HG21 ' A' ' 41' ' ' VAL . 11.8 mm -91.88 -33.35 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 O-C-N 121.122 -0.986 . . . . 0.0 110.075 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.602 ' HG2' ' CG2' ' A' ' 41' ' ' VAL . 15.3 mt-10 -78.18 -34.78 49.38 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 178.153 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.481 ' HB2' ' O ' ' A' ' 24' ' ' TRP . 0.7 OUTLIER -72.96 -30.36 63.78 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 176.918 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.549 ' HG3' ' HG2' ' A' ' 69' ' ' MET . 3.1 mm100 -77.49 -61.29 2.04 Favored 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 119.064 -1.054 . . . . 0.0 109.942 178.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.553 ' HA ' ' HB ' ' A' ' 33' ' ' VAL . 22.1 mm -59.06 -42.81 87.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.027 -1.046 . . . . 0.0 110.116 179.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.436 ' CA ' HG22 ' A' ' 39' ' ' ILE . . . -49.44 -53.35 20.69 Favored Glycine 0 N--CA 1.502 3.038 0 N-CA-C 110.014 -1.235 . . . . 0.0 110.014 179.203 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.413 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 11.0 pttm -104.05 24.79 10.84 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.257 -1.143 . . . . 0.0 110.898 179.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.553 ' HB ' ' HA ' ' A' ' 30' ' ' ILE . 9.9 p -64.42 -44.54 97.09 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 O-C-N 120.749 -1.219 . . . . 0.0 111.959 -178.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.401 ' N ' ' CG1' ' A' ' 33' ' ' VAL . 0.4 OUTLIER -179.58 -53.62 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.18 -0.95 . . . . 0.0 110.387 -179.37 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.532 ' O ' ' HA ' ' A' ' 52' ' ' TYR . . . -149.39 81.45 0.19 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.156 -1.578 . . . . 0.0 109.156 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.564 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 35.2 t -132.16 96.66 2.49 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-O 122.233 1.016 . . . . 0.0 108.81 179.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.416 ' HB2' HD12 ' A' ' 51' ' ' ILE . 58.2 m-70 -66.36 -12.4 56.61 Favored 'General case' 0 N--CA 1.505 2.294 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.647 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.632 ' HB3' HG21 ' A' ' 51' ' ' ILE . 6.4 t60 -170.4 122.88 0.66 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.412 -0.805 . . . . 0.0 109.242 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.519 HD13 ' CA ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -118.87 140.12 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.471 -0.768 . . . . 0.0 108.943 179.908 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.501 ' HB3' HG21 ' A' ' 49' ' ' THR . 1.2 ttpp -141.14 115.52 9.43 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.853 -1.154 . . . . 0.0 110.703 -179.194 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.602 ' CG2' ' HG2' ' A' ' 27' ' ' GLU . 90.8 t -108.05 161.19 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 CA-C-O 121.55 0.691 . . . . 0.0 110.769 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.672 ' HB3' ' HB3' ' A' ' 45' ' ' GLU . 0.1 OUTLIER -130.17 76.26 1.71 Allowed 'General case' 0 N--CA 1.485 1.278 0 O-C-N 121.368 -0.833 . . . . 0.0 110.517 -178.753 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.552 ' HB2' HG23 ' A' ' 23' ' ' VAL . 11.1 tp -34.43 -55.93 0.52 Allowed 'General case' 0 N--CA 1.503 2.18 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.481 ' O ' ' HD3' ' A' ' 46' ' ' LYS . 5.7 mp0 -85.12 -30.96 23.59 Favored 'General case' 0 N--CA 1.504 2.23 0 O-C-N 120.807 -1.183 . . . . 0.0 112.026 -178.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.672 ' HB3' ' HB3' ' A' ' 42' ' ' SER . 1.1 tt0 -76.31 -3.22 35.54 Favored 'General case' 0 C--N 1.296 -1.749 0 O-C-N 121.231 -0.918 . . . . 0.0 109.881 178.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.483 ' HG2' ' CD ' ' A' ' 15' ' ' GLU . 0.0 OUTLIER 52.5 52.73 13.54 Favored 'General case' 0 N--CA 1.504 2.263 0 O-C-N 121.275 -0.891 . . . . 0.0 111.587 179.428 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -158.84 148.71 19.29 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.81 -1.181 . . . . 0.0 110.936 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.527 ' HA ' ' HA ' ' A' ' 41' ' ' VAL . . . -132.05 127.87 37.06 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.607 -0.683 . . . . 0.0 109.536 179.12 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.534 ' HA ' ' HA ' ' A' ' 11' ' ' THR . 6.8 t -127.22 120.82 29.62 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.322 -0.861 . . . . 0.0 109.44 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.496 HG23 HG12 ' A' ' 39' ' ' ILE . 1.3 pp -136.48 167.2 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 121.185 -0.947 . . . . 0.0 111.094 -178.082 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.632 HG21 ' HB3' ' A' ' 38' ' ' HIS . 0.0 OUTLIER -109.47 153.05 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.367 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.717 ' CZ ' ' HB3' ' A' ' 8' ' ' ASN . 13.0 p90 -163.07 170.25 18.23 Favored 'General case' 0 C--N 1.296 -1.76 0 O-C-N 121.455 -0.778 . . . . 0.0 110.531 -178.191 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.581 ' HB3' ' HB3' ' A' ' 56' ' ' LEU . 5.7 t0 -82.17 117.77 69.57 Favored Pre-proline 0 C--N 1.293 -1.853 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 177.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.505 ' HD3' ' HB2' ' A' ' 8' ' ' ASN . 38.0 Cg_endo -64.07 -22.0 67.92 Favored 'Trans proline' 0 N--CA 1.491 1.36 0 O-C-N 123.428 1.225 . . . . 0.0 109.572 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.3 ptpp? -84.62 -22.13 30.07 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.973 -0.454 . . . . 0.0 109.812 178.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.581 ' HB3' ' HB3' ' A' ' 53' ' ' ASP . 0.6 OUTLIER -107.81 -39.4 5.58 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.027 -1.046 . . . . 0.0 110.353 179.195 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 14.0 mm-40 -128.34 161.14 30.12 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.251 -0.906 . . . . 0.0 110.829 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.586 ' HB ' ' HD2' ' A' ' 59' ' ' PRO . 15.6 p -145.54 170.53 7.86 Favored Pre-proline 0 N--CA 1.503 2.211 0 O-C-N 121.324 -0.86 . . . . 0.0 110.326 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.586 ' HD2' ' HB ' ' A' ' 58' ' ' THR . 38.1 Cg_endo -64.0 -12.44 32.17 Favored 'Trans proline' 0 N--CA 1.49 1.296 0 O-C-N 123.289 1.152 . . . . 0.0 110.192 178.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.5 ' O ' ' HB3' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -88.3 -29.53 20.29 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.294 -0.879 . . . . 0.0 109.012 178.279 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.49 ' HA ' ' CD ' ' A' ' 64' ' ' GLU . 40.1 p -90.92 -24.78 20.07 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 177.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.411 HD21 ' CD1' ' A' ' 50' ' ' ILE . 34.1 mt -76.84 -29.29 55.83 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 177.203 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.523 ' HB2' ' CG2' ' A' ' 75' ' ' ILE . 12.3 tt0 -79.87 -30.15 40.18 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 177.379 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.5 ' HB3' ' O ' ' A' ' 60' ' ' LYS . 0.3 OUTLIER -78.53 -22.3 47.52 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.214 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -80.24 -27.26 38.75 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 176.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.501 ' CG2' ' HB2' ' A' ' 73' ' ' ALA . 8.7 mm -83.2 -36.06 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 176.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.435 ' HB2' ' HA ' ' A' ' 64' ' ' GLU . 61.8 m-20 -72.38 -32.21 66.22 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 177.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.403 ' HB2' ' O ' ' A' ' 64' ' ' GLU . 31.3 t70 -68.15 -36.68 80.05 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 177.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.549 ' HG2' ' HG3' ' A' ' 29' ' ' GLN . 0.0 OUTLIER -64.86 -47.58 77.4 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.477 -0.765 . . . . 0.0 109.942 178.513 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 119.75 47.87 0.35 Allowed Glycine 0 N--CA 1.502 3.075 0 C-N-CA 120.196 -1.002 . . . . 0.0 111.335 178.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.698 ' CE1' ' HB3' ' A' ' 22' ' ' CYS . 78.2 m-85 -137.4 143.38 41.88 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.229 -1.159 . . . . 0.0 109.563 179.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.641 ' O ' ' HA ' ' A' ' 14' ' ' VAL . 23.4 m-20 -55.1 110.74 0.72 Allowed 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.042 -1.036 . . . . 0.0 109.33 179.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.501 ' HB2' ' CG2' ' A' ' 66' ' ' ILE . . . -109.77 127.37 54.59 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.163 -0.961 . . . . 0.0 112.067 -178.109 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.548 ' HB ' ' HB2' ' A' ' 13' ' ' SER . 77.1 t -137.38 80.69 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 178.193 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.797 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . 40.8 pt . . . . . 0 C--N 1.308 -1.224 0 CA-C-O 122.373 1.083 . . . . 0.0 111.849 -178.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.539 ' CG1' HD13 ' A' ' 51' ' ' ILE . 44.4 t . . . . . 0 N--CA 1.503 2.202 0 CA-C-O 120.978 0.418 . . . . 0.0 110.584 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.576 ' HB3' ' CZ ' ' A' ' 52' ' ' TYR . 0.8 OUTLIER -106.57 178.58 4.52 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.213 -0.93 . . . . 0.0 111.256 -179.303 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.669 ' HA ' ' HA ' ' A' ' 51' ' ' ILE . 9.4 t -141.96 131.89 24.45 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.307 -0.871 . . . . 0.0 111.371 179.352 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.586 ' CG2' ' HB3' ' A' ' 59' ' ' PRO . 0.9 OUTLIER -142.81 147.93 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 CA-C-O 121.944 0.878 . . . . 0.0 111.534 -179.137 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.6 ' HA ' ' HA ' ' A' ' 49' ' ' THR . 21.3 m -109.83 154.01 23.6 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.253 -0.904 . . . . 0.0 109.781 179.037 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.861 ' CA ' HG21 ' A' ' 75' ' ' ILE . 86.0 mt -134.16 110.92 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 122.251 -0.28 . . . . 0.0 111.744 -179.111 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.522 ' N ' HG12 ' A' ' 75' ' ' ILE . 7.2 p -83.05 121.3 26.85 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 119.746 -1.847 . . . . 0.0 107.095 177.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.12 126.15 73.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 O-C-N 121.187 -0.945 . . . . 0.0 110.214 -177.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.23 173.79 6.16 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.508 -0.745 . . . . 0.0 110.317 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.461 ' O ' ' C ' ' A' ' 17' ' ' MET . . . 88.48 -29.79 5.57 Favored Glycine 0 N--CA 1.499 2.853 0 C-N-CA 120.005 -1.093 . . . . 0.0 110.567 -179.201 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.659 ' HB3' ' HB2' ' A' ' 43' ' ' LEU . 28.2 mmm -28.13 97.49 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.657 0 CA-C-N 118.001 0.901 . . . . 0.0 111.403 -179.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.47 ' OG1' ' SG ' ' A' ' 22' ' ' CYS . 66.6 p -73.82 -28.91 61.86 Favored 'General case' 0 N--CA 1.512 2.641 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -177.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.483 ' CA ' HD11 ' A' ' 43' ' ' LEU . 14.8 p 178.76 173.81 0.7 Allowed 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.251 -0.905 . . . . 0.0 110.192 -178.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.636 ' HA ' ' CD2' ' A' ' 43' ' ' LEU . 7.7 m120 -38.34 -36.65 0.24 Allowed 'General case' 0 N--CA 1.507 2.397 0 CA-C-O 121.062 0.458 . . . . 0.0 110.926 179.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.6 ' HA ' ' HE3' ' A' ' 24' ' ' TRP . 5.9 p -52.46 -23.98 7.1 Favored 'General case' 0 N--CA 1.507 2.38 0 CA-C-O 121.883 0.849 . . . . 0.0 110.931 178.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.515 ' HB3' ' HE1' ' A' ' 17' ' ' MET . 74.0 m -88.2 -26.72 22.24 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.238 -0.914 . . . . 0.0 109.381 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.454 ' HB ' ' CD2' ' A' ' 43' ' ' LEU . 0.5 OUTLIER -79.41 -39.07 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 N-CA-C 105.955 -1.869 . . . . 0.0 105.955 176.339 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.6 ' HE3' ' HA ' ' A' ' 21' ' ' SER . 1.8 m0 -62.57 -32.25 73.2 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 118.82 -1.152 . . . . 0.0 108.033 176.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.473 ' CG2' ' SD ' ' A' ' 69' ' ' MET . 95.7 m -79.95 -32.43 39.95 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.787 -0.571 . . . . 0.0 112.304 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.513 HG23 HG22 ' A' ' 41' ' ' VAL . 18.9 mm -99.77 -22.47 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.242 0 O-C-N 120.785 -1.197 . . . . 0.0 111.297 -178.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.747 ' HG3' ' CD1' ' A' ' 39' ' ' ILE . 4.5 tt0 -85.78 -32.68 21.69 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 177.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.553 ' HB3' ' O ' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -80.27 -34.98 36.57 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 119.511 -0.876 . . . . 0.0 109.446 177.662 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.532 ' HB2' ' HE1' ' A' ' 69' ' ' MET . 5.5 tp60 -67.9 -62.96 1.16 Allowed 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 119.358 -0.937 . . . . 0.0 110.103 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.539 HG22 ' CG1' ' A' ' 39' ' ' ILE . 16.6 mm -58.87 -41.33 82.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.314 -0.866 . . . . 0.0 110.656 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.442 ' HA2' ' CG2' ' A' ' 39' ' ' ILE . . . -55.71 -38.23 71.75 Favored Glycine 0 N--CA 1.498 2.807 0 O-C-N 121.368 -0.833 . . . . 0.0 111.223 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.73 26.55 7.12 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.973 -1.31 . . . . 0.0 111.806 -179.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.448 ' HB ' ' O ' ' A' ' 29' ' ' GLN . 15.0 p -71.26 -41.23 74.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 120.778 -1.201 . . . . 0.0 111.214 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 16.6 t30 -162.22 -66.77 0.05 Allowed 'General case' 0 N--CA 1.501 2.084 0 O-C-N 120.643 -1.285 . . . . 0.0 111.471 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.464 ' O ' ' HA ' ' A' ' 52' ' ' TYR . . . -145.18 78.37 0.25 Allowed Glycine 0 N--CA 1.493 2.459 0 N-CA-C 108.804 -1.718 . . . . 0.0 108.804 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.648 HG11 HG13 ' A' ' 50' ' ' ILE . 20.8 t -126.2 89.68 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 CA-C-O 122.429 1.109 . . . . 0.0 108.583 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.666 ' HB2' ' CD1' ' A' ' 51' ' ' ILE . 41.7 m-70 -60.94 -28.8 69.23 Favored 'General case' 0 C--N 1.286 -2.192 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.983 -179.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.6 ' HB2' HG12 ' A' ' 51' ' ' ILE . 37.3 m-70 -141.89 125.63 16.97 Favored 'General case' 0 N--CA 1.506 2.331 0 O-C-N 121.038 -1.039 . . . . 0.0 109.637 178.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.747 ' CD1' ' HG3' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -133.96 140.19 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.187 -0.946 . . . . 0.0 109.408 -179.973 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.494 ' NZ ' ' O ' ' A' ' 41' ' ' VAL . 0.1 OUTLIER -146.0 121.34 10.26 Favored 'General case' 0 N--CA 1.507 2.39 0 O-C-N 120.537 -1.352 . . . . 0.0 111.084 178.947 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.513 HG22 HG23 ' A' ' 26' ' ' ILE . 82.0 t -112.6 161.63 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 CA-C-O 121.679 0.752 . . . . 0.0 110.976 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.7 m -142.67 77.26 1.57 Allowed 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.659 ' HB2' ' HB3' ' A' ' 17' ' ' MET . 0.5 OUTLIER -54.67 -30.34 55.14 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.493 -0.755 . . . . 0.0 111.636 -178.717 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.537 ' N ' ' HG ' ' A' ' 43' ' ' LEU . 15.1 mp0 -74.51 -50.0 19.88 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.959 -1.088 . . . . 0.0 109.597 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -79.52 5.99 11.55 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 177.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.473 ' HD3' ' CG ' ' A' ' 17' ' ' MET . 35.0 mmtp 46.53 64.96 1.32 Allowed 'General case' 0 N--CA 1.501 2.081 0 CA-C-O 121.5 0.667 . . . . 0.0 110.476 -179.352 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -165.55 174.33 10.01 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.019 -1.051 . . . . 0.0 110.439 -179.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -168.25 150.01 5.18 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.445 -0.785 . . . . 0.0 110.481 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.6 ' HA ' ' HA ' ' A' ' 11' ' ' THR . 0.4 OUTLIER -138.02 147.28 44.02 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.328 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.648 HG13 HG11 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -165.09 151.7 2.19 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 120.777 -1.202 . . . . 0.0 111.397 -178.083 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.669 ' HA ' ' HA ' ' A' ' 9' ' ' SER . 2.3 pp -108.04 163.62 5.59 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 O-C-N 121.194 -0.941 . . . . 0.0 109.083 178.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.579 ' CD1' ' N ' ' A' ' 52' ' ' TYR . 13.2 p90 -162.31 158.87 24.78 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.089 -1.045 . . . . 0.0 112.033 -176.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.652 ' HB3' ' HB2' ' A' ' 56' ' ' LEU . 18.5 t0 -75.42 111.12 12.52 Favored Pre-proline 0 N--CA 1.498 1.932 0 O-C-N 121.645 -0.66 . . . . 0.0 110.101 179.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.534 ' HD3' ' HB2' ' A' ' 8' ' ' ASN . 40.5 Cg_endo -66.56 -37.17 23.14 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 O-C-N 123.731 1.385 . . . . 0.0 109.766 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.13 -19.01 64.78 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.599 -0.688 . . . . 0.0 109.654 178.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.652 ' HB2' ' HB3' ' A' ' 53' ' ' ASP . 0.4 OUTLIER -96.49 -48.19 5.65 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.388 -0.82 . . . . 0.0 109.438 178.92 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.409 ' OE1' ' HA ' ' A' ' 57' ' ' GLN . 5.7 mm100 -153.56 -170.29 3.55 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.531 -0.731 . . . . 0.0 110.431 179.151 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.681 ' HB ' ' HD2' ' A' ' 59' ' ' PRO . 1.5 p -132.33 -176.3 0.55 Allowed Pre-proline 0 N--CA 1.502 2.131 0 O-C-N 120.861 -1.15 . . . . 0.0 110.109 -179.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.681 ' HD2' ' HB ' ' A' ' 58' ' ' THR . 38.8 Cg_endo -68.83 -0.6 6.37 Favored 'Trans proline' 0 N--CA 1.488 1.201 0 O-C-N 123.308 1.162 . . . . 0.0 110.809 178.219 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.52 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 0.1 OUTLIER -77.8 -31.65 51.92 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 177.659 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.695 ' HA ' ' HB2' ' A' ' 64' ' ' GLU . 0.8 OUTLIER -77.88 -23.2 48.86 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 177.577 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.458 HD21 ' CD1' ' A' ' 50' ' ' ILE . 10.9 mp -74.98 -27.52 60.19 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 175.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.5 mm100 -86.4 -26.03 24.97 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 176.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.695 ' HB2' ' HA ' ' A' ' 61' ' ' THR . 30.8 mt-10 -73.03 -25.39 60.93 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 177.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.433 ' HB1' HD12 ' A' ' 30' ' ' ILE . . . -89.59 -24.63 21.65 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 178.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.597 ' CG2' ' HB2' ' A' ' 73' ' ' ALA . 14.6 mm -88.08 -36.97 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 178.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -74.86 -27.77 60.39 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.335 -0.946 . . . . 0.0 108.632 178.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -76.52 -38.56 54.95 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.513 -0.742 . . . . 0.0 110.148 178.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.532 ' HE1' ' HB2' ' A' ' 29' ' ' GLN . 3.5 mmt -67.64 -35.74 79.47 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.895 -1.128 . . . . 0.0 110.471 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 105.9 48.98 0.97 Allowed Glycine 0 N--CA 1.499 2.863 0 C-N-CA 120.099 -1.048 . . . . 0.0 110.707 178.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.487 ' CD1' ' SD ' ' A' ' 17' ' ' MET . 55.0 m-85 -130.38 114.66 15.86 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.298 -1.119 . . . . 0.0 110.021 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -48.39 107.87 0.15 Allowed 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.553 -0.717 . . . . 0.0 110.684 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.597 ' HB2' ' CG2' ' A' ' 66' ' ' ILE . . . -111.23 164.58 12.73 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 122.068 0.937 . . . . 0.0 112.342 -178.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.751 ' C ' HG13 ' A' ' 75' ' ' ILE . 0.9 OUTLIER -168.91 103.72 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 179.618 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.861 HG21 ' CA ' ' A' ' 12' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.649 0 C-N-CA 118.834 -1.146 . . . . 0.0 113.638 -174.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.596 ' CG1' HD11 ' A' ' 51' ' ' ILE . 4.2 t . . . . . 0 N--CA 1.508 2.465 0 CA-C-O 121.014 0.435 . . . . 0.0 109.941 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.72 ' HB3' ' CZ ' ' A' ' 52' ' ' TYR . 1.0 OUTLIER -117.18 154.57 30.88 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.694 -1.254 . . . . 0.0 111.516 -179.232 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.61 ' HA ' ' HA ' ' A' ' 51' ' ' ILE . 14.7 t -118.98 146.51 44.94 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.336 -0.852 . . . . 0.0 110.012 178.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.539 ' CG1' HD11 ' A' ' 12' ' ' ILE . 1.0 OUTLIER -140.6 133.95 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.347 -0.845 . . . . 0.0 111.186 -178.833 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.519 ' HA ' ' HA ' ' A' ' 49' ' ' THR . 51.7 m -109.69 116.81 32.41 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.524 0.678 . . . . 0.0 109.273 179.16 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.595 ' HA ' ' HA ' ' A' ' 75' ' ' ILE . 5.7 mt -108.43 145.12 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.379 -0.826 . . . . 0.0 110.914 -178.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.426 ' N ' HG23 ' A' ' 12' ' ' ILE . 0.8 OUTLIER -78.98 137.74 37.73 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.747 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.457 ' CG1' ' O ' ' A' ' 14' ' ' VAL . 1.2 t -129.09 111.26 22.43 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 O-C-N 120.947 -1.095 . . . . 0.0 111.888 -178.166 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -122.56 170.19 10.26 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 73.81 25.43 71.87 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 -178.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.688 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 29.7 mmt -66.22 -36.08 82.12 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.106 -1.232 . . . . 0.0 110.178 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.411 ' OG1' ' SG ' ' A' ' 19' ' ' CYS . 1.0 OUTLIER 58.93 -42.84 0.07 Allowed 'General case' 0 N--CA 1.515 2.794 0 O-C-N 121.664 -0.648 . . . . 0.0 112.64 -179.708 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.52 ' N ' ' O ' ' A' ' 17' ' ' MET . 9.0 p 179.02 163.49 0.82 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.334 -0.854 . . . . 0.0 110.228 -178.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.581 ' HB2' ' CZ3' ' A' ' 24' ' ' TRP . 2.9 p30 -35.13 -36.71 0.06 Allowed 'General case' 0 N--CA 1.508 2.453 0 CA-C-O 120.947 0.403 . . . . 0.0 111.67 178.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.509 ' HA ' ' HE3' ' A' ' 24' ' ' TRP . 10.5 p -46.17 -30.67 2.05 Favored 'General case' 0 N--CA 1.504 2.258 0 CA-C-O 121.983 0.897 . . . . 0.0 110.912 178.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.688 ' SG ' ' O ' ' A' ' 17' ' ' MET . 69.6 m -90.3 -27.63 19.3 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.444 -0.785 . . . . 0.0 109.066 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.571 HG21 ' HB2' ' A' ' 43' ' ' LEU . 1.1 t -71.96 -37.65 61.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 175.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.623 ' O ' ' HB2' ' A' ' 28' ' ' GLN . 2.8 m0 -67.6 -32.14 72.67 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 119.142 -1.023 . . . . 0.0 108.488 177.133 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.596 ' O ' ' HB2' ' A' ' 29' ' ' GLN . 96.8 m -82.1 -23.98 35.41 Favored 'General case' 0 N--CA 1.505 2.285 0 C-N-CA 120.532 -0.467 . . . . 0.0 112.034 -179.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.448 HD12 ' N ' ' A' ' 26' ' ' ILE . 1.5 mp -98.49 -22.35 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.31 0 O-C-N 120.868 -1.145 . . . . 0.0 110.126 -179.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.636 ' HA ' HD11 ' A' ' 39' ' ' ILE . 4.7 tt0 -83.1 -36.32 24.93 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 178.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.623 ' HB2' ' O ' ' A' ' 24' ' ' TRP . 1.2 mp0 -80.13 -33.84 38.24 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.725 -0.79 . . . . 0.0 109.81 178.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.596 ' HB2' ' O ' ' A' ' 25' ' ' THR . 5.2 mm100 -77.46 -61.42 2.0 Allowed 'General case' 0 N--CA 1.501 2.088 0 C-N-CA 118.32 -1.352 . . . . 0.0 110.694 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.456 ' HA ' ' HB ' ' A' ' 33' ' ' VAL . 38.0 mt -64.98 -36.9 78.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 120.776 -1.202 . . . . 0.0 109.989 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -58.36 -46.47 92.93 Favored Glycine 0 N--CA 1.499 2.857 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 178.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.08 29.99 7.29 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.459 -1.024 . . . . 0.0 110.864 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.474 HG13 HG23 ' A' ' 36' ' ' VAL . 8.4 p -64.29 -38.19 81.89 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 O-C-N 121.083 -1.011 . . . . 0.0 111.049 -179.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -175.39 -60.38 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.333 -0.854 . . . . 0.0 110.357 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.534 ' O ' ' HA ' ' A' ' 52' ' ' TYR . . . -148.47 83.48 0.18 Allowed Glycine 0 N--CA 1.489 2.204 0 N-CA-C 108.307 -1.917 . . . . 0.0 108.307 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.596 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 17.1 t -124.15 93.71 2.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 CA-C-O 122.503 1.144 . . . . 0.0 108.637 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.472 ' HB2' ' CD1' ' A' ' 51' ' ' ILE . 68.2 m-70 -60.45 -18.53 51.83 Favored 'General case' 0 N--CA 1.503 2.209 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.676 -179.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.58 ' HB3' ' CG2' ' A' ' 51' ' ' ILE . 1.0 OUTLIER -158.92 129.49 5.99 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.791 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.636 HD11 ' HA ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -129.94 128.79 65.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.565 -0.71 . . . . 0.0 109.392 -179.927 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.538 ' HB3' HG23 ' A' ' 49' ' ' THR . 0.0 OUTLIER -121.02 121.54 38.18 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.882 -1.136 . . . . 0.0 110.073 179.743 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.455 ' O ' ' NZ ' ' A' ' 40' ' ' LYS . 10.6 p -106.89 152.54 8.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 178.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.748 ' HB3' ' HB3' ' A' ' 45' ' ' GLU . 0.4 OUTLIER -136.57 76.51 1.6 Allowed 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.09 -1.006 . . . . 0.0 111.073 -177.74 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.571 ' HB2' HG21 ' A' ' 23' ' ' VAL . 11.7 tp -39.32 -57.19 1.42 Allowed 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.461 ' O ' ' NZ ' ' A' ' 46' ' ' LYS . 0.7 OUTLIER -94.57 -32.69 13.34 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.831 -1.168 . . . . 0.0 111.409 -179.799 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.748 ' HB3' ' HB3' ' A' ' 42' ' ' SER . 9.7 tt0 -66.61 -7.47 20.61 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.038 -1.039 . . . . 0.0 109.929 177.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.461 ' NZ ' ' O ' ' A' ' 44' ' ' GLU . 0.0 OUTLIER 55.77 69.36 0.74 Allowed 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.47 -0.768 . . . . 0.0 111.17 179.008 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -170.31 161.15 8.06 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.72 -1.238 . . . . 0.0 113.037 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.446 ' HB1' ' CG2' ' A' ' 14' ' ' VAL . . . -147.93 97.25 2.77 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 115.518 -0.765 . . . . 0.0 108.984 179.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.538 HG23 ' HB3' ' A' ' 40' ' ' LYS . 1.0 OUTLIER -109.74 133.79 52.73 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.783 -1.198 . . . . 0.0 110.254 -179.674 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.556 HG22 ' HA ' ' A' ' 39' ' ' ILE . 2.6 pp -146.63 177.63 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.511 -0.743 . . . . 0.0 111.146 -178.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.61 ' HA ' ' HA ' ' A' ' 9' ' ' SER . 0.0 OUTLIER -123.82 158.89 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 178.541 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.72 ' CZ ' ' HB3' ' A' ' 8' ' ' ASN . 14.8 p90 -163.95 153.7 14.58 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.235 -0.915 . . . . 0.0 111.089 -177.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.532 ' HA ' HG13 ' A' ' 7' ' ' VAL . 0.4 OUTLIER -79.69 117.74 68.82 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.277 -0.89 . . . . 0.0 109.49 178.892 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -67.63 57.61 0.73 Allowed 'Trans proline' 0 N--CA 1.494 1.529 0 O-C-N 123.929 1.489 . . . . 0.0 111.408 -178.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.477 ' HG3' ' HB3' ' A' ' 53' ' ' ASP . 0.0 OUTLIER -135.47 -66.25 0.57 Allowed 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 179.073 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -96.84 -8.99 29.6 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.472 -0.768 . . . . 0.0 109.285 177.297 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.66 146.5 50.85 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.512 -0.742 . . . . 0.0 109.947 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.593 ' HB ' ' HD2' ' A' ' 59' ' ' PRO . 78.3 p -142.66 169.08 11.53 Favored Pre-proline 0 N--CA 1.497 1.922 0 O-C-N 121.493 -0.754 . . . . 0.0 110.14 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.593 ' HD2' ' HB ' ' A' ' 58' ' ' THR . 39.3 Cg_endo -65.41 -19.18 61.34 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 O-C-N 123.328 1.172 . . . . 0.0 111.226 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 2.2 tptt -92.0 -30.51 16.03 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.291 -0.881 . . . . 0.0 109.791 179.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.679 ' HA ' ' HB2' ' A' ' 64' ' ' GLU . 6.0 p -79.2 -24.17 43.33 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 177.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.536 HD11 ' CG ' ' A' ' 52' ' ' TYR . 14.2 mt -72.97 -30.68 64.01 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 106.314 -1.735 . . . . 0.0 106.314 175.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.485 ' O ' ' HB2' ' A' ' 67' ' ' ASP . 1.2 tt0 -82.36 -27.71 31.99 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 177.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.679 ' HB2' ' HA ' ' A' ' 61' ' ' THR . 10.3 mt-10 -82.09 -16.38 50.22 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 177.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -86.86 -27.22 23.6 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 177.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.529 HD12 HD12 ' A' ' 12' ' ' ILE . 26.2 mt -86.32 -38.52 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 177.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.485 ' HB2' ' O ' ' A' ' 63' ' ' GLN . 0.4 OUTLIER -66.27 -33.21 75.23 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 177.459 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.596 ' HB2' ' O ' ' A' ' 64' ' ' GLU . 2.6 t70 -79.37 -38.07 35.86 Favored 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 119.771 -0.772 . . . . 0.0 109.298 178.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.517 ' HE1' ' HA ' ' A' ' 66' ' ' ILE . 0.0 OUTLIER -47.65 -59.77 3.04 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.555 -0.716 . . . . 0.0 110.018 179.153 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 123.3 51.26 0.21 Allowed Glycine 0 N--CA 1.497 2.735 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 179.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.628 ' CE1' ' HB3' ' A' ' 22' ' ' CYS . 10.9 m-85 -140.73 147.61 39.44 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.435 -1.038 . . . . 0.0 111.029 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -72.39 81.46 1.04 Allowed 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.576 0.703 . . . . 0.0 109.245 179.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -134.59 142.17 46.86 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.999 -1.063 . . . . 0.0 110.961 -179.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.545 ' C ' HG13 ' A' ' 75' ' ' ILE . 2.5 t -117.51 -134.7 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.211 -0.939 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 178.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.595 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--N 1.282 -2.357 0 O-C-N 121.072 -1.018 . . . . 0.0 111.514 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.458 HG12 ' CD1' ' A' ' 51' ' ' ILE . 1.1 t . . . . . 0 N--CA 1.506 2.334 0 CA-C-O 121.533 0.683 . . . . 0.0 111.003 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.464 ' HB3' ' CZ ' ' A' ' 52' ' ' TYR . 2.5 m120 -112.17 -179.87 3.8 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.051 -1.031 . . . . 0.0 110.656 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.609 ' HA ' ' HA ' ' A' ' 51' ' ' ILE . 3.8 m -141.29 132.68 26.74 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.294 -0.879 . . . . 0.0 110.192 179.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.467 ' HB ' ' CE1' ' A' ' 52' ' ' TYR . 0.9 OUTLIER -130.99 135.82 59.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 CA-C-O 121.592 0.711 . . . . 0.0 111.953 -178.14 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.525 ' HA ' ' HA ' ' A' ' 49' ' ' THR . 27.5 m -115.3 118.94 34.68 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.066 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.533 HG12 ' CG2' ' A' ' 75' ' ' ILE . 64.9 mt -118.73 146.29 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.299 -0.876 . . . . 0.0 111.612 -178.01 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.563 ' CB ' HG12 ' A' ' 74' ' ' VAL . 0.9 OUTLIER -90.42 144.55 25.7 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 177.574 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.507 ' O ' ' HB3' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -141.55 126.38 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.82 -1.175 . . . . 0.0 110.824 -178.754 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.659 ' HB3' ' HB3' ' A' ' 72' ' ' ASP . 5.8 tp10 -108.95 165.42 11.59 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.418 -0.801 . . . . 0.0 110.247 179.209 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.71 -25.89 26.67 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 108.577 -1.809 . . . . 0.0 108.577 -177.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.492 ' HA ' ' CB ' ' A' ' 22' ' ' CYS . 51.2 mtm -73.87 102.7 4.15 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.253 -1.145 . . . . 0.0 109.888 179.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 14.9 t -106.59 9.41 31.41 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.532 -0.73 . . . . 0.0 111.367 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.436 ' O ' ' N ' ' A' ' 21' ' ' SER . 0.5 OUTLIER -178.99 139.64 0.16 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.183 -0.948 . . . . 0.0 109.295 179.822 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.647 ' HA ' ' CD2' ' A' ' 43' ' ' LEU . 7.8 m120 -23.08 -46.12 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.599 0 N-CA-C 112.719 0.636 . . . . 0.0 112.719 -179.269 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.573 ' HA ' ' HE3' ' A' ' 24' ' ' TRP . 3.0 p -47.66 -27.5 1.94 Allowed 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.391 -0.818 . . . . 0.0 111.518 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.633 ' HB3' ' CE1' ' A' ' 71' ' ' PHE . 60.2 m -87.04 -33.08 19.67 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.03 -1.044 . . . . 0.0 109.414 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.449 HG23 ' SD ' ' A' ' 17' ' ' MET . 9.1 t -77.47 -39.44 27.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 177.398 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.573 ' HE3' ' HA ' ' A' ' 21' ' ' SER . 1.4 m0 -59.24 -36.97 76.41 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 176.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.457 ' O ' ' HB2' ' A' ' 29' ' ' GLN . 64.1 m -66.0 -34.5 78.25 Favored 'General case' 0 N--CA 1.501 2.086 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.006 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.546 HD13 ' CD2' ' A' ' 71' ' ' PHE . 1.4 mp -94.8 -29.61 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.241 0 O-C-N 121.261 -0.899 . . . . 0.0 110.03 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.718 ' HG3' ' CD1' ' A' ' 39' ' ' ILE . 2.6 tt0 -74.16 -35.64 64.05 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 178.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.529 ' HB2' ' O ' ' A' ' 24' ' ' TRP . 28.9 mt-30 -79.3 -34.15 42.67 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 119.146 -1.022 . . . . 0.0 108.99 177.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.648 ' HB3' ' SD ' ' A' ' 69' ' ' MET . 2.2 mm100 -73.04 -51.36 18.45 Favored 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 118.44 -1.304 . . . . 0.0 110.112 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.548 ' CG2' ' HB ' ' A' ' 39' ' ' ILE . 0.4 OUTLIER -57.41 -41.11 77.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 120.98 -1.075 . . . . 0.0 109.859 179.094 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.55 ' HA2' HG23 ' A' ' 39' ' ' ILE . . . -64.61 -26.52 70.99 Favored Glycine 0 N--CA 1.498 2.772 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 178.372 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.496 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 3.2 ttpp -116.7 26.7 9.66 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.566 -0.961 . . . . 0.0 110.678 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.415 ' CG1' ' N ' ' A' ' 34' ' ' ASN . 8.1 p -87.41 -49.22 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 O-C-N 120.594 -1.316 . . . . 0.0 112.489 -178.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.415 ' N ' ' CG1' ' A' ' 33' ' ' VAL . 0.6 OUTLIER -169.66 -68.07 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.134 0 O-C-N 120.408 -1.433 . . . . 0.0 112.453 -179.581 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -142.74 73.17 0.37 Allowed Glycine 0 N--CA 1.496 2.676 0 C-N-CA 119.987 -1.102 . . . . 0.0 110.855 -178.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.598 HG11 HG21 ' A' ' 39' ' ' ILE . 61.5 t -127.57 89.2 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 CA-C-O 122.335 1.064 . . . . 0.0 108.564 178.218 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.585 ' HB2' ' CD1' ' A' ' 51' ' ' ILE . 38.9 m-70 -61.6 -23.26 65.89 Favored 'General case' 0 N--CA 1.507 2.402 0 CA-C-N 115.388 -0.823 . . . . 0.0 110.72 -179.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.625 ' HB2' HG12 ' A' ' 51' ' ' ILE . 65.8 m-70 -136.94 113.36 10.04 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.308 -0.87 . . . . 0.0 109.162 179.28 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.718 ' CD1' ' HG3' ' A' ' 27' ' ' GLU . 1.8 pp -114.28 136.42 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.286 -0.884 . . . . 0.0 109.637 -179.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.65 ' HA ' ' CE ' ' A' ' 40' ' ' LYS . 0.3 OUTLIER -150.58 122.91 8.39 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.168 -1.583 . . . . 0.0 112.408 -179.715 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.472 ' HA ' ' HA ' ' A' ' 48' ' ' ALA . 3.9 t -127.79 167.14 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.573 ' O ' HD21 ' A' ' 43' ' ' LEU . 1.4 m -108.84 -101.04 0.38 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.87 -1.144 . . . . 0.0 110.168 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.647 ' CD2' ' HA ' ' A' ' 20' ' ' ASN . 0.1 OUTLIER -179.13 -92.41 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.308 0 O-C-N 121.069 -1.019 . . . . 0.0 109.683 179.411 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.477 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -76.73 -9.77 58.9 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.512 -1.368 . . . . 0.0 109.594 178.538 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -74.59 -11.87 60.31 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 177.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.507 ' HB3' ' O ' ' A' ' 14' ' ' VAL . 21.5 mmtt 51.5 56.13 8.36 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.623 -0.673 . . . . 0.0 111.295 179.037 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.428 ' O ' HG12 ' A' ' 41' ' ' VAL . 0.3 OUTLIER -154.08 152.13 30.11 Favored 'General case' 0 N--CA 1.504 2.235 0 O-C-N 120.587 -1.32 . . . . 0.0 112.274 179.854 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.472 ' HA ' ' HA ' ' A' ' 41' ' ' VAL . . . -142.36 134.91 28.05 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.251 0.548 . . . . 0.0 110.592 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.525 ' HA ' ' HA ' ' A' ' 11' ' ' THR . 5.8 t -128.67 134.41 48.5 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.377 -0.827 . . . . 0.0 109.408 179.021 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.573 HD13 HD11 ' A' ' 62' ' ' LEU . 0.1 OUTLIER -149.59 164.85 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.072 -1.018 . . . . 0.0 110.975 -179.014 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.625 HG12 ' HB2' ' A' ' 38' ' ' HIS . 1.7 pp -107.03 167.52 3.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 178.056 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.508 ' HB2' ' HB3' ' A' ' 57' ' ' GLN . 28.8 p90 -170.52 161.83 7.91 Favored 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 119.159 -1.017 . . . . 0.0 110.731 -178.187 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.436 ' O ' ' N ' ' A' ' 55' ' ' LYS . 0.9 OUTLIER -78.84 121.62 83.67 Favored Pre-proline 0 C--N 1.302 -1.492 0 C-N-CA 119.701 -0.799 . . . . 0.0 109.726 179.182 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.416 ' C ' ' HG2' ' A' ' 55' ' ' LYS . 38.7 Cg_endo -64.67 70.31 0.24 Allowed 'Trans proline' 0 N--CA 1.492 1.395 0 O-C-N 124.1 1.579 . . . . 0.0 109.728 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.436 ' N ' ' O ' ' A' ' 53' ' ' ASP . 3.2 ptpp? -172.24 -45.48 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.756 -0.59 . . . . 0.0 110.877 -178.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.8 pp -111.8 -21.65 11.53 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.093 -1.004 . . . . 0.0 111.837 -179.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.508 ' HB3' ' HB2' ' A' ' 52' ' ' TYR . 5.5 tp60 -125.85 133.76 51.85 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.818 -1.176 . . . . 0.0 110.025 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.576 ' HB ' ' HD2' ' A' ' 59' ' ' PRO . 34.9 p -141.78 168.33 14.13 Favored Pre-proline 0 N--CA 1.504 2.239 0 O-C-N 121.111 -0.993 . . . . 0.0 109.988 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.576 ' HD2' ' HB ' ' A' ' 58' ' ' THR . 37.8 Cg_endo -62.39 -20.45 70.4 Favored 'Trans proline' 0 N--CA 1.498 1.78 0 O-C-N 123.418 1.22 . . . . 0.0 111.877 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.403 ' NZ ' ' HB3' ' A' ' 64' ' ' GLU . 0.4 OUTLIER -81.4 -30.53 33.57 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.097 -1.002 . . . . 0.0 108.777 178.241 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.517 ' HA ' ' CD ' ' A' ' 64' ' ' GLU . 0.9 OUTLIER -90.3 -24.15 20.97 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 178.033 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.573 HD11 HD13 ' A' ' 50' ' ' ILE . 5.2 mt -74.11 -28.07 61.18 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 177.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.677 ' HB2' ' CG2' ' A' ' 75' ' ' ILE . 15.8 tt0 -84.08 -30.22 26.18 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 177.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.517 ' CD ' ' HA ' ' A' ' 61' ' ' THR . 1.5 pt-20 -81.05 -18.99 44.77 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.4 ' O ' ' SD ' ' A' ' 69' ' ' MET . . . -82.95 -28.76 29.61 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 175.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.44 ' HA ' ' HE2' ' A' ' 69' ' ' MET . 51.5 mt -82.01 -38.77 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 177.136 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.429 ' HB2' ' HA ' ' A' ' 64' ' ' GLU . 1.2 m-20 -61.05 -28.54 69.14 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 176.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -71.05 -42.74 69.08 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.799 -0.563 . . . . 0.0 109.885 178.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.648 ' SD ' ' HB3' ' A' ' 29' ' ' GLN . 0.8 OUTLIER -54.73 -47.95 73.14 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.454 -0.779 . . . . 0.0 111.043 179.717 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 120.89 43.0 0.46 Allowed Glycine 0 N--CA 1.503 3.109 0 C-N-CA 120.069 -1.062 . . . . 0.0 110.586 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.633 ' CE1' ' HB3' ' A' ' 22' ' ' CYS . 61.8 m-85 -144.87 130.29 18.78 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.444 -1.033 . . . . 0.0 109.229 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.659 ' HB3' ' HB3' ' A' ' 15' ' ' GLU . 5.5 t70 -47.43 116.51 1.45 Allowed 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.525 -0.735 . . . . 0.0 110.005 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.43 150.17 28.48 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.382 -0.824 . . . . 0.0 111.554 -178.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.563 HG12 ' CB ' ' A' ' 13' ' ' SER . 1.0 OUTLIER -154.83 93.76 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 CA-C-O 122.559 1.171 . . . . 0.0 108.1 179.103 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.677 ' CG2' ' HB2' ' A' ' 63' ' ' GLN . 14.0 pt . . . . . 0 C--N 1.296 -1.744 0 CA-C-O 122.481 1.134 . . . . 0.0 112.455 -177.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 48.2 t . . . . . 0 N--CA 1.5 2.05 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.754 ' HB3' ' CZ ' ' A' ' 52' ' ' TYR . 1.0 OUTLIER -106.24 172.46 6.8 Favored 'General case' 0 N--CA 1.503 2.21 0 O-C-N 120.977 -1.077 . . . . 0.0 110.957 -179.789 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.519 ' HA ' ' HA ' ' A' ' 51' ' ' ILE . 6.8 t -130.52 131.04 44.89 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.352 -0.843 . . . . 0.0 110.27 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.641 ' HB ' ' CE1' ' A' ' 52' ' ' TYR . 0.5 OUTLIER -125.61 132.63 70.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.462 -0.774 . . . . 0.0 111.315 -178.411 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.583 ' HA ' ' HA ' ' A' ' 49' ' ' THR . 8.9 m -108.67 119.17 38.73 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.532 -0.73 . . . . 0.0 109.138 178.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.667 ' HA ' ' HA ' ' A' ' 75' ' ' ILE . 9.8 mt -110.93 122.13 64.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.294 -0.879 . . . . 0.0 110.9 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.662 ' HB2' ' CG1' ' A' ' 74' ' ' VAL . 0.7 OUTLIER -79.34 136.11 36.91 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 178.011 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.417 HG13 ' HB3' ' A' ' 71' ' ' PHE . 0.2 OUTLIER -131.27 130.14 63.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.17 -0.957 . . . . 0.0 110.987 -178.641 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -119.48 159.57 24.02 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.387 -0.82 . . . . 0.0 110.159 178.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.42 ' O ' HG23 ' A' ' 18' ' ' THR . . . 98.35 -31.14 8.36 Favored Glycine 0 N--CA 1.497 2.762 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 -179.145 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.554 ' SD ' ' HA ' ' A' ' 43' ' ' LEU . 8.0 ptp -62.43 122.63 16.2 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.171 -1.193 . . . . 0.0 110.302 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.42 HG23 ' O ' ' A' ' 16' ' ' GLY . 54.7 p -125.64 5.96 7.5 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.252 -0.905 . . . . 0.0 113.333 -178.073 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.466 ' O ' ' N ' ' A' ' 21' ' ' SER . 1.1 p -165.56 145.3 6.6 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.14 -1.6 . . . . 0.0 110.512 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.478 ' O ' HG11 ' A' ' 23' ' ' VAL . 28.9 m120 -25.8 -40.67 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.674 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -179.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.747 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 2.2 p -51.32 -19.75 1.42 Allowed 'General case' 0 N--CA 1.499 1.978 0 CA-C-O 122.294 1.045 . . . . 0.0 110.703 178.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.659 ' HB2' HD21 ' A' ' 43' ' ' LEU . 44.7 m -91.15 -20.87 21.53 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 119.32 -2.112 . . . . 0.0 109.221 179.002 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.679 ' CA ' HD12 ' A' ' 43' ' ' LEU . 0.3 OUTLIER -90.02 -35.51 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.411 -0.806 . . . . 0.0 108.868 178.531 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.747 ' CE3' ' HA ' ' A' ' 21' ' ' SER . 0.0 OUTLIER -78.96 -22.55 45.51 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 117.85 -1.54 . . . . 0.0 108.688 178.642 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.505 ' HB ' ' CZ3' ' A' ' 24' ' ' TRP . 1.3 t -86.18 -27.6 24.44 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 120.774 -1.204 . . . . 0.0 110.378 177.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 20.4 mm -90.77 -25.12 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.377 0 O-C-N 120.75 -1.218 . . . . 0.0 109.561 179.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.766 ' HA ' HD11 ' A' ' 39' ' ' ILE . 0.2 OUTLIER -81.24 -34.37 32.18 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 177.55 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.612 ' HB2' ' O ' ' A' ' 24' ' ' TRP . 0.9 OUTLIER -72.95 -33.01 65.63 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 177.413 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.458 ' O ' ' HB ' ' A' ' 33' ' ' VAL . 5.5 tp60 -70.88 -66.63 0.58 Allowed 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 120.045 -0.662 . . . . 0.0 110.527 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.584 HG22 HG22 ' A' ' 36' ' ' VAL . 84.1 mt -64.3 -45.7 95.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 O-C-N 121.245 -0.91 . . . . 0.0 110.35 -179.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.52 ' HA2' HG21 ' A' ' 39' ' ' ILE . . . -50.48 -34.44 27.02 Favored Glycine 0 N--CA 1.497 2.712 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 179.29 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 56.1 mtmt -126.71 29.9 5.61 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.008 -1.29 . . . . 0.0 111.865 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.458 ' HB ' ' O ' ' A' ' 29' ' ' GLN . 14.9 p -75.15 -49.83 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 O-C-N 120.633 -1.292 . . . . 0.0 111.541 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -178.47 -60.29 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.285 0 O-C-N 120.871 -1.143 . . . . 0.0 111.663 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.478 ' O ' ' HA ' ' A' ' 52' ' ' TYR . . . -122.94 67.71 0.48 Allowed Glycine 0 N--CA 1.495 2.586 0 C-N-CA 120.207 -0.997 . . . . 0.0 110.647 -178.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.584 HG22 HG22 ' A' ' 30' ' ' ILE . 50.4 t -136.57 92.4 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.487 -1.008 . . . . 0.0 108.585 178.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.732 ' HB2' HD11 ' A' ' 51' ' ' ILE . 50.3 m-70 -51.67 -29.27 17.39 Favored 'General case' 0 N--CA 1.512 2.667 0 CA-C-O 121.575 0.702 . . . . 0.0 109.709 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.529 ' CD2' ' CD1' ' A' ' 51' ' ' ILE . 0.2 OUTLIER -171.39 145.41 2.12 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 178.615 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.766 HD11 ' HA ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -121.06 144.86 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.145 -0.972 . . . . 0.0 110.023 -178.689 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.417 ' NZ ' ' O ' ' A' ' 41' ' ' VAL . 4.5 tptt -122.21 100.23 6.85 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.555 -1.341 . . . . 0.0 109.518 179.258 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.566 HG21 ' HB1' ' A' ' 48' ' ' ALA . 11.2 p -108.93 154.68 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 O-C-N 121.604 -0.685 . . . . 0.0 109.614 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.555 ' HB3' ' HB2' ' A' ' 45' ' ' GLU . 0.4 OUTLIER -139.93 79.31 1.71 Allowed 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.712 -0.618 . . . . 0.0 109.693 -179.834 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.679 HD12 ' CA ' ' A' ' 23' ' ' VAL . 1.8 tp -45.32 -32.66 2.1 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.595 -0.691 . . . . 0.0 110.994 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.5 mp0 -72.02 -51.74 20.33 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.151 -0.968 . . . . 0.0 109.97 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.555 ' HB2' ' HB3' ' A' ' 42' ' ' SER . 1.8 mp0 -73.43 1.42 9.79 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.619 -0.676 . . . . 0.0 109.747 177.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 51.38 56.16 8.35 Favored 'General case' 0 N--CA 1.506 2.349 0 O-C-N 121.367 -0.833 . . . . 0.0 111.713 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -171.22 158.84 5.6 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.893 -1.129 . . . . 0.0 110.38 179.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.566 ' HB1' HG21 ' A' ' 41' ' ' VAL . . . -144.49 137.43 26.89 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.967 -1.083 . . . . 0.0 111.85 -179.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.583 ' HA ' ' HA ' ' A' ' 11' ' ' THR . 5.6 t -127.22 135.78 51.1 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.014 -1.054 . . . . 0.0 109.299 178.035 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.645 HG22 HG12 ' A' ' 39' ' ' ILE . 1.4 pp -145.03 167.62 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 O-C-N 121.08 -1.013 . . . . 0.0 111.036 -177.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.732 HD11 ' HB2' ' A' ' 37' ' ' HIS . 0.0 OUTLIER -109.12 169.26 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 O-C-N 121.281 -0.887 . . . . 0.0 110.15 178.727 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.754 ' CZ ' ' HB3' ' A' ' 8' ' ' ASN . 15.4 p90 -170.43 159.73 7.14 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.54 -0.725 . . . . 0.0 110.672 -178.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.45 ' OD2' ' HB3' ' A' ' 56' ' ' LEU . 6.6 p-10 -79.26 117.37 66.63 Favored Pre-proline 0 C--N 1.3 -1.558 0 C-N-CA 119.631 -0.828 . . . . 0.0 109.425 179.037 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.484 ' C ' ' HG2' ' A' ' 55' ' ' LYS . 39.8 Cg_endo -68.54 66.2 1.15 Allowed 'Trans proline' 0 N--CA 1.487 1.115 0 O-C-N 123.516 1.272 . . . . 0.0 109.374 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.484 ' HG2' ' C ' ' A' ' 54' ' ' PRO . 0.0 OUTLIER -164.11 -55.3 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 -179.267 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.45 ' HB3' ' OD2' ' A' ' 53' ' ' ASP . 0.4 OUTLIER -98.55 -41.45 7.74 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.381 -0.824 . . . . 0.0 109.53 178.271 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.406 ' HB3' ' HB2' ' A' ' 52' ' ' TYR . 20.5 tp60 -104.14 140.38 37.88 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.026 -1.046 . . . . 0.0 111.036 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.709 ' HB ' ' HD2' ' A' ' 59' ' ' PRO . 29.9 p -140.75 171.55 7.49 Favored Pre-proline 0 N--CA 1.508 2.469 0 O-C-N 121.013 -1.055 . . . . 0.0 110.363 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.709 ' HD2' ' HB ' ' A' ' 58' ' ' THR . 38.5 Cg_endo -64.22 -20.24 66.75 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 O-C-N 123.455 1.24 . . . . 0.0 110.229 179.329 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.571 ' O ' ' HB3' ' A' ' 64' ' ' GLU . 1.4 tmtt? -77.02 -31.31 56.27 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 177.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.526 ' HA ' ' CD ' ' A' ' 64' ' ' GLU . 39.1 p -86.84 -25.41 24.54 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 177.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.631 ' CD2' HD13 ' A' ' 50' ' ' ILE . 20.3 mt -77.06 -26.6 53.73 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 176.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -86.05 -24.56 26.31 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 177.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.571 ' HB3' ' O ' ' A' ' 60' ' ' LYS . 1.1 pt-20 -87.14 -15.39 38.54 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 177.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -90.05 -27.96 19.36 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 177.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -86.41 -38.24 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.047 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -71.93 -29.74 64.61 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 177.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.417 ' CB ' ' O ' ' A' ' 64' ' ' GLU . 11.8 t70 -69.39 -41.55 76.31 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.413 -0.804 . . . . 0.0 109.181 177.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.29 -46.85 76.21 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.669 -0.645 . . . . 0.0 110.25 179.329 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 121.08 38.35 0.65 Allowed Glycine 0 N--CA 1.499 2.852 0 C-N-CA 120.043 -1.075 . . . . 0.0 110.856 179.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.417 ' HB3' HG13 ' A' ' 14' ' ' VAL . 59.9 m-85 -131.3 121.67 25.11 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.521 -0.988 . . . . 0.0 108.947 179.002 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -58.99 110.44 1.03 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.241 -0.912 . . . . 0.0 109.621 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.422 ' HA ' ' O ' ' A' ' 13' ' ' SER . . . -124.08 168.19 13.21 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 122.051 0.929 . . . . 0.0 112.029 -178.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.662 ' CG1' ' HB2' ' A' ' 13' ' ' SER . 2.7 p -149.2 91.75 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 178.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.667 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 122.488 1.137 . . . . 0.0 112.157 -177.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.601 HG13 ' CD2' ' A' ' 37' ' ' HIS . 26.7 m . . . . . 0 N--CA 1.506 2.351 0 CA-C-O 121.348 0.594 . . . . 0.0 111.23 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.465 ' O ' HG12 ' A' ' 51' ' ' ILE . 0.8 OUTLIER -117.16 167.72 10.93 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.226 -0.921 . . . . 0.0 110.289 179.802 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.524 ' HA ' ' HA ' ' A' ' 51' ' ' ILE . 1.9 m -116.58 136.48 52.94 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.104 -0.997 . . . . 0.0 110.776 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.594 HG12 HG13 ' A' ' 12' ' ' ILE . 1.0 OUTLIER -126.58 120.71 56.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.415 -0.803 . . . . 0.0 111.459 -179.396 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.54 ' HA ' ' HA ' ' A' ' 49' ' ' THR . 24.2 m -111.75 104.74 13.1 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 177.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.594 HG13 HG12 ' A' ' 10' ' ' VAL . 72.6 mt -113.6 138.86 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.258 -0.901 . . . . 0.0 111.391 -178.152 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.72 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 0.7 OUTLIER -74.57 134.02 42.18 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 177.984 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.545 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 23.3 t -120.29 120.71 63.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 121.274 -0.891 . . . . 0.0 110.945 -178.117 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.577 ' CB ' ' HB3' ' A' ' 72' ' ' ASP . 1.7 tm-20 -109.22 -171.58 1.87 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.796 -0.565 . . . . 0.0 109.864 179.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.96 21.96 67.01 Favored Glycine 0 N--CA 1.497 2.712 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -178.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.488 ' CG ' ' HG ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -66.35 154.32 40.35 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.256 -1.144 . . . . 0.0 111.386 -179.494 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.414 ' O ' ' HB3' ' A' ' 19' ' ' CYS . 1.6 p -146.91 -41.15 0.19 Allowed 'General case' 0 N--CA 1.508 2.439 0 O-C-N 121.407 -0.808 . . . . 0.0 111.556 -179.273 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.521 ' O ' HD23 ' A' ' 43' ' ' LEU . 29.5 p -179.79 169.23 1.31 Allowed 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.523 -0.735 . . . . 0.0 109.923 -178.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.443 ' O ' HG13 ' A' ' 23' ' ' VAL . 13.2 t-20 -31.72 -36.88 0.02 OUTLIER 'General case' 0 N--CA 1.512 2.639 0 CA-C-O 121.149 0.5 . . . . 0.0 112.095 179.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.782 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 4.5 p -55.99 -17.3 6.4 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 122.187 0.994 . . . . 0.0 111.354 179.064 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.684 ' CB ' HD12 ' A' ' 43' ' ' LEU . 62.4 m -93.25 -28.83 16.01 Favored 'General case' 0 C--N 1.287 -2.131 0 O-C-N 119.602 -1.936 . . . . 0.0 110.841 -178.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.627 ' HB ' ' HB2' ' A' ' 43' ' ' LEU . 10.7 p -85.49 -32.64 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.351 -0.843 . . . . 0.0 109.167 178.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.782 ' CE3' ' HA ' ' A' ' 21' ' ' SER . 0.0 OUTLIER -83.37 -23.07 32.61 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 117.745 -1.582 . . . . 0.0 108.886 178.488 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.605 ' HB ' ' O ' ' A' ' 21' ' ' SER . 1.2 t -82.26 -26.64 33.01 Favored 'General case' 0 N--CA 1.507 2.39 0 C-N-CA 118.722 -1.191 . . . . 0.0 111.061 178.001 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.548 ' CD1' ' CD2' ' A' ' 71' ' ' PHE . 20.8 mt -96.47 -28.86 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 O-C-N 120.81 -1.181 . . . . 0.0 110.25 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.53 ' HG3' HD13 ' A' ' 39' ' ' ILE . 1.0 OUTLIER -74.54 -35.39 63.12 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 178.369 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.577 ' HB2' ' O ' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -80.86 -31.91 35.18 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 119.423 -0.911 . . . . 0.0 108.607 177.545 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.551 ' HB2' ' O ' ' A' ' 25' ' ' THR . 1.6 tm0? -73.06 -60.44 2.23 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.036 -1.04 . . . . 0.0 110.162 179.222 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.454 HD13 HG21 ' A' ' 30' ' ' ILE . 88.5 mt -59.34 -39.27 78.55 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 120.945 -1.097 . . . . 0.0 109.952 179.5 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.619 ' HA2' ' CG2' ' A' ' 39' ' ' ILE . . . -48.53 -46.44 29.72 Favored Glycine 0 N--CA 1.497 2.741 0 N-CA-C 110.219 -1.152 . . . . 0.0 110.219 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.47 ' HG3' ' O ' ' A' ' 28' ' ' GLN . 0.2 OUTLIER -130.9 40.99 3.42 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.572 -0.958 . . . . 0.0 110.88 179.526 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.5 ' HB ' ' O ' ' A' ' 29' ' ' GLN . 15.0 p -72.76 -40.35 61.04 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.298 0 O-C-N 121.143 -0.973 . . . . 0.0 111.151 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -171.04 -51.64 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.092 0 O-C-N 120.903 -1.123 . . . . 0.0 111.08 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -150.12 82.64 0.18 Allowed Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.636 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 54.0 t -139.43 100.89 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.293 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.601 ' CD2' HG13 ' A' ' 7' ' ' VAL . 67.6 m-70 -70.09 -27.53 64.68 Favored 'General case' 0 C--N 1.289 -2.043 0 C-N-CA 120.288 -0.565 . . . . 0.0 110.155 -179.281 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.645 ' HB2' ' CG2' ' A' ' 51' ' ' ILE . 23.8 m-70 -142.78 130.71 21.7 Favored 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.047 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.619 ' CG2' ' HA2' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -127.88 139.08 52.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.081 -1.012 . . . . 0.0 110.252 -179.282 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.578 ' HB3' HG23 ' A' ' 49' ' ' THR . 0.3 OUTLIER -148.31 106.21 3.71 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.165 -0.959 . . . . 0.0 110.227 179.232 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.508 ' HA ' ' HA ' ' A' ' 48' ' ' ALA . 1.1 p -107.28 170.17 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.619 -0.676 . . . . 0.0 109.411 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.674 ' HB3' ' HB2' ' A' ' 45' ' ' GLU . 2.2 m -152.4 86.02 1.27 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.074 -1.016 . . . . 0.0 111.013 -178.187 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.684 HD12 ' CB ' ' A' ' 22' ' ' CYS . 1.9 tp -46.13 -34.04 3.97 Favored 'General case' 0 N--CA 1.509 2.489 0 O-C-N 121.768 -0.583 . . . . 0.0 111.617 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -82.75 -41.94 18.59 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.464 -1.397 . . . . 0.0 110.93 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.674 ' HB2' ' HB3' ' A' ' 42' ' ' SER . 18.9 mt-10 -80.37 5.54 14.64 Favored 'General case' 0 N--CA 1.498 1.938 0 C-N-CA 119.762 -0.775 . . . . 0.0 109.76 177.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.545 ' HG3' ' O ' ' A' ' 14' ' ' VAL . 0.0 OUTLIER 42.48 51.38 4.81 Favored 'General case' 0 N--CA 1.506 2.332 0 O-C-N 121.647 -0.658 . . . . 0.0 111.226 179.866 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.446 ' ND2' ' HA ' ' A' ' 13' ' ' SER . 0.4 OUTLIER -154.45 157.06 37.87 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 120.696 -1.252 . . . . 0.0 111.975 -179.382 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.508 ' HA ' ' HA ' ' A' ' 41' ' ' VAL . . . -136.63 127.16 26.88 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.491 -0.756 . . . . 0.0 109.863 178.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.578 HG23 ' HB3' ' A' ' 40' ' ' LYS . 15.1 t -127.75 119.69 26.31 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.353 -0.842 . . . . 0.0 110.071 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.559 HG22 HG12 ' A' ' 39' ' ' ILE . 1.9 pp -141.88 176.44 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.28 -0.887 . . . . 0.0 111.086 -178.421 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.645 ' CG2' ' HB2' ' A' ' 38' ' ' HIS . 0.0 OUTLIER -117.9 150.49 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 177.014 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.599 ' CD1' ' N ' ' A' ' 52' ' ' TYR . 19.6 p90 -154.09 171.69 18.72 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 119.796 -0.762 . . . . 0.0 111.082 -176.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.0 115.77 63.13 Favored Pre-proline 0 C--N 1.3 -1.569 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -60.17 -22.64 70.94 Favored 'Trans proline' 0 N--CA 1.493 1.457 0 O-C-N 123.587 1.309 . . . . 0.0 110.035 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.4 ptpp? -79.95 -8.98 59.63 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.729 -0.607 . . . . 0.0 110.471 178.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -131.44 -46.64 0.98 Allowed 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.073 -1.017 . . . . 0.0 110.826 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -110.87 154.8 23.52 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.175 -0.953 . . . . 0.0 110.277 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.758 ' HB ' ' HD2' ' A' ' 59' ' ' PRO . 12.2 p -143.46 176.07 2.5 Favored Pre-proline 0 N--CA 1.499 1.982 0 O-C-N 121.488 -0.758 . . . . 0.0 110.456 -179.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.758 ' HD2' ' HB ' ' A' ' 58' ' ' THR . 40.0 Cg_endo -65.26 -23.35 59.55 Favored 'Trans proline' 0 N--CA 1.497 1.717 0 O-C-N 123.317 1.167 . . . . 0.0 112.199 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.528 ' O ' ' HB3' ' A' ' 64' ' ' GLU . 4.7 mmtm -90.47 -29.39 17.97 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.092 -1.005 . . . . 0.0 110.188 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.411 ' OG1' ' N ' ' A' ' 58' ' ' THR . 8.3 p -82.27 -25.84 33.7 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 177.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.514 HD23 HD12 ' A' ' 50' ' ' ILE . 0.9 OUTLIER -77.03 -27.91 54.7 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 176.676 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.455 ' HG3' ' HB3' ' A' ' 73' ' ' ALA . 1.6 tt0 -82.62 -24.5 33.81 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 177.173 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.528 ' HB3' ' O ' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -84.7 -19.47 32.72 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 177.575 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -79.49 -30.54 42.05 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 176.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 32.3 mt -79.53 -37.58 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 176.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.431 ' HB2' ' HA ' ' A' ' 64' ' ' GLU . 0.9 OUTLIER -70.79 -29.35 65.53 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 176.778 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -69.73 -47.59 62.54 Favored 'General case' 0 N--CA 1.501 2.1 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 177.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.535 ' HE2' ' HB2' ' A' ' 29' ' ' GLN . 0.0 OUTLIER -56.53 -36.43 69.22 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.584 -0.698 . . . . 0.0 109.777 179.252 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 120.28 34.99 0.9 Allowed Glycine 0 N--CA 1.494 2.544 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 179.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.548 ' CD2' ' CD1' ' A' ' 26' ' ' ILE . 95.0 m-85 -135.99 144.09 45.16 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.306 -1.114 . . . . 0.0 110.546 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.577 ' HB3' ' CB ' ' A' ' 15' ' ' GLU . 5.2 t70 -60.52 129.78 43.3 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.344 -0.847 . . . . 0.0 109.972 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.455 ' HB3' ' HG3' ' A' ' 63' ' ' GLN . . . -108.76 116.98 33.01 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.459 -0.775 . . . . 0.0 110.565 -179.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.72 ' HB ' ' HB2' ' A' ' 13' ' ' SER . 53.1 t -123.12 73.07 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 CA-C-O 122.138 0.971 . . . . 0.0 108.742 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.584 HG12 HG12 ' A' ' 12' ' ' ILE . 38.1 mt . . . . . 0 N--CA 1.499 1.985 0 CA-C-O 121.827 0.822 . . . . 0.0 112.472 -178.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.553 ' CG1' HD13 ' A' ' 51' ' ' ILE . 9.1 t . . . . . 0 N--CA 1.499 1.987 0 CA-C-O 121.077 0.465 . . . . 0.0 110.041 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.494 ' HB3' ' CZ ' ' A' ' 52' ' ' TYR . 2.9 t-20 -115.24 169.88 8.8 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.058 -1.026 . . . . 0.0 110.92 -179.272 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.637 ' HA ' ' HA ' ' A' ' 51' ' ' ILE . 26.0 p -129.46 128.97 43.99 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.427 -0.796 . . . . 0.0 110.39 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.482 ' HB ' ' CE1' ' A' ' 52' ' ' TYR . 1.2 t -123.48 137.13 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 CA-C-O 121.632 0.73 . . . . 0.0 110.88 -178.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.528 ' HA ' ' HA ' ' A' ' 49' ' ' THR . 4.3 m -118.59 121.13 39.46 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.681 ' HA ' ' HA ' ' A' ' 75' ' ' ILE . 25.6 mt -110.56 118.45 57.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.365 -0.835 . . . . 0.0 111.549 -177.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.426 ' HB2' ' O ' ' A' ' 74' ' ' VAL . 1.1 m -71.89 114.8 10.37 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 177.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.562 ' HA ' ' O ' ' A' ' 72' ' ' ASP . 20.5 t -114.52 130.66 68.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.166 -0.959 . . . . 0.0 111.404 -177.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.632 ' HA ' ' HG2' ' A' ' 46' ' ' LYS . 2.6 mm-40 -112.54 -15.32 13.07 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.14 -0.975 . . . . 0.0 111.521 179.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -79.71 33.44 2.11 Favored Glycine 0 N--CA 1.499 2.866 0 O-C-N 120.845 -1.159 . . . . 0.0 111.493 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.644 ' HG3' ' HA ' ' A' ' 46' ' ' LYS . 32.6 mmt -77.25 75.99 3.8 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 120.682 -1.481 . . . . 0.0 109.486 178.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.516 ' OG1' ' SG ' ' A' ' 22' ' ' CYS . 17.4 p -52.76 -33.78 50.04 Favored 'General case' 0 N--CA 1.51 2.56 0 O-C-N 121.418 -0.802 . . . . 0.0 111.767 -179.017 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.461 ' SG ' ' OG ' ' A' ' 21' ' ' SER . 22.5 p 179.13 164.4 0.9 Allowed 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.644 ' HA ' ' HG ' ' A' ' 43' ' ' LEU . 17.4 m120 -38.58 -32.91 0.09 Allowed 'General case' 0 N--CA 1.509 2.51 0 CA-C-N 117.844 0.293 . . . . 0.0 111.475 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.511 ' HA ' ' HE3' ' A' ' 24' ' ' TRP . 5.0 p -52.09 -19.03 1.68 Allowed 'General case' 0 N--CA 1.507 2.406 0 O-C-N 121.095 -1.003 . . . . 0.0 111.208 177.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.668 ' HB3' ' CE1' ' A' ' 71' ' ' PHE . 84.6 m -88.92 -22.04 23.31 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.375 -0.828 . . . . 0.0 109.406 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.573 ' HA ' HG12 ' A' ' 41' ' ' VAL . 0.9 OUTLIER -80.56 -35.85 15.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 106.714 -1.588 . . . . 0.0 106.714 177.467 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.54 ' CZ3' ' CB ' ' A' ' 20' ' ' ASN . 4.2 m-90 -74.87 -30.7 61.4 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.028 -1.069 . . . . 0.0 109.188 178.188 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.485 ' O ' ' HB2' ' A' ' 29' ' ' GLN . 0.5 OUTLIER -80.73 -19.16 45.6 Favored 'General case' 0 N--CA 1.505 2.281 0 C-N-CA 119.701 -0.8 . . . . 0.0 110.849 179.232 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.509 ' HA ' HD12 ' A' ' 26' ' ' ILE . 7.8 mm -100.15 -21.17 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 O-C-N 121.179 -0.95 . . . . 0.0 109.519 179.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.73 ' HA ' HD12 ' A' ' 39' ' ' ILE . 0.1 OUTLIER -78.82 -36.16 43.04 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 177.309 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.439 ' HB2' ' O ' ' A' ' 24' ' ' TRP . 0.8 OUTLIER -81.06 -36.93 29.85 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 119.82 -0.752 . . . . 0.0 109.492 177.769 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.485 ' HB2' ' O ' ' A' ' 25' ' ' THR . 1.1 tm0? -74.1 -62.32 1.55 Allowed 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 118.94 -1.104 . . . . 0.0 110.257 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.461 ' HB ' ' O ' ' A' ' 26' ' ' ILE . 41.4 mm -61.39 -45.16 99.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.12 -0.988 . . . . 0.0 109.264 179.135 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -50.64 -35.78 30.77 Favored Glycine 0 N--CA 1.501 3.002 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 178.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.436 ' HA ' ' HD3' ' A' ' 32' ' ' LYS . 12.1 mmtm -128.25 34.57 4.54 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.145 -1.209 . . . . 0.0 110.565 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.475 ' HB ' ' O ' ' A' ' 29' ' ' GLN . 8.7 p -74.86 -41.53 46.67 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.017 -1.052 . . . . 0.0 111.799 -178.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -175.95 -54.86 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.113 0 O-C-N 120.903 -1.123 . . . . 0.0 111.08 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.427 ' O ' ' HA ' ' A' ' 52' ' ' TYR . . . -144.09 80.12 0.24 Allowed Glycine 0 N--CA 1.494 2.56 0 N-CA-C 108.763 -1.735 . . . . 0.0 108.763 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.655 HG12 ' HB ' ' A' ' 39' ' ' ILE . 28.7 t -133.82 88.78 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 CA-C-O 122.265 1.031 . . . . 0.0 110.076 -179.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.707 ' HB2' ' CD1' ' A' ' 51' ' ' ILE . 33.1 m-70 -67.16 -27.44 67.29 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.115 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.646 ' HB2' HG12 ' A' ' 51' ' ' ILE . 42.0 m-70 -141.16 125.57 17.62 Favored 'General case' 0 N--CA 1.5 2.025 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.153 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.73 HD12 ' HA ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -126.41 135.28 64.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.101 -0.999 . . . . 0.0 109.8 -179.537 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.465 ' NZ ' ' OG ' ' A' ' 42' ' ' SER . 0.0 OUTLIER -130.06 121.7 26.91 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.966 -1.083 . . . . 0.0 110.593 -179.868 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.573 HG12 ' HA ' ' A' ' 23' ' ' VAL . 2.0 t -109.21 163.51 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 178.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.626 ' HB3' ' HB2' ' A' ' 45' ' ' GLU . 0.6 OUTLIER -151.0 85.49 1.35 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.062 -1.023 . . . . 0.0 110.47 -178.864 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.644 ' HG ' ' HA ' ' A' ' 20' ' ' ASN . 0.2 OUTLIER -52.86 -58.02 8.32 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.713 -0.617 . . . . 0.0 111.372 -179.586 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.9 mp0 -69.69 -44.51 70.27 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.185 -0.947 . . . . 0.0 110.668 -179.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.626 ' HB2' ' HB3' ' A' ' 42' ' ' SER . 1.3 mt-10 -76.81 7.29 4.87 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 120.008 -0.677 . . . . 0.0 110.413 178.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.644 ' HA ' ' HG3' ' A' ' 17' ' ' MET . 0.0 OUTLIER 36.6 66.8 0.37 Allowed 'General case' 0 N--CA 1.5 2.046 0 CA-C-O 121.544 0.688 . . . . 0.0 111.754 178.994 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -157.79 145.18 18.36 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 120.693 -1.254 . . . . 0.0 112.51 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.466 ' HB2' ' HB ' ' A' ' 12' ' ' ILE . . . -124.0 109.15 13.18 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.574 -0.703 . . . . 0.0 109.126 179.1 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.528 ' HA ' ' HA ' ' A' ' 11' ' ' THR . 0.8 OUTLIER -114.92 142.53 46.47 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.047 -1.033 . . . . 0.0 109.194 179.988 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.54 ' CD1' HG22 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -165.25 157.13 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 120.71 -1.244 . . . . 0.0 110.724 -178.92 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.707 ' CD1' ' HB2' ' A' ' 37' ' ' HIS . 1.6 pp -107.08 159.91 6.56 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 O-C-N 121.275 -0.891 . . . . 0.0 109.301 179.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.631 ' CD1' ' N ' ' A' ' 52' ' ' TYR . 6.8 p90 -161.73 166.05 27.17 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.229 -0.919 . . . . 0.0 111.732 -176.013 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.31 113.05 17.31 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.651 -0.656 . . . . 0.0 110.63 179.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.476 ' HD3' ' N ' ' A' ' 8' ' ' ASN . 46.0 Cg_endo -70.25 67.16 2.04 Favored 'Trans proline' 0 N--CA 1.489 1.224 0 O-C-N 123.964 1.507 . . . . 0.0 109.039 179.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.54 -46.88 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 121.419 0.628 . . . . 0.0 109.425 -178.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -98.37 -25.57 14.77 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.603 -0.686 . . . . 0.0 109.997 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.41 ' HG3' ' N ' ' A' ' 58' ' ' THR . 2.3 tp60 -129.53 145.72 51.43 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.222 -0.924 . . . . 0.0 110.0 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.552 ' HB ' ' HD2' ' A' ' 59' ' ' PRO . 7.6 p -135.24 166.44 28.96 Favored Pre-proline 0 N--CA 1.504 2.272 0 O-C-N 121.045 -1.035 . . . . 0.0 110.783 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.552 ' HD2' ' HB ' ' A' ' 58' ' ' THR . 37.8 Cg_endo -62.06 -21.35 72.26 Favored 'Trans proline' 0 N--CA 1.493 1.499 0 O-C-N 123.957 1.504 . . . . 0.0 110.55 179.041 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.83 -38.02 54.6 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 177.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.582 ' HA ' ' HB2' ' A' ' 64' ' ' GLU . 34.4 p -77.74 -27.21 50.4 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 177.241 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.485 ' HB2' ' HA ' ' A' ' 59' ' ' PRO . 17.6 mt -73.02 -27.45 61.78 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 176.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.498 ' HG2' ' CD1' ' A' ' 75' ' ' ILE . 9.1 mm100 -85.62 -19.02 31.62 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 177.302 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.582 ' HB2' ' HA ' ' A' ' 61' ' ' THR . 4.8 mt-10 -90.36 -18.37 25.64 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 177.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.421 ' HB2' HG23 ' A' ' 33' ' ' VAL . . . -87.8 -29.63 20.83 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 177.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.585 HG12 ' HB3' ' A' ' 73' ' ' ALA . 6.9 tp -80.54 -31.61 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 177.179 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.414 ' HB2' ' O ' ' A' ' 63' ' ' GLN . 15.2 t70 -72.22 -29.84 64.33 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 176.272 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -64.52 -48.96 73.15 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.939 -0.475 . . . . 0.0 110.294 179.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.409 ' HB3' ' HD2' ' A' ' 71' ' ' PHE . 5.1 tpt -67.82 -36.94 81.28 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.349 -0.845 . . . . 0.0 110.6 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 108.74 59.1 0.54 Allowed Glycine 0 N--CA 1.498 2.795 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 179.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.668 ' CE1' ' HB3' ' A' ' 22' ' ' CYS . 43.0 m-85 -139.17 122.04 16.58 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.516 -0.991 . . . . 0.0 110.379 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.562 ' O ' ' HA ' ' A' ' 14' ' ' VAL . 6.3 t70 -54.06 104.03 0.1 Allowed 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.546 -0.721 . . . . 0.0 109.186 179.077 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.585 ' HB3' HG12 ' A' ' 66' ' ' ILE . . . -116.73 147.12 42.3 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 122.129 0.966 . . . . 0.0 112.596 -177.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.426 ' O ' ' HB2' ' A' ' 13' ' ' SER . 46.1 t -138.07 81.55 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 CA-C-O 122.011 0.91 . . . . 0.0 108.585 179.157 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.681 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.485 0 CA-C-O 122.679 1.228 . . . . 0.0 112.789 -178.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.499 1.984 0 CA-C-O 120.863 0.363 . . . . 0.0 110.382 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -120.68 72.74 22.0 Favored Pre-proline 0 N--CA 1.498 1.958 0 O-C-N 121.496 -0.753 . . . . 0.0 111.118 -179.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -70.84 -19.87 30.43 Favored 'Trans proline' 0 C--N 1.314 -1.276 0 N-CA-C 108.396 -1.425 . . . . 0.0 108.396 177.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.555 ' HA ' ' CG2' ' A' ' 7' ' ' VAL . 2.6 m -177.43 40.67 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.7 -0.625 . . . . 0.0 109.379 179.22 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -39.24 -40.74 0.79 Allowed 'General case' 0 N--CA 1.506 2.342 0 O-C-N 121.646 -0.659 . . . . 0.0 112.343 -179.058 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -141.98 47.33 0.84 Allowed Glycine 0 N--CA 1.498 2.78 0 C-N-CA 119.781 -1.2 . . . . 0.0 111.197 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.555 ' CG2' ' HA ' ' A' ' 4' ' ' SER . 1.7 m -141.18 176.81 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.463 0 CA-C-N 118.179 0.99 . . . . 0.0 110.298 178.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.409 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 0.5 OUTLIER -135.8 165.99 24.32 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.957 -1.089 . . . . 0.0 111.034 -179.827 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.62 ' HA ' ' HA ' ' A' ' 51' ' ' ILE . 38.0 t -114.4 150.68 34.28 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.232 -0.917 . . . . 0.0 111.421 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.434 ' CG1' HD21 ' A' ' 62' ' ' LEU . 0.9 OUTLIER -144.17 130.22 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.783 -0.573 . . . . 0.0 110.559 -179.234 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.568 ' HA ' ' HA ' ' A' ' 49' ' ' THR . 90.2 m -109.22 122.25 46.92 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.538 0.685 . . . . 0.0 110.595 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.648 HG12 ' CG2' ' A' ' 75' ' ' ILE . 45.9 mt -109.61 121.61 62.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.568 -0.707 . . . . 0.0 111.239 -178.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.639 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 1.4 m -70.71 133.28 46.48 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 177.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.485 HG21 ' HB2' ' A' ' 48' ' ' ALA . 2.1 t -127.03 161.06 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.11 -0.994 . . . . 0.0 111.083 -178.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.83 158.65 35.58 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.493 -0.754 . . . . 0.0 110.728 178.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 73.93 20.99 79.71 Favored Glycine 0 N--CA 1.497 2.706 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.591 ' HB3' ' CD1' ' A' ' 71' ' ' PHE . 0.0 OUTLIER -128.87 28.93 5.29 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.891 -1.358 . . . . 0.0 110.806 -179.816 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.8 m -71.59 49.17 0.16 Allowed 'General case' 0 N--CA 1.501 2.114 0 O-C-N 120.918 -1.114 . . . . 0.0 111.243 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.487 ' O ' ' N ' ' A' ' 21' ' ' SER . 0.0 OUTLIER -150.56 118.55 6.27 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.879 -1.138 . . . . 0.0 108.896 178.844 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.487 ' O ' HG13 ' A' ' 23' ' ' VAL . 76.5 m-20 -14.97 -51.55 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.761 0 C-N-CA 123.742 0.817 . . . . 0.0 113.115 -178.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.796 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 3.7 p -52.1 -14.46 0.42 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.399 -0.813 . . . . 0.0 112.973 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.604 ' HB2' HD21 ' A' ' 43' ' ' LEU . 63.8 m -91.63 -24.77 19.44 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 119.121 -2.237 . . . . 0.0 110.65 -179.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.725 ' HB ' ' HG ' ' A' ' 43' ' ' LEU . 1.6 p -87.8 -34.98 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.53 -0.731 . . . . 0.0 109.231 179.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.796 ' CE3' ' HA ' ' A' ' 21' ' ' SER . 0.0 OUTLIER -81.79 -22.67 37.0 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 117.687 -1.605 . . . . 0.0 109.094 178.828 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.633 ' HB ' ' CZ3' ' A' ' 24' ' ' TRP . 0.6 OUTLIER -87.6 -24.68 23.9 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 120.94 -1.1 . . . . 0.0 110.812 178.027 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.562 HD12 ' CB ' ' A' ' 69' ' ' MET . 12.5 mm -92.78 -26.53 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.388 0 O-C-N 120.874 -1.142 . . . . 0.0 109.656 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.621 ' HG2' HD11 ' A' ' 39' ' ' ILE . 4.4 tm-20 -78.83 -40.22 33.37 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 177.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.43 ' HB2' ' O ' ' A' ' 24' ' ' TRP . 68.9 mm-40 -70.44 -33.79 71.73 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 119.361 -0.936 . . . . 0.0 109.287 178.315 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.508 ' HA ' ' OE1' ' A' ' 29' ' ' GLN . 4.3 tp60 -75.89 -62.16 1.68 Allowed 'General case' 0 N--CA 1.496 1.849 0 C-N-CA 119.61 -0.836 . . . . 0.0 110.586 179.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.529 HG21 HG23 ' A' ' 50' ' ' ILE . 51.1 mt -60.85 -50.5 80.26 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 O-C-N 120.994 -1.066 . . . . 0.0 109.841 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -47.73 -44.2 23.33 Favored Glycine 0 N--CA 1.5 2.917 0 N-CA-C 110.849 -0.901 . . . . 0.0 110.849 179.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.01 16.86 24.46 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.98 -1.306 . . . . 0.0 112.447 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -65.79 -42.3 92.04 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.175 0 O-C-N 120.89 -1.131 . . . . 0.0 111.061 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -163.04 -76.75 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.222 -0.924 . . . . 0.0 110.784 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.524 ' O ' ' HA ' ' A' ' 52' ' ' TYR . . . -141.39 75.84 0.33 Allowed Glycine 0 N--CA 1.495 2.567 0 N-CA-C 108.758 -1.737 . . . . 0.0 108.758 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.729 HG12 ' HB ' ' A' ' 39' ' ' ILE . 41.1 t -103.04 91.43 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 CA-C-O 122.665 1.221 . . . . 0.0 108.128 179.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.454 ' HB2' ' CD1' ' A' ' 51' ' ' ILE . 63.2 m-70 -61.67 -14.27 29.82 Favored 'General case' 0 C--N 1.283 -2.325 0 CA-C-N 114.827 -1.079 . . . . 0.0 110.627 -179.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.575 ' HB3' HG22 ' A' ' 51' ' ' ILE . 6.8 t60 -170.83 121.1 0.56 Allowed 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.729 ' HB ' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -122.07 128.8 75.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.268 -0.895 . . . . 0.0 109.565 -179.438 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.457 ' HB3' HG22 ' A' ' 49' ' ' THR . 0.0 OUTLIER -125.19 99.83 6.26 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.599 -1.313 . . . . 0.0 111.445 -179.615 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.467 ' HA ' ' HA ' ' A' ' 48' ' ' ALA . 15.0 p -107.41 153.97 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 177.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.81 ' HB3' ' HB3' ' A' ' 45' ' ' GLU . 0.2 OUTLIER -153.15 94.33 1.82 Allowed 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.103 -0.998 . . . . 0.0 110.763 -178.057 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.725 ' HG ' ' HB ' ' A' ' 23' ' ' VAL . 14.5 mt -46.83 -25.17 0.7 Allowed 'General case' 0 N--CA 1.508 2.436 0 O-C-N 121.923 -0.486 . . . . 0.0 112.016 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.574 ' HG2' ' N ' ' A' ' 45' ' ' GLU . 0.4 OUTLIER -96.92 -38.48 9.8 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 120.4 -1.437 . . . . 0.0 111.332 179.651 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.81 ' HB3' ' HB3' ' A' ' 42' ' ' SER . 0.2 OUTLIER -74.61 -4.2 35.72 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.202 -0.936 . . . . 0.0 108.802 177.476 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.9 mptt 56.66 34.88 25.28 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.271 -0.893 . . . . 0.0 112.961 177.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -148.19 151.32 35.32 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.534 -1.353 . . . . 0.0 112.071 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.485 ' HB2' HG21 ' A' ' 14' ' ' VAL . . . -130.84 103.28 6.48 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.568 ' HA ' ' HA ' ' A' ' 11' ' ' THR . 14.8 t -116.55 134.72 54.51 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.233 -0.917 . . . . 0.0 110.376 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.609 ' CG1' HD23 ' A' ' 62' ' ' LEU . 1.3 pp -144.85 -178.71 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-O 121.621 0.724 . . . . 0.0 110.785 -178.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.62 ' HA ' ' HA ' ' A' ' 9' ' ' SER . 0.0 OUTLIER -121.59 145.38 28.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 177.918 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.586 ' CD1' ' N ' ' A' ' 52' ' ' TYR . 13.7 p90 -149.2 165.82 30.7 Favored 'General case' 0 C--N 1.296 -1.761 0 O-C-N 121.245 -0.909 . . . . 0.0 111.347 -177.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -84.5 107.14 10.09 Favored Pre-proline 0 N--CA 1.49 1.539 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.701 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.516 ' HD3' ' O ' ' A' ' 52' ' ' TYR . 48.2 Cg_endo -75.11 -9.12 20.48 Favored 'Trans proline' 0 C--N 1.319 -1.018 0 O-C-N 123.624 1.328 . . . . 0.0 109.75 178.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 8.8 mtmm -74.18 -35.97 64.01 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.5 pp -121.4 -17.16 7.68 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.523 -0.736 . . . . 0.0 111.44 179.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.482 ' OE1' ' HB ' ' A' ' 61' ' ' THR . 2.7 mm-40 -131.58 -179.39 5.35 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.796 -1.19 . . . . 0.0 110.484 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.516 ' OG1' ' HD2' ' A' ' 59' ' ' PRO . 0.5 OUTLIER -164.22 173.5 3.96 Favored Pre-proline 0 N--CA 1.497 1.914 0 O-C-N 120.874 -1.141 . . . . 0.0 110.01 -179.993 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.516 ' HD2' ' OG1' ' A' ' 58' ' ' THR . 37.9 Cg_endo -62.78 8.32 0.13 Allowed 'Trans proline' 0 N--CA 1.502 1.972 0 C-N-CA 121.227 1.285 . . . . 0.0 113.258 -179.164 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.553 ' HG3' ' N ' ' A' ' 61' ' ' THR . 0.2 OUTLIER -90.68 -28.27 18.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.973 -1.08 . . . . 0.0 108.525 177.773 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.553 ' N ' ' HG3' ' A' ' 60' ' ' LYS . 0.8 OUTLIER -85.85 -27.69 24.91 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 177.953 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.609 HD23 ' CG1' ' A' ' 50' ' ' ILE . 4.5 mp -72.15 -27.62 62.72 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 176.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.454 ' O ' ' HB2' ' A' ' 67' ' ' ASP . 14.2 tp60 -86.65 -20.21 28.14 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 177.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.52 ' HB3' ' O ' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -91.28 -22.15 20.71 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.159 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -85.27 -27.66 25.85 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.515 HG12 ' HB1' ' A' ' 73' ' ' ALA . 2.1 tp -85.17 -32.73 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 177.249 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.454 ' HB2' ' O ' ' A' ' 63' ' ' GLN . 27.8 t70 -74.37 -32.28 62.68 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 177.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.5 -43.39 69.79 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.878 -0.514 . . . . 0.0 109.868 178.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.562 ' CB ' HD12 ' A' ' 26' ' ' ILE . 23.6 mmm -59.86 -46.72 88.38 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.18 -0.95 . . . . 0.0 109.996 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 114.54 51.42 0.46 Allowed Glycine 0 N--CA 1.499 2.846 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.591 ' CD1' ' HB3' ' A' ' 17' ' ' MET . 75.1 m-85 -139.27 130.18 26.29 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.69 -0.888 . . . . 0.0 109.526 179.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.46 ' O ' ' HA ' ' A' ' 14' ' ' VAL . 1.7 m-20 -49.9 111.32 0.49 Allowed 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.433 -0.792 . . . . 0.0 110.045 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.515 ' HB1' HG12 ' A' ' 66' ' ' ILE . . . -109.77 127.26 54.52 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.185 -0.947 . . . . 0.0 111.582 -178.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.639 ' HB ' ' HB2' ' A' ' 13' ' ' SER . 75.5 t -131.67 76.4 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.487 -0.758 . . . . 0.0 109.071 178.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.648 ' CG2' HG12 ' A' ' 12' ' ' ILE . 33.3 pt -58.73 138.38 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 CA-C-O 121.763 0.792 . . . . 0.0 110.861 -179.106 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.493 ' NE2' HG21 ' A' ' 11' ' ' THR . 13.3 p80 -130.14 45.06 2.87 Favored 'General case' 0 N--CA 1.5 2.064 0 CA-C-O 121.459 0.647 . . . . 0.0 110.824 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.517 ' CB ' ' CD ' ' A' ' 78' ' ' PRO . 0.3 OUTLIER -109.93 -66.2 0.03 OUTLIER Pre-proline 0 N--CA 1.496 1.863 0 O-C-N 121.228 -0.92 . . . . 0.0 111.095 179.997 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.517 ' CD ' ' CB ' ' A' ' 77' ' ' ASN . 44.5 Cg_endo -75.0 -28.54 9.07 Favored 'Trans proline' 0 N--CA 1.488 1.152 0 O-C-N 123.113 1.06 . . . . 0.0 110.78 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 . . . . . 0 N--CA 1.486 1.334 0 CA-C-O 118.372 -0.823 . . . . 0.0 110.471 -179.764 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.795 0 CA-C-O 120.821 0.344 . . . . 0.0 110.18 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 47.24 66.93 4.99 Favored Pre-proline 0 N--CA 1.504 2.253 0 O-C-N 121.822 -0.549 . . . . 0.0 111.87 179.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -71.25 -17.46 31.07 Favored 'Trans proline' 0 C--N 1.313 -1.333 0 O-C-N 123.463 1.244 . . . . 0.0 109.114 177.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 95.3 p -135.95 -2.49 2.34 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.49 -0.757 . . . . 0.0 111.599 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 1.4 mtm 48.98 33.19 4.37 Favored 'General case' 0 N--CA 1.504 2.26 0 O-C-N 121.238 -0.913 . . . . 0.0 111.187 -179.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.482 ' O ' ' HB ' ' A' ' 7' ' ' VAL . . . 64.76 28.42 73.32 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.591 HG12 ' CD1' ' A' ' 51' ' ' ILE . 12.9 t 69.08 158.4 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.344 0 CA-C-N 117.778 0.789 . . . . 0.0 110.446 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.4 ' O ' HG12 ' A' ' 51' ' ' ILE . 9.8 m120 -124.6 166.3 16.35 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 120.785 -1.197 . . . . 0.0 111.306 -179.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.621 ' HA ' ' HA ' ' A' ' 51' ' ' ILE . 2.5 m -120.29 145.68 46.85 Favored 'General case' 0 N--CA 1.505 2.294 0 O-C-N 121.088 -1.007 . . . . 0.0 111.833 -179.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.405 ' CG2' ' HB3' ' A' ' 59' ' ' PRO . 1.0 OUTLIER -134.24 140.97 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.639 -0.663 . . . . 0.0 110.891 -179.29 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.6 ' HA ' ' HA ' ' A' ' 49' ' ' THR . 2.9 m -118.91 130.35 55.68 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.229 -0.919 . . . . 0.0 110.151 178.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.7 ' HA ' ' HA ' ' A' ' 75' ' ' ILE . 51.9 mt -122.74 133.02 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.363 -0.836 . . . . 0.0 111.553 -178.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.543 ' HB3' ' CG1' ' A' ' 74' ' ' VAL . 0.1 OUTLIER -87.75 117.2 26.42 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.071 -1.018 . . . . 0.0 108.703 178.129 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.592 HG13 ' CE ' ' A' ' 17' ' ' MET . 14.6 p -112.21 108.43 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 O-C-N 121.179 -0.951 . . . . 0.0 110.408 -178.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.506 ' HA ' ' HD2' ' A' ' 46' ' ' LYS . 0.1 OUTLIER -108.34 -32.11 7.58 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.052 -1.03 . . . . 0.0 112.008 -178.6 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -70.03 30.97 0.41 Allowed Glycine 0 N--CA 1.502 3.066 0 C-N-CA 120.423 -0.894 . . . . 0.0 112.255 -179.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.638 ' SD ' ' HA ' ' A' ' 43' ' ' LEU . 13.2 ptp -90.75 -173.21 3.64 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.474 -1.603 . . . . 0.0 109.799 178.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 16.9 p -147.22 -27.65 0.38 Allowed 'General case' 0 N--CA 1.514 2.745 0 O-C-N 121.248 -0.908 . . . . 0.0 112.283 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.428 ' C ' HD12 ' A' ' 43' ' ' LEU . 19.5 p -179.7 176.44 0.78 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.109 -0.994 . . . . 0.0 108.55 -179.048 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.603 ' HB3' ' CZ3' ' A' ' 24' ' ' TRP . 4.3 m120 -43.31 -31.69 0.68 Allowed 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.773 -0.579 . . . . 0.0 110.618 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.553 ' HA ' ' HE3' ' A' ' 24' ' ' TRP . 3.7 p -54.12 -26.29 26.68 Favored 'General case' 0 N--CA 1.506 2.339 0 O-C-N 121.06 -1.025 . . . . 0.0 110.398 178.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.533 ' HB3' ' CE1' ' A' ' 71' ' ' PHE . 80.7 m -91.49 -25.81 19.1 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.701 0.762 . . . . 0.0 108.977 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.568 HG22 ' CD1' ' A' ' 43' ' ' LEU . 12.0 t -79.47 -41.62 22.49 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 176.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.603 ' CZ3' ' HB3' ' A' ' 20' ' ' ASN . 2.1 m0 -60.79 -40.47 92.75 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 176.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 40.2 m -66.7 -31.05 71.47 Favored 'General case' 0 N--CA 1.502 2.127 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.608 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.538 ' HA ' ' SD ' ' A' ' 69' ' ' MET . 2.1 mt -99.07 -17.22 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.225 0 O-C-N 121.142 -0.974 . . . . 0.0 110.902 -179.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.676 ' HG3' HD13 ' A' ' 39' ' ' ILE . 1.1 tt0 -87.67 -31.66 19.63 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 177.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.472 ' HB3' ' O ' ' A' ' 24' ' ' TRP . 1.1 tm0? -80.41 -39.49 28.22 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 178.016 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.406 ' HB2' ' SD ' ' A' ' 69' ' ' MET . 7.2 mm100 -70.6 -60.02 2.5 Favored 'General case' 0 N--CA 1.502 2.154 0 C-N-CA 119.251 -0.98 . . . . 0.0 110.352 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.521 HG12 ' HE3' ' A' ' 69' ' ' MET . 45.4 mm -60.58 -42.38 91.37 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.113 -0.992 . . . . 0.0 110.497 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -51.73 -45.93 54.6 Favored Glycine 0 N--CA 1.5 2.961 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.4 mttt -114.98 27.53 9.34 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.331 -1.099 . . . . 0.0 111.494 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.476 HG21 ' HB1' ' A' ' 65' ' ' ALA . 12.2 p -66.46 -43.26 91.09 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 O-C-N 120.887 -1.133 . . . . 0.0 111.449 -179.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.481 ' HB3' ' HG2' ' A' ' 57' ' ' GLN . 0.7 OUTLIER -178.86 -52.13 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.109 -0.995 . . . . 0.0 110.777 179.847 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.417 ' O ' ' HA ' ' A' ' 52' ' ' TYR . . . -148.24 81.74 0.2 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -179.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.683 HG12 ' HB ' ' A' ' 39' ' ' ILE . 38.8 t -133.07 97.4 2.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.013 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.585 ' HB2' ' CD1' ' A' ' 51' ' ' ILE . 59.5 m-70 -72.1 -29.28 63.94 Favored 'General case' 0 C--N 1.289 -2.063 0 C-N-CA 120.043 -0.663 . . . . 0.0 109.818 -179.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.619 ' HB2' HG23 ' A' ' 51' ' ' ILE . 24.7 m-70 -144.57 117.23 8.66 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.683 ' HB ' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -117.79 126.02 74.52 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 179.391 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.558 ' HB3' HG21 ' A' ' 49' ' ' THR . 2.1 tmtm? -126.52 119.54 27.39 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.616 -1.303 . . . . 0.0 111.01 -179.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.511 HG21 HG21 ' A' ' 26' ' ' ILE . 47.0 t -107.29 170.77 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 178.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.679 ' HB3' ' HB2' ' A' ' 45' ' ' GLU . 0.6 OUTLIER -149.82 85.25 1.42 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.683 -1.261 . . . . 0.0 110.67 -179.51 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.638 ' HA ' ' SD ' ' A' ' 17' ' ' MET . 20.0 tp -42.53 -43.1 3.58 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.2 mp0 -82.92 -44.24 15.58 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.154 -0.966 . . . . 0.0 111.771 -178.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.679 ' HB2' ' HB3' ' A' ' 42' ' ' SER . 5.8 mt-10 -80.03 8.94 6.09 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.195 -0.941 . . . . 0.0 110.344 179.133 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.538 ' HD3' ' SD ' ' A' ' 17' ' ' MET . 8.1 mmtp 37.15 59.47 1.11 Allowed 'General case' 0 N--CA 1.504 2.253 0 CA-C-O 121.528 0.68 . . . . 0.0 110.967 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.402 ' HA ' ' H ' ' A' ' 14' ' ' VAL . 12.5 t-20 -159.08 149.08 19.14 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.031 -1.043 . . . . 0.0 111.202 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.477 ' HA ' ' O ' ' A' ' 40' ' ' LYS . . . -139.41 122.31 16.62 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.4 -0.813 . . . . 0.0 110.745 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.6 ' HA ' ' HA ' ' A' ' 11' ' ' THR . 6.9 t -113.59 151.93 31.01 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.302 -0.874 . . . . 0.0 109.539 178.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.566 HG13 HG23 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -160.13 157.23 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.026 -1.046 . . . . 0.0 111.954 -177.932 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.621 ' HA ' ' HA ' ' A' ' 9' ' ' SER . 0.0 OUTLIER -109.89 152.85 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.587 -0.696 . . . . 0.0 109.27 178.378 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.556 ' CD1' ' N ' ' A' ' 52' ' ' TYR . 33.9 p90 -158.04 160.16 37.11 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.899 -0.72 . . . . 0.0 111.874 -177.056 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -86.61 120.32 71.86 Favored Pre-proline 0 N--CA 1.492 1.669 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 177.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -59.23 -29.68 91.0 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 O-C-N 123.633 1.333 . . . . 0.0 109.73 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.38 -19.18 65.38 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.855 -0.528 . . . . 0.0 110.681 178.174 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -124.65 -36.82 2.55 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.096 -1.003 . . . . 0.0 111.441 -179.173 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.528 ' C ' HG22 ' A' ' 58' ' ' THR . 3.4 mm-40 -130.15 155.05 46.85 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.054 -1.029 . . . . 0.0 110.399 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.603 ' HB ' ' HD2' ' A' ' 59' ' ' PRO . 4.7 p -136.61 172.97 6.09 Favored Pre-proline 0 N--CA 1.5 2.074 0 O-C-N 121.004 -1.06 . . . . 0.0 109.807 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.603 ' HD2' ' HB ' ' A' ' 58' ' ' THR . 42.9 Cg_endo -68.45 -14.36 39.73 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 O-C-N 123.326 1.171 . . . . 0.0 110.896 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.8 -38.37 13.03 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.322 -0.861 . . . . 0.0 109.352 179.042 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.556 ' HA ' ' HB2' ' A' ' 64' ' ' GLU . 0.3 OUTLIER -73.14 -27.01 61.43 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.237 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.445 ' CD2' HD12 ' A' ' 50' ' ' ILE . 16.3 mt -72.18 -28.39 63.18 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 176.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -83.43 -32.24 26.19 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 177.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.556 ' HB2' ' HA ' ' A' ' 61' ' ' THR . 0.1 OUTLIER -71.58 -20.08 62.05 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 177.402 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.476 ' HB1' HG21 ' A' ' 33' ' ' VAL . . . -90.02 -25.18 20.97 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 177.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.504 HG13 HD12 ' A' ' 12' ' ' ILE . 0.4 OUTLIER -88.62 -39.49 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 178.042 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -68.87 -29.62 67.96 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 177.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.45 -44.01 59.05 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.552 -0.717 . . . . 0.0 109.881 178.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.538 ' SD ' ' HA ' ' A' ' 26' ' ' ILE . 28.7 mtm -51.69 -49.82 61.66 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.455 -0.778 . . . . 0.0 110.52 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 111.47 55.24 0.5 Allowed Glycine 0 N--CA 1.498 2.797 0 C-N-CA 119.542 -1.313 . . . . 0.0 110.096 179.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.533 ' CE1' ' HB3' ' A' ' 22' ' ' CYS . 25.4 m-85 -135.89 124.37 23.51 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.637 -0.92 . . . . 0.0 109.357 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -56.62 92.98 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.513 -0.742 . . . . 0.0 109.513 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.469 ' HA ' ' O ' ' A' ' 13' ' ' SER . . . -120.56 178.27 4.74 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 122.188 0.994 . . . . 0.0 112.13 -178.143 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.543 ' CG1' ' HB3' ' A' ' 13' ' ' SER . 3.6 p -159.26 91.68 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 179.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.7 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . 25.1 pt -57.15 153.18 2.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 CA-C-O 122.362 1.077 . . . . 0.0 111.772 -178.279 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -109.81 31.86 5.51 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.215 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -130.9 88.98 44.22 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 121.444 -0.785 . . . . 0.0 110.269 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -77.44 61.09 7.29 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 O-C-N 123.475 1.25 . . . . 0.0 110.467 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.534 ' HB2' ' HG3' ' A' ' 59' ' ' PRO . 7.2 m-20 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 117.826 -1.083 . . . . 0.0 110.131 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpp? . . . . . 0 N--CA 1.503 2.202 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 49.92 67.37 4.48 Favored Pre-proline 0 N--CA 1.496 1.865 0 O-C-N 121.797 -0.564 . . . . 0.0 111.555 178.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -70.07 -17.04 36.42 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 O-C-N 123.936 1.492 . . . . 0.0 109.057 177.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 89.7 p -126.4 -12.6 6.18 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.53 -0.731 . . . . 0.0 111.283 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 1.8 ttp 55.05 23.05 4.86 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.157 -0.964 . . . . 0.0 111.022 -179.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 85.69 6.96 82.37 Favored Glycine 0 N--CA 1.5 2.931 0 O-C-N 121.032 -1.043 . . . . 0.0 111.071 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.467 HG13 HD11 ' A' ' 51' ' ' ILE . 4.8 t -121.93 160.71 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.057 -1.261 . . . . 0.0 109.935 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.578 ' HB3' ' CZ ' ' A' ' 52' ' ' TYR . 0.9 OUTLIER -116.35 163.92 15.31 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.89 -1.131 . . . . 0.0 110.392 179.816 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.636 ' HA ' ' HA ' ' A' ' 51' ' ' ILE . 47.5 p -129.37 143.5 50.87 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.237 -0.915 . . . . 0.0 111.247 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.464 ' CG2' ' HB3' ' A' ' 59' ' ' PRO . 0.9 OUTLIER -142.26 142.26 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 CA-C-O 121.674 0.75 . . . . 0.0 110.806 -179.553 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.545 ' HA ' ' HA ' ' A' ' 49' ' ' THR . 20.7 m -106.47 145.99 31.11 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.892 ' HA ' HG12 ' A' ' 75' ' ' ILE . 23.3 mm -126.42 116.13 44.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -177.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.539 ' H ' ' CG2' ' A' ' 75' ' ' ILE . 1.4 t -82.91 111.25 18.62 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 176.089 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.525 HG23 ' HB3' ' A' ' 71' ' ' PHE . 9.8 p -108.91 135.06 48.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 O-C-N 121.538 -0.726 . . . . 0.0 112.325 -176.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -116.57 174.3 6.15 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.455 -0.778 . . . . 0.0 110.348 179.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 81.91 -7.73 62.02 Favored Glycine 0 N--CA 1.499 2.889 0 C-N-CA 120.483 -0.865 . . . . 0.0 111.164 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.674 ' HB3' HD12 ' A' ' 43' ' ' LEU . 12.4 mtm -82.46 112.09 19.08 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.76 -1.436 . . . . 0.0 111.041 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.4 t -139.56 25.14 2.42 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.07 -1.019 . . . . 0.0 111.984 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.456 ' O ' ' N ' ' A' ' 21' ' ' SER . 0.4 OUTLIER -170.07 139.33 1.81 Allowed 'General case' 0 N--CA 1.5 2.073 0 O-C-N 120.991 -1.068 . . . . 0.0 109.075 178.978 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.528 ' HA ' ' CD2' ' A' ' 43' ' ' LEU . 22.6 m120 -23.09 -45.44 0.01 OUTLIER 'General case' 0 N--CA 1.518 2.958 0 CA-C-O 121.453 0.644 . . . . 0.0 112.585 -178.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.815 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 1.5 p -56.46 -14.13 2.81 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.705 ' HB2' HD13 ' A' ' 43' ' ' LEU . 71.8 m -92.91 -26.83 17.43 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 119.808 -1.808 . . . . 0.0 111.678 -178.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.632 ' HB ' ' HB2' ' A' ' 43' ' ' LEU . 7.9 p -88.92 -34.73 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.119 -0.988 . . . . 0.0 108.706 178.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.815 ' CE3' ' HA ' ' A' ' 21' ' ' SER . 0.0 OUTLIER -79.98 -23.59 41.49 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 117.634 -1.626 . . . . 0.0 108.964 178.495 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.591 ' HB ' ' CZ3' ' A' ' 24' ' ' TRP . 1.7 t -84.46 -27.41 27.51 Favored 'General case' 0 N--CA 1.506 2.346 0 O-C-N 120.679 -1.263 . . . . 0.0 110.352 178.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.495 ' CD1' ' CD2' ' A' ' 71' ' ' PHE . 17.8 mm -89.48 -29.91 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 O-C-N 121.142 -0.973 . . . . 0.0 109.532 179.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.705 ' HG3' HG23 ' A' ' 39' ' ' ILE . 9.8 tt0 -81.31 -32.66 33.02 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 178.287 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.537 ' HB2' ' O ' ' A' ' 24' ' ' TRP . 0.9 OUTLIER -80.45 -26.5 38.29 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.281 177.872 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.418 ' O ' ' HB ' ' A' ' 33' ' ' VAL . 4.1 tp60 -71.43 -65.44 0.75 Allowed 'General case' 0 N--CA 1.497 1.92 0 C-N-CA 119.238 -0.985 . . . . 0.0 108.824 179.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.588 HG23 HG12 ' A' ' 50' ' ' ILE . 18.2 mm -59.51 -52.02 65.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.237 -0.915 . . . . 0.0 110.258 179.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -49.18 -39.75 27.94 Favored Glycine 0 N--CA 1.502 3.061 0 N-CA-C 110.404 -1.079 . . . . 0.0 110.404 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.15 26.39 10.51 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.232 -1.158 . . . . 0.0 111.047 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.502 HG12 ' OD1' ' A' ' 34' ' ' ASN . 11.1 p -74.36 -46.81 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 120.455 -1.403 . . . . 0.0 111.331 -179.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.502 ' OD1' HG12 ' A' ' 33' ' ' VAL . 1.0 OUTLIER -173.46 -32.14 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.33 0 O-C-N 120.907 -1.12 . . . . 0.0 111.633 179.259 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.507 ' O ' ' HA ' ' A' ' 52' ' ' TYR . . . -168.97 85.37 0.09 OUTLIER Glycine 0 N--CA 1.496 2.695 0 C-N-CA 119.873 -1.156 . . . . 0.0 110.509 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.755 HG12 ' CD1' ' A' ' 39' ' ' ILE . 42.8 t -130.38 90.34 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 CA-C-O 122.512 1.148 . . . . 0.0 109.307 178.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.562 ' HB2' HD13 ' A' ' 51' ' ' ILE . 42.1 m-70 -65.88 -13.46 59.68 Favored 'General case' 0 C--N 1.286 -2.153 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.926 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.743 ' HB3' HG12 ' A' ' 51' ' ' ILE . 0.2 OUTLIER -152.22 128.52 10.56 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 120.759 -1.213 . . . . 0.0 110.381 179.385 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.755 ' CD1' HG12 ' A' ' 36' ' ' VAL 0.293 2.0 mm -121.19 139.26 48.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.857 -177.906 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.687 ' HB3' HG23 ' A' ' 49' ' ' THR . 0.0 OUTLIER -142.1 83.17 1.83 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.556 -1.34 . . . . 0.0 109.685 176.621 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.505 HG21 ' HB2' ' A' ' 48' ' ' ALA . 17.2 t -107.33 155.94 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.068 -1.02 . . . . 0.0 109.272 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.729 ' HB2' ' HB3' ' A' ' 45' ' ' GLU . 41.5 m -152.33 91.07 1.55 Allowed 'General case' 0 C--N 1.308 -1.21 0 O-C-N 121.112 -0.992 . . . . 0.0 110.1 -178.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.705 HD13 ' HB2' ' A' ' 22' ' ' CYS . 6.9 tp -30.77 -53.38 0.19 Allowed 'General case' 0 N--CA 1.508 2.474 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -179.285 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.566 ' HA ' ' NZ ' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -78.5 -37.13 43.96 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.687 -1.258 . . . . 0.0 112.241 -178.81 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.729 ' HB3' ' HB2' ' A' ' 42' ' ' SER . 27.5 tt0 -59.48 -15.37 17.16 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 119.617 -0.833 . . . . 0.0 109.274 177.35 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.566 ' NZ ' ' HA ' ' A' ' 44' ' ' GLU . 0.1 OUTLIER 53.71 52.83 12.4 Favored 'General case' 0 N--CA 1.503 2.209 0 CA-C-O 121.816 0.817 . . . . 0.0 109.812 -179.813 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.465 ' ND2' ' HA ' ' A' ' 13' ' ' SER . 0.2 OUTLIER -170.75 159.37 6.44 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.579 -0.701 . . . . 0.0 109.716 179.905 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.505 ' HB2' HG21 ' A' ' 41' ' ' VAL . . . -150.7 116.85 5.63 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.302 -0.874 . . . . 0.0 109.492 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.687 HG23 ' HB3' ' A' ' 40' ' ' LYS . 4.8 t -110.13 127.38 54.86 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 120.843 -1.161 . . . . 0.0 109.069 179.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.622 ' HB ' HD13 ' A' ' 39' ' ' ILE . 1.8 pp -140.5 164.04 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.43 -0.793 . . . . 0.0 110.567 -177.155 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.743 HG12 ' HB3' ' A' ' 38' ' ' HIS . 1.5 pp -113.61 172.54 3.4 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 O-C-N 120.936 -1.103 . . . . 0.0 109.734 178.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.578 ' CZ ' ' HB3' ' A' ' 8' ' ' ASN . 11.0 p90 -163.3 167.36 21.98 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.343 -0.848 . . . . 0.0 110.963 -178.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -88.17 121.74 70.28 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.456 -0.778 . . . . 0.0 110.458 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -64.92 -29.58 57.87 Favored 'Trans proline' 0 N--CA 1.488 1.185 0 O-C-N 123.804 1.423 . . . . 0.0 108.784 178.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.1 ptpp? -77.62 -6.48 53.94 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.854 -0.529 . . . . 0.0 110.627 178.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.445 HD21 ' HG2' ' A' ' 57' ' ' GLN . 1.6 tt -117.13 -46.97 2.69 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.089 -1.007 . . . . 0.0 111.16 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.445 ' HG2' HD21 ' A' ' 56' ' ' LEU . 21.1 mm-40 -148.87 -174.05 4.52 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.077 -1.014 . . . . 0.0 110.951 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.581 ' HB ' ' HD2' ' A' ' 59' ' ' PRO . 1.1 p -144.07 176.82 2.05 Favored Pre-proline 0 N--CA 1.499 1.98 0 O-C-N 121.086 -1.009 . . . . 0.0 109.715 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.651 ' HB2' ' HA ' ' A' ' 77' ' ' ASN . 40.6 Cg_endo -68.29 -7.04 18.93 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 O-C-N 123.529 1.279 . . . . 0.0 110.791 178.362 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.86 -38.16 58.24 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.092 -1.005 . . . . 0.0 109.333 178.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.664 ' HA ' ' HB2' ' A' ' 64' ' ' GLU . 0.2 OUTLIER -90.74 -19.66 23.27 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 177.832 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.555 ' HB2' ' HA ' ' A' ' 59' ' ' PRO . 0.1 OUTLIER -71.17 -34.02 70.54 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 176.831 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -81.51 -30.82 33.11 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 176.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.664 ' HB2' ' HA ' ' A' ' 61' ' ' THR . 3.2 mt-10 -73.98 -17.98 60.93 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 176.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.464 ' HB2' HG21 ' A' ' 33' ' ' VAL . . . -86.94 -24.71 24.67 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 106.835 -1.542 . . . . 0.0 106.835 176.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.578 HG13 HG21 ' A' ' 12' ' ' ILE . 0.8 OUTLIER -86.57 -41.94 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 177.519 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.82 -31.83 72.91 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 177.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -75.19 -38.73 60.68 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.51 -0.744 . . . . 0.0 109.701 178.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.591 ' SD ' HG21 ' A' ' 25' ' ' THR . 0.0 OUTLIER -53.81 -46.61 71.17 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.54 -0.725 . . . . 0.0 111.396 179.86 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 119.0 35.06 0.98 Allowed Glycine 0 N--CA 1.501 3.028 0 C-N-CA 120.143 -1.027 . . . . 0.0 110.828 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.525 ' HB3' HG23 ' A' ' 14' ' ' VAL . 96.8 m-85 -140.5 136.61 33.11 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.284 -1.127 . . . . 0.0 109.62 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.04 135.02 56.3 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.359 -0.838 . . . . 0.0 111.233 -179.282 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.575 ' HB2' HG23 ' A' ' 66' ' ' ILE . . . -122.45 140.63 52.51 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.367 -0.833 . . . . 0.0 111.748 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.76 ' C ' HG13 ' A' ' 75' ' ' ILE . 4.4 t -155.7 99.02 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 178.329 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.892 HG12 ' HA ' ' A' ' 12' ' ' ILE . 0.2 OUTLIER -156.39 -135.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 C-N-CA 118.567 -1.253 . . . . 0.0 113.742 -174.869 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.433 ' H ' ' HB ' ' A' ' 75' ' ' ILE . 52.9 t-80 -103.7 53.52 0.75 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.932 -1.105 . . . . 0.0 109.496 -178.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.651 ' HA ' ' HB2' ' A' ' 59' ' ' PRO . 8.2 m120 -123.1 145.81 47.09 Favored Pre-proline 0 N--CA 1.493 1.72 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.306 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.565 ' HD3' ' HG2' ' A' ' 59' ' ' PRO . 42.2 Cg_endo -70.02 -61.44 0.06 OUTLIER 'Trans proline' 0 C--N 1.312 -1.344 0 O-C-N 123.286 1.15 . . . . 0.0 111.592 -179.273 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.4 p30 . . . . . 0 N--CA 1.491 1.623 0 O-C-N 121.321 -0.862 . . . . 0.0 110.577 -179.68 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.571 ' HG3' ' HB2' ' A' ' 79' ' ' ASP . 34.1 mtt . . . . . 0 N--CA 1.498 1.963 0 CA-C-O 121.075 0.464 . . . . 0.0 110.383 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.585 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 1.0 OUTLIER -137.38 38.25 0.36 Allowed Pre-proline 0 N--CA 1.497 1.923 0 O-C-N 121.28 -0.887 . . . . 0.0 112.096 -179.235 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' A' ' 2' ' ' ASP . 53.7 Cg_endo -77.37 -5.37 15.58 Favored 'Trans proline' 0 C--N 1.321 -0.893 0 N-CA-C 109.492 -1.003 . . . . 0.0 109.492 177.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.488 ' HB3' HG23 ' A' ' 7' ' ' VAL . 0.5 OUTLIER -142.27 9.06 1.85 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.219 -0.925 . . . . 0.0 111.515 -179.864 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.425 ' HB2' ' O ' ' A' ' 4' ' ' SER . 0.3 OUTLIER 62.79 -61.28 0.13 Allowed 'General case' 0 N--CA 1.51 2.535 0 O-C-N 121.323 -0.861 . . . . 0.0 112.233 179.397 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 4' ' ' SER . . . -88.93 -36.2 7.87 Favored Glycine 0 N--CA 1.502 3.08 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 -179.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.488 HG23 ' HB3' ' A' ' 4' ' ' SER . 3.3 m -129.0 -170.33 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 O-C-N 121.574 -0.956 . . . . 0.0 110.165 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.717 ' HB3' ' CZ ' ' A' ' 52' ' ' TYR . 1.9 t30 -129.79 161.8 29.91 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.276 -0.89 . . . . 0.0 110.368 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.572 ' HA ' ' HA ' ' A' ' 51' ' ' ILE . 0.3 OUTLIER -119.99 128.7 53.8 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.382 -0.824 . . . . 0.0 109.351 179.069 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.581 HG21 ' HB3' ' A' ' 59' ' ' PRO . 1.0 OUTLIER -121.14 133.75 66.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.384 -0.822 . . . . 0.0 112.061 -178.222 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.534 ' HA ' ' HA ' ' A' ' 49' ' ' THR . 19.0 m -114.68 121.27 42.86 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.797 ' HA ' ' HA ' ' A' ' 75' ' ' ILE . 13.1 tt -118.43 132.35 68.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 CA-C-O 121.831 0.824 . . . . 0.0 111.348 -179.072 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.548 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 49.1 m -77.17 121.75 24.05 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 178.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.641 ' HA ' ' O ' ' A' ' 72' ' ' ASP . 0.2 OUTLIER -126.43 121.49 58.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.271 -0.893 . . . . 0.0 111.65 -178.055 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.483 ' CD ' ' HG2' ' A' ' 46' ' ' LYS . 10.2 tp10 -109.49 158.07 18.34 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.457 -0.777 . . . . 0.0 110.559 179.458 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.51 10.09 59.56 Favored Glycine 0 N--CA 1.498 2.778 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 179.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.585 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 20.4 mmt -45.31 -41.47 8.77 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.026 -1.279 . . . . 0.0 110.46 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 40.1 m 61.51 -48.5 0.14 Allowed 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.841 -0.537 . . . . 0.0 112.249 178.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.425 ' N ' ' O ' ' A' ' 17' ' ' MET . 14.0 p -170.42 152.14 3.92 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.11 -0.994 . . . . 0.0 111.163 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.545 ' HB2' ' CZ3' ' A' ' 24' ' ' TRP . 3.2 p30 -29.28 -40.97 0.02 OUTLIER 'General case' 0 N--CA 1.511 2.589 0 C-N-CA 123.103 0.561 . . . . 0.0 112.431 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.551 ' HA ' ' HE3' ' A' ' 24' ' ' TRP . 4.2 p -48.28 -23.91 1.03 Allowed 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.257 -0.902 . . . . 0.0 111.374 179.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.698 ' HB3' ' CE1' ' A' ' 71' ' ' PHE . 68.9 m -89.59 -21.11 23.0 Favored 'General case' 0 N--CA 1.503 2.175 0 O-C-N 121.124 -0.985 . . . . 0.0 109.78 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.552 HG23 ' HB2' ' A' ' 43' ' ' LEU . 1.0 OUTLIER -85.74 -38.29 12.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 176.096 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.551 ' HE3' ' HA ' ' A' ' 21' ' ' SER . 4.2 m0 -64.0 -32.57 74.16 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 119.098 -1.041 . . . . 0.0 108.844 177.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.467 ' O ' ' HB2' ' A' ' 29' ' ' GLN . 0.6 OUTLIER -83.84 -24.68 30.83 Favored 'General case' 0 N--CA 1.505 2.28 0 C-N-CA 119.812 -0.755 . . . . 0.0 111.345 179.868 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.501 HG23 HG21 ' A' ' 41' ' ' VAL . 11.8 mm -91.88 -33.35 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 O-C-N 121.122 -0.986 . . . . 0.0 110.075 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.602 ' HG2' ' CG2' ' A' ' 41' ' ' VAL . 15.3 mt-10 -78.18 -34.78 49.38 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 178.153 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.481 ' HB2' ' O ' ' A' ' 24' ' ' TRP . 0.7 OUTLIER -72.96 -30.36 63.78 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 176.918 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.549 ' HG3' ' HG2' ' A' ' 69' ' ' MET . 3.1 mm100 -77.49 -61.29 2.04 Favored 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 119.064 -1.054 . . . . 0.0 109.942 178.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.553 ' HA ' ' HB ' ' A' ' 33' ' ' VAL . 22.1 mm -59.06 -42.81 87.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.027 -1.046 . . . . 0.0 110.116 179.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.436 ' CA ' HG22 ' A' ' 39' ' ' ILE . . . -49.44 -53.35 20.69 Favored Glycine 0 N--CA 1.502 3.038 0 N-CA-C 110.014 -1.235 . . . . 0.0 110.014 179.203 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.413 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 11.0 pttm -104.05 24.79 10.84 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.257 -1.143 . . . . 0.0 110.898 179.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.553 ' HB ' ' HA ' ' A' ' 30' ' ' ILE . 9.9 p -64.42 -44.54 97.09 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 O-C-N 120.749 -1.219 . . . . 0.0 111.959 -178.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.401 ' N ' ' CG1' ' A' ' 33' ' ' VAL . 0.4 OUTLIER -179.58 -53.62 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.18 -0.95 . . . . 0.0 110.387 -179.37 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.532 ' O ' ' HA ' ' A' ' 52' ' ' TYR . . . -149.39 81.45 0.19 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.156 -1.578 . . . . 0.0 109.156 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.564 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 35.2 t -132.16 96.66 2.49 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-O 122.233 1.016 . . . . 0.0 108.81 179.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.416 ' HB2' HD12 ' A' ' 51' ' ' ILE . 58.2 m-70 -66.36 -12.4 56.61 Favored 'General case' 0 N--CA 1.505 2.294 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.647 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.632 ' HB3' HG21 ' A' ' 51' ' ' ILE . 6.4 t60 -170.4 122.88 0.66 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.412 -0.805 . . . . 0.0 109.242 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.519 HD13 ' CA ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -118.87 140.12 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.471 -0.768 . . . . 0.0 108.943 179.908 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.501 ' HB3' HG21 ' A' ' 49' ' ' THR . 1.2 ttpp -141.14 115.52 9.43 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.853 -1.154 . . . . 0.0 110.703 -179.194 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.602 ' CG2' ' HG2' ' A' ' 27' ' ' GLU . 90.8 t -108.05 161.19 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 CA-C-O 121.55 0.691 . . . . 0.0 110.769 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.672 ' HB3' ' HB3' ' A' ' 45' ' ' GLU . 0.1 OUTLIER -130.17 76.26 1.71 Allowed 'General case' 0 N--CA 1.485 1.278 0 O-C-N 121.368 -0.833 . . . . 0.0 110.517 -178.753 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.552 ' HB2' HG23 ' A' ' 23' ' ' VAL . 11.1 tp -34.43 -55.93 0.52 Allowed 'General case' 0 N--CA 1.503 2.18 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.481 ' O ' ' HD3' ' A' ' 46' ' ' LYS . 5.7 mp0 -85.12 -30.96 23.59 Favored 'General case' 0 N--CA 1.504 2.23 0 O-C-N 120.807 -1.183 . . . . 0.0 112.026 -178.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.672 ' HB3' ' HB3' ' A' ' 42' ' ' SER . 1.1 tt0 -76.31 -3.22 35.54 Favored 'General case' 0 C--N 1.296 -1.749 0 O-C-N 121.231 -0.918 . . . . 0.0 109.881 178.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.483 ' HG2' ' CD ' ' A' ' 15' ' ' GLU . 0.0 OUTLIER 52.5 52.73 13.54 Favored 'General case' 0 N--CA 1.504 2.263 0 O-C-N 121.275 -0.891 . . . . 0.0 111.587 179.428 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -158.84 148.71 19.29 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.81 -1.181 . . . . 0.0 110.936 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.527 ' HA ' ' HA ' ' A' ' 41' ' ' VAL . . . -132.05 127.87 37.06 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.607 -0.683 . . . . 0.0 109.536 179.12 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.534 ' HA ' ' HA ' ' A' ' 11' ' ' THR . 6.8 t -127.22 120.82 29.62 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.322 -0.861 . . . . 0.0 109.44 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.496 HG23 HG12 ' A' ' 39' ' ' ILE . 1.3 pp -136.48 167.2 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 121.185 -0.947 . . . . 0.0 111.094 -178.082 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.632 HG21 ' HB3' ' A' ' 38' ' ' HIS . 0.0 OUTLIER -109.47 153.05 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.367 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.717 ' CZ ' ' HB3' ' A' ' 8' ' ' ASN . 13.0 p90 -163.07 170.25 18.23 Favored 'General case' 0 C--N 1.296 -1.76 0 O-C-N 121.455 -0.778 . . . . 0.0 110.531 -178.191 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.581 ' HB3' ' HB3' ' A' ' 56' ' ' LEU . 5.7 t0 -82.17 117.77 69.57 Favored Pre-proline 0 C--N 1.293 -1.853 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 177.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.505 ' HD3' ' HB2' ' A' ' 8' ' ' ASN . 38.0 Cg_endo -64.07 -22.0 67.92 Favored 'Trans proline' 0 N--CA 1.491 1.36 0 O-C-N 123.428 1.225 . . . . 0.0 109.572 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.3 ptpp? -84.62 -22.13 30.07 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.973 -0.454 . . . . 0.0 109.812 178.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.581 ' HB3' ' HB3' ' A' ' 53' ' ' ASP . 0.6 OUTLIER -107.81 -39.4 5.58 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.027 -1.046 . . . . 0.0 110.353 179.195 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 14.0 mm-40 -128.34 161.14 30.12 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.251 -0.906 . . . . 0.0 110.829 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.586 ' HB ' ' HD2' ' A' ' 59' ' ' PRO . 15.6 p -145.54 170.53 7.86 Favored Pre-proline 0 N--CA 1.503 2.211 0 O-C-N 121.324 -0.86 . . . . 0.0 110.326 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.586 ' HD2' ' HB ' ' A' ' 58' ' ' THR . 38.1 Cg_endo -64.0 -12.44 32.17 Favored 'Trans proline' 0 N--CA 1.49 1.296 0 O-C-N 123.289 1.152 . . . . 0.0 110.192 178.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.5 ' O ' ' HB3' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -88.3 -29.53 20.29 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.294 -0.879 . . . . 0.0 109.012 178.279 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.49 ' HA ' ' CD ' ' A' ' 64' ' ' GLU . 40.1 p -90.92 -24.78 20.07 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 177.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.411 HD21 ' CD1' ' A' ' 50' ' ' ILE . 34.1 mt -76.84 -29.29 55.83 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 177.203 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.523 ' HB2' ' CG2' ' A' ' 75' ' ' ILE . 12.3 tt0 -79.87 -30.15 40.18 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 177.379 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.5 ' HB3' ' O ' ' A' ' 60' ' ' LYS . 0.3 OUTLIER -78.53 -22.3 47.52 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.214 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -80.24 -27.26 38.75 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 176.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.501 ' CG2' ' HB2' ' A' ' 73' ' ' ALA . 8.7 mm -83.2 -36.06 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 176.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.435 ' HB2' ' HA ' ' A' ' 64' ' ' GLU . 61.8 m-20 -72.38 -32.21 66.22 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 177.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.403 ' HB2' ' O ' ' A' ' 64' ' ' GLU . 31.3 t70 -68.15 -36.68 80.05 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 177.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.549 ' HG2' ' HG3' ' A' ' 29' ' ' GLN . 0.0 OUTLIER -64.86 -47.58 77.4 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.477 -0.765 . . . . 0.0 109.942 178.513 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 119.75 47.87 0.35 Allowed Glycine 0 N--CA 1.502 3.075 0 C-N-CA 120.196 -1.002 . . . . 0.0 111.335 178.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.698 ' CE1' ' HB3' ' A' ' 22' ' ' CYS . 78.2 m-85 -137.4 143.38 41.88 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.229 -1.159 . . . . 0.0 109.563 179.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.641 ' O ' ' HA ' ' A' ' 14' ' ' VAL . 23.4 m-20 -55.1 110.74 0.72 Allowed 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.042 -1.036 . . . . 0.0 109.33 179.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.501 ' HB2' ' CG2' ' A' ' 66' ' ' ILE . . . -109.77 127.37 54.59 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.163 -0.961 . . . . 0.0 112.067 -178.109 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.548 ' HB ' ' HB2' ' A' ' 13' ' ' SER . 77.1 t -137.38 80.69 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 178.193 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.797 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . 40.8 pt -57.14 140.78 14.99 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 CA-C-O 122.373 1.083 . . . . 0.0 111.849 -178.067 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 5.0 m80 -115.13 36.16 4.02 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.166 178.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -110.54 126.71 28.29 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.62 -0.675 . . . . 0.0 111.166 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -79.63 -9.35 14.69 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 O-C-N 123.539 1.284 . . . . 0.0 110.09 178.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.571 ' HB2' ' HG3' ' A' ' 1' ' ' MET . 10.0 p-10 . . . . . 0 N--CA 1.487 1.414 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.238 -179.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 tpt . . . . . 0 N--CA 1.495 1.806 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 49.66 62.16 12.48 Favored Pre-proline 0 N--CA 1.499 2.016 0 O-C-N 121.96 -0.462 . . . . 0.0 111.274 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -70.83 -17.11 32.94 Favored 'Trans proline' 0 C--N 1.316 -1.175 0 O-C-N 123.564 1.297 . . . . 0.0 108.778 177.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.463 ' O ' HG22 ' A' ' 7' ' ' VAL . 2.0 p -107.41 -18.33 13.89 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.789 -0.569 . . . . 0.0 109.998 178.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 3.0 mtt 55.29 43.62 28.78 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.352 -0.842 . . . . 0.0 110.883 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 98.08 -15.66 61.2 Favored Glycine 0 N--CA 1.501 2.999 0 C-N-CA 120.395 -0.907 . . . . 0.0 110.988 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.539 ' CG1' HD13 ' A' ' 51' ' ' ILE . 44.4 t -79.57 162.19 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 O-C-N 120.993 -1.298 . . . . 0.0 110.584 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.576 ' HB3' ' CZ ' ' A' ' 52' ' ' TYR . 0.8 OUTLIER -106.57 178.58 4.52 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.213 -0.93 . . . . 0.0 111.256 -179.303 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.669 ' HA ' ' HA ' ' A' ' 51' ' ' ILE . 9.4 t -141.96 131.89 24.45 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.307 -0.871 . . . . 0.0 111.371 179.352 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.586 ' CG2' ' HB3' ' A' ' 59' ' ' PRO . 0.9 OUTLIER -142.81 147.93 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 CA-C-O 121.944 0.878 . . . . 0.0 111.534 -179.137 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.6 ' HA ' ' HA ' ' A' ' 49' ' ' THR . 21.3 m -109.83 154.01 23.6 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.253 -0.904 . . . . 0.0 109.781 179.037 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.861 ' CA ' HG21 ' A' ' 75' ' ' ILE . 86.0 mt -134.16 110.92 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 122.251 -0.28 . . . . 0.0 111.744 -179.111 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.522 ' N ' HG12 ' A' ' 75' ' ' ILE . 7.2 p -83.05 121.3 26.85 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 119.746 -1.847 . . . . 0.0 107.095 177.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.12 126.15 73.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 O-C-N 121.187 -0.945 . . . . 0.0 110.214 -177.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.23 173.79 6.16 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.508 -0.745 . . . . 0.0 110.317 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.461 ' O ' ' C ' ' A' ' 17' ' ' MET . . . 88.48 -29.79 5.57 Favored Glycine 0 N--CA 1.499 2.853 0 C-N-CA 120.005 -1.093 . . . . 0.0 110.567 -179.201 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.659 ' HB3' ' HB2' ' A' ' 43' ' ' LEU . 28.2 mmm -28.13 97.49 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.657 0 CA-C-N 118.001 0.901 . . . . 0.0 111.403 -179.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.428 ' O ' ' HB3' ' A' ' 19' ' ' CYS . 66.6 p -73.82 -28.91 61.86 Favored 'General case' 0 N--CA 1.512 2.641 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -177.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.483 ' CA ' HD11 ' A' ' 43' ' ' LEU . 14.8 p 178.76 173.81 0.7 Allowed 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.251 -0.905 . . . . 0.0 110.192 -178.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.636 ' HA ' ' CD2' ' A' ' 43' ' ' LEU . 7.7 m120 -38.34 -36.65 0.24 Allowed 'General case' 0 N--CA 1.507 2.397 0 CA-C-O 121.062 0.458 . . . . 0.0 110.926 179.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.6 ' HA ' ' HE3' ' A' ' 24' ' ' TRP . 5.9 p -52.46 -23.98 7.1 Favored 'General case' 0 N--CA 1.507 2.38 0 CA-C-O 121.883 0.849 . . . . 0.0 110.931 178.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.515 ' HB3' ' HE1' ' A' ' 17' ' ' MET . 74.0 m -88.2 -26.72 22.24 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.238 -0.914 . . . . 0.0 109.381 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.454 ' HB ' ' CD2' ' A' ' 43' ' ' LEU . 0.5 OUTLIER -79.41 -39.07 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 N-CA-C 105.955 -1.869 . . . . 0.0 105.955 176.339 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.6 ' HE3' ' HA ' ' A' ' 21' ' ' SER . 1.8 m0 -62.57 -32.25 73.2 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 118.82 -1.152 . . . . 0.0 108.033 176.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.473 ' CG2' ' SD ' ' A' ' 69' ' ' MET . 95.7 m -79.95 -32.43 39.95 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.787 -0.571 . . . . 0.0 112.304 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.513 HG23 HG22 ' A' ' 41' ' ' VAL . 18.9 mm -99.77 -22.47 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.242 0 O-C-N 120.785 -1.197 . . . . 0.0 111.297 -178.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.747 ' HG3' ' CD1' ' A' ' 39' ' ' ILE . 4.5 tt0 -85.78 -32.68 21.69 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 177.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.553 ' HB3' ' O ' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -80.27 -34.98 36.57 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 119.511 -0.876 . . . . 0.0 109.446 177.662 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.532 ' HB2' ' HE1' ' A' ' 69' ' ' MET . 5.5 tp60 -67.9 -62.96 1.16 Allowed 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 119.358 -0.937 . . . . 0.0 110.103 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.539 HG22 ' CG1' ' A' ' 39' ' ' ILE . 16.6 mm -58.87 -41.33 82.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.314 -0.866 . . . . 0.0 110.656 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.442 ' HA2' ' CG2' ' A' ' 39' ' ' ILE . . . -55.71 -38.23 71.75 Favored Glycine 0 N--CA 1.498 2.807 0 O-C-N 121.368 -0.833 . . . . 0.0 111.223 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.73 26.55 7.12 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.973 -1.31 . . . . 0.0 111.806 -179.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.448 ' HB ' ' O ' ' A' ' 29' ' ' GLN . 15.0 p -71.26 -41.23 74.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 120.778 -1.201 . . . . 0.0 111.214 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 16.6 t30 -162.22 -66.77 0.05 Allowed 'General case' 0 N--CA 1.501 2.084 0 O-C-N 120.643 -1.285 . . . . 0.0 111.471 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.464 ' O ' ' HA ' ' A' ' 52' ' ' TYR . . . -145.18 78.37 0.25 Allowed Glycine 0 N--CA 1.493 2.459 0 N-CA-C 108.804 -1.718 . . . . 0.0 108.804 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.648 HG11 HG13 ' A' ' 50' ' ' ILE . 20.8 t -126.2 89.68 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 CA-C-O 122.429 1.109 . . . . 0.0 108.583 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.666 ' HB2' ' CD1' ' A' ' 51' ' ' ILE . 41.7 m-70 -60.94 -28.8 69.23 Favored 'General case' 0 C--N 1.286 -2.192 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.983 -179.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.6 ' HB2' HG12 ' A' ' 51' ' ' ILE . 37.3 m-70 -141.89 125.63 16.97 Favored 'General case' 0 N--CA 1.506 2.331 0 O-C-N 121.038 -1.039 . . . . 0.0 109.637 178.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.747 ' CD1' ' HG3' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -133.96 140.19 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.187 -0.946 . . . . 0.0 109.408 -179.973 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.494 ' NZ ' ' O ' ' A' ' 41' ' ' VAL . 0.1 OUTLIER -146.0 121.34 10.26 Favored 'General case' 0 N--CA 1.507 2.39 0 O-C-N 120.537 -1.352 . . . . 0.0 111.084 178.947 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.513 HG22 HG23 ' A' ' 26' ' ' ILE . 82.0 t -112.6 161.63 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 CA-C-O 121.679 0.752 . . . . 0.0 110.976 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.7 m -142.67 77.26 1.57 Allowed 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.659 ' HB2' ' HB3' ' A' ' 17' ' ' MET . 0.5 OUTLIER -54.67 -30.34 55.14 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.493 -0.755 . . . . 0.0 111.636 -178.717 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.537 ' N ' ' HG ' ' A' ' 43' ' ' LEU . 15.1 mp0 -74.51 -50.0 19.88 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.959 -1.088 . . . . 0.0 109.597 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -79.52 5.99 11.55 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 177.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.473 ' HD3' ' CG ' ' A' ' 17' ' ' MET . 35.0 mmtp 46.53 64.96 1.32 Allowed 'General case' 0 N--CA 1.501 2.081 0 CA-C-O 121.5 0.667 . . . . 0.0 110.476 -179.352 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -165.55 174.33 10.01 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.019 -1.051 . . . . 0.0 110.439 -179.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -168.25 150.01 5.18 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.445 -0.785 . . . . 0.0 110.481 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.6 ' HA ' ' HA ' ' A' ' 11' ' ' THR . 0.4 OUTLIER -138.02 147.28 44.02 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.328 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.648 HG13 HG11 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -165.09 151.7 2.19 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 120.777 -1.202 . . . . 0.0 111.397 -178.083 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.669 ' HA ' ' HA ' ' A' ' 9' ' ' SER . 2.3 pp -108.04 163.62 5.59 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 O-C-N 121.194 -0.941 . . . . 0.0 109.083 178.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.579 ' CD1' ' N ' ' A' ' 52' ' ' TYR . 13.2 p90 -162.31 158.87 24.78 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.089 -1.045 . . . . 0.0 112.033 -176.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.652 ' HB3' ' HB2' ' A' ' 56' ' ' LEU . 18.5 t0 -75.42 111.12 12.52 Favored Pre-proline 0 N--CA 1.498 1.932 0 O-C-N 121.645 -0.66 . . . . 0.0 110.101 179.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.534 ' HD3' ' HB2' ' A' ' 8' ' ' ASN . 40.5 Cg_endo -66.56 -37.17 23.14 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 O-C-N 123.731 1.385 . . . . 0.0 109.766 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.13 -19.01 64.78 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.599 -0.688 . . . . 0.0 109.654 178.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.652 ' HB2' ' HB3' ' A' ' 53' ' ' ASP . 0.4 OUTLIER -96.49 -48.19 5.65 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.388 -0.82 . . . . 0.0 109.438 178.92 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.409 ' OE1' ' HA ' ' A' ' 57' ' ' GLN . 5.7 mm100 -153.56 -170.29 3.55 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.531 -0.731 . . . . 0.0 110.431 179.151 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.681 ' HB ' ' HD2' ' A' ' 59' ' ' PRO . 1.5 p -132.33 -176.3 0.55 Allowed Pre-proline 0 N--CA 1.502 2.131 0 O-C-N 120.861 -1.15 . . . . 0.0 110.109 -179.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.688 ' HG2' ' HD3' ' A' ' 78' ' ' PRO . 38.8 Cg_endo -68.83 -0.6 6.37 Favored 'Trans proline' 0 N--CA 1.488 1.201 0 O-C-N 123.308 1.162 . . . . 0.0 110.809 178.219 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.52 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 0.1 OUTLIER -77.8 -31.65 51.92 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 177.659 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.695 ' HA ' ' HB2' ' A' ' 64' ' ' GLU . 0.8 OUTLIER -77.88 -23.2 48.86 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 177.577 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.458 HD21 ' CD1' ' A' ' 50' ' ' ILE . 10.9 mp -74.98 -27.52 60.19 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 175.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.5 mm100 -86.4 -26.03 24.97 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 176.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.695 ' HB2' ' HA ' ' A' ' 61' ' ' THR . 30.8 mt-10 -73.03 -25.39 60.93 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 177.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.433 ' HB1' HD12 ' A' ' 30' ' ' ILE . . . -89.59 -24.63 21.65 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 178.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.597 ' CG2' ' HB2' ' A' ' 73' ' ' ALA . 14.6 mm -88.08 -36.97 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 178.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -74.86 -27.77 60.39 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.335 -0.946 . . . . 0.0 108.632 178.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -76.52 -38.56 54.95 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.513 -0.742 . . . . 0.0 110.148 178.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.532 ' HE1' ' HB2' ' A' ' 29' ' ' GLN . 3.5 mmt -67.64 -35.74 79.47 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.895 -1.128 . . . . 0.0 110.471 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 105.9 48.98 0.97 Allowed Glycine 0 N--CA 1.499 2.863 0 C-N-CA 120.099 -1.048 . . . . 0.0 110.707 178.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.487 ' CD1' ' SD ' ' A' ' 17' ' ' MET . 55.0 m-85 -130.38 114.66 15.86 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.298 -1.119 . . . . 0.0 110.021 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -48.39 107.87 0.15 Allowed 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.553 -0.717 . . . . 0.0 110.684 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.597 ' HB2' ' CG2' ' A' ' 66' ' ' ILE . . . -111.23 164.58 12.73 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 122.068 0.937 . . . . 0.0 112.342 -178.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.751 ' C ' HG13 ' A' ' 75' ' ' ILE . 0.9 OUTLIER -168.91 103.72 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 179.618 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.861 HG21 ' CA ' ' A' ' 12' ' ' ILE . 0.2 OUTLIER -157.65 -137.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 C-N-CA 118.834 -1.146 . . . . 0.0 113.638 -174.759 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.403 ' H ' ' HB ' ' A' ' 75' ' ' ILE . 52.6 t-80 -104.65 71.14 0.97 Allowed 'General case' 0 N--CA 1.499 1.995 0 O-C-N 120.856 -1.152 . . . . 0.0 111.062 -178.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -119.08 162.59 30.82 Favored Pre-proline 0 N--CA 1.493 1.695 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 178.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.688 ' HD3' ' HG2' ' A' ' 59' ' ' PRO . 49.5 Cg_endo -84.24 -57.49 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.313 0 O-C-N 123.098 1.051 . . . . 0.0 109.986 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 118.368 -0.825 . . . . 0.0 110.473 179.947 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.5 2.05 0 CA-C-O 120.894 0.378 . . . . 0.0 110.829 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 40.65 65.49 4.11 Favored Pre-proline 0 N--CA 1.504 2.237 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.404 ' O ' ' NZ ' ' A' ' 55' ' ' LYS . 43.5 Cg_endo -70.78 -17.6 32.82 Favored 'Trans proline' 0 C--N 1.313 -1.322 0 O-C-N 123.614 1.323 . . . . 0.0 109.64 177.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -138.66 -0.31 1.95 Allowed 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.32 -0.862 . . . . 0.0 111.989 179.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 46.51 28.32 0.74 Allowed 'General case' 0 N--CA 1.505 2.317 0 O-C-N 121.207 -0.933 . . . . 0.0 112.429 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 91.76 3.65 68.29 Favored Glycine 0 N--CA 1.501 2.995 0 O-C-N 120.988 -1.07 . . . . 0.0 111.457 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.596 ' CG1' HD11 ' A' ' 51' ' ' ILE . 4.2 t 64.81 174.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.465 0 CA-C-N 118.625 1.213 . . . . 0.0 109.941 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.72 ' HB3' ' CZ ' ' A' ' 52' ' ' TYR . 1.0 OUTLIER -117.18 154.57 30.88 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.694 -1.254 . . . . 0.0 111.516 -179.232 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.61 ' HA ' ' HA ' ' A' ' 51' ' ' ILE . 14.7 t -118.98 146.51 44.94 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.336 -0.852 . . . . 0.0 110.012 178.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.539 ' CG1' HD11 ' A' ' 12' ' ' ILE . 1.0 OUTLIER -140.6 133.95 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.347 -0.845 . . . . 0.0 111.186 -178.833 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.519 ' HA ' ' HA ' ' A' ' 49' ' ' THR . 51.7 m -109.69 116.81 32.41 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.524 0.678 . . . . 0.0 109.273 179.16 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.595 ' HA ' ' HA ' ' A' ' 75' ' ' ILE . 5.7 mt -108.43 145.12 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.379 -0.826 . . . . 0.0 110.914 -178.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.426 ' N ' HG23 ' A' ' 12' ' ' ILE . 0.8 OUTLIER -78.98 137.74 37.73 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.747 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.457 ' CG1' ' O ' ' A' ' 14' ' ' VAL . 1.2 t -129.09 111.26 22.43 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 O-C-N 120.947 -1.095 . . . . 0.0 111.888 -178.166 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -122.56 170.19 10.26 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 73.81 25.43 71.87 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 -178.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.688 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 29.7 mmt -66.22 -36.08 82.12 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.106 -1.232 . . . . 0.0 110.178 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER 58.93 -42.84 0.07 Allowed 'General case' 0 N--CA 1.515 2.794 0 O-C-N 121.664 -0.648 . . . . 0.0 112.64 -179.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.52 ' N ' ' O ' ' A' ' 17' ' ' MET . 9.0 p 179.02 163.49 0.82 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.334 -0.854 . . . . 0.0 110.228 -178.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.581 ' HB2' ' CZ3' ' A' ' 24' ' ' TRP . 2.9 p30 -35.13 -36.71 0.06 Allowed 'General case' 0 N--CA 1.508 2.453 0 CA-C-O 120.947 0.403 . . . . 0.0 111.67 178.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.509 ' HA ' ' HE3' ' A' ' 24' ' ' TRP . 10.5 p -46.17 -30.67 2.05 Favored 'General case' 0 N--CA 1.504 2.258 0 CA-C-O 121.983 0.897 . . . . 0.0 110.912 178.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.688 ' SG ' ' O ' ' A' ' 17' ' ' MET . 69.6 m -90.3 -27.63 19.3 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.444 -0.785 . . . . 0.0 109.066 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.571 HG21 ' HB2' ' A' ' 43' ' ' LEU . 1.1 t -71.96 -37.65 61.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 175.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.623 ' O ' ' HB2' ' A' ' 28' ' ' GLN . 2.8 m0 -67.6 -32.14 72.67 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 119.142 -1.023 . . . . 0.0 108.488 177.133 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.596 ' O ' ' HB2' ' A' ' 29' ' ' GLN . 96.8 m -82.1 -23.98 35.41 Favored 'General case' 0 N--CA 1.505 2.285 0 C-N-CA 120.532 -0.467 . . . . 0.0 112.034 -179.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.448 HD12 ' N ' ' A' ' 26' ' ' ILE . 1.5 mp -98.49 -22.35 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.31 0 O-C-N 120.868 -1.145 . . . . 0.0 110.126 -179.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.636 ' HA ' HD11 ' A' ' 39' ' ' ILE . 4.7 tt0 -83.1 -36.32 24.93 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 178.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.623 ' HB2' ' O ' ' A' ' 24' ' ' TRP . 1.2 mp0 -80.13 -33.84 38.24 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.725 -0.79 . . . . 0.0 109.81 178.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.596 ' HB2' ' O ' ' A' ' 25' ' ' THR . 5.2 mm100 -77.46 -61.42 2.0 Allowed 'General case' 0 N--CA 1.501 2.088 0 C-N-CA 118.32 -1.352 . . . . 0.0 110.694 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.456 ' HA ' ' HB ' ' A' ' 33' ' ' VAL . 38.0 mt -64.98 -36.9 78.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 120.776 -1.202 . . . . 0.0 109.989 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -58.36 -46.47 92.93 Favored Glycine 0 N--CA 1.499 2.857 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 178.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.08 29.99 7.29 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.459 -1.024 . . . . 0.0 110.864 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.474 HG13 HG23 ' A' ' 36' ' ' VAL . 8.4 p -64.29 -38.19 81.89 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 O-C-N 121.083 -1.011 . . . . 0.0 111.049 -179.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -175.39 -60.38 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.333 -0.854 . . . . 0.0 110.357 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.534 ' O ' ' HA ' ' A' ' 52' ' ' TYR . . . -148.47 83.48 0.18 Allowed Glycine 0 N--CA 1.489 2.204 0 N-CA-C 108.307 -1.917 . . . . 0.0 108.307 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.596 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 17.1 t -124.15 93.71 2.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 CA-C-O 122.503 1.144 . . . . 0.0 108.637 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.472 ' HB2' ' CD1' ' A' ' 51' ' ' ILE . 68.2 m-70 -60.45 -18.53 51.83 Favored 'General case' 0 N--CA 1.503 2.209 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.676 -179.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.58 ' HB3' ' CG2' ' A' ' 51' ' ' ILE . 1.0 OUTLIER -158.92 129.49 5.99 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.791 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.636 HD11 ' HA ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -129.94 128.79 65.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.565 -0.71 . . . . 0.0 109.392 -179.927 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.538 ' HB3' HG23 ' A' ' 49' ' ' THR . 0.0 OUTLIER -121.02 121.54 38.18 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.882 -1.136 . . . . 0.0 110.073 179.743 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.455 ' O ' ' NZ ' ' A' ' 40' ' ' LYS . 10.6 p -106.89 152.54 8.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 178.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.748 ' HB3' ' HB3' ' A' ' 45' ' ' GLU . 0.4 OUTLIER -136.57 76.51 1.6 Allowed 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.09 -1.006 . . . . 0.0 111.073 -177.74 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.571 ' HB2' HG21 ' A' ' 23' ' ' VAL . 11.7 tp -39.32 -57.19 1.42 Allowed 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.461 ' O ' ' NZ ' ' A' ' 46' ' ' LYS . 0.7 OUTLIER -94.57 -32.69 13.34 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.831 -1.168 . . . . 0.0 111.409 -179.799 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.748 ' HB3' ' HB3' ' A' ' 42' ' ' SER . 9.7 tt0 -66.61 -7.47 20.61 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.038 -1.039 . . . . 0.0 109.929 177.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.461 ' NZ ' ' O ' ' A' ' 44' ' ' GLU . 0.0 OUTLIER 55.77 69.36 0.74 Allowed 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.47 -0.768 . . . . 0.0 111.17 179.008 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -170.31 161.15 8.06 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.72 -1.238 . . . . 0.0 113.037 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.446 ' HB1' ' CG2' ' A' ' 14' ' ' VAL . . . -147.93 97.25 2.77 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 115.518 -0.765 . . . . 0.0 108.984 179.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.538 HG23 ' HB3' ' A' ' 40' ' ' LYS . 1.0 OUTLIER -109.74 133.79 52.73 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.783 -1.198 . . . . 0.0 110.254 -179.674 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.556 HG22 ' HA ' ' A' ' 39' ' ' ILE . 2.6 pp -146.63 177.63 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.511 -0.743 . . . . 0.0 111.146 -178.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.61 ' HA ' ' HA ' ' A' ' 9' ' ' SER . 0.0 OUTLIER -123.82 158.89 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 178.541 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.72 ' CZ ' ' HB3' ' A' ' 8' ' ' ASN . 14.8 p90 -163.95 153.7 14.58 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.235 -0.915 . . . . 0.0 111.089 -177.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.532 ' HA ' HG13 ' A' ' 7' ' ' VAL . 0.4 OUTLIER -79.69 117.74 68.82 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.277 -0.89 . . . . 0.0 109.49 178.892 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -67.63 57.61 0.73 Allowed 'Trans proline' 0 N--CA 1.494 1.529 0 O-C-N 123.929 1.489 . . . . 0.0 111.408 -178.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.477 ' HG3' ' HB3' ' A' ' 53' ' ' ASP . 0.0 OUTLIER -135.47 -66.25 0.57 Allowed 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 179.073 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -96.84 -8.99 29.6 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.472 -0.768 . . . . 0.0 109.285 177.297 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.66 146.5 50.85 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.512 -0.742 . . . . 0.0 109.947 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.593 ' HB ' ' HD2' ' A' ' 59' ' ' PRO . 78.3 p -142.66 169.08 11.53 Favored Pre-proline 0 N--CA 1.497 1.922 0 O-C-N 121.493 -0.754 . . . . 0.0 110.14 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.593 ' HD2' ' HB ' ' A' ' 58' ' ' THR . 39.3 Cg_endo -65.41 -19.18 61.34 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 O-C-N 123.328 1.172 . . . . 0.0 111.226 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 2.2 tptt -92.0 -30.51 16.03 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.291 -0.881 . . . . 0.0 109.791 179.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.679 ' HA ' ' HB2' ' A' ' 64' ' ' GLU . 6.0 p -79.2 -24.17 43.33 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 177.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.536 HD11 ' CG ' ' A' ' 52' ' ' TYR . 14.2 mt -72.97 -30.68 64.01 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 106.314 -1.735 . . . . 0.0 106.314 175.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.485 ' O ' ' HB2' ' A' ' 67' ' ' ASP . 1.2 tt0 -82.36 -27.71 31.99 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 177.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.679 ' HB2' ' HA ' ' A' ' 61' ' ' THR . 10.3 mt-10 -82.09 -16.38 50.22 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 177.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -86.86 -27.22 23.6 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 177.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.529 HD12 HD12 ' A' ' 12' ' ' ILE . 26.2 mt -86.32 -38.52 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 177.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.485 ' HB2' ' O ' ' A' ' 63' ' ' GLN . 0.4 OUTLIER -66.27 -33.21 75.23 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 177.459 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.596 ' HB2' ' O ' ' A' ' 64' ' ' GLU . 2.6 t70 -79.37 -38.07 35.86 Favored 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 119.771 -0.772 . . . . 0.0 109.298 178.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.517 ' HE1' ' HA ' ' A' ' 66' ' ' ILE . 0.0 OUTLIER -47.65 -59.77 3.04 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.555 -0.716 . . . . 0.0 110.018 179.153 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 123.3 51.26 0.21 Allowed Glycine 0 N--CA 1.497 2.735 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 179.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.628 ' CE1' ' HB3' ' A' ' 22' ' ' CYS . 10.9 m-85 -140.73 147.61 39.44 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.435 -1.038 . . . . 0.0 111.029 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -72.39 81.46 1.04 Allowed 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.576 0.703 . . . . 0.0 109.245 179.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -134.59 142.17 46.86 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.999 -1.063 . . . . 0.0 110.961 -179.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.545 ' C ' HG13 ' A' ' 75' ' ' ILE . 2.5 t -117.51 -134.7 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.211 -0.939 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 178.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.595 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . 0.1 OUTLIER -151.83 146.62 15.57 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.357 0 O-C-N 121.072 -1.018 . . . . 0.0 111.514 -179.912 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 -112.61 20.99 16.07 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 177.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.406 ' HB3' ' OD2' ' A' ' 79' ' ' ASP . 0.7 OUTLIER -109.29 139.17 20.8 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.833 -0.542 . . . . 0.0 110.108 -179.617 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.61 56.14 3.34 Favored 'Trans proline' 0 N--CA 1.493 1.48 0 O-C-N 123.585 1.308 . . . . 0.0 110.816 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.406 ' OD2' ' HB3' ' A' ' 77' ' ' ASN . 56.2 m-20 . . . . . 0 N--CA 1.491 1.592 0 O-C-N 121.356 -0.84 . . . . 0.0 110.836 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.3 tpt . . . . . 0 N--CA 1.498 1.939 0 CA-C-O 120.675 0.274 . . . . 0.0 110.738 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -117.39 80.57 12.87 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.12 -0.987 . . . . 0.0 111.461 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.503 ' HB2' ' HE2' ' A' ' 55' ' ' LYS . 46.9 Cg_endo -72.45 -13.03 27.63 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 O-C-N 123.814 1.428 . . . . 0.0 108.593 177.131 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.2 m -141.17 -22.49 0.76 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.721 -0.612 . . . . 0.0 111.981 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 55.55 56.55 6.14 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 120.821 -1.175 . . . . 0.0 110.357 -179.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 177.08 -52.81 0.1 Allowed Glycine 0 N--CA 1.501 3.022 0 N-CA-C 110.451 -1.06 . . . . 0.0 110.451 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.458 HG12 ' CD1' ' A' ' 51' ' ' ILE . 1.1 t 67.97 165.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.334 0 O-C-N 121.901 -0.764 . . . . 0.0 111.003 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.464 ' HB3' ' CZ ' ' A' ' 52' ' ' TYR . 2.5 m120 -112.17 -179.87 3.8 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.051 -1.031 . . . . 0.0 110.656 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.609 ' HA ' ' HA ' ' A' ' 51' ' ' ILE . 3.8 m -141.29 132.68 26.74 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.294 -0.879 . . . . 0.0 110.192 179.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.467 ' HB ' ' CE1' ' A' ' 52' ' ' TYR . 0.9 OUTLIER -130.99 135.82 59.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 CA-C-O 121.592 0.711 . . . . 0.0 111.953 -178.14 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.525 ' HA ' ' HA ' ' A' ' 49' ' ' THR . 27.5 m -115.3 118.94 34.68 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.066 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.533 HG12 ' CG2' ' A' ' 75' ' ' ILE . 64.9 mt -118.73 146.29 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.299 -0.876 . . . . 0.0 111.612 -178.01 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.563 ' CB ' HG12 ' A' ' 74' ' ' VAL . 0.9 OUTLIER -90.42 144.55 25.7 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 177.574 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.507 ' O ' ' HB3' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -141.55 126.38 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.82 -1.175 . . . . 0.0 110.824 -178.754 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.659 ' HB3' ' HB3' ' A' ' 72' ' ' ASP . 5.8 tp10 -108.95 165.42 11.59 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.418 -0.801 . . . . 0.0 110.247 179.209 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.71 -25.89 26.67 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 108.577 -1.809 . . . . 0.0 108.577 -177.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.492 ' HA ' ' CB ' ' A' ' 22' ' ' CYS . 51.2 mtm -73.87 102.7 4.15 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.253 -1.145 . . . . 0.0 109.888 179.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 14.9 t -106.59 9.41 31.41 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.532 -0.73 . . . . 0.0 111.367 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.436 ' O ' ' N ' ' A' ' 21' ' ' SER . 0.5 OUTLIER -178.99 139.64 0.16 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.183 -0.948 . . . . 0.0 109.295 179.822 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.647 ' HA ' ' CD2' ' A' ' 43' ' ' LEU . 7.8 m120 -23.08 -46.12 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.599 0 N-CA-C 112.719 0.636 . . . . 0.0 112.719 -179.269 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.573 ' HA ' ' HE3' ' A' ' 24' ' ' TRP . 3.0 p -47.66 -27.5 1.94 Allowed 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.391 -0.818 . . . . 0.0 111.518 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.633 ' HB3' ' CE1' ' A' ' 71' ' ' PHE . 60.2 m -87.04 -33.08 19.67 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.03 -1.044 . . . . 0.0 109.414 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.449 HG23 ' SD ' ' A' ' 17' ' ' MET . 9.1 t -77.47 -39.44 27.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 177.398 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.573 ' HE3' ' HA ' ' A' ' 21' ' ' SER . 1.4 m0 -59.24 -36.97 76.41 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 176.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.457 ' O ' ' HB2' ' A' ' 29' ' ' GLN . 64.1 m -66.0 -34.5 78.25 Favored 'General case' 0 N--CA 1.501 2.086 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.006 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.546 HD13 ' CD2' ' A' ' 71' ' ' PHE . 1.4 mp -94.8 -29.61 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.241 0 O-C-N 121.261 -0.899 . . . . 0.0 110.03 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.718 ' HG3' ' CD1' ' A' ' 39' ' ' ILE . 2.6 tt0 -74.16 -35.64 64.05 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 178.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.529 ' HB2' ' O ' ' A' ' 24' ' ' TRP . 28.9 mt-30 -79.3 -34.15 42.67 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 119.146 -1.022 . . . . 0.0 108.99 177.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.648 ' HB3' ' SD ' ' A' ' 69' ' ' MET . 2.2 mm100 -73.04 -51.36 18.45 Favored 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 118.44 -1.304 . . . . 0.0 110.112 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.548 ' CG2' ' HB ' ' A' ' 39' ' ' ILE . 0.4 OUTLIER -57.41 -41.11 77.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 120.98 -1.075 . . . . 0.0 109.859 179.094 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.55 ' HA2' HG23 ' A' ' 39' ' ' ILE . . . -64.61 -26.52 70.99 Favored Glycine 0 N--CA 1.498 2.772 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 178.372 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.496 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 3.2 ttpp -116.7 26.7 9.66 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.566 -0.961 . . . . 0.0 110.678 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.415 ' CG1' ' N ' ' A' ' 34' ' ' ASN . 8.1 p -87.41 -49.22 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 O-C-N 120.594 -1.316 . . . . 0.0 112.489 -178.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.415 ' N ' ' CG1' ' A' ' 33' ' ' VAL . 0.6 OUTLIER -169.66 -68.07 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.134 0 O-C-N 120.408 -1.433 . . . . 0.0 112.453 -179.581 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -142.74 73.17 0.37 Allowed Glycine 0 N--CA 1.496 2.676 0 C-N-CA 119.987 -1.102 . . . . 0.0 110.855 -178.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.598 HG11 HG21 ' A' ' 39' ' ' ILE . 61.5 t -127.57 89.2 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 CA-C-O 122.335 1.064 . . . . 0.0 108.564 178.218 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.585 ' HB2' ' CD1' ' A' ' 51' ' ' ILE . 38.9 m-70 -61.6 -23.26 65.89 Favored 'General case' 0 N--CA 1.507 2.402 0 CA-C-N 115.388 -0.823 . . . . 0.0 110.72 -179.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.625 ' HB2' HG12 ' A' ' 51' ' ' ILE . 65.8 m-70 -136.94 113.36 10.04 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.308 -0.87 . . . . 0.0 109.162 179.28 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.718 ' CD1' ' HG3' ' A' ' 27' ' ' GLU . 1.8 pp -114.28 136.42 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.286 -0.884 . . . . 0.0 109.637 -179.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.65 ' HA ' ' CE ' ' A' ' 40' ' ' LYS . 0.3 OUTLIER -150.58 122.91 8.39 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.168 -1.583 . . . . 0.0 112.408 -179.715 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.472 ' HA ' ' HA ' ' A' ' 48' ' ' ALA . 3.9 t -127.79 167.14 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.573 ' O ' HD21 ' A' ' 43' ' ' LEU . 1.4 m -108.84 -101.04 0.38 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.87 -1.144 . . . . 0.0 110.168 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.647 ' CD2' ' HA ' ' A' ' 20' ' ' ASN . 0.1 OUTLIER -179.13 -92.41 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.308 0 O-C-N 121.069 -1.019 . . . . 0.0 109.683 179.411 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.477 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -76.73 -9.77 58.9 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.512 -1.368 . . . . 0.0 109.594 178.538 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -74.59 -11.87 60.31 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 177.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.507 ' HB3' ' O ' ' A' ' 14' ' ' VAL . 21.5 mmtt 51.5 56.13 8.36 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.623 -0.673 . . . . 0.0 111.295 179.037 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.428 ' O ' HG12 ' A' ' 41' ' ' VAL . 0.3 OUTLIER -154.08 152.13 30.11 Favored 'General case' 0 N--CA 1.504 2.235 0 O-C-N 120.587 -1.32 . . . . 0.0 112.274 179.854 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.472 ' HA ' ' HA ' ' A' ' 41' ' ' VAL . . . -142.36 134.91 28.05 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.251 0.548 . . . . 0.0 110.592 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.525 ' HA ' ' HA ' ' A' ' 11' ' ' THR . 5.8 t -128.67 134.41 48.5 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.377 -0.827 . . . . 0.0 109.408 179.021 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.573 HD13 HD11 ' A' ' 62' ' ' LEU . 0.1 OUTLIER -149.59 164.85 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.072 -1.018 . . . . 0.0 110.975 -179.014 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.625 HG12 ' HB2' ' A' ' 38' ' ' HIS . 1.7 pp -107.03 167.52 3.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 178.056 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.508 ' HB2' ' HB3' ' A' ' 57' ' ' GLN . 28.8 p90 -170.52 161.83 7.91 Favored 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 119.159 -1.017 . . . . 0.0 110.731 -178.187 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.436 ' O ' ' N ' ' A' ' 55' ' ' LYS . 0.9 OUTLIER -78.84 121.62 83.67 Favored Pre-proline 0 C--N 1.302 -1.492 0 C-N-CA 119.701 -0.799 . . . . 0.0 109.726 179.182 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.416 ' C ' ' HG2' ' A' ' 55' ' ' LYS . 38.7 Cg_endo -64.67 70.31 0.24 Allowed 'Trans proline' 0 N--CA 1.492 1.395 0 O-C-N 124.1 1.579 . . . . 0.0 109.728 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.503 ' HE2' ' HB2' ' A' ' 3' ' ' PRO . 3.2 ptpp? -172.24 -45.48 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.756 -0.59 . . . . 0.0 110.877 -178.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.8 pp -111.8 -21.65 11.53 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.093 -1.004 . . . . 0.0 111.837 -179.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.508 ' HB3' ' HB2' ' A' ' 52' ' ' TYR . 5.5 tp60 -125.85 133.76 51.85 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.818 -1.176 . . . . 0.0 110.025 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.576 ' HB ' ' HD2' ' A' ' 59' ' ' PRO . 34.9 p -141.78 168.33 14.13 Favored Pre-proline 0 N--CA 1.504 2.239 0 O-C-N 121.111 -0.993 . . . . 0.0 109.988 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.576 ' HD2' ' HB ' ' A' ' 58' ' ' THR . 37.8 Cg_endo -62.39 -20.45 70.4 Favored 'Trans proline' 0 N--CA 1.498 1.78 0 O-C-N 123.418 1.22 . . . . 0.0 111.877 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.403 ' NZ ' ' HB3' ' A' ' 64' ' ' GLU . 0.4 OUTLIER -81.4 -30.53 33.57 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.097 -1.002 . . . . 0.0 108.777 178.241 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.517 ' HA ' ' CD ' ' A' ' 64' ' ' GLU . 0.9 OUTLIER -90.3 -24.15 20.97 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 178.033 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.573 HD11 HD13 ' A' ' 50' ' ' ILE . 5.2 mt -74.11 -28.07 61.18 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 177.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.677 ' HB2' ' CG2' ' A' ' 75' ' ' ILE . 15.8 tt0 -84.08 -30.22 26.18 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 177.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.517 ' CD ' ' HA ' ' A' ' 61' ' ' THR . 1.5 pt-20 -81.05 -18.99 44.77 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.4 ' O ' ' SD ' ' A' ' 69' ' ' MET . . . -82.95 -28.76 29.61 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 175.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.44 ' HA ' ' HE2' ' A' ' 69' ' ' MET . 51.5 mt -82.01 -38.77 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 177.136 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.429 ' HB2' ' HA ' ' A' ' 64' ' ' GLU . 1.2 m-20 -61.05 -28.54 69.14 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 176.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -71.05 -42.74 69.08 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.799 -0.563 . . . . 0.0 109.885 178.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.648 ' SD ' ' HB3' ' A' ' 29' ' ' GLN . 0.8 OUTLIER -54.73 -47.95 73.14 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.454 -0.779 . . . . 0.0 111.043 179.717 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 120.89 43.0 0.46 Allowed Glycine 0 N--CA 1.503 3.109 0 C-N-CA 120.069 -1.062 . . . . 0.0 110.586 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.633 ' CE1' ' HB3' ' A' ' 22' ' ' CYS . 61.8 m-85 -144.87 130.29 18.78 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.444 -1.033 . . . . 0.0 109.229 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.659 ' HB3' ' HB3' ' A' ' 15' ' ' GLU . 5.5 t70 -47.43 116.51 1.45 Allowed 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.525 -0.735 . . . . 0.0 110.005 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.43 150.17 28.48 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.382 -0.824 . . . . 0.0 111.554 -178.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.563 HG12 ' CB ' ' A' ' 13' ' ' SER . 1.0 OUTLIER -154.83 93.76 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 CA-C-O 122.559 1.171 . . . . 0.0 108.1 179.103 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.677 ' CG2' ' HB2' ' A' ' 63' ' ' GLN . 14.0 pt -69.62 150.73 10.17 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 CA-C-O 122.481 1.134 . . . . 0.0 112.455 -177.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 17.8 m-70 -109.93 14.95 22.91 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.147 178.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 30.0 m120 -133.38 140.13 36.14 Favored Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 121.018 -1.051 . . . . 0.0 110.302 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -79.33 -53.67 0.05 OUTLIER 'Trans proline' 0 C--N 1.315 -1.235 0 O-C-N 123.853 1.449 . . . . 0.0 110.527 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 118.439 -0.791 . . . . 0.0 110.603 -179.778 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.0 tpt . . . . . 0 N--CA 1.495 1.806 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.435 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 12.9 m-20 49.17 52.05 12.06 Favored Pre-proline 0 N--CA 1.503 2.203 0 O-C-N 121.756 -0.59 . . . . 0.0 111.563 179.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.435 ' CD ' ' N ' ' A' ' 2' ' ' ASP . 45.2 Cg_endo -72.03 -13.48 28.85 Favored 'Trans proline' 0 C--N 1.317 -1.087 0 O-C-N 123.483 1.254 . . . . 0.0 109.022 177.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.4 p -156.01 29.02 0.36 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.586 -0.696 . . . . 0.0 110.843 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -41.45 107.05 0.07 Allowed 'General case' 0 N--CA 1.505 2.282 0 O-C-N 121.41 -0.806 . . . . 0.0 110.426 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.531 ' O ' ' HD2' ' A' ' 54' ' ' PRO . . . 118.66 -24.67 8.39 Favored Glycine 0 N--CA 1.497 2.716 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 -179.018 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 48.2 t -108.32 145.25 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 O-C-N 121.137 -1.213 . . . . 0.0 109.717 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.754 ' HB3' ' CZ ' ' A' ' 52' ' ' TYR . 1.0 OUTLIER -106.24 172.46 6.8 Favored 'General case' 0 N--CA 1.503 2.21 0 O-C-N 120.977 -1.077 . . . . 0.0 110.957 -179.789 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.519 ' HA ' ' HA ' ' A' ' 51' ' ' ILE . 6.8 t -130.52 131.04 44.89 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.352 -0.843 . . . . 0.0 110.27 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.641 ' HB ' ' CE1' ' A' ' 52' ' ' TYR . 0.5 OUTLIER -125.61 132.63 70.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.462 -0.774 . . . . 0.0 111.315 -178.411 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.583 ' HA ' ' HA ' ' A' ' 49' ' ' THR . 8.9 m -108.67 119.17 38.73 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.532 -0.73 . . . . 0.0 109.138 178.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.667 ' HA ' ' HA ' ' A' ' 75' ' ' ILE . 9.8 mt -110.93 122.13 64.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.294 -0.879 . . . . 0.0 110.9 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.662 ' HB2' ' CG1' ' A' ' 74' ' ' VAL . 0.7 OUTLIER -79.34 136.11 36.91 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 178.011 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.417 HG13 ' HB3' ' A' ' 71' ' ' PHE . 0.2 OUTLIER -131.27 130.14 63.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.17 -0.957 . . . . 0.0 110.987 -178.641 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -119.48 159.57 24.02 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.387 -0.82 . . . . 0.0 110.159 178.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.42 ' O ' HG23 ' A' ' 18' ' ' THR . . . 98.35 -31.14 8.36 Favored Glycine 0 N--CA 1.497 2.762 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 -179.145 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.554 ' SD ' ' HA ' ' A' ' 43' ' ' LEU . 8.0 ptp -62.43 122.63 16.2 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.171 -1.193 . . . . 0.0 110.302 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.42 HG23 ' O ' ' A' ' 16' ' ' GLY . 54.7 p -125.64 5.96 7.5 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.252 -0.905 . . . . 0.0 113.333 -178.073 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.466 ' O ' ' N ' ' A' ' 21' ' ' SER . 1.1 p -165.56 145.3 6.6 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.14 -1.6 . . . . 0.0 110.512 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.478 ' O ' HG11 ' A' ' 23' ' ' VAL . 28.9 m120 -25.8 -40.67 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.674 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -179.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.747 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 2.2 p -51.32 -19.75 1.42 Allowed 'General case' 0 N--CA 1.499 1.978 0 CA-C-O 122.294 1.045 . . . . 0.0 110.703 178.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.659 ' HB2' HD21 ' A' ' 43' ' ' LEU . 44.7 m -91.15 -20.87 21.53 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 119.32 -2.112 . . . . 0.0 109.221 179.002 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.679 ' CA ' HD12 ' A' ' 43' ' ' LEU . 0.3 OUTLIER -90.02 -35.51 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.411 -0.806 . . . . 0.0 108.868 178.531 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.747 ' CE3' ' HA ' ' A' ' 21' ' ' SER . 0.0 OUTLIER -78.96 -22.55 45.51 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 117.85 -1.54 . . . . 0.0 108.688 178.642 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.505 ' HB ' ' CZ3' ' A' ' 24' ' ' TRP . 1.3 t -86.18 -27.6 24.44 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 120.774 -1.204 . . . . 0.0 110.378 177.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 20.4 mm -90.77 -25.12 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.377 0 O-C-N 120.75 -1.218 . . . . 0.0 109.561 179.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.766 ' HA ' HD11 ' A' ' 39' ' ' ILE . 0.2 OUTLIER -81.24 -34.37 32.18 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 177.55 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.612 ' HB2' ' O ' ' A' ' 24' ' ' TRP . 0.9 OUTLIER -72.95 -33.01 65.63 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 177.413 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.458 ' O ' ' HB ' ' A' ' 33' ' ' VAL . 5.5 tp60 -70.88 -66.63 0.58 Allowed 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 120.045 -0.662 . . . . 0.0 110.527 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.584 HG22 HG22 ' A' ' 36' ' ' VAL . 84.1 mt -64.3 -45.7 95.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 O-C-N 121.245 -0.91 . . . . 0.0 110.35 -179.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.52 ' HA2' HG21 ' A' ' 39' ' ' ILE . . . -50.48 -34.44 27.02 Favored Glycine 0 N--CA 1.497 2.712 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 179.29 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 56.1 mtmt -126.71 29.9 5.61 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.008 -1.29 . . . . 0.0 111.865 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.458 ' HB ' ' O ' ' A' ' 29' ' ' GLN . 14.9 p -75.15 -49.83 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 O-C-N 120.633 -1.292 . . . . 0.0 111.541 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -178.47 -60.29 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.285 0 O-C-N 120.871 -1.143 . . . . 0.0 111.663 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.478 ' O ' ' HA ' ' A' ' 52' ' ' TYR . . . -122.94 67.71 0.48 Allowed Glycine 0 N--CA 1.495 2.586 0 C-N-CA 120.207 -0.997 . . . . 0.0 110.647 -178.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.584 HG22 HG22 ' A' ' 30' ' ' ILE . 50.4 t -136.57 92.4 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.487 -1.008 . . . . 0.0 108.585 178.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.732 ' HB2' HD11 ' A' ' 51' ' ' ILE . 50.3 m-70 -51.67 -29.27 17.39 Favored 'General case' 0 N--CA 1.512 2.667 0 CA-C-O 121.575 0.702 . . . . 0.0 109.709 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.529 ' CD2' ' CD1' ' A' ' 51' ' ' ILE . 0.2 OUTLIER -171.39 145.41 2.12 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 178.615 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.766 HD11 ' HA ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -121.06 144.86 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.145 -0.972 . . . . 0.0 110.023 -178.689 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.417 ' NZ ' ' O ' ' A' ' 41' ' ' VAL . 4.5 tptt -122.21 100.23 6.85 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.555 -1.341 . . . . 0.0 109.518 179.258 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.566 HG21 ' HB1' ' A' ' 48' ' ' ALA . 11.2 p -108.93 154.68 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 O-C-N 121.604 -0.685 . . . . 0.0 109.614 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.555 ' HB3' ' HB2' ' A' ' 45' ' ' GLU . 0.4 OUTLIER -139.93 79.31 1.71 Allowed 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.712 -0.618 . . . . 0.0 109.693 -179.834 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.679 HD12 ' CA ' ' A' ' 23' ' ' VAL . 1.8 tp -45.32 -32.66 2.1 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.595 -0.691 . . . . 0.0 110.994 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.5 mp0 -72.02 -51.74 20.33 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.151 -0.968 . . . . 0.0 109.97 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.555 ' HB2' ' HB3' ' A' ' 42' ' ' SER . 1.8 mp0 -73.43 1.42 9.79 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.619 -0.676 . . . . 0.0 109.747 177.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 51.38 56.16 8.35 Favored 'General case' 0 N--CA 1.506 2.349 0 O-C-N 121.367 -0.833 . . . . 0.0 111.713 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -171.22 158.84 5.6 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.893 -1.129 . . . . 0.0 110.38 179.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.566 ' HB1' HG21 ' A' ' 41' ' ' VAL . . . -144.49 137.43 26.89 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.967 -1.083 . . . . 0.0 111.85 -179.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.583 ' HA ' ' HA ' ' A' ' 11' ' ' THR . 5.6 t -127.22 135.78 51.1 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.014 -1.054 . . . . 0.0 109.299 178.035 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.645 HG22 HG12 ' A' ' 39' ' ' ILE . 1.4 pp -145.03 167.62 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 O-C-N 121.08 -1.013 . . . . 0.0 111.036 -177.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.732 HD11 ' HB2' ' A' ' 37' ' ' HIS . 0.0 OUTLIER -109.12 169.26 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 O-C-N 121.281 -0.887 . . . . 0.0 110.15 178.727 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.754 ' CZ ' ' HB3' ' A' ' 8' ' ' ASN . 15.4 p90 -170.43 159.73 7.14 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.54 -0.725 . . . . 0.0 110.672 -178.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.45 ' OD2' ' HB3' ' A' ' 56' ' ' LEU . 6.6 p-10 -79.26 117.37 66.63 Favored Pre-proline 0 C--N 1.3 -1.558 0 C-N-CA 119.631 -0.828 . . . . 0.0 109.425 179.037 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.531 ' HD2' ' O ' ' A' ' 6' ' ' GLY . 39.8 Cg_endo -68.54 66.2 1.15 Allowed 'Trans proline' 0 N--CA 1.487 1.115 0 O-C-N 123.516 1.272 . . . . 0.0 109.374 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.484 ' HG2' ' C ' ' A' ' 54' ' ' PRO . 0.0 OUTLIER -164.11 -55.3 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 -179.267 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.45 ' HB3' ' OD2' ' A' ' 53' ' ' ASP . 0.4 OUTLIER -98.55 -41.45 7.74 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.381 -0.824 . . . . 0.0 109.53 178.271 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.406 ' HB3' ' HB2' ' A' ' 52' ' ' TYR . 20.5 tp60 -104.14 140.38 37.88 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.026 -1.046 . . . . 0.0 111.036 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.709 ' HB ' ' HD2' ' A' ' 59' ' ' PRO . 29.9 p -140.75 171.55 7.49 Favored Pre-proline 0 N--CA 1.508 2.469 0 O-C-N 121.013 -1.055 . . . . 0.0 110.363 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.709 ' HD2' ' HB ' ' A' ' 58' ' ' THR . 38.5 Cg_endo -64.22 -20.24 66.75 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 O-C-N 123.455 1.24 . . . . 0.0 110.229 179.329 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.571 ' O ' ' HB3' ' A' ' 64' ' ' GLU . 1.4 tmtt? -77.02 -31.31 56.27 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 177.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.526 ' HA ' ' CD ' ' A' ' 64' ' ' GLU . 39.1 p -86.84 -25.41 24.54 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 177.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.631 ' CD2' HD13 ' A' ' 50' ' ' ILE . 20.3 mt -77.06 -26.6 53.73 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 176.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -86.05 -24.56 26.31 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 177.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.571 ' HB3' ' O ' ' A' ' 60' ' ' LYS . 1.1 pt-20 -87.14 -15.39 38.54 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 177.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -90.05 -27.96 19.36 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 177.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -86.41 -38.24 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.047 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -71.93 -29.74 64.61 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 177.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.417 ' CB ' ' O ' ' A' ' 64' ' ' GLU . 11.8 t70 -69.39 -41.55 76.31 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.413 -0.804 . . . . 0.0 109.181 177.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.29 -46.85 76.21 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.669 -0.645 . . . . 0.0 110.25 179.329 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 121.08 38.35 0.65 Allowed Glycine 0 N--CA 1.499 2.852 0 C-N-CA 120.043 -1.075 . . . . 0.0 110.856 179.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.417 ' HB3' HG13 ' A' ' 14' ' ' VAL . 59.9 m-85 -131.3 121.67 25.11 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.521 -0.988 . . . . 0.0 108.947 179.002 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -58.99 110.44 1.03 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.241 -0.912 . . . . 0.0 109.621 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.422 ' HA ' ' O ' ' A' ' 13' ' ' SER . . . -124.08 168.19 13.21 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 122.051 0.929 . . . . 0.0 112.029 -178.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.662 ' CG1' ' HB2' ' A' ' 13' ' ' SER . 2.7 p -149.2 91.75 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 178.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.667 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . 0.0 OUTLIER -51.74 143.49 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 CA-C-O 122.488 1.137 . . . . 0.0 112.157 -177.728 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -109.64 10.63 24.9 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.657 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -131.0 100.22 17.4 Favored Pre-proline 0 N--CA 1.496 1.872 0 O-C-N 121.331 -0.855 . . . . 0.0 110.642 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -83.59 46.38 2.05 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 O-C-N 123.586 1.309 . . . . 0.0 110.569 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.453 ' O ' ' HD3' ' A' ' 59' ' ' PRO . 5.5 m-20 . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.434 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.8 ttt . . . . . 0 N--CA 1.501 2.11 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.462 ' N ' ' HD3' ' A' ' 3' ' ' PRO . 1.9 m-20 46.64 53.04 12.82 Favored Pre-proline 0 N--CA 1.502 2.125 0 O-C-N 121.789 -0.57 . . . . 0.0 111.94 177.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.462 ' HD3' ' N ' ' A' ' 2' ' ' ASP . 51.9 Cg_endo -78.68 -8.59 15.87 Favored 'Trans proline' 0 C--N 1.318 -1.05 0 O-C-N 123.61 1.321 . . . . 0.0 109.286 177.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.41 ' O ' ' N ' ' A' ' 6' ' ' GLY . 0.7 OUTLIER -139.14 10.63 2.57 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.304 -0.872 . . . . 0.0 111.246 179.58 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.45 92.03 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.24 0 O-C-N 120.904 -1.123 . . . . 0.0 111.001 -179.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 4' ' ' SER . . . 116.73 -10.31 16.11 Favored Glycine 0 N--CA 1.5 2.92 0 O-C-N 121.204 -0.935 . . . . 0.0 111.704 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.601 HG13 ' CD2' ' A' ' 37' ' ' HIS . 26.7 m -131.13 165.84 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.351 0 CA-C-N 119.355 1.577 . . . . 0.0 111.23 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.465 ' O ' HG12 ' A' ' 51' ' ' ILE . 0.8 OUTLIER -117.16 167.72 10.93 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.226 -0.921 . . . . 0.0 110.289 179.802 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.524 ' HA ' ' HA ' ' A' ' 51' ' ' ILE . 1.9 m -116.58 136.48 52.94 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.104 -0.997 . . . . 0.0 110.776 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.594 HG12 HG13 ' A' ' 12' ' ' ILE . 1.0 OUTLIER -126.58 120.71 56.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.415 -0.803 . . . . 0.0 111.459 -179.396 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.54 ' HA ' ' HA ' ' A' ' 49' ' ' THR . 24.2 m -111.75 104.74 13.1 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 177.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.594 HG13 HG12 ' A' ' 10' ' ' VAL . 72.6 mt -113.6 138.86 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.258 -0.901 . . . . 0.0 111.391 -178.152 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.72 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 0.7 OUTLIER -74.57 134.02 42.18 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 177.984 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.545 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 23.3 t -120.29 120.71 63.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 121.274 -0.891 . . . . 0.0 110.945 -178.117 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.577 ' CB ' ' HB3' ' A' ' 72' ' ' ASP . 1.7 tm-20 -109.22 -171.58 1.87 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.796 -0.565 . . . . 0.0 109.864 179.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.96 21.96 67.01 Favored Glycine 0 N--CA 1.497 2.712 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -178.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.488 ' CG ' ' HG ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -66.35 154.32 40.35 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.256 -1.144 . . . . 0.0 111.386 -179.494 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.414 ' O ' ' HB3' ' A' ' 19' ' ' CYS . 1.6 p -146.91 -41.15 0.19 Allowed 'General case' 0 N--CA 1.508 2.439 0 O-C-N 121.407 -0.808 . . . . 0.0 111.556 -179.273 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.521 ' O ' HD23 ' A' ' 43' ' ' LEU . 29.5 p -179.79 169.23 1.31 Allowed 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.523 -0.735 . . . . 0.0 109.923 -178.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.443 ' O ' HG13 ' A' ' 23' ' ' VAL . 13.2 t-20 -31.72 -36.88 0.02 OUTLIER 'General case' 0 N--CA 1.512 2.639 0 CA-C-O 121.149 0.5 . . . . 0.0 112.095 179.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.782 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 4.5 p -55.99 -17.3 6.4 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 122.187 0.994 . . . . 0.0 111.354 179.064 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.684 ' CB ' HD12 ' A' ' 43' ' ' LEU . 62.4 m -93.25 -28.83 16.01 Favored 'General case' 0 C--N 1.287 -2.131 0 O-C-N 119.602 -1.936 . . . . 0.0 110.841 -178.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.627 ' HB ' ' HB2' ' A' ' 43' ' ' LEU . 10.7 p -85.49 -32.64 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.351 -0.843 . . . . 0.0 109.167 178.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.782 ' CE3' ' HA ' ' A' ' 21' ' ' SER . 0.0 OUTLIER -83.37 -23.07 32.61 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 117.745 -1.582 . . . . 0.0 108.886 178.488 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.605 ' HB ' ' O ' ' A' ' 21' ' ' SER . 1.2 t -82.26 -26.64 33.01 Favored 'General case' 0 N--CA 1.507 2.39 0 C-N-CA 118.722 -1.191 . . . . 0.0 111.061 178.001 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.548 ' CD1' ' CD2' ' A' ' 71' ' ' PHE . 20.8 mt -96.47 -28.86 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 O-C-N 120.81 -1.181 . . . . 0.0 110.25 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.53 ' HG3' HD13 ' A' ' 39' ' ' ILE . 1.0 OUTLIER -74.54 -35.39 63.12 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 178.369 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.577 ' HB2' ' O ' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -80.86 -31.91 35.18 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 119.423 -0.911 . . . . 0.0 108.607 177.545 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.551 ' HB2' ' O ' ' A' ' 25' ' ' THR . 1.6 tm0? -73.06 -60.44 2.23 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.036 -1.04 . . . . 0.0 110.162 179.222 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.454 HD13 HG21 ' A' ' 30' ' ' ILE . 88.5 mt -59.34 -39.27 78.55 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 120.945 -1.097 . . . . 0.0 109.952 179.5 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.619 ' HA2' ' CG2' ' A' ' 39' ' ' ILE . . . -48.53 -46.44 29.72 Favored Glycine 0 N--CA 1.497 2.741 0 N-CA-C 110.219 -1.152 . . . . 0.0 110.219 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.47 ' HG3' ' O ' ' A' ' 28' ' ' GLN . 0.2 OUTLIER -130.9 40.99 3.42 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.572 -0.958 . . . . 0.0 110.88 179.526 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.5 ' HB ' ' O ' ' A' ' 29' ' ' GLN . 15.0 p -72.76 -40.35 61.04 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.298 0 O-C-N 121.143 -0.973 . . . . 0.0 111.151 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -171.04 -51.64 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.092 0 O-C-N 120.903 -1.123 . . . . 0.0 111.08 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -150.12 82.64 0.18 Allowed Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.636 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 54.0 t -139.43 100.89 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.293 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.601 ' CD2' HG13 ' A' ' 7' ' ' VAL . 67.6 m-70 -70.09 -27.53 64.68 Favored 'General case' 0 C--N 1.289 -2.043 0 C-N-CA 120.288 -0.565 . . . . 0.0 110.155 -179.281 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.645 ' HB2' ' CG2' ' A' ' 51' ' ' ILE . 23.8 m-70 -142.78 130.71 21.7 Favored 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.047 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.619 ' CG2' ' HA2' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -127.88 139.08 52.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.081 -1.012 . . . . 0.0 110.252 -179.282 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.578 ' HB3' HG23 ' A' ' 49' ' ' THR . 0.3 OUTLIER -148.31 106.21 3.71 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.165 -0.959 . . . . 0.0 110.227 179.232 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.508 ' HA ' ' HA ' ' A' ' 48' ' ' ALA . 1.1 p -107.28 170.17 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.619 -0.676 . . . . 0.0 109.411 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.674 ' HB3' ' HB2' ' A' ' 45' ' ' GLU . 2.2 m -152.4 86.02 1.27 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.074 -1.016 . . . . 0.0 111.013 -178.187 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.684 HD12 ' CB ' ' A' ' 22' ' ' CYS . 1.9 tp -46.13 -34.04 3.97 Favored 'General case' 0 N--CA 1.509 2.489 0 O-C-N 121.768 -0.583 . . . . 0.0 111.617 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -82.75 -41.94 18.59 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.464 -1.397 . . . . 0.0 110.93 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.674 ' HB2' ' HB3' ' A' ' 42' ' ' SER . 18.9 mt-10 -80.37 5.54 14.64 Favored 'General case' 0 N--CA 1.498 1.938 0 C-N-CA 119.762 -0.775 . . . . 0.0 109.76 177.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.545 ' HG3' ' O ' ' A' ' 14' ' ' VAL . 0.0 OUTLIER 42.48 51.38 4.81 Favored 'General case' 0 N--CA 1.506 2.332 0 O-C-N 121.647 -0.658 . . . . 0.0 111.226 179.866 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.446 ' ND2' ' HA ' ' A' ' 13' ' ' SER . 0.4 OUTLIER -154.45 157.06 37.87 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 120.696 -1.252 . . . . 0.0 111.975 -179.382 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.508 ' HA ' ' HA ' ' A' ' 41' ' ' VAL . . . -136.63 127.16 26.88 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.491 -0.756 . . . . 0.0 109.863 178.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.578 HG23 ' HB3' ' A' ' 40' ' ' LYS . 15.1 t -127.75 119.69 26.31 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.353 -0.842 . . . . 0.0 110.071 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.559 HG22 HG12 ' A' ' 39' ' ' ILE . 1.9 pp -141.88 176.44 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.28 -0.887 . . . . 0.0 111.086 -178.421 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.645 ' CG2' ' HB2' ' A' ' 38' ' ' HIS . 0.0 OUTLIER -117.9 150.49 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 177.014 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.599 ' CD1' ' N ' ' A' ' 52' ' ' TYR . 19.6 p90 -154.09 171.69 18.72 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 119.796 -0.762 . . . . 0.0 111.082 -176.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.0 115.77 63.13 Favored Pre-proline 0 C--N 1.3 -1.569 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -60.17 -22.64 70.94 Favored 'Trans proline' 0 N--CA 1.493 1.457 0 O-C-N 123.587 1.309 . . . . 0.0 110.035 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.4 ptpp? -79.95 -8.98 59.63 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.729 -0.607 . . . . 0.0 110.471 178.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -131.44 -46.64 0.98 Allowed 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.073 -1.017 . . . . 0.0 110.826 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -110.87 154.8 23.52 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.175 -0.953 . . . . 0.0 110.277 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.758 ' HB ' ' HD2' ' A' ' 59' ' ' PRO . 12.2 p -143.46 176.07 2.5 Favored Pre-proline 0 N--CA 1.499 1.982 0 O-C-N 121.488 -0.758 . . . . 0.0 110.456 -179.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.758 ' HD2' ' HB ' ' A' ' 58' ' ' THR . 40.0 Cg_endo -65.26 -23.35 59.55 Favored 'Trans proline' 0 N--CA 1.497 1.717 0 O-C-N 123.317 1.167 . . . . 0.0 112.199 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.528 ' O ' ' HB3' ' A' ' 64' ' ' GLU . 4.7 mmtm -90.47 -29.39 17.97 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.092 -1.005 . . . . 0.0 110.188 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.411 ' OG1' ' N ' ' A' ' 58' ' ' THR . 8.3 p -82.27 -25.84 33.7 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 177.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.514 HD23 HD12 ' A' ' 50' ' ' ILE . 0.9 OUTLIER -77.03 -27.91 54.7 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 176.676 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.455 ' HG3' ' HB3' ' A' ' 73' ' ' ALA . 1.6 tt0 -82.62 -24.5 33.81 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 177.173 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.528 ' HB3' ' O ' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -84.7 -19.47 32.72 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 177.575 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -79.49 -30.54 42.05 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 176.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 32.3 mt -79.53 -37.58 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 176.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.431 ' HB2' ' HA ' ' A' ' 64' ' ' GLU . 0.9 OUTLIER -70.79 -29.35 65.53 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 176.778 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -69.73 -47.59 62.54 Favored 'General case' 0 N--CA 1.501 2.1 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 177.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.535 ' HE2' ' HB2' ' A' ' 29' ' ' GLN . 0.0 OUTLIER -56.53 -36.43 69.22 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.584 -0.698 . . . . 0.0 109.777 179.252 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 120.28 34.99 0.9 Allowed Glycine 0 N--CA 1.494 2.544 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 179.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.548 ' CD2' ' CD1' ' A' ' 26' ' ' ILE . 95.0 m-85 -135.99 144.09 45.16 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.306 -1.114 . . . . 0.0 110.546 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.577 ' HB3' ' CB ' ' A' ' 15' ' ' GLU . 5.2 t70 -60.52 129.78 43.3 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.344 -0.847 . . . . 0.0 109.972 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.455 ' HB3' ' HG3' ' A' ' 63' ' ' GLN . . . -108.76 116.98 33.01 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.459 -0.775 . . . . 0.0 110.565 -179.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.72 ' HB ' ' HB2' ' A' ' 13' ' ' SER . 53.1 t -123.12 73.07 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 CA-C-O 122.138 0.971 . . . . 0.0 108.742 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.584 HG12 HG12 ' A' ' 12' ' ' ILE . 38.1 mt -35.4 137.25 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 CA-C-O 121.827 0.822 . . . . 0.0 112.472 -178.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -117.18 2.19 12.58 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.861 -0.525 . . . . 0.0 110.707 178.259 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.431 ' OD1' ' HD2' ' A' ' 78' ' ' PRO . 31.5 t30 -125.62 147.46 58.35 Favored Pre-proline 0 N--CA 1.499 2.004 0 O-C-N 120.983 -1.073 . . . . 0.0 109.916 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.431 ' HD2' ' OD1' ' A' ' 77' ' ' ASN . 38.9 Cg_endo -66.61 -40.0 14.55 Favored 'Trans proline' 0 N--CA 1.493 1.489 0 O-C-N 123.382 1.201 . . . . 0.0 110.26 179.449 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.487 1.396 0 CA-C-O 118.47 -0.776 . . . . 0.0 109.501 178.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.502 2.133 0 CA-C-O 120.967 0.413 . . . . 0.0 110.233 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -127.96 65.24 68.12 Favored Pre-proline 0 N--CA 1.496 1.872 0 O-C-N 121.407 -0.808 . . . . 0.0 111.411 -179.017 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.35 -21.73 19.56 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 O-C-N 123.642 1.338 . . . . 0.0 108.988 177.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.467 ' HA ' HG23 ' A' ' 7' ' ' VAL . 1.9 p -175.2 29.48 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.779 -0.575 . . . . 0.0 111.424 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 37.5 mmm -52.93 -43.01 65.97 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.085 -1.009 . . . . 0.0 109.515 179.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -125.54 35.76 2.96 Favored Glycine 0 N--CA 1.496 2.693 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 178.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.553 ' CG1' HD13 ' A' ' 51' ' ' ILE . 9.1 t -118.06 168.14 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.589 -0.947 . . . . 0.0 110.041 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.494 ' HB3' ' CZ ' ' A' ' 52' ' ' TYR . 2.9 t-20 -115.24 169.88 8.8 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.058 -1.026 . . . . 0.0 110.92 -179.272 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.637 ' HA ' ' HA ' ' A' ' 51' ' ' ILE . 26.0 p -129.46 128.97 43.99 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.427 -0.796 . . . . 0.0 110.39 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.482 ' HB ' ' CE1' ' A' ' 52' ' ' TYR . 1.2 t -123.48 137.13 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 CA-C-O 121.632 0.73 . . . . 0.0 110.88 -178.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.528 ' HA ' ' HA ' ' A' ' 49' ' ' THR . 4.3 m -118.59 121.13 39.46 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.681 ' HA ' ' HA ' ' A' ' 75' ' ' ILE . 25.6 mt -110.56 118.45 57.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.365 -0.835 . . . . 0.0 111.549 -177.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.426 ' HB2' ' O ' ' A' ' 74' ' ' VAL . 1.1 m -71.89 114.8 10.37 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 177.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.562 ' HA ' ' O ' ' A' ' 72' ' ' ASP . 20.5 t -114.52 130.66 68.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.166 -0.959 . . . . 0.0 111.404 -177.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.632 ' HA ' ' HG2' ' A' ' 46' ' ' LYS . 2.6 mm-40 -112.54 -15.32 13.07 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.14 -0.975 . . . . 0.0 111.521 179.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -79.71 33.44 2.11 Favored Glycine 0 N--CA 1.499 2.866 0 O-C-N 120.845 -1.159 . . . . 0.0 111.493 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.644 ' HG3' ' HA ' ' A' ' 46' ' ' LYS . 32.6 mmt -77.25 75.99 3.8 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 120.682 -1.481 . . . . 0.0 109.486 178.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.4 p -52.76 -33.78 50.04 Favored 'General case' 0 N--CA 1.51 2.56 0 O-C-N 121.418 -0.802 . . . . 0.0 111.767 -179.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 22.5 p 179.13 164.4 0.9 Allowed 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.644 ' HA ' ' HG ' ' A' ' 43' ' ' LEU . 17.4 m120 -38.58 -32.91 0.09 Allowed 'General case' 0 N--CA 1.509 2.51 0 CA-C-N 117.844 0.293 . . . . 0.0 111.475 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.511 ' HA ' ' HE3' ' A' ' 24' ' ' TRP . 5.0 p -52.09 -19.03 1.68 Allowed 'General case' 0 N--CA 1.507 2.406 0 O-C-N 121.095 -1.003 . . . . 0.0 111.208 177.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.668 ' HB3' ' CE1' ' A' ' 71' ' ' PHE . 84.6 m -88.92 -22.04 23.31 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.375 -0.828 . . . . 0.0 109.406 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.573 ' HA ' HG12 ' A' ' 41' ' ' VAL . 0.9 OUTLIER -80.56 -35.85 15.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 106.714 -1.588 . . . . 0.0 106.714 177.467 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.54 ' CZ3' ' CB ' ' A' ' 20' ' ' ASN . 4.2 m-90 -74.87 -30.7 61.4 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.028 -1.069 . . . . 0.0 109.188 178.188 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.485 ' O ' ' HB2' ' A' ' 29' ' ' GLN . 0.5 OUTLIER -80.73 -19.16 45.6 Favored 'General case' 0 N--CA 1.505 2.281 0 C-N-CA 119.701 -0.8 . . . . 0.0 110.849 179.232 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.509 ' HA ' HD12 ' A' ' 26' ' ' ILE . 7.8 mm -100.15 -21.17 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 O-C-N 121.179 -0.95 . . . . 0.0 109.519 179.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.73 ' HA ' HD12 ' A' ' 39' ' ' ILE . 0.1 OUTLIER -78.82 -36.16 43.04 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 177.309 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.439 ' HB2' ' O ' ' A' ' 24' ' ' TRP . 0.8 OUTLIER -81.06 -36.93 29.85 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 119.82 -0.752 . . . . 0.0 109.492 177.769 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.485 ' HB2' ' O ' ' A' ' 25' ' ' THR . 1.1 tm0? -74.1 -62.32 1.55 Allowed 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 118.94 -1.104 . . . . 0.0 110.257 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.461 ' HB ' ' O ' ' A' ' 26' ' ' ILE . 41.4 mm -61.39 -45.16 99.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.12 -0.988 . . . . 0.0 109.264 179.135 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -50.64 -35.78 30.77 Favored Glycine 0 N--CA 1.501 3.002 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 178.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.436 ' HA ' ' HD3' ' A' ' 32' ' ' LYS . 12.1 mmtm -128.25 34.57 4.54 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.145 -1.209 . . . . 0.0 110.565 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.475 ' HB ' ' O ' ' A' ' 29' ' ' GLN . 8.7 p -74.86 -41.53 46.67 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.017 -1.052 . . . . 0.0 111.799 -178.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -175.95 -54.86 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.113 0 O-C-N 120.903 -1.123 . . . . 0.0 111.08 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.427 ' O ' ' HA ' ' A' ' 52' ' ' TYR . . . -144.09 80.12 0.24 Allowed Glycine 0 N--CA 1.494 2.56 0 N-CA-C 108.763 -1.735 . . . . 0.0 108.763 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.655 HG12 ' HB ' ' A' ' 39' ' ' ILE . 28.7 t -133.82 88.78 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 CA-C-O 122.265 1.031 . . . . 0.0 110.076 -179.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.707 ' HB2' ' CD1' ' A' ' 51' ' ' ILE . 33.1 m-70 -67.16 -27.44 67.29 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.115 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.646 ' HB2' HG12 ' A' ' 51' ' ' ILE . 42.0 m-70 -141.16 125.57 17.62 Favored 'General case' 0 N--CA 1.5 2.025 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.153 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.73 HD12 ' HA ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -126.41 135.28 64.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.101 -0.999 . . . . 0.0 109.8 -179.537 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.465 ' NZ ' ' OG ' ' A' ' 42' ' ' SER . 0.0 OUTLIER -130.06 121.7 26.91 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.966 -1.083 . . . . 0.0 110.593 -179.868 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.573 HG12 ' HA ' ' A' ' 23' ' ' VAL . 2.0 t -109.21 163.51 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 178.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.626 ' HB3' ' HB2' ' A' ' 45' ' ' GLU . 0.6 OUTLIER -151.0 85.49 1.35 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.062 -1.023 . . . . 0.0 110.47 -178.864 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.644 ' HG ' ' HA ' ' A' ' 20' ' ' ASN . 0.2 OUTLIER -52.86 -58.02 8.32 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.713 -0.617 . . . . 0.0 111.372 -179.586 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.9 mp0 -69.69 -44.51 70.27 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.185 -0.947 . . . . 0.0 110.668 -179.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.626 ' HB2' ' HB3' ' A' ' 42' ' ' SER . 1.3 mt-10 -76.81 7.29 4.87 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 120.008 -0.677 . . . . 0.0 110.413 178.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.644 ' HA ' ' HG3' ' A' ' 17' ' ' MET . 0.0 OUTLIER 36.6 66.8 0.37 Allowed 'General case' 0 N--CA 1.5 2.046 0 CA-C-O 121.544 0.688 . . . . 0.0 111.754 178.994 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -157.79 145.18 18.36 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 120.693 -1.254 . . . . 0.0 112.51 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.466 ' HB2' ' HB ' ' A' ' 12' ' ' ILE . . . -124.0 109.15 13.18 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.574 -0.703 . . . . 0.0 109.126 179.1 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.528 ' HA ' ' HA ' ' A' ' 11' ' ' THR . 0.8 OUTLIER -114.92 142.53 46.47 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.047 -1.033 . . . . 0.0 109.194 179.988 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.54 ' CD1' HG22 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -165.25 157.13 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 120.71 -1.244 . . . . 0.0 110.724 -178.92 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.707 ' CD1' ' HB2' ' A' ' 37' ' ' HIS . 1.6 pp -107.08 159.91 6.56 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 O-C-N 121.275 -0.891 . . . . 0.0 109.301 179.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.631 ' CD1' ' N ' ' A' ' 52' ' ' TYR . 6.8 p90 -161.73 166.05 27.17 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.229 -0.919 . . . . 0.0 111.732 -176.013 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.31 113.05 17.31 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.651 -0.656 . . . . 0.0 110.63 179.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.476 ' HD3' ' N ' ' A' ' 8' ' ' ASN . 46.0 Cg_endo -70.25 67.16 2.04 Favored 'Trans proline' 0 N--CA 1.489 1.224 0 O-C-N 123.964 1.507 . . . . 0.0 109.039 179.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.54 -46.88 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 121.419 0.628 . . . . 0.0 109.425 -178.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -98.37 -25.57 14.77 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.603 -0.686 . . . . 0.0 109.997 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.41 ' HG3' ' N ' ' A' ' 58' ' ' THR . 2.3 tp60 -129.53 145.72 51.43 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.222 -0.924 . . . . 0.0 110.0 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.552 ' HB ' ' HD2' ' A' ' 59' ' ' PRO . 7.6 p -135.24 166.44 28.96 Favored Pre-proline 0 N--CA 1.504 2.272 0 O-C-N 121.045 -1.035 . . . . 0.0 110.783 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.552 ' HD2' ' HB ' ' A' ' 58' ' ' THR . 37.8 Cg_endo -62.06 -21.35 72.26 Favored 'Trans proline' 0 N--CA 1.493 1.499 0 O-C-N 123.957 1.504 . . . . 0.0 110.55 179.041 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.83 -38.02 54.6 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 177.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.582 ' HA ' ' HB2' ' A' ' 64' ' ' GLU . 34.4 p -77.74 -27.21 50.4 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 177.241 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.485 ' HB2' ' HA ' ' A' ' 59' ' ' PRO . 17.6 mt -73.02 -27.45 61.78 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 176.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.498 ' HG2' ' CD1' ' A' ' 75' ' ' ILE . 9.1 mm100 -85.62 -19.02 31.62 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 177.302 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.582 ' HB2' ' HA ' ' A' ' 61' ' ' THR . 4.8 mt-10 -90.36 -18.37 25.64 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 177.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.421 ' HB2' HG23 ' A' ' 33' ' ' VAL . . . -87.8 -29.63 20.83 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 177.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.585 HG12 ' HB3' ' A' ' 73' ' ' ALA . 6.9 tp -80.54 -31.61 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 177.179 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.414 ' HB2' ' O ' ' A' ' 63' ' ' GLN . 15.2 t70 -72.22 -29.84 64.33 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 176.272 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -64.52 -48.96 73.15 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.939 -0.475 . . . . 0.0 110.294 179.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.409 ' HB3' ' HD2' ' A' ' 71' ' ' PHE . 5.1 tpt -67.82 -36.94 81.28 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.349 -0.845 . . . . 0.0 110.6 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 108.74 59.1 0.54 Allowed Glycine 0 N--CA 1.498 2.795 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 179.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.668 ' CE1' ' HB3' ' A' ' 22' ' ' CYS . 43.0 m-85 -139.17 122.04 16.58 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.516 -0.991 . . . . 0.0 110.379 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.562 ' O ' ' HA ' ' A' ' 14' ' ' VAL . 6.3 t70 -54.06 104.03 0.1 Allowed 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.546 -0.721 . . . . 0.0 109.186 179.077 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.585 ' HB3' HG12 ' A' ' 66' ' ' ILE . . . -116.73 147.12 42.3 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 122.129 0.966 . . . . 0.0 112.596 -177.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.426 ' O ' ' HB2' ' A' ' 13' ' ' SER . 46.1 t -138.07 81.55 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 CA-C-O 122.011 0.91 . . . . 0.0 108.585 179.157 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.681 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . 0.3 OUTLIER -49.83 152.47 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 CA-C-O 122.679 1.228 . . . . 0.0 112.789 -178.366 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 47.9 t-80 -108.98 11.59 25.81 Favored 'General case' 0 N--CA 1.498 1.962 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.172 179.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -130.77 141.02 40.45 Favored Pre-proline 0 N--CA 1.5 2.027 0 O-C-N 121.146 -0.971 . . . . 0.0 110.064 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -81.52 -58.54 0.03 OUTLIER 'Trans proline' 0 N--CA 1.489 1.208 0 O-C-N 123.806 1.424 . . . . 0.0 111.991 -179.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 117.894 -1.05 . . . . 0.0 110.609 -179.132 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.795 HG11 ' CE1' ' A' ' 37' ' ' HIS . 1.7 m . . . . . 0 N--CA 1.508 2.463 0 CA-C-O 120.924 0.392 . . . . 0.0 110.298 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.47 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 0.5 OUTLIER -135.8 165.99 24.32 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.957 -1.089 . . . . 0.0 111.034 -179.827 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.614 ' HA ' ' HA ' ' A' ' 51' ' ' ILE . 38.0 t -114.4 150.68 34.28 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.232 -0.917 . . . . 0.0 111.421 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.626 HG21 ' HB3' ' A' ' 59' ' ' PRO . 0.9 OUTLIER -144.17 130.22 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.783 -0.573 . . . . 0.0 110.559 -179.234 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.594 HG23 ' HB ' ' A' ' 49' ' ' THR . 90.2 m -109.22 122.25 46.92 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.538 0.685 . . . . 0.0 110.595 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 1.032 HG12 HG22 ' A' ' 75' ' ' ILE . 45.9 mt -109.61 121.61 62.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.568 -0.707 . . . . 0.0 111.239 -178.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.655 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 1.4 m -70.71 133.28 46.48 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 177.814 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.516 HG12 ' HG2' ' A' ' 17' ' ' MET . 2.1 t -127.03 161.06 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.11 -0.994 . . . . 0.0 111.083 -178.584 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.83 158.65 35.58 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.493 -0.754 . . . . 0.0 110.728 178.714 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 73.93 20.99 79.71 Favored Glycine 0 N--CA 1.497 2.706 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.768 ' HE2' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -128.87 28.93 5.29 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.891 -1.358 . . . . 0.0 110.806 -179.816 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.8 m -71.59 49.17 0.16 Allowed 'General case' 0 N--CA 1.501 2.114 0 O-C-N 120.918 -1.114 . . . . 0.0 111.243 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.487 ' O ' ' N ' ' A' ' 21' ' ' SER . 0.0 OUTLIER -150.56 118.55 6.27 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.879 -1.138 . . . . 0.0 108.896 178.844 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.488 ' O ' HG12 ' A' ' 23' ' ' VAL . 76.5 m-20 -14.97 -51.55 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.761 0 C-N-CA 123.742 0.817 . . . . 0.0 113.115 -178.654 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.864 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 3.7 p -52.1 -14.46 0.42 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.399 -0.813 . . . . 0.0 112.973 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.766 ' HB2' HD22 ' A' ' 43' ' ' LEU . 63.8 m -91.63 -24.77 19.44 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 119.121 -2.237 . . . . 0.0 110.65 -179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.843 HG23 HG13 ' A' ' 41' ' ' VAL . 1.6 p -87.8 -34.98 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.53 -0.731 . . . . 0.0 109.231 179.366 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.864 ' CE3' ' HA ' ' A' ' 21' ' ' SER . 0.0 OUTLIER -81.79 -22.67 37.0 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 117.687 -1.605 . . . . 0.0 109.094 178.828 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.687 HG23 ' HE2' ' A' ' 69' ' ' MET . 0.6 OUTLIER -87.6 -24.68 23.9 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 120.94 -1.1 . . . . 0.0 110.812 178.027 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.649 HD12 HD12 ' A' ' 66' ' ' ILE . 12.5 mm -92.78 -26.53 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.388 0 O-C-N 120.874 -1.142 . . . . 0.0 109.656 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.705 ' HG2' HD12 ' A' ' 39' ' ' ILE . 4.4 tm-20 -78.83 -40.22 33.37 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 177.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.423 ' HB2' ' O ' ' A' ' 24' ' ' TRP . 68.9 mm-40 -70.44 -33.79 71.73 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 119.361 -0.936 . . . . 0.0 109.287 178.315 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.532 ' HA ' ' OE1' ' A' ' 29' ' ' GLN . 4.3 tp60 -75.89 -62.16 1.68 Allowed 'General case' 0 N--CA 1.496 1.849 0 C-N-CA 119.61 -0.836 . . . . 0.0 110.586 179.61 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.861 HG21 HG21 ' A' ' 50' ' ' ILE . 51.1 mt -60.85 -50.5 80.26 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 O-C-N 120.994 -1.066 . . . . 0.0 109.841 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -47.73 -44.2 23.33 Favored Glycine 0 N--CA 1.5 2.917 0 N-CA-C 110.849 -0.901 . . . . 0.0 110.849 179.452 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.01 16.86 24.46 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.98 -1.306 . . . . 0.0 112.447 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.496 HG21 ' HB2' ' A' ' 65' ' ' ALA . 0.5 OUTLIER -65.79 -42.3 92.04 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.175 0 O-C-N 120.89 -1.131 . . . . 0.0 111.061 -179.908 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.428 ' N ' HG12 ' A' ' 33' ' ' VAL . 0.1 OUTLIER -163.04 -76.75 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.222 -0.924 . . . . 0.0 110.784 -179.747 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.549 ' O ' ' HA ' ' A' ' 52' ' ' TYR . . . -141.39 75.84 0.33 Allowed Glycine 0 N--CA 1.495 2.567 0 N-CA-C 108.758 -1.737 . . . . 0.0 108.758 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.84 HG22 HD13 ' A' ' 50' ' ' ILE . 41.1 t -103.04 91.43 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 CA-C-O 122.665 1.221 . . . . 0.0 108.128 179.55 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.94 ' HB2' HD12 ' A' ' 51' ' ' ILE . 67.9 m80 -61.67 -14.27 29.82 Favored 'General case' 0 C--N 1.283 -2.325 0 CA-C-N 114.827 -1.079 . . . . 0.0 110.627 -179.572 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.567 ' HB3' ' CG2' ' A' ' 51' ' ' ILE . 7.2 t-80 -170.83 121.1 0.56 Allowed 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.817 ' HB ' HG11 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -122.07 128.8 75.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.268 -0.895 . . . . 0.0 109.565 -179.438 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.481 ' HD3' HG22 ' A' ' 49' ' ' THR . 0.0 OUTLIER -125.19 99.83 6.26 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.599 -1.313 . . . . 0.0 111.445 -179.615 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.843 HG13 HG23 ' A' ' 23' ' ' VAL . 15.0 p -107.41 153.97 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 177.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.845 ' HB3' ' HB3' ' A' ' 45' ' ' GLU . 0.2 OUTLIER -153.15 94.33 1.82 Allowed 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.103 -0.998 . . . . 0.0 110.763 -178.057 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.768 ' HA ' ' HE2' ' A' ' 17' ' ' MET . 14.5 mt -46.83 -25.17 0.7 Allowed 'General case' 0 N--CA 1.508 2.436 0 O-C-N 121.923 -0.486 . . . . 0.0 112.016 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.574 ' HG2' ' N ' ' A' ' 45' ' ' GLU . 0.4 OUTLIER -96.92 -38.48 9.8 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 120.4 -1.437 . . . . 0.0 111.332 179.651 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.845 ' HB3' ' HB3' ' A' ' 42' ' ' SER . 0.2 OUTLIER -74.61 -4.2 35.72 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.202 -0.936 . . . . 0.0 108.802 177.476 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.9 mptt 56.66 34.88 25.28 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.271 -0.893 . . . . 0.0 112.961 177.487 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -148.19 151.32 35.32 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.534 -1.353 . . . . 0.0 112.071 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.437 ' HA ' ' HA ' ' A' ' 41' ' ' VAL . . . -130.84 103.28 6.48 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.209 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.594 ' HB ' HG23 ' A' ' 11' ' ' THR . 14.8 t -116.55 134.72 54.51 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.233 -0.917 . . . . 0.0 110.376 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.954 HD11 HD21 ' A' ' 62' ' ' LEU . 1.3 pp -144.85 -178.71 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-O 121.621 0.724 . . . . 0.0 110.785 -178.55 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.94 HD12 ' HB2' ' A' ' 37' ' ' HIS . 0.0 OUTLIER -121.59 145.38 28.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 177.918 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.744 ' N ' HD13 ' A' ' 51' ' ' ILE . 13.7 p90 -149.2 165.82 30.7 Favored 'General case' 0 C--N 1.296 -1.761 0 O-C-N 121.245 -0.909 . . . . 0.0 111.347 -177.669 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.447 ' HA ' HG12 ' A' ' 7' ' ' VAL . 0.3 OUTLIER -84.5 107.14 10.09 Favored Pre-proline 0 N--CA 1.49 1.539 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.701 179.924 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.547 ' HD2' ' HA ' ' A' ' 7' ' ' VAL . 48.2 Cg_endo -75.11 -9.12 20.48 Favored 'Trans proline' 0 C--N 1.319 -1.018 0 O-C-N 123.624 1.328 . . . . 0.0 109.75 178.81 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 8.8 mtmm -74.18 -35.97 64.01 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.5 pp -121.4 -17.16 7.68 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.523 -0.736 . . . . 0.0 111.44 179.145 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.517 ' O ' ' HA ' ' A' ' 54' ' ' PRO . 2.7 mm-40 -131.58 -179.39 5.35 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.796 -1.19 . . . . 0.0 110.484 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.542 ' OG1' ' HD2' ' A' ' 59' ' ' PRO . 0.5 OUTLIER -164.22 173.5 3.96 Favored Pre-proline 0 N--CA 1.497 1.914 0 O-C-N 120.874 -1.141 . . . . 0.0 110.01 -179.993 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.626 ' HB3' HG21 ' A' ' 10' ' ' VAL . 37.9 Cg_endo -62.78 8.32 0.13 Allowed 'Trans proline' 0 N--CA 1.502 1.972 0 C-N-CA 121.227 1.285 . . . . 0.0 113.258 -179.164 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.555 ' HG3' ' N ' ' A' ' 61' ' ' THR . 0.2 OUTLIER -90.68 -28.27 18.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.973 -1.08 . . . . 0.0 108.525 177.773 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.555 ' N ' ' HG3' ' A' ' 60' ' ' LYS . 0.8 OUTLIER -85.85 -27.69 24.91 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 177.953 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.954 HD21 HD11 ' A' ' 50' ' ' ILE . 4.5 mp -72.15 -27.62 62.72 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 176.707 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.483 ' O ' ' HB2' ' A' ' 67' ' ' ASP . 14.2 tp60 -86.65 -20.21 28.14 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 177.716 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.537 ' HB3' ' O ' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -91.28 -22.15 20.71 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.159 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.496 ' HB2' HG21 ' A' ' 33' ' ' VAL . . . -85.27 -27.66 25.85 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.538 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.676 HG12 ' HB2' ' A' ' 73' ' ' ALA . 2.1 tp -85.17 -32.73 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 177.249 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.483 ' HB2' ' O ' ' A' ' 63' ' ' GLN . 27.8 t70 -74.37 -32.28 62.68 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 177.214 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.407 ' HB3' ' O ' ' A' ' 64' ' ' GLU . 0.2 OUTLIER -70.5 -43.39 69.79 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.878 -0.514 . . . . 0.0 109.868 178.915 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.687 ' HE2' HG23 ' A' ' 25' ' ' THR . 23.6 mmm -59.86 -46.72 88.38 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.18 -0.95 . . . . 0.0 109.996 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 114.54 51.42 0.46 Allowed Glycine 0 N--CA 1.499 2.846 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.592 ' CD1' ' HB3' ' A' ' 17' ' ' MET . 75.1 m-85 -139.27 130.18 26.29 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.69 -0.888 . . . . 0.0 109.526 179.506 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.495 ' O ' ' HA ' ' A' ' 14' ' ' VAL . 1.7 m-20 -49.9 111.32 0.49 Allowed 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.433 -0.792 . . . . 0.0 110.045 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.676 ' HB2' HG12 ' A' ' 66' ' ' ILE . . . -109.77 127.26 54.52 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.185 -0.947 . . . . 0.0 111.582 -178.814 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.655 ' HB ' ' HB2' ' A' ' 13' ' ' SER . 75.5 t -131.67 76.4 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.487 -0.758 . . . . 0.0 109.071 178.775 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 1.032 HG22 HG12 ' A' ' 12' ' ' ILE . 33.3 pt . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 121.763 0.792 . . . . 0.0 110.861 -179.106 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 1.071 HG11 HD11 ' A' ' 51' ' ' ILE . 12.9 t . . . . . 0 N--CA 1.506 2.344 0 CA-C-O 121.45 0.643 . . . . 0.0 110.446 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.406 ' O ' HG12 ' A' ' 51' ' ' ILE . 9.8 m120 -124.6 166.3 16.35 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 120.785 -1.197 . . . . 0.0 111.306 -179.011 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.616 ' HA ' ' HA ' ' A' ' 51' ' ' ILE . 2.5 m -120.29 145.68 46.85 Favored 'General case' 0 N--CA 1.505 2.294 0 O-C-N 121.088 -1.007 . . . . 0.0 111.833 -179.556 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.457 HG21 ' HA ' ' A' ' 59' ' ' PRO . 1.0 OUTLIER -134.24 140.97 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.639 -0.663 . . . . 0.0 110.891 -179.29 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.604 ' HA ' ' HA ' ' A' ' 49' ' ' THR . 2.9 m -118.91 130.35 55.68 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.229 -0.919 . . . . 0.0 110.151 178.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.706 ' HA ' ' HA ' ' A' ' 75' ' ' ILE . 51.9 mt -122.74 133.02 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.363 -0.836 . . . . 0.0 111.553 -178.48 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.563 ' HB3' ' CG1' ' A' ' 74' ' ' VAL . 0.1 OUTLIER -87.75 117.2 26.42 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.071 -1.018 . . . . 0.0 108.703 178.129 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.568 HG13 ' O ' ' A' ' 14' ' ' VAL . 14.6 p -112.21 108.43 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 O-C-N 121.179 -0.951 . . . . 0.0 110.408 -178.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.577 ' HA ' ' HD2' ' A' ' 46' ' ' LYS . 0.1 OUTLIER -108.34 -32.11 7.58 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.052 -1.03 . . . . 0.0 112.008 -178.6 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -70.03 30.97 0.41 Allowed Glycine 0 N--CA 1.502 3.066 0 C-N-CA 120.423 -0.894 . . . . 0.0 112.255 -179.464 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.824 ' SD ' HD12 ' A' ' 43' ' ' LEU . 13.2 ptp -90.75 -173.21 3.64 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.474 -1.603 . . . . 0.0 109.799 178.782 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 16.9 p -147.22 -27.65 0.38 Allowed 'General case' 0 N--CA 1.514 2.745 0 O-C-N 121.248 -0.908 . . . . 0.0 112.283 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.434 ' CA ' HD11 ' A' ' 43' ' ' LEU . 19.5 p -179.7 176.44 0.78 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.109 -0.994 . . . . 0.0 108.55 -179.048 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.633 ' HB3' ' CZ3' ' A' ' 24' ' ' TRP . 4.3 m120 -43.31 -31.69 0.68 Allowed 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.773 -0.579 . . . . 0.0 110.618 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.546 ' HA ' ' HE3' ' A' ' 24' ' ' TRP . 3.7 p -54.12 -26.29 26.68 Favored 'General case' 0 N--CA 1.506 2.339 0 O-C-N 121.06 -1.025 . . . . 0.0 110.398 178.319 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.824 ' O ' HD12 ' A' ' 26' ' ' ILE . 80.7 m -91.49 -25.81 19.1 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.701 0.762 . . . . 0.0 108.977 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.685 HG21 ' HB2' ' A' ' 43' ' ' LEU . 12.0 t -79.47 -41.62 22.49 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 176.487 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.633 ' CZ3' ' HB3' ' A' ' 20' ' ' ASN . 2.1 m0 -60.79 -40.47 92.75 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 176.826 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.421 HG21 ' HE2' ' A' ' 71' ' ' PHE . 40.2 m -66.7 -31.05 71.47 Favored 'General case' 0 N--CA 1.502 2.127 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.608 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.824 HD12 ' O ' ' A' ' 22' ' ' CYS . 2.1 mt -99.07 -17.22 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.225 0 O-C-N 121.142 -0.974 . . . . 0.0 110.902 -179.114 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.691 ' HG3' HD12 ' A' ' 39' ' ' ILE . 1.1 tt0 -87.67 -31.66 19.63 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 177.339 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.495 ' HB3' ' O ' ' A' ' 24' ' ' TRP . 1.1 tm0? -80.41 -39.49 28.22 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 178.016 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.423 ' HB2' ' SD ' ' A' ' 69' ' ' MET . 7.2 mm100 -70.6 -60.02 2.5 Favored 'General case' 0 N--CA 1.502 2.154 0 C-N-CA 119.251 -0.98 . . . . 0.0 110.352 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.485 ' HB ' HG13 ' A' ' 39' ' ' ILE . 45.4 mm -60.58 -42.38 91.37 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.113 -0.992 . . . . 0.0 110.497 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -51.73 -45.93 54.6 Favored Glycine 0 N--CA 1.5 2.961 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.4 mttt -114.98 27.53 9.34 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.331 -1.099 . . . . 0.0 111.494 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.471 HG13 ' N ' ' A' ' 34' ' ' ASN . 12.2 p -66.46 -43.26 91.09 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 O-C-N 120.887 -1.133 . . . . 0.0 111.449 -179.521 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.528 ' HB3' ' HG2' ' A' ' 57' ' ' GLN . 0.7 OUTLIER -178.86 -52.13 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.109 -0.995 . . . . 0.0 110.777 179.847 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.419 ' HA3' HD23 ' A' ' 56' ' ' LEU . . . -148.24 81.74 0.2 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -179.278 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.856 HG22 HD11 ' A' ' 50' ' ' ILE . 38.8 t -133.07 97.4 2.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.013 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 1.031 ' HB2' HD12 ' A' ' 51' ' ' ILE . 67.7 m80 -72.1 -29.28 63.94 Favored 'General case' 0 C--N 1.289 -2.063 0 C-N-CA 120.043 -0.663 . . . . 0.0 109.818 -179.412 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.718 ' HB2' HG22 ' A' ' 51' ' ' ILE . 31.3 m80 -144.57 117.23 8.66 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.242 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.786 ' HB ' HG11 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -117.79 126.02 74.52 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 179.391 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.625 ' HB3' HG22 ' A' ' 49' ' ' THR . 2.1 tmtm? -126.52 119.54 27.39 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.616 -1.303 . . . . 0.0 111.01 -179.552 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.492 ' O ' ' NZ ' ' A' ' 40' ' ' LYS . 47.0 t -107.29 170.77 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 178.542 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.698 ' HB3' ' HB2' ' A' ' 45' ' ' GLU . 0.6 OUTLIER -149.82 85.25 1.42 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.683 -1.261 . . . . 0.0 110.67 -179.51 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.824 HD12 ' SD ' ' A' ' 17' ' ' MET . 20.0 tp -42.53 -43.1 3.58 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.2 mp0 -82.92 -44.24 15.58 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.154 -0.966 . . . . 0.0 111.771 -178.584 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.698 ' HB2' ' HB3' ' A' ' 42' ' ' SER . 5.8 mt-10 -80.03 8.94 6.09 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.195 -0.941 . . . . 0.0 110.344 179.133 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.577 ' HD2' ' HA ' ' A' ' 15' ' ' GLU . 8.1 mmtp 37.15 59.47 1.11 Allowed 'General case' 0 N--CA 1.504 2.253 0 CA-C-O 121.528 0.68 . . . . 0.0 110.967 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.425 ' HA ' ' H ' ' A' ' 14' ' ' VAL . 12.5 t-20 -159.08 149.08 19.14 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.031 -1.043 . . . . 0.0 111.202 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.532 ' HA ' ' O ' ' A' ' 40' ' ' LYS . . . -139.41 122.31 16.62 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.4 -0.813 . . . . 0.0 110.745 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.625 HG22 ' HB3' ' A' ' 40' ' ' LYS . 6.9 t -113.59 151.93 31.01 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.302 -0.874 . . . . 0.0 109.539 178.723 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.856 HD11 HG22 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -160.13 157.23 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.026 -1.046 . . . . 0.0 111.954 -177.932 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 1.071 HD11 HG11 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -109.89 152.85 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.587 -0.696 . . . . 0.0 109.27 178.378 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.556 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 33.9 p90 -158.04 160.16 37.11 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.899 -0.72 . . . . 0.0 111.874 -177.056 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.431 ' HA ' ' HD2' ' A' ' 54' ' ' PRO . 5.1 t0 -86.61 120.32 71.86 Favored Pre-proline 0 N--CA 1.492 1.669 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 177.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.431 ' HD2' ' HA ' ' A' ' 53' ' ' ASP . 36.7 Cg_endo -59.23 -29.68 91.0 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 O-C-N 123.633 1.333 . . . . 0.0 109.73 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.38 -19.18 65.38 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.855 -0.528 . . . . 0.0 110.681 178.174 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.477 HD21 ' C ' ' A' ' 34' ' ' ASN . 0.4 OUTLIER -124.65 -36.82 2.55 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.096 -1.003 . . . . 0.0 111.441 -179.173 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.528 ' HG2' ' HB3' ' A' ' 34' ' ' ASN . 3.4 mm-40 -130.15 155.05 46.85 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.054 -1.029 . . . . 0.0 110.399 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.627 ' HB ' ' HD2' ' A' ' 59' ' ' PRO . 4.7 p -136.61 172.97 6.09 Favored Pre-proline 0 N--CA 1.5 2.074 0 O-C-N 121.004 -1.06 . . . . 0.0 109.807 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.627 ' HD2' ' HB ' ' A' ' 58' ' ' THR . 42.9 Cg_endo -68.45 -14.36 39.73 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 O-C-N 123.326 1.171 . . . . 0.0 110.896 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.8 -38.37 13.03 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.322 -0.861 . . . . 0.0 109.352 179.042 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.602 ' HA ' ' HB2' ' A' ' 64' ' ' GLU . 0.3 OUTLIER -73.14 -27.01 61.43 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.237 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.498 ' CD2' HD12 ' A' ' 50' ' ' ILE . 16.3 mt -72.18 -28.39 63.18 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 176.716 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -83.43 -32.24 26.19 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 177.225 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.602 ' HB2' ' HA ' ' A' ' 61' ' ' THR . 0.1 OUTLIER -71.58 -20.08 62.05 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 177.402 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -90.02 -25.18 20.97 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 177.516 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.532 ' HA ' ' HE3' ' A' ' 69' ' ' MET . 0.4 OUTLIER -88.62 -39.49 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 178.042 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -68.87 -29.62 67.96 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 177.663 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.45 -44.01 59.05 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.552 -0.717 . . . . 0.0 109.881 178.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.556 ' SD ' HG13 ' A' ' 26' ' ' ILE . 28.7 mtm -51.69 -49.82 61.66 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.455 -0.778 . . . . 0.0 110.52 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 111.47 55.24 0.5 Allowed Glycine 0 N--CA 1.498 2.797 0 C-N-CA 119.542 -1.313 . . . . 0.0 110.096 179.05 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.65 ' CD2' HD11 ' A' ' 26' ' ' ILE . 25.4 m-85 -135.89 124.37 23.51 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.637 -0.92 . . . . 0.0 109.357 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -56.62 92.98 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.513 -0.742 . . . . 0.0 109.513 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.487 ' HA ' ' O ' ' A' ' 13' ' ' SER . . . -120.56 178.27 4.74 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 122.188 0.994 . . . . 0.0 112.13 -178.143 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.563 ' CG1' ' HB3' ' A' ' 13' ' ' SER . 3.6 p -159.26 91.68 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 179.448 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.706 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . 25.1 pt . . . . . 0 C--N 1.302 -1.462 0 CA-C-O 122.362 1.077 . . . . 0.0 111.772 -178.279 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.543 HG11 HD13 ' A' ' 51' ' ' ILE . 4.8 t . . . . . 0 N--CA 1.499 2.002 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.601 ' HB3' ' CZ ' ' A' ' 52' ' ' TYR . 0.9 OUTLIER -116.35 163.92 15.31 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.89 -1.131 . . . . 0.0 110.392 179.816 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.675 ' HA ' ' HA ' ' A' ' 51' ' ' ILE . 47.5 p -129.37 143.5 50.87 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.237 -0.915 . . . . 0.0 111.247 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.895 HG21 ' HB3' ' A' ' 59' ' ' PRO . 0.9 OUTLIER -142.26 142.26 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 CA-C-O 121.674 0.75 . . . . 0.0 110.806 -179.553 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.625 ' HA ' ' HA ' ' A' ' 49' ' ' THR . 20.7 m -106.47 145.99 31.11 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.817 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.946 ' HA ' HG12 ' A' ' 75' ' ' ILE . 23.3 mm -126.42 116.13 44.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -177.477 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.57 ' H ' ' CG2' ' A' ' 75' ' ' ILE . 1.4 t -82.91 111.25 18.62 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 176.089 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' A' ' 72' ' ' ASP . 9.8 p -108.91 135.06 48.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 O-C-N 121.538 -0.726 . . . . 0.0 112.325 -176.297 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -116.57 174.3 6.15 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.455 -0.778 . . . . 0.0 110.348 179.152 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 81.91 -7.73 62.02 Favored Glycine 0 N--CA 1.499 2.889 0 C-N-CA 120.483 -0.865 . . . . 0.0 111.164 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.592 ' HG2' ' HB3' ' A' ' 22' ' ' CYS . 12.4 mtm -82.46 112.09 19.08 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.76 -1.436 . . . . 0.0 111.041 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.4 t -139.56 25.14 2.42 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.07 -1.019 . . . . 0.0 111.984 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.77 ' C ' HD21 ' A' ' 43' ' ' LEU . 0.4 OUTLIER -170.07 139.33 1.81 Allowed 'General case' 0 N--CA 1.5 2.073 0 O-C-N 120.991 -1.068 . . . . 0.0 109.075 178.978 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.573 ' HA ' ' CD2' ' A' ' 43' ' ' LEU . 22.6 m120 -23.09 -45.44 0.01 OUTLIER 'General case' 0 N--CA 1.518 2.958 0 CA-C-O 121.453 0.644 . . . . 0.0 112.585 -178.735 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.884 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 1.5 p -56.46 -14.13 2.81 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 1.102 ' HB2' HD11 ' A' ' 43' ' ' LEU . 71.8 m -92.91 -26.83 17.43 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 119.808 -1.808 . . . . 0.0 111.678 -178.422 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.87 HG12 HD22 ' A' ' 43' ' ' LEU . 7.9 p -88.92 -34.73 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.119 -0.988 . . . . 0.0 108.706 178.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.884 ' CE3' ' HA ' ' A' ' 21' ' ' SER . 0.0 OUTLIER -79.98 -23.59 41.49 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 117.634 -1.626 . . . . 0.0 108.964 178.495 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.597 ' HB ' ' CZ3' ' A' ' 24' ' ' TRP . 1.7 t -84.46 -27.41 27.51 Favored 'General case' 0 N--CA 1.506 2.346 0 O-C-N 120.679 -1.263 . . . . 0.0 110.352 178.103 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.934 HD11 ' CD2' ' A' ' 71' ' ' PHE . 17.8 mm -89.48 -29.91 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 O-C-N 121.142 -0.973 . . . . 0.0 109.532 179.372 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.635 ' HG3' ' CG2' ' A' ' 39' ' ' ILE . 9.8 tt0 -81.31 -32.66 33.02 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 178.287 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.567 ' HB2' ' O ' ' A' ' 24' ' ' TRP . 0.9 OUTLIER -80.45 -26.5 38.29 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.281 177.872 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.436 ' O ' ' HB ' ' A' ' 33' ' ' VAL . 4.1 tp60 -71.43 -65.44 0.75 Allowed 'General case' 0 N--CA 1.497 1.92 0 C-N-CA 119.238 -0.985 . . . . 0.0 108.824 179.1 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.686 HG22 HD11 ' A' ' 39' ' ' ILE . 18.2 mm -59.51 -52.02 65.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.237 -0.915 . . . . 0.0 110.258 179.514 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -49.18 -39.75 27.94 Favored Glycine 0 N--CA 1.502 3.061 0 N-CA-C 110.404 -1.079 . . . . 0.0 110.404 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.15 26.39 10.51 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.232 -1.158 . . . . 0.0 111.047 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.642 HG12 ' O ' ' A' ' 30' ' ' ILE . 11.1 p -74.36 -46.81 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 120.455 -1.403 . . . . 0.0 111.331 -179.44 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.454 ' N ' HG13 ' A' ' 33' ' ' VAL . 1.0 OUTLIER -173.46 -32.14 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.33 0 O-C-N 120.907 -1.12 . . . . 0.0 111.633 179.259 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.498 ' O ' ' HA ' ' A' ' 52' ' ' TYR . . . -168.97 85.37 0.09 OUTLIER Glycine 0 N--CA 1.496 2.695 0 C-N-CA 119.873 -1.156 . . . . 0.0 110.509 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.878 HG11 ' CD1' ' A' ' 39' ' ' ILE . 42.8 t -130.38 90.34 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 CA-C-O 122.512 1.148 . . . . 0.0 109.307 178.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.964 ' HB2' HD11 ' A' ' 51' ' ' ILE . 40.9 m80 -65.88 -13.46 59.68 Favored 'General case' 0 C--N 1.286 -2.153 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.926 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.79 ' HB3' HG12 ' A' ' 51' ' ' ILE . 0.1 OUTLIER -152.22 128.52 10.56 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 120.759 -1.213 . . . . 0.0 110.381 179.385 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.878 ' CD1' HG11 ' A' ' 36' ' ' VAL 0.293 2.0 mm -121.19 139.26 48.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.857 -177.906 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.917 ' HB3' HG22 ' A' ' 49' ' ' THR . 0.0 OUTLIER -142.1 83.17 1.83 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.556 -1.34 . . . . 0.0 109.685 176.621 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.727 HG22 ' HB1' ' A' ' 48' ' ' ALA . 17.2 t -107.33 155.94 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.068 -1.02 . . . . 0.0 109.272 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.793 ' HB2' ' HB3' ' A' ' 45' ' ' GLU . 41.5 m -152.33 91.07 1.55 Allowed 'General case' 0 C--N 1.308 -1.21 0 O-C-N 121.112 -0.992 . . . . 0.0 110.1 -178.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 1.102 HD11 ' HB2' ' A' ' 22' ' ' CYS . 6.9 tp -30.77 -53.38 0.19 Allowed 'General case' 0 N--CA 1.508 2.474 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -179.285 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.618 ' HA ' ' NZ ' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -78.5 -37.13 43.96 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.687 -1.258 . . . . 0.0 112.241 -178.81 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.793 ' HB3' ' HB2' ' A' ' 42' ' ' SER . 27.5 tt0 -59.48 -15.37 17.16 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 119.617 -0.833 . . . . 0.0 109.274 177.35 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.618 ' NZ ' ' HA ' ' A' ' 44' ' ' GLU . 0.1 OUTLIER 53.71 52.83 12.4 Favored 'General case' 0 N--CA 1.503 2.209 0 CA-C-O 121.816 0.817 . . . . 0.0 109.812 -179.813 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -170.75 159.37 6.44 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.579 -0.701 . . . . 0.0 109.716 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.727 ' HB1' HG22 ' A' ' 41' ' ' VAL . . . -150.7 116.85 5.63 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.302 -0.874 . . . . 0.0 109.492 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.917 HG22 ' HB3' ' A' ' 40' ' ' LYS . 4.8 t -110.13 127.38 54.86 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 120.843 -1.161 . . . . 0.0 109.069 179.353 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 1.08 HD11 HD21 ' A' ' 62' ' ' LEU . 1.8 pp -140.5 164.04 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.43 -0.793 . . . . 0.0 110.567 -177.155 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.964 HD11 ' HB2' ' A' ' 37' ' ' HIS . 1.5 pp -113.61 172.54 3.4 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 O-C-N 120.936 -1.103 . . . . 0.0 109.734 178.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.649 ' N ' HD12 ' A' ' 51' ' ' ILE . 11.0 p90 -163.3 167.36 21.98 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.343 -0.848 . . . . 0.0 110.963 -178.341 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.423 ' HB3' ' HB2' ' A' ' 56' ' ' LEU . 1.2 t0 -88.17 121.74 70.28 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.456 -0.778 . . . . 0.0 110.458 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.404 ' HD3' ' N ' ' A' ' 8' ' ' ASN . 38.4 Cg_endo -64.92 -29.58 57.87 Favored 'Trans proline' 0 N--CA 1.488 1.185 0 O-C-N 123.804 1.423 . . . . 0.0 108.784 178.634 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.1 ptpp? -77.62 -6.48 53.94 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.854 -0.529 . . . . 0.0 110.627 178.169 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.54 HD23 ' HG2' ' A' ' 57' ' ' GLN . 1.6 tt -117.13 -46.97 2.69 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.089 -1.007 . . . . 0.0 111.16 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.54 ' HG2' HD23 ' A' ' 56' ' ' LEU . 21.1 mm-40 -148.87 -174.05 4.52 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.077 -1.014 . . . . 0.0 110.951 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.6 ' HB ' ' HD2' ' A' ' 59' ' ' PRO . 1.1 p -144.07 176.82 2.05 Favored Pre-proline 0 N--CA 1.499 1.98 0 O-C-N 121.086 -1.009 . . . . 0.0 109.715 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.895 ' HB3' HG21 ' A' ' 10' ' ' VAL . 40.6 Cg_endo -68.29 -7.04 18.93 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 O-C-N 123.529 1.279 . . . . 0.0 110.791 178.362 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.86 -38.16 58.24 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.092 -1.005 . . . . 0.0 109.333 178.562 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.7 ' HA ' ' HB2' ' A' ' 64' ' ' GLU . 0.2 OUTLIER -90.74 -19.66 23.27 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 177.832 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 1.08 HD21 HD11 ' A' ' 50' ' ' ILE . 0.1 OUTLIER -71.17 -34.02 70.54 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 176.831 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -81.51 -30.82 33.11 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 176.554 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.7 ' HB2' ' HA ' ' A' ' 61' ' ' THR . 3.2 mt-10 -73.98 -17.98 60.93 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 176.705 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.447 ' CB ' HG21 ' A' ' 33' ' ' VAL . . . -86.94 -24.71 24.67 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 106.835 -1.542 . . . . 0.0 106.835 176.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.863 HG21 ' HB2' ' A' ' 73' ' ' ALA . 0.8 OUTLIER -86.57 -41.94 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 177.519 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.82 -31.83 72.91 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 177.678 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -75.19 -38.73 60.68 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.51 -0.744 . . . . 0.0 109.701 178.401 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.755 ' HG3' HD13 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -53.81 -46.61 71.17 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.54 -0.725 . . . . 0.0 111.396 179.86 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 119.0 35.06 0.98 Allowed Glycine 0 N--CA 1.501 3.028 0 C-N-CA 120.143 -1.027 . . . . 0.0 110.828 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.934 ' CD2' HD11 ' A' ' 26' ' ' ILE . 96.8 m-85 -140.5 136.61 33.11 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.284 -1.127 . . . . 0.0 109.62 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.448 ' O ' ' HA ' ' A' ' 14' ' ' VAL . 0.5 OUTLIER -57.04 135.02 56.3 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.359 -0.838 . . . . 0.0 111.233 -179.282 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.863 ' HB2' HG21 ' A' ' 66' ' ' ILE . . . -122.45 140.63 52.51 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.367 -0.833 . . . . 0.0 111.748 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.772 ' C ' HG13 ' A' ' 75' ' ' ILE . 4.4 t -155.7 99.02 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 178.329 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.946 HG12 ' HA ' ' A' ' 12' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.629 0 C-N-CA 118.567 -1.253 . . . . 0.0 113.742 -174.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.537 HG11 ' CE1' ' A' ' 37' ' ' HIS . 3.3 m . . . . . 0 N--CA 1.501 2.096 0 CA-C-O 121.152 0.501 . . . . 0.0 110.165 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.732 ' HB3' ' CZ ' ' A' ' 52' ' ' TYR . 1.9 t30 -129.79 161.8 29.91 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.276 -0.89 . . . . 0.0 110.368 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.554 ' HA ' ' HA ' ' A' ' 51' ' ' ILE . 0.3 OUTLIER -119.99 128.7 53.8 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.382 -0.824 . . . . 0.0 109.351 179.069 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.576 HG23 ' OH ' ' A' ' 52' ' ' TYR . 1.0 OUTLIER -121.14 133.75 66.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.384 -0.822 . . . . 0.0 112.061 -178.222 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.489 ' HA ' ' HA ' ' A' ' 49' ' ' THR . 19.0 m -114.68 121.27 42.86 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.682 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.997 HD11 ' HB1' ' A' ' 73' ' ' ALA . 13.1 tt -118.43 132.35 68.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 CA-C-O 121.831 0.824 . . . . 0.0 111.348 -179.072 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.581 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 49.1 m -77.17 121.75 24.05 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 178.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.671 ' HA ' ' O ' ' A' ' 72' ' ' ASP . 0.2 OUTLIER -126.43 121.49 58.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.271 -0.893 . . . . 0.0 111.65 -178.055 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.504 ' CD ' ' HG2' ' A' ' 46' ' ' LYS . 10.2 tp10 -109.49 158.07 18.34 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.457 -0.777 . . . . 0.0 110.559 179.458 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.51 10.09 59.56 Favored Glycine 0 N--CA 1.498 2.778 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 179.494 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.585 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 20.4 mmt -45.31 -41.47 8.77 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.026 -1.279 . . . . 0.0 110.46 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 40.1 m 61.51 -48.5 0.14 Allowed 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.841 -0.537 . . . . 0.0 112.249 178.664 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.517 ' N ' ' O ' ' A' ' 17' ' ' MET . 14.0 p -170.42 152.14 3.92 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.11 -0.994 . . . . 0.0 111.163 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.56 ' N ' HD21 ' A' ' 43' ' ' LEU . 3.2 p30 -29.28 -40.97 0.02 OUTLIER 'General case' 0 N--CA 1.511 2.589 0 C-N-CA 123.103 0.561 . . . . 0.0 112.431 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.539 ' HA ' ' HE3' ' A' ' 24' ' ' TRP . 4.2 p -48.28 -23.91 1.03 Allowed 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.257 -0.902 . . . . 0.0 111.374 179.388 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.694 ' HB3' ' CE1' ' A' ' 71' ' ' PHE . 68.9 m -89.59 -21.11 23.0 Favored 'General case' 0 N--CA 1.503 2.175 0 O-C-N 121.124 -0.985 . . . . 0.0 109.78 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.578 ' HB ' HD13 ' A' ' 43' ' ' LEU . 1.0 OUTLIER -85.74 -38.29 12.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 176.096 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.539 ' HE3' ' HA ' ' A' ' 21' ' ' SER . 4.2 m0 -64.0 -32.57 74.16 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 119.098 -1.041 . . . . 0.0 108.844 177.435 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.46 ' O ' ' HB2' ' A' ' 29' ' ' GLN . 0.6 OUTLIER -83.84 -24.68 30.83 Favored 'General case' 0 N--CA 1.505 2.28 0 C-N-CA 119.812 -0.755 . . . . 0.0 111.345 179.868 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.64 HD12 HD13 ' A' ' 66' ' ' ILE . 11.8 mm -91.88 -33.35 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 O-C-N 121.122 -0.986 . . . . 0.0 110.075 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.628 ' HG2' ' CG2' ' A' ' 41' ' ' VAL . 15.3 mt-10 -78.18 -34.78 49.38 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 178.153 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.509 ' HB2' ' O ' ' A' ' 24' ' ' TRP . 0.7 OUTLIER -72.96 -30.36 63.78 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 176.918 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.576 ' HG3' ' HG2' ' A' ' 69' ' ' MET . 3.1 mm100 -77.49 -61.29 2.04 Favored 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 119.064 -1.054 . . . . 0.0 109.942 178.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.999 HG21 HG21 ' A' ' 50' ' ' ILE . 22.1 mm -59.06 -42.81 87.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.027 -1.046 . . . . 0.0 110.116 179.413 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.581 ' CA ' HG21 ' A' ' 39' ' ' ILE . . . -49.44 -53.35 20.69 Favored Glycine 0 N--CA 1.502 3.038 0 N-CA-C 110.014 -1.235 . . . . 0.0 110.014 179.203 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.426 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 11.0 pttm -104.05 24.79 10.84 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.257 -1.143 . . . . 0.0 110.898 179.507 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.588 ' HB ' ' HA ' ' A' ' 30' ' ' ILE . 9.9 p -64.42 -44.54 97.09 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 O-C-N 120.749 -1.219 . . . . 0.0 111.959 -178.441 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.46 ' N ' HG13 ' A' ' 33' ' ' VAL . 0.4 OUTLIER -179.58 -53.62 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.18 -0.95 . . . . 0.0 110.387 -179.37 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.511 ' O ' ' HA ' ' A' ' 52' ' ' TYR . . . -149.39 81.45 0.19 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.156 -1.578 . . . . 0.0 109.156 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.594 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 35.2 t -132.16 96.66 2.49 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-O 122.233 1.016 . . . . 0.0 108.81 179.457 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.911 ' HB2' HD12 ' A' ' 51' ' ' ILE . 64.6 m80 -66.36 -12.4 56.61 Favored 'General case' 0 N--CA 1.505 2.294 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.647 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.657 ' O ' HG22 ' A' ' 51' ' ' ILE . 6.4 t60 -170.4 122.88 0.66 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.412 -0.805 . . . . 0.0 109.242 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.602 HD13 ' O ' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -118.87 140.12 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.471 -0.768 . . . . 0.0 108.943 179.908 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.511 ' H ' HG22 ' A' ' 50' ' ' ILE . 1.2 ttpp -141.14 115.52 9.43 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.853 -1.154 . . . . 0.0 110.703 -179.194 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.628 ' CG2' ' HG2' ' A' ' 27' ' ' GLU . 90.8 t -108.05 161.19 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 CA-C-O 121.55 0.691 . . . . 0.0 110.769 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.694 ' HB3' ' HB3' ' A' ' 45' ' ' GLU . 0.1 OUTLIER -130.17 76.26 1.71 Allowed 'General case' 0 N--CA 1.485 1.278 0 O-C-N 121.368 -0.833 . . . . 0.0 110.517 -178.753 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.578 HD13 ' HB ' ' A' ' 23' ' ' VAL . 11.1 tp -34.43 -55.93 0.52 Allowed 'General case' 0 N--CA 1.503 2.18 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.498 ' O ' ' HD3' ' A' ' 46' ' ' LYS . 5.7 mp0 -85.12 -30.96 23.59 Favored 'General case' 0 N--CA 1.504 2.23 0 O-C-N 120.807 -1.183 . . . . 0.0 112.026 -178.557 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.694 ' HB3' ' HB3' ' A' ' 42' ' ' SER . 1.1 tt0 -76.31 -3.22 35.54 Favored 'General case' 0 C--N 1.296 -1.749 0 O-C-N 121.231 -0.918 . . . . 0.0 109.881 178.643 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.504 ' HG2' ' CD ' ' A' ' 15' ' ' GLU . 0.0 OUTLIER 52.5 52.73 13.54 Favored 'General case' 0 N--CA 1.504 2.263 0 O-C-N 121.275 -0.891 . . . . 0.0 111.587 179.428 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -158.84 148.71 19.29 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.81 -1.181 . . . . 0.0 110.936 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.679 ' HB3' ' CG2' ' A' ' 12' ' ' ILE . . . -132.05 127.87 37.06 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.607 -0.683 . . . . 0.0 109.536 179.12 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.489 ' HA ' ' HA ' ' A' ' 11' ' ' THR . 6.8 t -127.22 120.82 29.62 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.322 -0.861 . . . . 0.0 109.44 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.999 HG21 HG21 ' A' ' 30' ' ' ILE . 1.3 pp -136.48 167.2 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 121.185 -0.947 . . . . 0.0 111.094 -178.082 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.911 HD12 ' HB2' ' A' ' 37' ' ' HIS . 0.0 OUTLIER -109.47 153.05 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.367 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.76 ' N ' HD13 ' A' ' 51' ' ' ILE . 13.0 p90 -163.07 170.25 18.23 Favored 'General case' 0 C--N 1.296 -1.76 0 O-C-N 121.455 -0.778 . . . . 0.0 110.531 -178.191 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.626 ' HB3' ' HB3' ' A' ' 56' ' ' LEU . 5.7 t0 -82.17 117.77 69.57 Favored Pre-proline 0 C--N 1.293 -1.853 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 177.731 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.493 ' HD3' ' HB2' ' A' ' 8' ' ' ASN . 38.0 Cg_endo -64.07 -22.0 67.92 Favored 'Trans proline' 0 N--CA 1.491 1.36 0 O-C-N 123.428 1.225 . . . . 0.0 109.572 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.422 ' NZ ' ' OD1' ' A' ' 53' ' ' ASP . 3.3 ptpp? -84.62 -22.13 30.07 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.973 -0.454 . . . . 0.0 109.812 178.207 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.626 ' HB3' ' HB3' ' A' ' 53' ' ' ASP . 0.6 OUTLIER -107.81 -39.4 5.58 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.027 -1.046 . . . . 0.0 110.353 179.195 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 14.0 mm-40 -128.34 161.14 30.12 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.251 -0.906 . . . . 0.0 110.829 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.601 ' HB ' ' HD2' ' A' ' 59' ' ' PRO . 15.6 p -145.54 170.53 7.86 Favored Pre-proline 0 N--CA 1.503 2.211 0 O-C-N 121.324 -0.86 . . . . 0.0 110.326 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.601 ' HD2' ' HB ' ' A' ' 58' ' ' THR . 38.1 Cg_endo -64.0 -12.44 32.17 Favored 'Trans proline' 0 N--CA 1.49 1.296 0 O-C-N 123.289 1.152 . . . . 0.0 110.192 178.411 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.514 ' O ' ' HB3' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -88.3 -29.53 20.29 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.294 -0.879 . . . . 0.0 109.012 178.279 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.52 ' HA ' ' CD ' ' A' ' 64' ' ' GLU . 40.1 p -90.92 -24.78 20.07 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 177.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.772 HD22 HD11 ' A' ' 50' ' ' ILE . 34.1 mt -76.84 -29.29 55.83 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 177.203 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.616 ' HB2' HG21 ' A' ' 75' ' ' ILE . 12.3 tt0 -79.87 -30.15 40.18 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 177.379 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.52 ' CD ' ' HA ' ' A' ' 61' ' ' THR . 0.3 OUTLIER -78.53 -22.3 47.52 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.214 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -80.24 -27.26 38.75 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 176.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.825 HG13 HD13 ' A' ' 12' ' ' ILE . 8.7 mm -83.2 -36.06 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 176.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.466 ' HB2' ' HA ' ' A' ' 64' ' ' GLU . 61.8 m-20 -72.38 -32.21 66.22 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 177.802 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.427 ' HB2' ' O ' ' A' ' 64' ' ' GLU . 31.3 t70 -68.15 -36.68 80.05 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 177.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.576 ' HG2' ' HG3' ' A' ' 29' ' ' GLN . 0.0 OUTLIER -64.86 -47.58 77.4 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.477 -0.765 . . . . 0.0 109.942 178.513 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 119.75 47.87 0.35 Allowed Glycine 0 N--CA 1.502 3.075 0 C-N-CA 120.196 -1.002 . . . . 0.0 111.335 178.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.694 ' CE1' ' HB3' ' A' ' 22' ' ' CYS . 78.2 m-85 -137.4 143.38 41.88 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.229 -1.159 . . . . 0.0 109.563 179.329 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.671 ' O ' ' HA ' ' A' ' 14' ' ' VAL . 23.4 m-20 -55.1 110.74 0.72 Allowed 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.042 -1.036 . . . . 0.0 109.33 179.441 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.997 ' HB1' HD11 ' A' ' 12' ' ' ILE . . . -109.77 127.37 54.59 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.163 -0.961 . . . . 0.0 112.067 -178.109 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.581 ' HB ' ' HB2' ' A' ' 13' ' ' SER . 77.1 t -137.38 80.69 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 178.193 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.81 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . 40.8 pt . . . . . 0 C--N 1.308 -1.224 0 CA-C-O 122.373 1.083 . . . . 0.0 111.849 -178.067 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.656 HG11 HD13 ' A' ' 51' ' ' ILE . 44.4 t . . . . . 0 N--CA 1.503 2.202 0 CA-C-O 120.978 0.418 . . . . 0.0 110.584 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.582 ' HB3' ' CZ ' ' A' ' 52' ' ' TYR . 0.8 OUTLIER -106.57 178.58 4.52 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.213 -0.93 . . . . 0.0 111.256 -179.303 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.689 ' HA ' ' HA ' ' A' ' 51' ' ' ILE . 9.4 t -141.96 131.89 24.45 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.307 -0.871 . . . . 0.0 111.371 179.352 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 1.036 HG21 ' HB3' ' A' ' 59' ' ' PRO . 0.9 OUTLIER -142.81 147.93 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 CA-C-O 121.944 0.878 . . . . 0.0 111.534 -179.137 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.64 ' HA ' ' HA ' ' A' ' 49' ' ' THR . 21.3 m -109.83 154.01 23.6 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.253 -0.904 . . . . 0.0 109.781 179.037 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.904 ' HA ' ' CG1' ' A' ' 75' ' ' ILE . 86.0 mt -134.16 110.92 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 122.251 -0.28 . . . . 0.0 111.744 -179.111 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.572 ' H ' HG23 ' A' ' 75' ' ' ILE . 7.2 p -83.05 121.3 26.85 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 119.746 -1.847 . . . . 0.0 107.095 177.385 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.12 126.15 73.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 O-C-N 121.187 -0.945 . . . . 0.0 110.214 -177.603 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.23 173.79 6.16 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.508 -0.745 . . . . 0.0 110.317 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.461 ' O ' ' C ' ' A' ' 17' ' ' MET . . . 88.48 -29.79 5.57 Favored Glycine 0 N--CA 1.499 2.853 0 C-N-CA 120.005 -1.093 . . . . 0.0 110.567 -179.201 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.679 ' HB3' ' HB2' ' A' ' 43' ' ' LEU . 28.2 mmm -28.13 97.49 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.657 0 CA-C-N 118.001 0.901 . . . . 0.0 111.403 -179.486 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.417 ' O ' ' HB3' ' A' ' 19' ' ' CYS . 66.6 p -73.82 -28.91 61.86 Favored 'General case' 0 N--CA 1.512 2.641 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -177.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.417 ' HB3' ' O ' ' A' ' 18' ' ' THR . 14.8 p 178.76 173.81 0.7 Allowed 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.251 -0.905 . . . . 0.0 110.192 -178.665 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.624 ' HA ' ' CD2' ' A' ' 43' ' ' LEU . 7.7 m120 -38.34 -36.65 0.24 Allowed 'General case' 0 N--CA 1.507 2.397 0 CA-C-O 121.062 0.458 . . . . 0.0 110.926 179.275 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.598 ' HA ' ' HE3' ' A' ' 24' ' ' TRP . 5.9 p -52.46 -23.98 7.1 Favored 'General case' 0 N--CA 1.507 2.38 0 CA-C-O 121.883 0.849 . . . . 0.0 110.931 178.492 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.414 ' HB3' ' CE1' ' A' ' 71' ' ' PHE . 74.0 m -88.2 -26.72 22.24 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.238 -0.914 . . . . 0.0 109.381 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.445 ' HB ' ' CD2' ' A' ' 43' ' ' LEU . 0.5 OUTLIER -79.41 -39.07 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 N-CA-C 105.955 -1.869 . . . . 0.0 105.955 176.339 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.618 ' CZ3' ' HB2' ' A' ' 20' ' ' ASN . 1.8 m0 -62.57 -32.25 73.2 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 118.82 -1.152 . . . . 0.0 108.033 176.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.473 ' CG2' ' SD ' ' A' ' 69' ' ' MET . 95.7 m -79.95 -32.43 39.95 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.787 -0.571 . . . . 0.0 112.304 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.828 HD12 HD13 ' A' ' 66' ' ' ILE . 18.9 mm -99.77 -22.47 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.242 0 O-C-N 120.785 -1.197 . . . . 0.0 111.297 -178.662 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.775 ' HA ' HD11 ' A' ' 39' ' ' ILE . 4.5 tt0 -85.78 -32.68 21.69 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 177.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.586 ' HB3' ' O ' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -80.27 -34.98 36.57 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 119.511 -0.876 . . . . 0.0 109.446 177.662 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.696 ' HG3' ' HB1' ' A' ' 65' ' ' ALA . 5.5 tp60 -67.9 -62.96 1.16 Allowed 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 119.358 -0.937 . . . . 0.0 110.103 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.509 ' CG2' HG13 ' A' ' 50' ' ' ILE . 16.6 mm -58.87 -41.33 82.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.314 -0.866 . . . . 0.0 110.656 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.782 ' CA ' HG21 ' A' ' 39' ' ' ILE . . . -55.71 -38.23 71.75 Favored Glycine 0 N--CA 1.498 2.807 0 O-C-N 121.368 -0.833 . . . . 0.0 111.223 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.73 26.55 7.12 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.973 -1.31 . . . . 0.0 111.806 -179.482 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.805 HG21 ' HB2' ' A' ' 65' ' ' ALA . 15.0 p -71.26 -41.23 74.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 120.778 -1.201 . . . . 0.0 111.214 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -162.22 -66.77 0.05 Allowed 'General case' 0 N--CA 1.501 2.084 0 O-C-N 120.643 -1.285 . . . . 0.0 111.471 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.467 ' O ' ' HA ' ' A' ' 52' ' ' TYR . . . -145.18 78.37 0.25 Allowed Glycine 0 N--CA 1.493 2.459 0 N-CA-C 108.804 -1.718 . . . . 0.0 108.804 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.898 HG22 HD11 ' A' ' 50' ' ' ILE . 20.8 t -126.2 89.68 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 CA-C-O 122.429 1.109 . . . . 0.0 108.583 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 1.009 ' HB2' HD11 ' A' ' 51' ' ' ILE . 50.0 m80 -60.94 -28.8 69.23 Favored 'General case' 0 C--N 1.286 -2.192 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.983 -179.561 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.628 ' HB2' HG12 ' A' ' 51' ' ' ILE . 41.5 m80 -141.89 125.63 16.97 Favored 'General case' 0 N--CA 1.506 2.331 0 O-C-N 121.038 -1.039 . . . . 0.0 109.637 178.459 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.838 ' C ' HD13 ' A' ' 39' ' ' ILE . 0.0 OUTLIER -133.96 140.19 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.187 -0.946 . . . . 0.0 109.408 -179.973 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.48 ' HD3' ' C ' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -146.0 121.34 10.26 Favored 'General case' 0 N--CA 1.507 2.39 0 O-C-N 120.537 -1.352 . . . . 0.0 111.084 178.947 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.528 HG21 HG22 ' A' ' 26' ' ' ILE . 82.0 t -112.6 161.63 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 CA-C-O 121.679 0.752 . . . . 0.0 110.976 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.405 ' HB3' ' HB2' ' A' ' 45' ' ' GLU . 1.7 m -142.67 77.26 1.57 Allowed 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.444 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.679 ' HB2' ' HB3' ' A' ' 17' ' ' MET . 0.5 OUTLIER -54.67 -30.34 55.14 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.493 -0.755 . . . . 0.0 111.636 -178.717 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.552 ' N ' ' HG ' ' A' ' 43' ' ' LEU . 15.1 mp0 -74.51 -50.0 19.88 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.959 -1.088 . . . . 0.0 109.597 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.405 ' HB2' ' HB3' ' A' ' 42' ' ' SER . 2.2 mp0 -79.52 5.99 11.55 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 177.325 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.497 ' HD3' ' CG ' ' A' ' 17' ' ' MET . 35.0 mmtp 46.53 64.96 1.32 Allowed 'General case' 0 N--CA 1.501 2.081 0 CA-C-O 121.5 0.667 . . . . 0.0 110.476 -179.352 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -165.55 174.33 10.01 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.019 -1.051 . . . . 0.0 110.439 -179.594 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -168.25 150.01 5.18 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.445 -0.785 . . . . 0.0 110.481 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.64 ' HA ' ' HA ' ' A' ' 11' ' ' THR . 0.4 OUTLIER -138.02 147.28 44.02 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.328 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.898 HD11 HG22 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -165.09 151.7 2.19 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 120.777 -1.202 . . . . 0.0 111.397 -178.083 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 1.009 HD11 ' HB2' ' A' ' 37' ' ' HIS . 2.3 pp -108.04 163.62 5.59 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 O-C-N 121.194 -0.941 . . . . 0.0 109.083 178.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.582 ' CZ ' ' HB3' ' A' ' 8' ' ' ASN . 13.2 p90 -162.31 158.87 24.78 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.089 -1.045 . . . . 0.0 112.033 -176.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.677 ' HB3' ' HB2' ' A' ' 56' ' ' LEU . 18.5 t0 -75.42 111.12 12.52 Favored Pre-proline 0 N--CA 1.498 1.932 0 O-C-N 121.645 -0.66 . . . . 0.0 110.101 179.6 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.515 ' HD3' ' HB2' ' A' ' 8' ' ' ASN . 40.5 Cg_endo -66.56 -37.17 23.14 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 O-C-N 123.731 1.385 . . . . 0.0 109.766 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.13 -19.01 64.78 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.599 -0.688 . . . . 0.0 109.654 178.266 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.677 ' HB2' ' HB3' ' A' ' 53' ' ' ASP . 0.4 OUTLIER -96.49 -48.19 5.65 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.388 -0.82 . . . . 0.0 109.438 178.92 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.401 ' O ' ' HA ' ' A' ' 54' ' ' PRO . 5.7 mm100 -153.56 -170.29 3.55 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.531 -0.731 . . . . 0.0 110.431 179.151 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.706 ' HB ' ' HD2' ' A' ' 59' ' ' PRO . 1.5 p -132.33 -176.3 0.55 Allowed Pre-proline 0 N--CA 1.502 2.131 0 O-C-N 120.861 -1.15 . . . . 0.0 110.109 -179.441 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 1.036 ' HB3' HG21 ' A' ' 10' ' ' VAL . 38.8 Cg_endo -68.83 -0.6 6.37 Favored 'Trans proline' 0 N--CA 1.488 1.201 0 O-C-N 123.308 1.162 . . . . 0.0 110.809 178.219 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.516 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 0.1 OUTLIER -77.8 -31.65 51.92 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 177.659 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.752 ' HA ' ' HB2' ' A' ' 64' ' ' GLU . 0.8 OUTLIER -77.88 -23.2 48.86 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 177.577 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.498 HD12 HG22 ' A' ' 61' ' ' THR . 10.9 mp -74.98 -27.52 60.19 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 175.76 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.401 ' O ' ' HB2' ' A' ' 67' ' ' ASP . 1.5 mm100 -86.4 -26.03 24.97 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 176.72 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.752 ' HB2' ' HA ' ' A' ' 61' ' ' THR . 30.8 mt-10 -73.03 -25.39 60.93 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 177.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.805 ' HB2' HG21 ' A' ' 33' ' ' VAL . . . -89.59 -24.63 21.65 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 178.586 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.828 HD13 HD12 ' A' ' 26' ' ' ILE . 14.6 mm -88.08 -36.97 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 178.486 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.401 ' HB2' ' O ' ' A' ' 63' ' ' GLN . 18.5 t70 -74.86 -27.77 60.39 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.335 -0.946 . . . . 0.0 108.632 178.123 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -76.52 -38.56 54.95 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.513 -0.742 . . . . 0.0 110.148 178.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.473 ' SD ' ' CG2' ' A' ' 25' ' ' THR . 3.5 mmt -67.64 -35.74 79.47 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.895 -1.128 . . . . 0.0 110.471 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 105.9 48.98 0.97 Allowed Glycine 0 N--CA 1.499 2.863 0 C-N-CA 120.099 -1.048 . . . . 0.0 110.707 178.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.664 ' CD2' HD11 ' A' ' 26' ' ' ILE . 55.0 m-85 -130.38 114.66 15.86 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.298 -1.119 . . . . 0.0 110.021 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -48.39 107.87 0.15 Allowed 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.553 -0.717 . . . . 0.0 110.684 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.641 ' HB2' HG21 ' A' ' 66' ' ' ILE . . . -111.23 164.58 12.73 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 122.068 0.937 . . . . 0.0 112.342 -178.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.787 ' C ' HG13 ' A' ' 75' ' ' ILE . 0.9 OUTLIER -168.91 103.72 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 179.618 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.904 ' CG1' ' HA ' ' A' ' 12' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.649 0 C-N-CA 118.834 -1.146 . . . . 0.0 113.638 -174.759 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 1.075 HG11 HD11 ' A' ' 51' ' ' ILE . 4.2 t . . . . . 0 N--CA 1.508 2.465 0 CA-C-O 121.014 0.435 . . . . 0.0 109.941 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.738 ' HB3' ' CZ ' ' A' ' 52' ' ' TYR . 1.0 OUTLIER -117.18 154.57 30.88 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.694 -1.254 . . . . 0.0 111.516 -179.232 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.626 ' HA ' ' HA ' ' A' ' 51' ' ' ILE . 14.7 t -118.98 146.51 44.94 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.336 -0.852 . . . . 0.0 110.012 178.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -140.6 133.95 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.347 -0.845 . . . . 0.0 111.186 -178.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.509 ' HA ' ' HA ' ' A' ' 49' ' ' THR . 51.7 m -109.69 116.81 32.41 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.524 0.678 . . . . 0.0 109.273 179.16 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 1.093 HG21 HD13 ' A' ' 66' ' ' ILE . 5.7 mt -108.43 145.12 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.379 -0.826 . . . . 0.0 110.914 -178.432 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.546 ' O ' ' HB1' ' A' ' 73' ' ' ALA . 0.8 OUTLIER -78.98 137.74 37.73 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.747 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.644 HG13 ' CE ' ' A' ' 17' ' ' MET . 1.2 t -129.09 111.26 22.43 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 O-C-N 120.947 -1.095 . . . . 0.0 111.888 -178.166 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -122.56 170.19 10.26 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.047 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.552 ' O ' HG23 ' A' ' 18' ' ' THR . . . 73.81 25.43 71.87 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 -178.54 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.688 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 29.7 mmt -66.22 -36.08 82.12 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.106 -1.232 . . . . 0.0 110.178 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.552 HG23 ' O ' ' A' ' 16' ' ' GLY . 1.0 OUTLIER 58.93 -42.84 0.07 Allowed 'General case' 0 N--CA 1.515 2.794 0 O-C-N 121.664 -0.648 . . . . 0.0 112.64 -179.708 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.529 ' N ' ' O ' ' A' ' 17' ' ' MET . 9.0 p 179.02 163.49 0.82 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.334 -0.854 . . . . 0.0 110.228 -178.578 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.579 ' HB2' ' CZ3' ' A' ' 24' ' ' TRP . 2.9 p30 -35.13 -36.71 0.06 Allowed 'General case' 0 N--CA 1.508 2.453 0 CA-C-O 120.947 0.403 . . . . 0.0 111.67 178.776 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.513 ' HA ' ' HE3' ' A' ' 24' ' ' TRP . 10.5 p -46.17 -30.67 2.05 Favored 'General case' 0 N--CA 1.504 2.258 0 CA-C-O 121.983 0.897 . . . . 0.0 110.912 178.667 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.688 ' SG ' ' O ' ' A' ' 17' ' ' MET . 69.6 m -90.3 -27.63 19.3 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.444 -0.785 . . . . 0.0 109.066 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.542 HG21 ' HB2' ' A' ' 43' ' ' LEU . 1.1 t -71.96 -37.65 61.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 175.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.634 ' O ' ' HB2' ' A' ' 28' ' ' GLN . 2.8 m0 -67.6 -32.14 72.67 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 119.142 -1.023 . . . . 0.0 108.488 177.133 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.6 ' O ' ' HB2' ' A' ' 29' ' ' GLN . 96.8 m -82.1 -23.98 35.41 Favored 'General case' 0 N--CA 1.505 2.285 0 C-N-CA 120.532 -0.467 . . . . 0.0 112.034 -179.435 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.739 HD11 ' CD2' ' A' ' 71' ' ' PHE . 1.5 mp -98.49 -22.35 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.31 0 O-C-N 120.868 -1.145 . . . . 0.0 110.126 -179.588 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.595 ' HA ' HD11 ' A' ' 39' ' ' ILE . 4.7 tt0 -83.1 -36.32 24.93 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 178.231 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.634 ' HB2' ' O ' ' A' ' 24' ' ' TRP . 1.2 mp0 -80.13 -33.84 38.24 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.725 -0.79 . . . . 0.0 109.81 178.355 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.6 ' HB2' ' O ' ' A' ' 25' ' ' THR . 5.2 mm100 -77.46 -61.42 2.0 Allowed 'General case' 0 N--CA 1.501 2.088 0 C-N-CA 118.32 -1.352 . . . . 0.0 110.694 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.75 ' CG2' HG21 ' A' ' 50' ' ' ILE . 38.0 mt -64.98 -36.9 78.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 120.776 -1.202 . . . . 0.0 109.989 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.495 ' CA ' HG21 ' A' ' 39' ' ' ILE . . . -58.36 -46.47 92.93 Favored Glycine 0 N--CA 1.499 2.857 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 178.732 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.08 29.99 7.29 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.459 -1.024 . . . . 0.0 110.864 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.476 ' HB ' ' HA ' ' A' ' 30' ' ' ILE . 8.4 p -64.29 -38.19 81.89 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 O-C-N 121.083 -1.011 . . . . 0.0 111.049 -179.651 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -175.39 -60.38 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.333 -0.854 . . . . 0.0 110.357 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.517 ' O ' ' HA ' ' A' ' 52' ' ' TYR . . . -148.47 83.48 0.18 Allowed Glycine 0 N--CA 1.489 2.204 0 N-CA-C 108.307 -1.917 . . . . 0.0 108.307 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.723 HG11 ' HB ' ' A' ' 39' ' ' ILE . 17.1 t -124.15 93.71 2.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 CA-C-O 122.503 1.144 . . . . 0.0 108.637 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.961 ' HB2' HD12 ' A' ' 51' ' ' ILE . 74.8 m80 -60.45 -18.53 51.83 Favored 'General case' 0 N--CA 1.503 2.209 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.676 -179.428 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.584 ' HB3' ' CG2' ' A' ' 51' ' ' ILE . 0.6 OUTLIER -158.92 129.49 5.99 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.791 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.989 ' HA ' HG22 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -129.94 128.79 65.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.565 -0.71 . . . . 0.0 109.392 -179.927 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.695 ' HB3' HG22 ' A' ' 49' ' ' THR . 0.0 OUTLIER -121.02 121.54 38.18 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.882 -1.136 . . . . 0.0 110.073 179.743 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.523 ' O ' ' NZ ' ' A' ' 40' ' ' LYS . 10.6 p -106.89 152.54 8.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 178.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.771 ' HB3' ' HB3' ' A' ' 45' ' ' GLU . 0.4 OUTLIER -136.57 76.51 1.6 Allowed 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.09 -1.006 . . . . 0.0 111.073 -177.74 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.542 ' HB2' HG21 ' A' ' 23' ' ' VAL . 11.7 tp -39.32 -57.19 1.42 Allowed 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.461 ' O ' ' NZ ' ' A' ' 46' ' ' LYS . 0.7 OUTLIER -94.57 -32.69 13.34 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.831 -1.168 . . . . 0.0 111.409 -179.799 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.771 ' HB3' ' HB3' ' A' ' 42' ' ' SER . 9.7 tt0 -66.61 -7.47 20.61 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.038 -1.039 . . . . 0.0 109.929 177.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.461 ' NZ ' ' O ' ' A' ' 44' ' ' GLU . 0.0 OUTLIER 55.77 69.36 0.74 Allowed 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.47 -0.768 . . . . 0.0 111.17 179.008 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -170.31 161.15 8.06 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.72 -1.238 . . . . 0.0 113.037 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.535 ' HB2' HG21 ' A' ' 14' ' ' VAL . . . -147.93 97.25 2.77 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 115.518 -0.765 . . . . 0.0 108.984 179.263 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.695 HG22 ' HB3' ' A' ' 40' ' ' LYS . 1.0 OUTLIER -109.74 133.79 52.73 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.783 -1.198 . . . . 0.0 110.254 -179.674 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.989 HG22 ' HA ' ' A' ' 39' ' ' ILE . 2.6 pp -146.63 177.63 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.511 -0.743 . . . . 0.0 111.146 -178.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 1.075 HD11 HG11 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -123.82 158.89 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 178.541 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.738 ' CZ ' ' HB3' ' A' ' 8' ' ' ASN . 14.8 p90 -163.95 153.7 14.58 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.235 -0.915 . . . . 0.0 111.089 -177.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.478 ' HB3' ' HG3' ' A' ' 55' ' ' LYS . 0.4 OUTLIER -79.69 117.74 68.82 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.277 -0.89 . . . . 0.0 109.49 178.892 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -67.63 57.61 0.73 Allowed 'Trans proline' 0 N--CA 1.494 1.529 0 O-C-N 123.929 1.489 . . . . 0.0 111.408 -178.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.478 ' HG3' ' HB3' ' A' ' 53' ' ' ASP . 0.0 OUTLIER -135.47 -66.25 0.57 Allowed 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 179.073 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -96.84 -8.99 29.6 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.472 -0.768 . . . . 0.0 109.285 177.297 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.66 146.5 50.85 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.512 -0.742 . . . . 0.0 109.947 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.609 ' HB ' ' HD2' ' A' ' 59' ' ' PRO . 78.3 p -142.66 169.08 11.53 Favored Pre-proline 0 N--CA 1.497 1.922 0 O-C-N 121.493 -0.754 . . . . 0.0 110.14 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.609 ' HD2' ' HB ' ' A' ' 58' ' ' THR . 39.3 Cg_endo -65.41 -19.18 61.34 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 O-C-N 123.328 1.172 . . . . 0.0 111.226 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 2.2 tptt -92.0 -30.51 16.03 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.291 -0.881 . . . . 0.0 109.791 179.014 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.709 ' HA ' ' HB2' ' A' ' 64' ' ' GLU . 6.0 p -79.2 -24.17 43.33 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 177.658 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.574 HD22 HD11 ' A' ' 50' ' ' ILE . 14.2 mt -72.97 -30.68 64.01 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 106.314 -1.735 . . . . 0.0 106.314 175.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.478 ' HG3' HD11 ' A' ' 75' ' ' ILE . 1.2 tt0 -82.36 -27.71 31.99 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 177.716 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.709 ' HB2' ' HA ' ' A' ' 61' ' ' THR . 10.3 mt-10 -82.09 -16.38 50.22 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 177.567 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -86.86 -27.22 23.6 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 177.058 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 1.093 HD13 HG21 ' A' ' 12' ' ' ILE . 26.2 mt -86.32 -38.52 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 177.527 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.478 ' HB2' ' O ' ' A' ' 63' ' ' GLN . 0.4 OUTLIER -66.27 -33.21 75.23 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 177.459 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.619 ' HB2' ' O ' ' A' ' 64' ' ' GLU . 2.6 t70 -79.37 -38.07 35.86 Favored 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 119.771 -0.772 . . . . 0.0 109.298 178.539 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.571 ' HE1' HG13 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -47.65 -59.77 3.04 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.555 -0.716 . . . . 0.0 110.018 179.153 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 123.3 51.26 0.21 Allowed Glycine 0 N--CA 1.497 2.735 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 179.249 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.739 ' CD2' HD11 ' A' ' 26' ' ' ILE . 10.9 m-85 -140.73 147.61 39.44 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.435 -1.038 . . . . 0.0 111.029 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -72.39 81.46 1.04 Allowed 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.576 0.703 . . . . 0.0 109.245 179.154 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.546 ' HB1' ' O ' ' A' ' 13' ' ' SER . . . -134.59 142.17 46.86 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.999 -1.063 . . . . 0.0 110.961 -179.116 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.837 ' O ' HG23 ' A' ' 12' ' ' ILE . 2.5 t -117.51 -134.7 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.211 -0.939 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 178.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.641 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--N 1.282 -2.357 0 O-C-N 121.072 -1.018 . . . . 0.0 111.514 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 1.029 HG11 HD13 ' A' ' 51' ' ' ILE . 1.1 t . . . . . 0 N--CA 1.506 2.334 0 CA-C-O 121.533 0.683 . . . . 0.0 111.003 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.486 ' HB3' ' CZ ' ' A' ' 52' ' ' TYR . 2.5 m120 -112.17 -179.87 3.8 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.051 -1.031 . . . . 0.0 110.656 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.62 ' HA ' ' HA ' ' A' ' 51' ' ' ILE . 3.8 m -141.29 132.68 26.74 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.294 -0.879 . . . . 0.0 110.192 179.593 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.593 HG23 ' OH ' ' A' ' 52' ' ' TYR . 0.9 OUTLIER -130.99 135.82 59.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 CA-C-O 121.592 0.711 . . . . 0.0 111.953 -178.14 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.504 ' HA ' ' HA ' ' A' ' 49' ' ' THR . 27.5 m -115.3 118.94 34.68 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.066 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.761 HG12 HG22 ' A' ' 75' ' ' ILE . 64.9 mt -118.73 146.29 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.299 -0.876 . . . . 0.0 111.612 -178.01 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.867 ' CB ' HG13 ' A' ' 74' ' ' VAL . 0.9 OUTLIER -90.42 144.55 25.7 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 177.574 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.51 ' O ' ' HB3' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -141.55 126.38 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.82 -1.175 . . . . 0.0 110.824 -178.754 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.7 ' HB3' ' HB3' ' A' ' 72' ' ' ASP . 5.8 tp10 -108.95 165.42 11.59 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.418 -0.801 . . . . 0.0 110.247 179.209 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.71 -25.89 26.67 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 108.577 -1.809 . . . . 0.0 108.577 -177.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.501 ' HA ' ' CB ' ' A' ' 22' ' ' CYS . 51.2 mtm -73.87 102.7 4.15 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.253 -1.145 . . . . 0.0 109.888 179.344 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 14.9 t -106.59 9.41 31.41 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.532 -0.73 . . . . 0.0 111.367 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.436 ' O ' ' N ' ' A' ' 21' ' ' SER . 0.5 OUTLIER -178.99 139.64 0.16 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.183 -0.948 . . . . 0.0 109.295 179.822 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 1.024 ' HA ' HD21 ' A' ' 43' ' ' LEU . 7.8 m120 -23.08 -46.12 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.599 0 N-CA-C 112.719 0.636 . . . . 0.0 112.719 -179.269 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.554 ' HA ' ' HE3' ' A' ' 24' ' ' TRP . 3.0 p -47.66 -27.5 1.94 Allowed 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.391 -0.818 . . . . 0.0 111.518 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.631 ' HB3' ' CE1' ' A' ' 71' ' ' PHE . 60.2 m -87.04 -33.08 19.67 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.03 -1.044 . . . . 0.0 109.414 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.913 HG21 HD22 ' A' ' 43' ' ' LEU . 9.1 t -77.47 -39.44 27.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 177.398 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.554 ' HE3' ' HA ' ' A' ' 21' ' ' SER . 1.4 m0 -59.24 -36.97 76.41 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 176.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.455 ' O ' ' HB2' ' A' ' 29' ' ' GLN . 64.1 m -66.0 -34.5 78.25 Favored 'General case' 0 N--CA 1.501 2.086 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.006 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.588 HD11 ' CD2' ' A' ' 71' ' ' PHE . 1.4 mp -94.8 -29.61 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.241 0 O-C-N 121.261 -0.899 . . . . 0.0 110.03 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.733 ' HG3' ' CD1' ' A' ' 39' ' ' ILE . 2.6 tt0 -74.16 -35.64 64.05 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 178.639 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.522 ' HB2' ' O ' ' A' ' 24' ' ' TRP . 28.9 mt-30 -79.3 -34.15 42.67 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 119.146 -1.022 . . . . 0.0 108.99 177.639 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.664 ' HB3' ' SD ' ' A' ' 69' ' ' MET . 2.2 mm100 -73.04 -51.36 18.45 Favored 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 118.44 -1.304 . . . . 0.0 110.112 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.553 ' CG2' ' HB ' ' A' ' 39' ' ' ILE . 0.4 OUTLIER -57.41 -41.11 77.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 120.98 -1.075 . . . . 0.0 109.859 179.094 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.874 ' HA2' HG21 ' A' ' 39' ' ' ILE . . . -64.61 -26.52 70.99 Favored Glycine 0 N--CA 1.498 2.772 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 178.372 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.5 ' HB3' ' HE3' ' A' ' 32' ' ' LYS . 3.2 ttpp -116.7 26.7 9.66 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.566 -0.961 . . . . 0.0 110.678 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.562 HG21 ' HB1' ' A' ' 65' ' ' ALA . 8.1 p -87.41 -49.22 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 O-C-N 120.594 -1.316 . . . . 0.0 112.489 -178.793 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.503 ' N ' HG13 ' A' ' 33' ' ' VAL . 0.6 OUTLIER -169.66 -68.07 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.134 0 O-C-N 120.408 -1.433 . . . . 0.0 112.453 -179.581 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.606 ' HA3' HD11 ' A' ' 56' ' ' LEU . . . -142.74 73.17 0.37 Allowed Glycine 0 N--CA 1.496 2.676 0 C-N-CA 119.987 -1.102 . . . . 0.0 110.855 -178.725 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.928 ' CG1' HG22 ' A' ' 39' ' ' ILE . 61.5 t -127.57 89.2 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 CA-C-O 122.335 1.064 . . . . 0.0 108.564 178.218 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 1.009 ' HB2' HD11 ' A' ' 51' ' ' ILE . 36.3 m80 -61.6 -23.26 65.89 Favored 'General case' 0 N--CA 1.507 2.402 0 CA-C-N 115.388 -0.823 . . . . 0.0 110.72 -179.271 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.64 ' HB2' HG12 ' A' ' 51' ' ' ILE . 75.4 m80 -136.94 113.36 10.04 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.308 -0.87 . . . . 0.0 109.162 179.28 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.928 HG22 ' CG1' ' A' ' 36' ' ' VAL . 1.8 pp -114.28 136.42 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.286 -0.884 . . . . 0.0 109.637 -179.521 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.634 ' HA ' ' CE ' ' A' ' 40' ' ' LYS . 0.3 OUTLIER -150.58 122.91 8.39 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.168 -1.583 . . . . 0.0 112.408 -179.715 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.489 HG13 ' HB2' ' A' ' 48' ' ' ALA . 3.9 t -127.79 167.14 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.191 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.4 m -108.84 -101.04 0.38 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.87 -1.144 . . . . 0.0 110.168 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 1.024 HD21 ' HA ' ' A' ' 20' ' ' ASN . 0.1 OUTLIER -179.13 -92.41 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.308 0 O-C-N 121.069 -1.019 . . . . 0.0 109.683 179.411 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.49 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -76.73 -9.77 58.9 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.512 -1.368 . . . . 0.0 109.594 178.538 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -74.59 -11.87 60.31 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 177.108 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.51 ' HB3' ' O ' ' A' ' 14' ' ' VAL . 21.5 mmtt 51.5 56.13 8.36 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.623 -0.673 . . . . 0.0 111.295 179.037 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -154.08 152.13 30.11 Favored 'General case' 0 N--CA 1.504 2.235 0 O-C-N 120.587 -1.32 . . . . 0.0 112.274 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.489 ' HB2' HG13 ' A' ' 41' ' ' VAL . . . -142.36 134.91 28.05 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.251 0.548 . . . . 0.0 110.592 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.504 ' HA ' ' HA ' ' A' ' 11' ' ' THR . 5.8 t -128.67 134.41 48.5 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.377 -0.827 . . . . 0.0 109.408 179.021 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.48 ' CD1' HD22 ' A' ' 62' ' ' LEU . 0.1 OUTLIER -149.59 164.85 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.072 -1.018 . . . . 0.0 110.975 -179.014 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 1.029 HD13 HG11 ' A' ' 7' ' ' VAL . 1.7 pp -107.03 167.52 3.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 178.056 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.593 ' OH ' HG23 ' A' ' 10' ' ' VAL . 28.8 p90 -170.52 161.83 7.91 Favored 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 119.159 -1.017 . . . . 0.0 110.731 -178.187 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.436 ' O ' ' N ' ' A' ' 55' ' ' LYS . 0.9 OUTLIER -78.84 121.62 83.67 Favored Pre-proline 0 C--N 1.302 -1.492 0 C-N-CA 119.701 -0.799 . . . . 0.0 109.726 179.182 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.421 ' C ' ' HG2' ' A' ' 55' ' ' LYS . 38.7 Cg_endo -64.67 70.31 0.24 Allowed 'Trans proline' 0 N--CA 1.492 1.395 0 O-C-N 124.1 1.579 . . . . 0.0 109.728 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.436 ' N ' ' O ' ' A' ' 53' ' ' ASP . 3.2 ptpp? -172.24 -45.48 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.756 -0.59 . . . . 0.0 110.877 -178.748 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.606 HD11 ' HA3' ' A' ' 35' ' ' GLY . 1.8 pp -111.8 -21.65 11.53 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.093 -1.004 . . . . 0.0 111.837 -179.293 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.517 ' HB3' ' HB2' ' A' ' 52' ' ' TYR . 5.5 tp60 -125.85 133.76 51.85 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.818 -1.176 . . . . 0.0 110.025 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.777 ' C ' HD12 ' A' ' 62' ' ' LEU . 34.9 p -141.78 168.33 14.13 Favored Pre-proline 0 N--CA 1.504 2.239 0 O-C-N 121.111 -0.993 . . . . 0.0 109.988 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.612 ' HA ' ' HB2' ' A' ' 62' ' ' LEU . 37.8 Cg_endo -62.39 -20.45 70.4 Favored 'Trans proline' 0 N--CA 1.498 1.78 0 O-C-N 123.418 1.22 . . . . 0.0 111.877 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.425 ' NZ ' ' HB3' ' A' ' 64' ' ' GLU . 0.4 OUTLIER -81.4 -30.53 33.57 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.097 -1.002 . . . . 0.0 108.777 178.241 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.548 ' HA ' ' CD ' ' A' ' 64' ' ' GLU . 0.9 OUTLIER -90.3 -24.15 20.97 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 178.033 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.777 HD12 ' C ' ' A' ' 58' ' ' THR . 5.2 mt -74.11 -28.07 61.18 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 177.389 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.823 ' HB2' HG21 ' A' ' 75' ' ' ILE . 15.8 tt0 -84.08 -30.22 26.18 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 177.553 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.548 ' CD ' ' HA ' ' A' ' 61' ' ' THR . 1.5 pt-20 -81.05 -18.99 44.77 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.293 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.562 ' HB1' HG21 ' A' ' 33' ' ' VAL . . . -82.95 -28.76 29.61 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 175.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.711 HG22 ' HB2' ' A' ' 73' ' ' ALA . 51.5 mt -82.01 -38.77 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 177.136 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.46 ' HB2' ' HA ' ' A' ' 64' ' ' GLU . 1.2 m-20 -61.05 -28.54 69.14 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 176.607 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -71.05 -42.74 69.08 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.799 -0.563 . . . . 0.0 109.885 178.347 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.664 ' SD ' ' HB3' ' A' ' 29' ' ' GLN . 0.8 OUTLIER -54.73 -47.95 73.14 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.454 -0.779 . . . . 0.0 111.043 179.717 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 120.89 43.0 0.46 Allowed Glycine 0 N--CA 1.503 3.109 0 C-N-CA 120.069 -1.062 . . . . 0.0 110.586 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.631 ' CE1' ' HB3' ' A' ' 22' ' ' CYS . 61.8 m-85 -144.87 130.29 18.78 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.444 -1.033 . . . . 0.0 109.229 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.7 ' HB3' ' HB3' ' A' ' 15' ' ' GLU . 5.5 t70 -47.43 116.51 1.45 Allowed 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.525 -0.735 . . . . 0.0 110.005 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.711 ' HB2' HG22 ' A' ' 66' ' ' ILE . . . -109.43 150.17 28.48 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.382 -0.824 . . . . 0.0 111.554 -178.706 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.867 HG13 ' CB ' ' A' ' 13' ' ' SER . 1.0 OUTLIER -154.83 93.76 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 CA-C-O 122.559 1.171 . . . . 0.0 108.1 179.103 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.823 HG21 ' HB2' ' A' ' 63' ' ' GLN . 14.0 pt . . . . . 0 C--N 1.296 -1.744 0 CA-C-O 122.481 1.134 . . . . 0.0 112.455 -177.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 48.2 t . . . . . 0 N--CA 1.5 2.05 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.772 ' HB3' ' CZ ' ' A' ' 52' ' ' TYR . 1.0 OUTLIER -106.24 172.46 6.8 Favored 'General case' 0 N--CA 1.503 2.21 0 O-C-N 120.977 -1.077 . . . . 0.0 110.957 -179.789 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.499 ' HA ' ' HA ' ' A' ' 51' ' ' ILE . 6.8 t -130.52 131.04 44.89 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.352 -0.843 . . . . 0.0 110.27 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.941 HG11 HD13 ' A' ' 62' ' ' LEU . 0.5 OUTLIER -125.61 132.63 70.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.462 -0.774 . . . . 0.0 111.315 -178.411 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.587 ' HA ' ' HA ' ' A' ' 49' ' ' THR . 8.9 m -108.67 119.17 38.73 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.532 -0.73 . . . . 0.0 109.138 178.728 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.68 ' HA ' ' HA ' ' A' ' 75' ' ' ILE . 9.8 mt -110.93 122.13 64.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.294 -0.879 . . . . 0.0 110.9 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.675 ' HB2' ' CG1' ' A' ' 74' ' ' VAL . 0.7 OUTLIER -79.34 136.11 36.91 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 178.011 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.42 HG12 ' HB3' ' A' ' 71' ' ' PHE . 0.2 OUTLIER -131.27 130.14 63.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.17 -0.957 . . . . 0.0 110.987 -178.641 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -119.48 159.57 24.02 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.387 -0.82 . . . . 0.0 110.159 178.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.527 ' O ' HG23 ' A' ' 18' ' ' THR . . . 98.35 -31.14 8.36 Favored Glycine 0 N--CA 1.497 2.762 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 -179.145 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.58 ' SD ' ' HA ' ' A' ' 43' ' ' LEU . 8.0 ptp -62.43 122.63 16.2 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.171 -1.193 . . . . 0.0 110.302 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.527 HG23 ' O ' ' A' ' 16' ' ' GLY . 54.7 p -125.64 5.96 7.5 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.252 -0.905 . . . . 0.0 113.333 -178.073 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.484 ' O ' HD21 ' A' ' 43' ' ' LEU . 1.1 p -165.56 145.3 6.6 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.14 -1.6 . . . . 0.0 110.512 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.49 ' O ' HG12 ' A' ' 23' ' ' VAL . 28.9 m120 -25.8 -40.67 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.674 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -179.334 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.811 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 2.2 p -51.32 -19.75 1.42 Allowed 'General case' 0 N--CA 1.499 1.978 0 CA-C-O 122.294 1.045 . . . . 0.0 110.703 178.624 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.791 ' HB2' HD21 ' A' ' 43' ' ' LEU . 44.7 m -91.15 -20.87 21.53 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 119.32 -2.112 . . . . 0.0 109.221 179.002 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.775 ' HB ' HD22 ' A' ' 43' ' ' LEU . 0.3 OUTLIER -90.02 -35.51 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.411 -0.806 . . . . 0.0 108.868 178.531 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.811 ' CE3' ' HA ' ' A' ' 21' ' ' SER . 0.0 OUTLIER -78.96 -22.55 45.51 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 117.85 -1.54 . . . . 0.0 108.688 178.642 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.509 ' HB ' ' CZ3' ' A' ' 24' ' ' TRP . 1.3 t -86.18 -27.6 24.44 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 120.774 -1.204 . . . . 0.0 110.378 177.552 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.676 HD11 ' CD2' ' A' ' 71' ' ' PHE . 20.4 mm -90.77 -25.12 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.377 0 O-C-N 120.75 -1.218 . . . . 0.0 109.561 179.052 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.574 ' HA ' HD12 ' A' ' 39' ' ' ILE . 0.2 OUTLIER -81.24 -34.37 32.18 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 177.55 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.638 ' HB2' ' O ' ' A' ' 24' ' ' TRP . 0.9 OUTLIER -72.95 -33.01 65.63 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 177.413 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.482 ' O ' ' HB ' ' A' ' 33' ' ' VAL . 5.5 tp60 -70.88 -66.63 0.58 Allowed 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 120.045 -0.662 . . . . 0.0 110.527 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.844 HG21 HG21 ' A' ' 50' ' ' ILE . 84.1 mt -64.3 -45.7 95.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 O-C-N 121.245 -0.91 . . . . 0.0 110.35 -179.405 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.498 ' CA ' HG21 ' A' ' 39' ' ' ILE . . . -50.48 -34.44 27.02 Favored Glycine 0 N--CA 1.497 2.712 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 179.29 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 56.1 mtmt -126.71 29.9 5.61 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.008 -1.29 . . . . 0.0 111.865 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.508 HG13 ' N ' ' A' ' 34' ' ' ASN . 14.9 p -75.15 -49.83 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 O-C-N 120.633 -1.292 . . . . 0.0 111.541 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.508 ' N ' HG13 ' A' ' 33' ' ' VAL . 0.4 OUTLIER -178.47 -60.29 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.285 0 O-C-N 120.871 -1.143 . . . . 0.0 111.663 179.772 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.451 ' O ' ' HA ' ' A' ' 52' ' ' TYR . . . -122.94 67.71 0.48 Allowed Glycine 0 N--CA 1.495 2.586 0 C-N-CA 120.207 -0.997 . . . . 0.0 110.647 -178.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.88 HG22 HD13 ' A' ' 50' ' ' ILE . 50.4 t -136.57 92.4 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.487 -1.008 . . . . 0.0 108.585 178.511 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.793 ' N ' HD11 ' A' ' 51' ' ' ILE . 60.3 m80 -51.67 -29.27 17.39 Favored 'General case' 0 N--CA 1.512 2.667 0 CA-C-O 121.575 0.702 . . . . 0.0 109.709 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.69 ' ND1' HD12 ' A' ' 51' ' ' ILE . 0.1 OUTLIER -171.39 145.41 2.12 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 178.615 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.876 HG12 HG22 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -121.06 144.86 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.145 -0.972 . . . . 0.0 110.023 -178.689 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.594 ' HG3' HG22 ' A' ' 49' ' ' THR . 4.5 tptt -122.21 100.23 6.85 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.555 -1.341 . . . . 0.0 109.518 179.258 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.643 HG23 ' HB2' ' A' ' 48' ' ' ALA . 11.2 p -108.93 154.68 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 O-C-N 121.604 -0.685 . . . . 0.0 109.614 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.57 ' HB3' ' HB2' ' A' ' 45' ' ' GLU . 0.4 OUTLIER -139.93 79.31 1.71 Allowed 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.712 -0.618 . . . . 0.0 109.693 -179.834 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.791 HD21 ' HB2' ' A' ' 22' ' ' CYS . 1.8 tp -45.32 -32.66 2.1 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.595 -0.691 . . . . 0.0 110.994 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.5 mp0 -72.02 -51.74 20.33 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.151 -0.968 . . . . 0.0 109.97 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.57 ' HB2' ' HB3' ' A' ' 42' ' ' SER . 1.8 mp0 -73.43 1.42 9.79 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.619 -0.676 . . . . 0.0 109.747 177.592 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 51.38 56.16 8.35 Favored 'General case' 0 N--CA 1.506 2.349 0 O-C-N 121.367 -0.833 . . . . 0.0 111.713 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -171.22 158.84 5.6 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.893 -1.129 . . . . 0.0 110.38 179.162 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.643 ' HB2' HG23 ' A' ' 41' ' ' VAL . . . -144.49 137.43 26.89 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.967 -1.083 . . . . 0.0 111.85 -179.45 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.594 HG22 ' HG3' ' A' ' 40' ' ' LYS . 5.6 t -127.22 135.78 51.1 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.014 -1.054 . . . . 0.0 109.299 178.035 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.88 HD13 HG22 ' A' ' 36' ' ' VAL . 1.4 pp -145.03 167.62 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 O-C-N 121.08 -1.013 . . . . 0.0 111.036 -177.838 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.793 HD11 ' N ' ' A' ' 37' ' ' HIS . 0.0 OUTLIER -109.12 169.26 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 O-C-N 121.281 -0.887 . . . . 0.0 110.15 178.727 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.772 ' CZ ' ' HB3' ' A' ' 8' ' ' ASN . 15.4 p90 -170.43 159.73 7.14 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.54 -0.725 . . . . 0.0 110.672 -178.611 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.465 ' OD2' ' HB3' ' A' ' 56' ' ' LEU . 6.6 p-10 -79.26 117.37 66.63 Favored Pre-proline 0 C--N 1.3 -1.558 0 C-N-CA 119.631 -0.828 . . . . 0.0 109.425 179.037 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.49 ' C ' ' HG2' ' A' ' 55' ' ' LYS . 39.8 Cg_endo -68.54 66.2 1.15 Allowed 'Trans proline' 0 N--CA 1.487 1.115 0 O-C-N 123.516 1.272 . . . . 0.0 109.374 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.49 ' HG2' ' C ' ' A' ' 54' ' ' PRO . 0.0 OUTLIER -164.11 -55.3 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 -179.267 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.465 ' HB3' ' OD2' ' A' ' 53' ' ' ASP . 0.4 OUTLIER -98.55 -41.45 7.74 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.381 -0.824 . . . . 0.0 109.53 178.271 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.416 ' HB3' ' HB2' ' A' ' 52' ' ' TYR . 20.5 tp60 -104.14 140.38 37.88 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.026 -1.046 . . . . 0.0 111.036 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.72 ' HB ' ' HD2' ' A' ' 59' ' ' PRO . 29.9 p -140.75 171.55 7.49 Favored Pre-proline 0 N--CA 1.508 2.469 0 O-C-N 121.013 -1.055 . . . . 0.0 110.363 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.72 ' HD2' ' HB ' ' A' ' 58' ' ' THR . 38.5 Cg_endo -64.22 -20.24 66.75 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 O-C-N 123.455 1.24 . . . . 0.0 110.229 179.329 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.579 ' O ' ' HB3' ' A' ' 64' ' ' GLU . 1.4 tmtt? -77.02 -31.31 56.27 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 177.673 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.546 ' HA ' ' CD ' ' A' ' 64' ' ' GLU . 39.1 p -86.84 -25.41 24.54 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 177.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.941 HD13 HG11 ' A' ' 10' ' ' VAL . 20.3 mt -77.06 -26.6 53.73 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 176.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.438 ' HA ' HG22 ' A' ' 66' ' ' ILE . 1.3 tp60 -86.05 -24.56 26.31 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 177.34 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.579 ' HB3' ' O ' ' A' ' 60' ' ' LYS . 1.1 pt-20 -87.14 -15.39 38.54 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 177.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -90.05 -27.96 19.36 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 177.431 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.438 HG22 ' HA ' ' A' ' 63' ' ' GLN . 0.4 OUTLIER -86.41 -38.24 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.047 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -71.93 -29.74 64.61 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 177.421 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.435 ' HB2' ' O ' ' A' ' 64' ' ' GLU . 11.8 t70 -69.39 -41.55 76.31 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.413 -0.804 . . . . 0.0 109.181 177.68 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.29 -46.85 76.21 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.669 -0.645 . . . . 0.0 110.25 179.329 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 121.08 38.35 0.65 Allowed Glycine 0 N--CA 1.499 2.852 0 C-N-CA 120.043 -1.075 . . . . 0.0 110.856 179.293 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.676 ' CD2' HD11 ' A' ' 26' ' ' ILE . 59.9 m-85 -131.3 121.67 25.11 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.521 -0.988 . . . . 0.0 108.947 179.002 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -58.99 110.44 1.03 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.241 -0.912 . . . . 0.0 109.621 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.427 ' HA ' ' O ' ' A' ' 13' ' ' SER . . . -124.08 168.19 13.21 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 122.051 0.929 . . . . 0.0 112.029 -178.664 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.675 ' CG1' ' HB2' ' A' ' 13' ' ' SER . 2.7 p -149.2 91.75 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 178.685 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.68 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 122.488 1.137 . . . . 0.0 112.157 -177.728 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.64 ' HB ' HD11 ' A' ' 51' ' ' ILE . 26.7 m . . . . . 0 N--CA 1.506 2.351 0 CA-C-O 121.348 0.594 . . . . 0.0 111.23 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.511 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 8.1 m-20 -117.16 167.72 10.93 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.226 -0.921 . . . . 0.0 110.289 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.534 ' HA ' ' HA ' ' A' ' 51' ' ' ILE . 1.9 m -116.58 136.48 52.94 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.104 -0.997 . . . . 0.0 110.776 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.56 HG23 ' CE1' ' A' ' 52' ' ' TYR . 1.0 OUTLIER -126.58 120.71 56.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.415 -0.803 . . . . 0.0 111.459 -179.396 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.489 ' HA ' ' HA ' ' A' ' 49' ' ' THR . 24.2 m -111.75 104.74 13.1 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 177.59 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.604 ' HA ' ' HA ' ' A' ' 75' ' ' ILE . 72.6 mt -113.6 138.86 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.258 -0.901 . . . . 0.0 111.391 -178.152 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.747 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 0.7 OUTLIER -74.57 134.02 42.18 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 177.984 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.549 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 23.3 t -120.29 120.71 63.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 121.274 -0.891 . . . . 0.0 110.945 -178.117 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.606 ' CB ' ' HB3' ' A' ' 72' ' ' ASP . 1.7 tm-20 -109.22 -171.58 1.87 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.796 -0.565 . . . . 0.0 109.864 179.294 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.96 21.96 67.01 Favored Glycine 0 N--CA 1.497 2.712 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -178.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.497 ' CG ' ' HG ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -66.35 154.32 40.35 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.256 -1.144 . . . . 0.0 111.386 -179.494 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.41 ' O ' ' HB3' ' A' ' 19' ' ' CYS . 1.6 p -146.91 -41.15 0.19 Allowed 'General case' 0 N--CA 1.508 2.439 0 O-C-N 121.407 -0.808 . . . . 0.0 111.556 -179.273 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.541 ' O ' HD21 ' A' ' 43' ' ' LEU . 29.5 p -179.79 169.23 1.31 Allowed 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.523 -0.735 . . . . 0.0 109.923 -178.646 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.558 ' O ' HG12 ' A' ' 23' ' ' VAL . 13.2 t-20 -31.72 -36.88 0.02 OUTLIER 'General case' 0 N--CA 1.512 2.639 0 CA-C-O 121.149 0.5 . . . . 0.0 112.095 179.226 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.85 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 4.5 p -55.99 -17.3 6.4 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 122.187 0.994 . . . . 0.0 111.354 179.064 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.686 ' CB ' HD11 ' A' ' 43' ' ' LEU . 62.4 m -93.25 -28.83 16.01 Favored 'General case' 0 C--N 1.287 -2.131 0 O-C-N 119.602 -1.936 . . . . 0.0 110.841 -178.706 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.66 ' CA ' HD13 ' A' ' 43' ' ' LEU . 10.7 p -85.49 -32.64 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.351 -0.843 . . . . 0.0 109.167 178.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.85 ' CE3' ' HA ' ' A' ' 21' ' ' SER . 0.0 OUTLIER -83.37 -23.07 32.61 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 117.745 -1.582 . . . . 0.0 108.886 178.488 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.629 ' HB ' ' O ' ' A' ' 21' ' ' SER . 1.2 t -82.26 -26.64 33.01 Favored 'General case' 0 N--CA 1.507 2.39 0 C-N-CA 118.722 -1.191 . . . . 0.0 111.061 178.001 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.996 HD11 ' CD2' ' A' ' 71' ' ' PHE . 20.8 mt -96.47 -28.86 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 O-C-N 120.81 -1.181 . . . . 0.0 110.25 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.611 ' HA ' HD11 ' A' ' 39' ' ' ILE . 1.0 OUTLIER -74.54 -35.39 63.12 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 178.369 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.606 ' HB2' ' O ' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -80.86 -31.91 35.18 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 119.423 -0.911 . . . . 0.0 108.607 177.545 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.578 ' HB2' ' O ' ' A' ' 25' ' ' THR . 1.6 tm0? -73.06 -60.44 2.23 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.036 -1.04 . . . . 0.0 110.162 179.222 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.868 HG21 HG21 ' A' ' 50' ' ' ILE . 88.5 mt -59.34 -39.27 78.55 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 120.945 -1.097 . . . . 0.0 109.952 179.5 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.75 ' HA2' HG21 ' A' ' 39' ' ' ILE . . . -48.53 -46.44 29.72 Favored Glycine 0 N--CA 1.497 2.741 0 N-CA-C 110.219 -1.152 . . . . 0.0 110.219 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.491 ' HG3' ' O ' ' A' ' 28' ' ' GLN . 0.2 OUTLIER -130.9 40.99 3.42 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.572 -0.958 . . . . 0.0 110.88 179.526 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.519 ' HB ' ' O ' ' A' ' 29' ' ' GLN . 15.0 p -72.76 -40.35 61.04 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.298 0 O-C-N 121.143 -0.973 . . . . 0.0 111.151 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.4 ' N ' HG13 ' A' ' 33' ' ' VAL . 0.3 OUTLIER -171.04 -51.64 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.092 0 O-C-N 120.903 -1.123 . . . . 0.0 111.08 179.844 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -150.12 82.64 0.18 Allowed Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.901 HG22 HD13 ' A' ' 50' ' ' ILE . 54.0 t -139.43 100.89 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.293 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.993 ' HB2' HD12 ' A' ' 51' ' ' ILE . 67.5 m80 -70.09 -27.53 64.68 Favored 'General case' 0 C--N 1.289 -2.043 0 C-N-CA 120.288 -0.565 . . . . 0.0 110.155 -179.281 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.812 ' HB2' HG22 ' A' ' 51' ' ' ILE . 31.0 m80 -142.78 130.71 21.7 Favored 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.047 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.781 ' C ' HD13 ' A' ' 39' ' ' ILE . 0.0 OUTLIER -127.88 139.08 52.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.081 -1.012 . . . . 0.0 110.252 -179.282 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.538 ' H ' HG22 ' A' ' 50' ' ' ILE . 0.3 OUTLIER -148.31 106.21 3.71 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.165 -0.959 . . . . 0.0 110.227 179.232 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.682 HG21 ' CG2' ' A' ' 26' ' ' ILE . 1.1 p -107.28 170.17 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.619 -0.676 . . . . 0.0 109.411 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.699 ' HB3' ' HB2' ' A' ' 45' ' ' GLU . 2.2 m -152.4 86.02 1.27 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.074 -1.016 . . . . 0.0 111.013 -178.187 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.686 HD11 ' CB ' ' A' ' 22' ' ' CYS . 1.9 tp -46.13 -34.04 3.97 Favored 'General case' 0 N--CA 1.509 2.489 0 O-C-N 121.768 -0.583 . . . . 0.0 111.617 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.416 ' O ' ' NZ ' ' A' ' 46' ' ' LYS . 14.3 mm-40 -82.75 -41.94 18.59 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.464 -1.397 . . . . 0.0 110.93 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.699 ' HB2' ' HB3' ' A' ' 42' ' ' SER . 18.9 mt-10 -80.37 5.54 14.64 Favored 'General case' 0 N--CA 1.498 1.938 0 C-N-CA 119.762 -0.775 . . . . 0.0 109.76 177.717 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.549 ' HG3' ' O ' ' A' ' 14' ' ' VAL . 0.0 OUTLIER 42.48 51.38 4.81 Favored 'General case' 0 N--CA 1.506 2.332 0 O-C-N 121.647 -0.658 . . . . 0.0 111.226 179.866 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.452 ' ND2' ' HA ' ' A' ' 13' ' ' SER . 0.4 OUTLIER -154.45 157.06 37.87 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 120.696 -1.252 . . . . 0.0 111.975 -179.382 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.594 ' HB2' HG23 ' A' ' 41' ' ' VAL . . . -136.63 127.16 26.88 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.491 -0.756 . . . . 0.0 109.863 178.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.522 HG22 ' HD3' ' A' ' 40' ' ' LYS . 15.1 t -127.75 119.69 26.31 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.353 -0.842 . . . . 0.0 110.071 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.901 HD13 HG22 ' A' ' 36' ' ' VAL . 1.9 pp -141.88 176.44 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.28 -0.887 . . . . 0.0 111.086 -178.421 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.993 HD12 ' HB2' ' A' ' 37' ' ' HIS . 0.0 OUTLIER -117.9 150.49 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 177.014 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.599 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 19.6 p90 -154.09 171.69 18.72 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 119.796 -0.762 . . . . 0.0 111.082 -176.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.445 ' HA ' ' HD2' ' A' ' 54' ' ' PRO . 0.4 OUTLIER -86.0 115.77 63.13 Favored Pre-proline 0 C--N 1.3 -1.569 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.294 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.445 ' HD2' ' HA ' ' A' ' 53' ' ' ASP . 37.5 Cg_endo -60.17 -22.64 70.94 Favored 'Trans proline' 0 N--CA 1.493 1.457 0 O-C-N 123.587 1.309 . . . . 0.0 110.035 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.4 ptpp? -79.95 -8.98 59.63 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.729 -0.607 . . . . 0.0 110.471 178.14 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -131.44 -46.64 0.98 Allowed 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.073 -1.017 . . . . 0.0 110.826 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -110.87 154.8 23.52 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.175 -0.953 . . . . 0.0 110.277 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.777 ' HB ' ' HD2' ' A' ' 59' ' ' PRO . 12.2 p -143.46 176.07 2.5 Favored Pre-proline 0 N--CA 1.499 1.982 0 O-C-N 121.488 -0.758 . . . . 0.0 110.456 -179.45 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.777 ' HD2' ' HB ' ' A' ' 58' ' ' THR . 40.0 Cg_endo -65.26 -23.35 59.55 Favored 'Trans proline' 0 N--CA 1.497 1.717 0 O-C-N 123.317 1.167 . . . . 0.0 112.199 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.542 ' O ' ' HB3' ' A' ' 64' ' ' GLU . 4.7 mmtm -90.47 -29.39 17.97 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.092 -1.005 . . . . 0.0 110.188 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.411 ' OG1' ' N ' ' A' ' 58' ' ' THR . 8.3 p -82.27 -25.84 33.7 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 177.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.552 HD13 ' CB ' ' A' ' 10' ' ' VAL . 0.9 OUTLIER -77.03 -27.91 54.7 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 176.676 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -82.62 -24.5 33.81 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 177.173 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.542 ' HB3' ' O ' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -84.7 -19.47 32.72 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 177.575 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -79.49 -30.54 42.05 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 176.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.492 HD13 HG22 ' A' ' 14' ' ' VAL . 32.3 mt -79.53 -37.58 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 176.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.458 ' HB2' ' HA ' ' A' ' 64' ' ' GLU . 0.9 OUTLIER -70.79 -29.35 65.53 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 176.778 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -69.73 -47.59 62.54 Favored 'General case' 0 N--CA 1.501 2.1 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 177.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.553 ' HE3' ' HB2' ' A' ' 29' ' ' GLN . 0.0 OUTLIER -56.53 -36.43 69.22 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.584 -0.698 . . . . 0.0 109.777 179.252 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 120.28 34.99 0.9 Allowed Glycine 0 N--CA 1.494 2.544 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 179.141 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.996 ' CD2' HD11 ' A' ' 26' ' ' ILE . 95.0 m-85 -135.99 144.09 45.16 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.306 -1.114 . . . . 0.0 110.546 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.606 ' HB3' ' CB ' ' A' ' 15' ' ' GLU . 5.2 t70 -60.52 129.78 43.3 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.344 -0.847 . . . . 0.0 109.972 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -108.76 116.98 33.01 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.459 -0.775 . . . . 0.0 110.565 -179.386 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.747 ' HB ' ' HB2' ' A' ' 13' ' ' SER . 53.1 t -123.12 73.07 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 CA-C-O 122.138 0.971 . . . . 0.0 108.742 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.604 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . 38.1 mt . . . . . 0 N--CA 1.499 1.985 0 CA-C-O 121.827 0.822 . . . . 0.0 112.472 -178.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.638 HG11 ' CD1' ' A' ' 51' ' ' ILE . 9.1 t . . . . . 0 N--CA 1.499 1.987 0 CA-C-O 121.077 0.465 . . . . 0.0 110.041 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.494 ' HB3' ' CZ ' ' A' ' 52' ' ' TYR . 2.9 t-20 -115.24 169.88 8.8 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.058 -1.026 . . . . 0.0 110.92 -179.272 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.658 ' HA ' ' HA ' ' A' ' 51' ' ' ILE . 26.0 p -129.46 128.97 43.99 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.427 -0.796 . . . . 0.0 110.39 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.689 HG11 HD13 ' A' ' 62' ' ' LEU . 1.2 t -123.48 137.13 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 CA-C-O 121.632 0.73 . . . . 0.0 110.88 -178.84 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.522 ' HA ' ' HA ' ' A' ' 49' ' ' THR . 4.3 m -118.59 121.13 39.46 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.587 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.915 HG12 HD12 ' A' ' 75' ' ' ILE . 25.6 mt -110.56 118.45 57.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.365 -0.835 . . . . 0.0 111.549 -177.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.469 ' O ' ' HA ' ' A' ' 73' ' ' ALA . 1.1 m -71.89 114.8 10.37 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 177.791 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.621 ' HA ' ' O ' ' A' ' 72' ' ' ASP . 20.5 t -114.52 130.66 68.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.166 -0.959 . . . . 0.0 111.404 -177.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.69 ' HA ' ' HG2' ' A' ' 46' ' ' LYS . 2.6 mm-40 -112.54 -15.32 13.07 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.14 -0.975 . . . . 0.0 111.521 179.373 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -79.71 33.44 2.11 Favored Glycine 0 N--CA 1.499 2.866 0 O-C-N 120.845 -1.159 . . . . 0.0 111.493 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.667 ' HG3' ' HA ' ' A' ' 46' ' ' LYS . 32.6 mmt -77.25 75.99 3.8 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 120.682 -1.481 . . . . 0.0 109.486 178.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.442 HG23 ' H ' ' A' ' 18' ' ' THR . 17.4 p -52.76 -33.78 50.04 Favored 'General case' 0 N--CA 1.51 2.56 0 O-C-N 121.418 -0.802 . . . . 0.0 111.767 -179.017 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.515 ' O ' HD21 ' A' ' 43' ' ' LEU . 22.5 p 179.13 164.4 0.9 Allowed 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.61 ' HA ' ' HG ' ' A' ' 43' ' ' LEU . 17.4 m120 -38.58 -32.91 0.09 Allowed 'General case' 0 N--CA 1.509 2.51 0 CA-C-N 117.844 0.293 . . . . 0.0 111.475 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.531 ' HA ' ' HE3' ' A' ' 24' ' ' TRP . 5.0 p -52.09 -19.03 1.68 Allowed 'General case' 0 N--CA 1.507 2.406 0 O-C-N 121.095 -1.003 . . . . 0.0 111.208 177.652 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.661 ' HB3' ' CE1' ' A' ' 71' ' ' PHE . 84.6 m -88.92 -22.04 23.31 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.375 -0.828 . . . . 0.0 109.406 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.738 ' HB ' HD23 ' A' ' 43' ' ' LEU . 0.9 OUTLIER -80.56 -35.85 15.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 106.714 -1.588 . . . . 0.0 106.714 177.467 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.54 ' CZ3' ' CB ' ' A' ' 20' ' ' ASN . 4.2 m-90 -74.87 -30.7 61.4 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.028 -1.069 . . . . 0.0 109.188 178.188 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.512 ' O ' ' HB2' ' A' ' 29' ' ' GLN . 0.5 OUTLIER -80.73 -19.16 45.6 Favored 'General case' 0 N--CA 1.505 2.281 0 C-N-CA 119.701 -0.8 . . . . 0.0 110.849 179.232 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.47 ' O ' ' HB ' ' A' ' 30' ' ' ILE . 7.8 mm -100.15 -21.17 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 O-C-N 121.179 -0.95 . . . . 0.0 109.519 179.255 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.506 ' HB3' ' O ' ' A' ' 23' ' ' VAL . 0.1 OUTLIER -78.82 -36.16 43.04 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 177.309 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.44 ' HB2' ' O ' ' A' ' 24' ' ' TRP . 0.8 OUTLIER -81.06 -36.93 29.85 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 119.82 -0.752 . . . . 0.0 109.492 177.769 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.512 ' HB2' ' O ' ' A' ' 25' ' ' THR . 1.1 tm0? -74.1 -62.32 1.55 Allowed 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 118.94 -1.104 . . . . 0.0 110.257 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.47 ' HB ' ' O ' ' A' ' 26' ' ' ILE . 41.4 mm -61.39 -45.16 99.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.12 -0.988 . . . . 0.0 109.264 179.135 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -50.64 -35.78 30.77 Favored Glycine 0 N--CA 1.501 3.002 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 178.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.449 ' HA ' ' HD3' ' A' ' 32' ' ' LYS . 12.1 mmtm -128.25 34.57 4.54 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.145 -1.209 . . . . 0.0 110.565 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.487 ' HB ' ' O ' ' A' ' 29' ' ' GLN . 8.7 p -74.86 -41.53 46.67 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.017 -1.052 . . . . 0.0 111.799 -178.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.417 ' N ' HG13 ' A' ' 33' ' ' VAL . 6.2 t-20 -175.95 -54.86 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.113 0 O-C-N 120.903 -1.123 . . . . 0.0 111.08 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -144.09 80.12 0.24 Allowed Glycine 0 N--CA 1.494 2.56 0 N-CA-C 108.763 -1.735 . . . . 0.0 108.763 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.724 HG22 HD11 ' A' ' 50' ' ' ILE . 28.7 t -133.82 88.78 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 CA-C-O 122.265 1.031 . . . . 0.0 110.076 -179.404 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 1.024 ' HB2' HD11 ' A' ' 51' ' ' ILE . 43.4 m80 -67.16 -27.44 67.29 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.115 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.669 ' HB2' HG12 ' A' ' 51' ' ' ILE . 52.7 m80 -141.16 125.57 17.62 Favored 'General case' 0 N--CA 1.5 2.025 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.153 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.825 ' C ' HD13 ' A' ' 39' ' ' ILE . 0.0 OUTLIER -126.41 135.28 64.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.101 -0.999 . . . . 0.0 109.8 -179.537 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.493 ' NZ ' ' O ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -130.06 121.7 26.91 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.966 -1.083 . . . . 0.0 110.593 -179.868 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.686 HG11 ' HA ' ' A' ' 23' ' ' VAL . 2.0 t -109.21 163.51 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 178.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.642 ' HB3' ' HB2' ' A' ' 45' ' ' GLU . 0.6 OUTLIER -151.0 85.49 1.35 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.062 -1.023 . . . . 0.0 110.47 -178.864 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.738 HD23 ' HB ' ' A' ' 23' ' ' VAL . 0.2 OUTLIER -52.86 -58.02 8.32 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.713 -0.617 . . . . 0.0 111.372 -179.586 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.9 mp0 -69.69 -44.51 70.27 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.185 -0.947 . . . . 0.0 110.668 -179.166 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.642 ' HB2' ' HB3' ' A' ' 42' ' ' SER . 1.3 mt-10 -76.81 7.29 4.87 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 120.008 -0.677 . . . . 0.0 110.413 178.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.69 ' HG2' ' HA ' ' A' ' 15' ' ' GLU . 0.0 OUTLIER 36.6 66.8 0.37 Allowed 'General case' 0 N--CA 1.5 2.046 0 CA-C-O 121.544 0.688 . . . . 0.0 111.754 178.994 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -157.79 145.18 18.36 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 120.693 -1.254 . . . . 0.0 112.51 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.513 ' HB3' ' HB ' ' A' ' 12' ' ' ILE . . . -124.0 109.15 13.18 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.574 -0.703 . . . . 0.0 109.126 179.1 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.522 ' HA ' ' HA ' ' A' ' 11' ' ' THR . 0.8 OUTLIER -114.92 142.53 46.47 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.047 -1.033 . . . . 0.0 109.194 179.988 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.724 HD11 HG22 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -165.25 157.13 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 120.71 -1.244 . . . . 0.0 110.724 -178.92 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 1.024 HD11 ' HB2' ' A' ' 37' ' ' HIS . 1.6 pp -107.08 159.91 6.56 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 O-C-N 121.275 -0.891 . . . . 0.0 109.301 179.525 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.631 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 6.8 p90 -161.73 166.05 27.17 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.229 -0.919 . . . . 0.0 111.732 -176.013 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.31 113.05 17.31 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.651 -0.656 . . . . 0.0 110.63 179.638 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.49 ' HD3' ' N ' ' A' ' 8' ' ' ASN . 46.0 Cg_endo -70.25 67.16 2.04 Favored 'Trans proline' 0 N--CA 1.489 1.224 0 O-C-N 123.964 1.507 . . . . 0.0 109.039 179.221 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.54 -46.88 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 121.419 0.628 . . . . 0.0 109.425 -178.319 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.405 HD23 ' N ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -98.37 -25.57 14.77 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.603 -0.686 . . . . 0.0 109.997 179.357 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.415 ' HG3' ' N ' ' A' ' 58' ' ' THR . 2.3 tp60 -129.53 145.72 51.43 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.222 -0.924 . . . . 0.0 110.0 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.567 ' HB ' ' HD2' ' A' ' 59' ' ' PRO . 7.6 p -135.24 166.44 28.96 Favored Pre-proline 0 N--CA 1.504 2.272 0 O-C-N 121.045 -1.035 . . . . 0.0 110.783 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.567 ' HD2' ' HB ' ' A' ' 58' ' ' THR . 37.8 Cg_endo -62.06 -21.35 72.26 Favored 'Trans proline' 0 N--CA 1.493 1.499 0 O-C-N 123.957 1.504 . . . . 0.0 110.55 179.041 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.83 -38.02 54.6 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 177.785 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.608 ' HA ' ' HB2' ' A' ' 64' ' ' GLU . 34.4 p -77.74 -27.21 50.4 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 177.241 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.689 HD13 HG11 ' A' ' 10' ' ' VAL . 17.6 mt -73.02 -27.45 61.78 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 176.566 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.696 ' HG2' HD13 ' A' ' 75' ' ' ILE . 9.1 mm100 -85.62 -19.02 31.62 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 177.302 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.608 ' HB2' ' HA ' ' A' ' 61' ' ' THR . 4.8 mt-10 -90.36 -18.37 25.64 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 177.614 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.423 ' HB1' HG21 ' A' ' 33' ' ' VAL . . . -87.8 -29.63 20.83 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 177.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.596 HG12 ' HB2' ' A' ' 73' ' ' ALA . 6.9 tp -80.54 -31.61 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 177.179 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.434 ' HB2' ' O ' ' A' ' 63' ' ' GLN . 15.2 t70 -72.22 -29.84 64.33 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 176.272 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -64.52 -48.96 73.15 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.939 -0.475 . . . . 0.0 110.294 179.033 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.415 ' HB3' ' HD2' ' A' ' 71' ' ' PHE . 5.1 tpt -67.82 -36.94 81.28 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.349 -0.845 . . . . 0.0 110.6 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 108.74 59.1 0.54 Allowed Glycine 0 N--CA 1.498 2.795 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 179.319 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.661 ' CE1' ' HB3' ' A' ' 22' ' ' CYS . 43.0 m-85 -139.17 122.04 16.58 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.516 -0.991 . . . . 0.0 110.379 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.621 ' O ' ' HA ' ' A' ' 14' ' ' VAL . 6.3 t70 -54.06 104.03 0.1 Allowed 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.546 -0.721 . . . . 0.0 109.186 179.077 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.78 ' HB1' ' CG2' ' A' ' 12' ' ' ILE . . . -116.73 147.12 42.3 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 122.129 0.966 . . . . 0.0 112.596 -177.849 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.432 ' N ' ' O ' ' A' ' 13' ' ' SER . 46.1 t -138.07 81.55 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 CA-C-O 122.011 0.91 . . . . 0.0 108.585 179.157 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.915 HD12 HG12 ' A' ' 12' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.485 0 CA-C-O 122.679 1.228 . . . . 0.0 112.789 -178.366 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.499 1.984 0 CA-C-O 120.863 0.363 . . . . 0.0 110.382 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -120.68 72.74 22.0 Favored Pre-proline 0 N--CA 1.498 1.958 0 O-C-N 121.496 -0.753 . . . . 0.0 111.118 -179.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -70.84 -19.87 30.43 Favored 'Trans proline' 0 C--N 1.314 -1.276 0 N-CA-C 108.396 -1.425 . . . . 0.0 108.396 177.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.583 ' HA ' ' CG2' ' A' ' 7' ' ' VAL . 2.6 m -177.43 40.67 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.7 -0.625 . . . . 0.0 109.379 179.22 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -39.24 -40.74 0.79 Allowed 'General case' 0 N--CA 1.506 2.342 0 O-C-N 121.646 -0.659 . . . . 0.0 112.343 -179.058 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -141.98 47.33 0.84 Allowed Glycine 0 N--CA 1.498 2.78 0 C-N-CA 119.781 -1.2 . . . . 0.0 111.197 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.795 HG11 ' CE1' ' A' ' 37' ' ' HIS . 1.7 m -141.18 176.81 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.463 0 CA-C-N 118.179 0.99 . . . . 0.0 110.298 178.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.47 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 0.5 OUTLIER -135.8 165.99 24.32 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.957 -1.089 . . . . 0.0 111.034 -179.827 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.614 ' HA ' ' HA ' ' A' ' 51' ' ' ILE . 38.0 t -114.4 150.68 34.28 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.232 -0.917 . . . . 0.0 111.421 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.626 HG21 ' HB3' ' A' ' 59' ' ' PRO . 0.9 OUTLIER -144.17 130.22 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.783 -0.573 . . . . 0.0 110.559 -179.234 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.594 HG23 ' HB ' ' A' ' 49' ' ' THR . 90.2 m -109.22 122.25 46.92 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.538 0.685 . . . . 0.0 110.595 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 1.032 HG12 HG22 ' A' ' 75' ' ' ILE . 45.9 mt -109.61 121.61 62.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.568 -0.707 . . . . 0.0 111.239 -178.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.655 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 1.4 m -70.71 133.28 46.48 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 177.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.516 HG12 ' HG2' ' A' ' 17' ' ' MET . 2.1 t -127.03 161.06 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.11 -0.994 . . . . 0.0 111.083 -178.584 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.83 158.65 35.58 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.493 -0.754 . . . . 0.0 110.728 178.714 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 73.93 20.99 79.71 Favored Glycine 0 N--CA 1.497 2.706 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.768 ' HE2' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -128.87 28.93 5.29 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.891 -1.358 . . . . 0.0 110.806 -179.816 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.8 m -71.59 49.17 0.16 Allowed 'General case' 0 N--CA 1.501 2.114 0 O-C-N 120.918 -1.114 . . . . 0.0 111.243 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.487 ' O ' ' N ' ' A' ' 21' ' ' SER . 0.0 OUTLIER -150.56 118.55 6.27 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.879 -1.138 . . . . 0.0 108.896 178.844 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.488 ' O ' HG12 ' A' ' 23' ' ' VAL . 76.5 m-20 -14.97 -51.55 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.761 0 C-N-CA 123.742 0.817 . . . . 0.0 113.115 -178.654 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.864 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 3.7 p -52.1 -14.46 0.42 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.399 -0.813 . . . . 0.0 112.973 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.766 ' HB2' HD22 ' A' ' 43' ' ' LEU . 63.8 m -91.63 -24.77 19.44 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 119.121 -2.237 . . . . 0.0 110.65 -179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.843 HG23 HG13 ' A' ' 41' ' ' VAL . 1.6 p -87.8 -34.98 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.53 -0.731 . . . . 0.0 109.231 179.366 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.864 ' CE3' ' HA ' ' A' ' 21' ' ' SER . 0.0 OUTLIER -81.79 -22.67 37.0 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 117.687 -1.605 . . . . 0.0 109.094 178.828 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.687 HG23 ' HE2' ' A' ' 69' ' ' MET . 0.6 OUTLIER -87.6 -24.68 23.9 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 120.94 -1.1 . . . . 0.0 110.812 178.027 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.649 HD12 HD12 ' A' ' 66' ' ' ILE . 12.5 mm -92.78 -26.53 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.388 0 O-C-N 120.874 -1.142 . . . . 0.0 109.656 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.705 ' HG2' HD12 ' A' ' 39' ' ' ILE . 4.4 tm-20 -78.83 -40.22 33.37 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 177.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.423 ' HB2' ' O ' ' A' ' 24' ' ' TRP . 68.9 mm-40 -70.44 -33.79 71.73 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 119.361 -0.936 . . . . 0.0 109.287 178.315 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.532 ' HA ' ' OE1' ' A' ' 29' ' ' GLN . 4.3 tp60 -75.89 -62.16 1.68 Allowed 'General case' 0 N--CA 1.496 1.849 0 C-N-CA 119.61 -0.836 . . . . 0.0 110.586 179.61 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.861 HG21 HG21 ' A' ' 50' ' ' ILE . 51.1 mt -60.85 -50.5 80.26 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 O-C-N 120.994 -1.066 . . . . 0.0 109.841 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -47.73 -44.2 23.33 Favored Glycine 0 N--CA 1.5 2.917 0 N-CA-C 110.849 -0.901 . . . . 0.0 110.849 179.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.01 16.86 24.46 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.98 -1.306 . . . . 0.0 112.447 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.496 HG21 ' HB2' ' A' ' 65' ' ' ALA . 0.5 OUTLIER -65.79 -42.3 92.04 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.175 0 O-C-N 120.89 -1.131 . . . . 0.0 111.061 -179.908 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.428 ' N ' HG12 ' A' ' 33' ' ' VAL . 0.1 OUTLIER -163.04 -76.75 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.222 -0.924 . . . . 0.0 110.784 -179.747 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.549 ' O ' ' HA ' ' A' ' 52' ' ' TYR . . . -141.39 75.84 0.33 Allowed Glycine 0 N--CA 1.495 2.567 0 N-CA-C 108.758 -1.737 . . . . 0.0 108.758 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.84 HG22 HD13 ' A' ' 50' ' ' ILE . 41.1 t -103.04 91.43 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 CA-C-O 122.665 1.221 . . . . 0.0 108.128 179.55 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.94 ' HB2' HD12 ' A' ' 51' ' ' ILE . 67.9 m80 -61.67 -14.27 29.82 Favored 'General case' 0 C--N 1.283 -2.325 0 CA-C-N 114.827 -1.079 . . . . 0.0 110.627 -179.572 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.567 ' HB3' ' CG2' ' A' ' 51' ' ' ILE . 7.2 t-80 -170.83 121.1 0.56 Allowed 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.817 ' HB ' HG11 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -122.07 128.8 75.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.268 -0.895 . . . . 0.0 109.565 -179.438 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.481 ' HD3' HG22 ' A' ' 49' ' ' THR . 0.0 OUTLIER -125.19 99.83 6.26 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.599 -1.313 . . . . 0.0 111.445 -179.615 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.843 HG13 HG23 ' A' ' 23' ' ' VAL . 15.0 p -107.41 153.97 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 177.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.845 ' HB3' ' HB3' ' A' ' 45' ' ' GLU . 0.2 OUTLIER -153.15 94.33 1.82 Allowed 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.103 -0.998 . . . . 0.0 110.763 -178.057 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.768 ' HA ' ' HE2' ' A' ' 17' ' ' MET . 14.5 mt -46.83 -25.17 0.7 Allowed 'General case' 0 N--CA 1.508 2.436 0 O-C-N 121.923 -0.486 . . . . 0.0 112.016 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.574 ' HG2' ' N ' ' A' ' 45' ' ' GLU . 0.4 OUTLIER -96.92 -38.48 9.8 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 120.4 -1.437 . . . . 0.0 111.332 179.651 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.845 ' HB3' ' HB3' ' A' ' 42' ' ' SER . 0.2 OUTLIER -74.61 -4.2 35.72 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.202 -0.936 . . . . 0.0 108.802 177.476 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.9 mptt 56.66 34.88 25.28 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.271 -0.893 . . . . 0.0 112.961 177.487 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -148.19 151.32 35.32 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.534 -1.353 . . . . 0.0 112.071 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.437 ' HA ' ' HA ' ' A' ' 41' ' ' VAL . . . -130.84 103.28 6.48 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.209 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.594 ' HB ' HG23 ' A' ' 11' ' ' THR . 14.8 t -116.55 134.72 54.51 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.233 -0.917 . . . . 0.0 110.376 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.954 HD11 HD21 ' A' ' 62' ' ' LEU . 1.3 pp -144.85 -178.71 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-O 121.621 0.724 . . . . 0.0 110.785 -178.55 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.94 HD12 ' HB2' ' A' ' 37' ' ' HIS . 0.0 OUTLIER -121.59 145.38 28.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 177.918 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.744 ' N ' HD13 ' A' ' 51' ' ' ILE . 13.7 p90 -149.2 165.82 30.7 Favored 'General case' 0 C--N 1.296 -1.761 0 O-C-N 121.245 -0.909 . . . . 0.0 111.347 -177.669 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.447 ' HA ' HG12 ' A' ' 7' ' ' VAL . 0.3 OUTLIER -84.5 107.14 10.09 Favored Pre-proline 0 N--CA 1.49 1.539 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.701 179.924 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.547 ' HD2' ' HA ' ' A' ' 7' ' ' VAL . 48.2 Cg_endo -75.11 -9.12 20.48 Favored 'Trans proline' 0 C--N 1.319 -1.018 0 O-C-N 123.624 1.328 . . . . 0.0 109.75 178.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 8.8 mtmm -74.18 -35.97 64.01 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.5 pp -121.4 -17.16 7.68 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.523 -0.736 . . . . 0.0 111.44 179.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.517 ' O ' ' HA ' ' A' ' 54' ' ' PRO . 2.7 mm-40 -131.58 -179.39 5.35 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.796 -1.19 . . . . 0.0 110.484 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.542 ' OG1' ' HD2' ' A' ' 59' ' ' PRO . 0.5 OUTLIER -164.22 173.5 3.96 Favored Pre-proline 0 N--CA 1.497 1.914 0 O-C-N 120.874 -1.141 . . . . 0.0 110.01 -179.993 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.626 ' HB3' HG21 ' A' ' 10' ' ' VAL . 37.9 Cg_endo -62.78 8.32 0.13 Allowed 'Trans proline' 0 N--CA 1.502 1.972 0 C-N-CA 121.227 1.285 . . . . 0.0 113.258 -179.164 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.555 ' HG3' ' N ' ' A' ' 61' ' ' THR . 0.2 OUTLIER -90.68 -28.27 18.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.973 -1.08 . . . . 0.0 108.525 177.773 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.555 ' N ' ' HG3' ' A' ' 60' ' ' LYS . 0.8 OUTLIER -85.85 -27.69 24.91 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 177.953 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.954 HD21 HD11 ' A' ' 50' ' ' ILE . 4.5 mp -72.15 -27.62 62.72 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 176.707 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.483 ' O ' ' HB2' ' A' ' 67' ' ' ASP . 14.2 tp60 -86.65 -20.21 28.14 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 177.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.537 ' HB3' ' O ' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -91.28 -22.15 20.71 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.159 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.496 ' HB2' HG21 ' A' ' 33' ' ' VAL . . . -85.27 -27.66 25.85 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.538 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.676 HG12 ' HB2' ' A' ' 73' ' ' ALA . 2.1 tp -85.17 -32.73 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 177.249 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.483 ' HB2' ' O ' ' A' ' 63' ' ' GLN . 27.8 t70 -74.37 -32.28 62.68 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 177.214 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.407 ' HB3' ' O ' ' A' ' 64' ' ' GLU . 0.2 OUTLIER -70.5 -43.39 69.79 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.878 -0.514 . . . . 0.0 109.868 178.915 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.687 ' HE2' HG23 ' A' ' 25' ' ' THR . 23.6 mmm -59.86 -46.72 88.38 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.18 -0.95 . . . . 0.0 109.996 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 114.54 51.42 0.46 Allowed Glycine 0 N--CA 1.499 2.846 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.592 ' CD1' ' HB3' ' A' ' 17' ' ' MET . 75.1 m-85 -139.27 130.18 26.29 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.69 -0.888 . . . . 0.0 109.526 179.506 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.495 ' O ' ' HA ' ' A' ' 14' ' ' VAL . 1.7 m-20 -49.9 111.32 0.49 Allowed 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.433 -0.792 . . . . 0.0 110.045 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.676 ' HB2' HG12 ' A' ' 66' ' ' ILE . . . -109.77 127.26 54.52 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.185 -0.947 . . . . 0.0 111.582 -178.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.655 ' HB ' ' HB2' ' A' ' 13' ' ' SER . 75.5 t -131.67 76.4 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.487 -0.758 . . . . 0.0 109.071 178.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 1.032 HG22 HG12 ' A' ' 12' ' ' ILE . 33.3 pt -58.73 138.38 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 CA-C-O 121.763 0.792 . . . . 0.0 110.861 -179.106 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.45 ' O ' ' ND1' ' A' ' 76' ' ' HIS . 13.3 p80 -130.14 45.06 2.87 Favored 'General case' 0 N--CA 1.5 2.064 0 CA-C-O 121.459 0.647 . . . . 0.0 110.824 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.53 ' HB3' ' HD3' ' A' ' 78' ' ' PRO . 0.3 OUTLIER -109.93 -66.2 0.03 OUTLIER Pre-proline 0 N--CA 1.496 1.863 0 O-C-N 121.228 -0.92 . . . . 0.0 111.095 179.997 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.53 ' HD3' ' HB3' ' A' ' 77' ' ' ASN . 44.5 Cg_endo -75.0 -28.54 9.07 Favored 'Trans proline' 0 N--CA 1.488 1.152 0 O-C-N 123.113 1.06 . . . . 0.0 110.78 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 . . . . . 0 N--CA 1.486 1.334 0 CA-C-O 118.372 -0.823 . . . . 0.0 110.471 -179.764 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 85' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.795 0 CA-C-O 120.821 0.344 . . . . 0.0 110.18 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 47.24 66.93 4.99 Favored Pre-proline 0 N--CA 1.504 2.253 0 O-C-N 121.822 -0.549 . . . . 0.0 111.87 179.26 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -71.25 -17.46 31.07 Favored 'Trans proline' 0 C--N 1.313 -1.333 0 O-C-N 123.463 1.244 . . . . 0.0 109.114 177.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 95.3 p -135.95 -2.49 2.34 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.49 -0.757 . . . . 0.0 111.599 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 1.4 mtm 48.98 33.19 4.37 Favored 'General case' 0 N--CA 1.504 2.26 0 O-C-N 121.238 -0.913 . . . . 0.0 111.187 -179.202 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.507 ' O ' ' HB ' ' A' ' 7' ' ' VAL . . . 64.76 28.42 73.32 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 1.071 HG11 HD11 ' A' ' 51' ' ' ILE . 12.9 t 69.08 158.4 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.344 0 CA-C-N 117.778 0.789 . . . . 0.0 110.446 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.406 ' O ' HG12 ' A' ' 51' ' ' ILE . 9.8 m120 -124.6 166.3 16.35 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 120.785 -1.197 . . . . 0.0 111.306 -179.011 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.616 ' HA ' ' HA ' ' A' ' 51' ' ' ILE . 2.5 m -120.29 145.68 46.85 Favored 'General case' 0 N--CA 1.505 2.294 0 O-C-N 121.088 -1.007 . . . . 0.0 111.833 -179.556 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.457 HG21 ' HA ' ' A' ' 59' ' ' PRO . 1.0 OUTLIER -134.24 140.97 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.639 -0.663 . . . . 0.0 110.891 -179.29 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.604 ' HA ' ' HA ' ' A' ' 49' ' ' THR . 2.9 m -118.91 130.35 55.68 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.229 -0.919 . . . . 0.0 110.151 178.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.706 ' HA ' ' HA ' ' A' ' 75' ' ' ILE . 51.9 mt -122.74 133.02 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.363 -0.836 . . . . 0.0 111.553 -178.48 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.563 ' HB3' ' CG1' ' A' ' 74' ' ' VAL . 0.1 OUTLIER -87.75 117.2 26.42 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.071 -1.018 . . . . 0.0 108.703 178.129 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.568 HG13 ' O ' ' A' ' 14' ' ' VAL . 14.6 p -112.21 108.43 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 O-C-N 121.179 -0.951 . . . . 0.0 110.408 -178.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.577 ' HA ' ' HD2' ' A' ' 46' ' ' LYS . 0.1 OUTLIER -108.34 -32.11 7.58 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.052 -1.03 . . . . 0.0 112.008 -178.6 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -70.03 30.97 0.41 Allowed Glycine 0 N--CA 1.502 3.066 0 C-N-CA 120.423 -0.894 . . . . 0.0 112.255 -179.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.824 ' SD ' HD12 ' A' ' 43' ' ' LEU . 13.2 ptp -90.75 -173.21 3.64 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.474 -1.603 . . . . 0.0 109.799 178.782 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 16.9 p -147.22 -27.65 0.38 Allowed 'General case' 0 N--CA 1.514 2.745 0 O-C-N 121.248 -0.908 . . . . 0.0 112.283 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.434 ' CA ' HD11 ' A' ' 43' ' ' LEU . 19.5 p -179.7 176.44 0.78 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.109 -0.994 . . . . 0.0 108.55 -179.048 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.633 ' HB3' ' CZ3' ' A' ' 24' ' ' TRP . 4.3 m120 -43.31 -31.69 0.68 Allowed 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.773 -0.579 . . . . 0.0 110.618 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.546 ' HA ' ' HE3' ' A' ' 24' ' ' TRP . 3.7 p -54.12 -26.29 26.68 Favored 'General case' 0 N--CA 1.506 2.339 0 O-C-N 121.06 -1.025 . . . . 0.0 110.398 178.319 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.824 ' O ' HD12 ' A' ' 26' ' ' ILE . 80.7 m -91.49 -25.81 19.1 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.701 0.762 . . . . 0.0 108.977 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.685 HG21 ' HB2' ' A' ' 43' ' ' LEU . 12.0 t -79.47 -41.62 22.49 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 176.487 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.633 ' CZ3' ' HB3' ' A' ' 20' ' ' ASN . 2.1 m0 -60.79 -40.47 92.75 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 176.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.421 HG21 ' HE2' ' A' ' 71' ' ' PHE . 40.2 m -66.7 -31.05 71.47 Favored 'General case' 0 N--CA 1.502 2.127 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.608 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.824 HD12 ' O ' ' A' ' 22' ' ' CYS . 2.1 mt -99.07 -17.22 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.225 0 O-C-N 121.142 -0.974 . . . . 0.0 110.902 -179.114 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.691 ' HG3' HD12 ' A' ' 39' ' ' ILE . 1.1 tt0 -87.67 -31.66 19.63 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 177.339 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.495 ' HB3' ' O ' ' A' ' 24' ' ' TRP . 1.1 tm0? -80.41 -39.49 28.22 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 178.016 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.423 ' HB2' ' SD ' ' A' ' 69' ' ' MET . 7.2 mm100 -70.6 -60.02 2.5 Favored 'General case' 0 N--CA 1.502 2.154 0 C-N-CA 119.251 -0.98 . . . . 0.0 110.352 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.485 ' HB ' HG13 ' A' ' 39' ' ' ILE . 45.4 mm -60.58 -42.38 91.37 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.113 -0.992 . . . . 0.0 110.497 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -51.73 -45.93 54.6 Favored Glycine 0 N--CA 1.5 2.961 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.4 mttt -114.98 27.53 9.34 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.331 -1.099 . . . . 0.0 111.494 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.471 HG13 ' N ' ' A' ' 34' ' ' ASN . 12.2 p -66.46 -43.26 91.09 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 O-C-N 120.887 -1.133 . . . . 0.0 111.449 -179.521 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.528 ' HB3' ' HG2' ' A' ' 57' ' ' GLN . 0.7 OUTLIER -178.86 -52.13 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.109 -0.995 . . . . 0.0 110.777 179.847 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.419 ' HA3' HD23 ' A' ' 56' ' ' LEU . . . -148.24 81.74 0.2 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -179.278 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.856 HG22 HD11 ' A' ' 50' ' ' ILE . 38.8 t -133.07 97.4 2.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.013 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 1.031 ' HB2' HD12 ' A' ' 51' ' ' ILE . 67.7 m80 -72.1 -29.28 63.94 Favored 'General case' 0 C--N 1.289 -2.063 0 C-N-CA 120.043 -0.663 . . . . 0.0 109.818 -179.412 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.718 ' HB2' HG22 ' A' ' 51' ' ' ILE . 31.3 m80 -144.57 117.23 8.66 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.242 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.786 ' HB ' HG11 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -117.79 126.02 74.52 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 179.391 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.625 ' HB3' HG22 ' A' ' 49' ' ' THR . 2.1 tmtm? -126.52 119.54 27.39 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.616 -1.303 . . . . 0.0 111.01 -179.552 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.492 ' O ' ' NZ ' ' A' ' 40' ' ' LYS . 47.0 t -107.29 170.77 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 178.542 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.698 ' HB3' ' HB2' ' A' ' 45' ' ' GLU . 0.6 OUTLIER -149.82 85.25 1.42 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.683 -1.261 . . . . 0.0 110.67 -179.51 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.824 HD12 ' SD ' ' A' ' 17' ' ' MET . 20.0 tp -42.53 -43.1 3.58 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.2 mp0 -82.92 -44.24 15.58 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.154 -0.966 . . . . 0.0 111.771 -178.584 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.698 ' HB2' ' HB3' ' A' ' 42' ' ' SER . 5.8 mt-10 -80.03 8.94 6.09 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.195 -0.941 . . . . 0.0 110.344 179.133 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.577 ' HD2' ' HA ' ' A' ' 15' ' ' GLU . 8.1 mmtp 37.15 59.47 1.11 Allowed 'General case' 0 N--CA 1.504 2.253 0 CA-C-O 121.528 0.68 . . . . 0.0 110.967 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.425 ' HA ' ' H ' ' A' ' 14' ' ' VAL . 12.5 t-20 -159.08 149.08 19.14 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.031 -1.043 . . . . 0.0 111.202 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.532 ' HA ' ' O ' ' A' ' 40' ' ' LYS . . . -139.41 122.31 16.62 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.4 -0.813 . . . . 0.0 110.745 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.625 HG22 ' HB3' ' A' ' 40' ' ' LYS . 6.9 t -113.59 151.93 31.01 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.302 -0.874 . . . . 0.0 109.539 178.723 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.856 HD11 HG22 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -160.13 157.23 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.026 -1.046 . . . . 0.0 111.954 -177.932 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 1.071 HD11 HG11 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -109.89 152.85 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.587 -0.696 . . . . 0.0 109.27 178.378 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.556 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 33.9 p90 -158.04 160.16 37.11 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.899 -0.72 . . . . 0.0 111.874 -177.056 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.431 ' HA ' ' HD2' ' A' ' 54' ' ' PRO . 5.1 t0 -86.61 120.32 71.86 Favored Pre-proline 0 N--CA 1.492 1.669 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 177.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.431 ' HD2' ' HA ' ' A' ' 53' ' ' ASP . 36.7 Cg_endo -59.23 -29.68 91.0 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 O-C-N 123.633 1.333 . . . . 0.0 109.73 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.38 -19.18 65.38 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.855 -0.528 . . . . 0.0 110.681 178.174 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.477 HD21 ' C ' ' A' ' 34' ' ' ASN . 0.4 OUTLIER -124.65 -36.82 2.55 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.096 -1.003 . . . . 0.0 111.441 -179.173 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.528 ' HG2' ' HB3' ' A' ' 34' ' ' ASN . 3.4 mm-40 -130.15 155.05 46.85 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.054 -1.029 . . . . 0.0 110.399 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.627 ' HB ' ' HD2' ' A' ' 59' ' ' PRO . 4.7 p -136.61 172.97 6.09 Favored Pre-proline 0 N--CA 1.5 2.074 0 O-C-N 121.004 -1.06 . . . . 0.0 109.807 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.627 ' HD2' ' HB ' ' A' ' 58' ' ' THR . 42.9 Cg_endo -68.45 -14.36 39.73 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 O-C-N 123.326 1.171 . . . . 0.0 110.896 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.8 -38.37 13.03 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.322 -0.861 . . . . 0.0 109.352 179.042 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.602 ' HA ' ' HB2' ' A' ' 64' ' ' GLU . 0.3 OUTLIER -73.14 -27.01 61.43 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.237 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.498 ' CD2' HD12 ' A' ' 50' ' ' ILE . 16.3 mt -72.18 -28.39 63.18 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 176.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -83.43 -32.24 26.19 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 177.225 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.602 ' HB2' ' HA ' ' A' ' 61' ' ' THR . 0.1 OUTLIER -71.58 -20.08 62.05 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 177.402 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -90.02 -25.18 20.97 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 177.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.532 ' HA ' ' HE3' ' A' ' 69' ' ' MET . 0.4 OUTLIER -88.62 -39.49 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 178.042 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -68.87 -29.62 67.96 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 177.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.45 -44.01 59.05 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.552 -0.717 . . . . 0.0 109.881 178.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.556 ' SD ' HG13 ' A' ' 26' ' ' ILE . 28.7 mtm -51.69 -49.82 61.66 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.455 -0.778 . . . . 0.0 110.52 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 111.47 55.24 0.5 Allowed Glycine 0 N--CA 1.498 2.797 0 C-N-CA 119.542 -1.313 . . . . 0.0 110.096 179.05 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.65 ' CD2' HD11 ' A' ' 26' ' ' ILE . 25.4 m-85 -135.89 124.37 23.51 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.637 -0.92 . . . . 0.0 109.357 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -56.62 92.98 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.513 -0.742 . . . . 0.0 109.513 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.487 ' HA ' ' O ' ' A' ' 13' ' ' SER . . . -120.56 178.27 4.74 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 122.188 0.994 . . . . 0.0 112.13 -178.143 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.563 ' CG1' ' HB3' ' A' ' 13' ' ' SER . 3.6 p -159.26 91.68 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 179.448 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.706 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . 25.1 pt -57.15 153.18 2.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 CA-C-O 122.362 1.077 . . . . 0.0 111.772 -178.279 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -109.81 31.86 5.51 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.215 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -130.9 88.98 44.22 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 121.444 -0.785 . . . . 0.0 110.269 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -77.44 61.09 7.29 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 O-C-N 123.475 1.25 . . . . 0.0 110.467 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.582 ' HB2' ' HG3' ' A' ' 59' ' ' PRO . 7.2 m-20 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 117.826 -1.083 . . . . 0.0 110.131 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpp? . . . . . 0 N--CA 1.503 2.202 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 49.92 67.37 4.48 Favored Pre-proline 0 N--CA 1.496 1.865 0 O-C-N 121.797 -0.564 . . . . 0.0 111.555 178.039 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -70.07 -17.04 36.42 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 O-C-N 123.936 1.492 . . . . 0.0 109.057 177.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 89.7 p -126.4 -12.6 6.18 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.53 -0.731 . . . . 0.0 111.283 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 1.8 ttp 55.05 23.05 4.86 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.157 -0.964 . . . . 0.0 111.022 -179.115 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 85.69 6.96 82.37 Favored Glycine 0 N--CA 1.5 2.931 0 O-C-N 121.032 -1.043 . . . . 0.0 111.071 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.543 HG11 HD13 ' A' ' 51' ' ' ILE . 4.8 t -121.93 160.71 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.057 -1.261 . . . . 0.0 109.935 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.601 ' HB3' ' CZ ' ' A' ' 52' ' ' TYR . 0.9 OUTLIER -116.35 163.92 15.31 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.89 -1.131 . . . . 0.0 110.392 179.816 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.675 ' HA ' ' HA ' ' A' ' 51' ' ' ILE . 47.5 p -129.37 143.5 50.87 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.237 -0.915 . . . . 0.0 111.247 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.895 HG21 ' HB3' ' A' ' 59' ' ' PRO . 0.9 OUTLIER -142.26 142.26 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 CA-C-O 121.674 0.75 . . . . 0.0 110.806 -179.553 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.625 ' HA ' ' HA ' ' A' ' 49' ' ' THR . 20.7 m -106.47 145.99 31.11 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.946 ' HA ' HG12 ' A' ' 75' ' ' ILE . 23.3 mm -126.42 116.13 44.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -177.477 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.57 ' H ' ' CG2' ' A' ' 75' ' ' ILE . 1.4 t -82.91 111.25 18.62 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 176.089 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' A' ' 72' ' ' ASP . 9.8 p -108.91 135.06 48.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 O-C-N 121.538 -0.726 . . . . 0.0 112.325 -176.297 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -116.57 174.3 6.15 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.455 -0.778 . . . . 0.0 110.348 179.152 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 81.91 -7.73 62.02 Favored Glycine 0 N--CA 1.499 2.889 0 C-N-CA 120.483 -0.865 . . . . 0.0 111.164 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.592 ' HG2' ' HB3' ' A' ' 22' ' ' CYS . 12.4 mtm -82.46 112.09 19.08 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.76 -1.436 . . . . 0.0 111.041 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.4 t -139.56 25.14 2.42 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.07 -1.019 . . . . 0.0 111.984 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.77 ' C ' HD21 ' A' ' 43' ' ' LEU . 0.4 OUTLIER -170.07 139.33 1.81 Allowed 'General case' 0 N--CA 1.5 2.073 0 O-C-N 120.991 -1.068 . . . . 0.0 109.075 178.978 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.573 ' HA ' ' CD2' ' A' ' 43' ' ' LEU . 22.6 m120 -23.09 -45.44 0.01 OUTLIER 'General case' 0 N--CA 1.518 2.958 0 CA-C-O 121.453 0.644 . . . . 0.0 112.585 -178.735 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.884 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 1.5 p -56.46 -14.13 2.81 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 1.102 ' HB2' HD11 ' A' ' 43' ' ' LEU . 71.8 m -92.91 -26.83 17.43 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 119.808 -1.808 . . . . 0.0 111.678 -178.422 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.87 HG12 HD22 ' A' ' 43' ' ' LEU . 7.9 p -88.92 -34.73 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.119 -0.988 . . . . 0.0 108.706 178.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.884 ' CE3' ' HA ' ' A' ' 21' ' ' SER . 0.0 OUTLIER -79.98 -23.59 41.49 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 117.634 -1.626 . . . . 0.0 108.964 178.495 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.597 ' HB ' ' CZ3' ' A' ' 24' ' ' TRP . 1.7 t -84.46 -27.41 27.51 Favored 'General case' 0 N--CA 1.506 2.346 0 O-C-N 120.679 -1.263 . . . . 0.0 110.352 178.103 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.934 HD11 ' CD2' ' A' ' 71' ' ' PHE . 17.8 mm -89.48 -29.91 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 O-C-N 121.142 -0.973 . . . . 0.0 109.532 179.372 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.635 ' HG3' ' CG2' ' A' ' 39' ' ' ILE . 9.8 tt0 -81.31 -32.66 33.02 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 178.287 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.567 ' HB2' ' O ' ' A' ' 24' ' ' TRP . 0.9 OUTLIER -80.45 -26.5 38.29 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.281 177.872 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.436 ' O ' ' HB ' ' A' ' 33' ' ' VAL . 4.1 tp60 -71.43 -65.44 0.75 Allowed 'General case' 0 N--CA 1.497 1.92 0 C-N-CA 119.238 -0.985 . . . . 0.0 108.824 179.1 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.686 HG22 HD11 ' A' ' 39' ' ' ILE . 18.2 mm -59.51 -52.02 65.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.237 -0.915 . . . . 0.0 110.258 179.514 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -49.18 -39.75 27.94 Favored Glycine 0 N--CA 1.502 3.061 0 N-CA-C 110.404 -1.079 . . . . 0.0 110.404 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.15 26.39 10.51 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.232 -1.158 . . . . 0.0 111.047 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.642 HG12 ' O ' ' A' ' 30' ' ' ILE . 11.1 p -74.36 -46.81 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 120.455 -1.403 . . . . 0.0 111.331 -179.44 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.454 ' N ' HG13 ' A' ' 33' ' ' VAL . 1.0 OUTLIER -173.46 -32.14 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.33 0 O-C-N 120.907 -1.12 . . . . 0.0 111.633 179.259 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.498 ' O ' ' HA ' ' A' ' 52' ' ' TYR . . . -168.97 85.37 0.09 OUTLIER Glycine 0 N--CA 1.496 2.695 0 C-N-CA 119.873 -1.156 . . . . 0.0 110.509 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.878 HG11 ' CD1' ' A' ' 39' ' ' ILE . 42.8 t -130.38 90.34 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 CA-C-O 122.512 1.148 . . . . 0.0 109.307 178.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.964 ' HB2' HD11 ' A' ' 51' ' ' ILE . 40.9 m80 -65.88 -13.46 59.68 Favored 'General case' 0 C--N 1.286 -2.153 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.926 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.79 ' HB3' HG12 ' A' ' 51' ' ' ILE . 0.1 OUTLIER -152.22 128.52 10.56 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 120.759 -1.213 . . . . 0.0 110.381 179.385 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.878 ' CD1' HG11 ' A' ' 36' ' ' VAL 0.293 2.0 mm -121.19 139.26 48.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.857 -177.906 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.917 ' HB3' HG22 ' A' ' 49' ' ' THR . 0.0 OUTLIER -142.1 83.17 1.83 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.556 -1.34 . . . . 0.0 109.685 176.621 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.727 HG22 ' HB1' ' A' ' 48' ' ' ALA . 17.2 t -107.33 155.94 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.068 -1.02 . . . . 0.0 109.272 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.793 ' HB2' ' HB3' ' A' ' 45' ' ' GLU . 41.5 m -152.33 91.07 1.55 Allowed 'General case' 0 C--N 1.308 -1.21 0 O-C-N 121.112 -0.992 . . . . 0.0 110.1 -178.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 1.102 HD11 ' HB2' ' A' ' 22' ' ' CYS . 6.9 tp -30.77 -53.38 0.19 Allowed 'General case' 0 N--CA 1.508 2.474 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -179.285 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.618 ' HA ' ' NZ ' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -78.5 -37.13 43.96 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.687 -1.258 . . . . 0.0 112.241 -178.81 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.793 ' HB3' ' HB2' ' A' ' 42' ' ' SER . 27.5 tt0 -59.48 -15.37 17.16 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 119.617 -0.833 . . . . 0.0 109.274 177.35 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.618 ' NZ ' ' HA ' ' A' ' 44' ' ' GLU . 0.1 OUTLIER 53.71 52.83 12.4 Favored 'General case' 0 N--CA 1.503 2.209 0 CA-C-O 121.816 0.817 . . . . 0.0 109.812 -179.813 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -170.75 159.37 6.44 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.579 -0.701 . . . . 0.0 109.716 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.727 ' HB1' HG22 ' A' ' 41' ' ' VAL . . . -150.7 116.85 5.63 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.302 -0.874 . . . . 0.0 109.492 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.917 HG22 ' HB3' ' A' ' 40' ' ' LYS . 4.8 t -110.13 127.38 54.86 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 120.843 -1.161 . . . . 0.0 109.069 179.353 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 1.08 HD11 HD21 ' A' ' 62' ' ' LEU . 1.8 pp -140.5 164.04 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.43 -0.793 . . . . 0.0 110.567 -177.155 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.964 HD11 ' HB2' ' A' ' 37' ' ' HIS . 1.5 pp -113.61 172.54 3.4 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 O-C-N 120.936 -1.103 . . . . 0.0 109.734 178.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.649 ' N ' HD12 ' A' ' 51' ' ' ILE . 11.0 p90 -163.3 167.36 21.98 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.343 -0.848 . . . . 0.0 110.963 -178.341 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.423 ' HB3' ' HB2' ' A' ' 56' ' ' LEU . 1.2 t0 -88.17 121.74 70.28 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.456 -0.778 . . . . 0.0 110.458 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.404 ' HD3' ' N ' ' A' ' 8' ' ' ASN . 38.4 Cg_endo -64.92 -29.58 57.87 Favored 'Trans proline' 0 N--CA 1.488 1.185 0 O-C-N 123.804 1.423 . . . . 0.0 108.784 178.634 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.1 ptpp? -77.62 -6.48 53.94 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.854 -0.529 . . . . 0.0 110.627 178.169 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.54 HD23 ' HG2' ' A' ' 57' ' ' GLN . 1.6 tt -117.13 -46.97 2.69 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.089 -1.007 . . . . 0.0 111.16 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.54 ' HG2' HD23 ' A' ' 56' ' ' LEU . 21.1 mm-40 -148.87 -174.05 4.52 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.077 -1.014 . . . . 0.0 110.951 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.6 ' HB ' ' HD2' ' A' ' 59' ' ' PRO . 1.1 p -144.07 176.82 2.05 Favored Pre-proline 0 N--CA 1.499 1.98 0 O-C-N 121.086 -1.009 . . . . 0.0 109.715 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.895 ' HB3' HG21 ' A' ' 10' ' ' VAL . 40.6 Cg_endo -68.29 -7.04 18.93 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 O-C-N 123.529 1.279 . . . . 0.0 110.791 178.362 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.86 -38.16 58.24 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.092 -1.005 . . . . 0.0 109.333 178.562 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.7 ' HA ' ' HB2' ' A' ' 64' ' ' GLU . 0.2 OUTLIER -90.74 -19.66 23.27 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 177.832 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 1.08 HD21 HD11 ' A' ' 50' ' ' ILE . 0.1 OUTLIER -71.17 -34.02 70.54 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 176.831 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -81.51 -30.82 33.11 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 176.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.7 ' HB2' ' HA ' ' A' ' 61' ' ' THR . 3.2 mt-10 -73.98 -17.98 60.93 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 176.705 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.447 ' CB ' HG21 ' A' ' 33' ' ' VAL . . . -86.94 -24.71 24.67 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 106.835 -1.542 . . . . 0.0 106.835 176.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.863 HG21 ' HB2' ' A' ' 73' ' ' ALA . 0.8 OUTLIER -86.57 -41.94 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 177.519 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.82 -31.83 72.91 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 177.678 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -75.19 -38.73 60.68 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.51 -0.744 . . . . 0.0 109.701 178.401 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.755 ' HG3' HD13 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -53.81 -46.61 71.17 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.54 -0.725 . . . . 0.0 111.396 179.86 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 119.0 35.06 0.98 Allowed Glycine 0 N--CA 1.501 3.028 0 C-N-CA 120.143 -1.027 . . . . 0.0 110.828 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.934 ' CD2' HD11 ' A' ' 26' ' ' ILE . 96.8 m-85 -140.5 136.61 33.11 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.284 -1.127 . . . . 0.0 109.62 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.448 ' O ' ' HA ' ' A' ' 14' ' ' VAL . 0.5 OUTLIER -57.04 135.02 56.3 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.359 -0.838 . . . . 0.0 111.233 -179.282 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.863 ' HB2' HG21 ' A' ' 66' ' ' ILE . . . -122.45 140.63 52.51 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.367 -0.833 . . . . 0.0 111.748 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.772 ' C ' HG13 ' A' ' 75' ' ' ILE . 4.4 t -155.7 99.02 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 178.329 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.946 HG12 ' HA ' ' A' ' 12' ' ' ILE . 0.2 OUTLIER -156.39 -135.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 C-N-CA 118.567 -1.253 . . . . 0.0 113.742 -174.869 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.441 ' H ' ' HB ' ' A' ' 75' ' ' ILE . 52.9 t-80 -103.7 53.52 0.75 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.932 -1.105 . . . . 0.0 109.496 -178.746 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.668 ' HA ' ' HB2' ' A' ' 59' ' ' PRO . 8.2 m120 -123.1 145.81 47.09 Favored Pre-proline 0 N--CA 1.493 1.72 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.306 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.619 ' HD3' ' HG2' ' A' ' 59' ' ' PRO . 42.2 Cg_endo -70.02 -61.44 0.06 OUTLIER 'Trans proline' 0 C--N 1.312 -1.344 0 O-C-N 123.286 1.15 . . . . 0.0 111.592 -179.273 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.4 p30 . . . . . 0 N--CA 1.491 1.623 0 O-C-N 121.321 -0.862 . . . . 0.0 110.577 -179.68 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 85' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.613 ' HG3' ' HB2' ' A' ' 79' ' ' ASP . 34.1 mtt . . . . . 0 N--CA 1.498 1.963 0 CA-C-O 121.075 0.464 . . . . 0.0 110.383 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.585 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 1.0 OUTLIER -137.38 38.25 0.36 Allowed Pre-proline 0 N--CA 1.497 1.923 0 O-C-N 121.28 -0.887 . . . . 0.0 112.096 -179.235 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' A' ' 2' ' ' ASP . 53.7 Cg_endo -77.37 -5.37 15.58 Favored 'Trans proline' 0 C--N 1.321 -0.893 0 N-CA-C 109.492 -1.003 . . . . 0.0 109.492 177.685 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.484 ' HB3' HG23 ' A' ' 7' ' ' VAL . 0.5 OUTLIER -142.27 9.06 1.85 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.219 -0.925 . . . . 0.0 111.515 -179.864 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.412 ' HB2' ' O ' ' A' ' 4' ' ' SER . 0.3 OUTLIER 62.79 -61.28 0.13 Allowed 'General case' 0 N--CA 1.51 2.535 0 O-C-N 121.323 -0.861 . . . . 0.0 112.233 179.397 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 4' ' ' SER . . . -88.93 -36.2 7.87 Favored Glycine 0 N--CA 1.502 3.08 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 -179.64 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.537 HG11 ' CE1' ' A' ' 37' ' ' HIS . 3.3 m -129.0 -170.33 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 O-C-N 121.574 -0.956 . . . . 0.0 110.165 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.732 ' HB3' ' CZ ' ' A' ' 52' ' ' TYR . 1.9 t30 -129.79 161.8 29.91 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.276 -0.89 . . . . 0.0 110.368 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.554 ' HA ' ' HA ' ' A' ' 51' ' ' ILE . 0.3 OUTLIER -119.99 128.7 53.8 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.382 -0.824 . . . . 0.0 109.351 179.069 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.576 HG23 ' OH ' ' A' ' 52' ' ' TYR . 1.0 OUTLIER -121.14 133.75 66.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.384 -0.822 . . . . 0.0 112.061 -178.222 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.489 ' HA ' ' HA ' ' A' ' 49' ' ' THR . 19.0 m -114.68 121.27 42.86 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.682 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.997 HD11 ' HB1' ' A' ' 73' ' ' ALA . 13.1 tt -118.43 132.35 68.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 CA-C-O 121.831 0.824 . . . . 0.0 111.348 -179.072 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.581 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 49.1 m -77.17 121.75 24.05 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 178.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.671 ' HA ' ' O ' ' A' ' 72' ' ' ASP . 0.2 OUTLIER -126.43 121.49 58.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.271 -0.893 . . . . 0.0 111.65 -178.055 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.504 ' CD ' ' HG2' ' A' ' 46' ' ' LYS . 10.2 tp10 -109.49 158.07 18.34 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.457 -0.777 . . . . 0.0 110.559 179.458 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.51 10.09 59.56 Favored Glycine 0 N--CA 1.498 2.778 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 179.494 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.585 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 20.4 mmt -45.31 -41.47 8.77 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.026 -1.279 . . . . 0.0 110.46 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 40.1 m 61.51 -48.5 0.14 Allowed 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.841 -0.537 . . . . 0.0 112.249 178.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.517 ' N ' ' O ' ' A' ' 17' ' ' MET . 14.0 p -170.42 152.14 3.92 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.11 -0.994 . . . . 0.0 111.163 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.56 ' N ' HD21 ' A' ' 43' ' ' LEU . 3.2 p30 -29.28 -40.97 0.02 OUTLIER 'General case' 0 N--CA 1.511 2.589 0 C-N-CA 123.103 0.561 . . . . 0.0 112.431 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.539 ' HA ' ' HE3' ' A' ' 24' ' ' TRP . 4.2 p -48.28 -23.91 1.03 Allowed 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.257 -0.902 . . . . 0.0 111.374 179.388 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.694 ' HB3' ' CE1' ' A' ' 71' ' ' PHE . 68.9 m -89.59 -21.11 23.0 Favored 'General case' 0 N--CA 1.503 2.175 0 O-C-N 121.124 -0.985 . . . . 0.0 109.78 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.578 ' HB ' HD13 ' A' ' 43' ' ' LEU . 1.0 OUTLIER -85.74 -38.29 12.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 176.096 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.539 ' HE3' ' HA ' ' A' ' 21' ' ' SER . 4.2 m0 -64.0 -32.57 74.16 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 119.098 -1.041 . . . . 0.0 108.844 177.435 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.46 ' O ' ' HB2' ' A' ' 29' ' ' GLN . 0.6 OUTLIER -83.84 -24.68 30.83 Favored 'General case' 0 N--CA 1.505 2.28 0 C-N-CA 119.812 -0.755 . . . . 0.0 111.345 179.868 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.64 HD12 HD13 ' A' ' 66' ' ' ILE . 11.8 mm -91.88 -33.35 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 O-C-N 121.122 -0.986 . . . . 0.0 110.075 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.628 ' HG2' ' CG2' ' A' ' 41' ' ' VAL . 15.3 mt-10 -78.18 -34.78 49.38 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 178.153 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.509 ' HB2' ' O ' ' A' ' 24' ' ' TRP . 0.7 OUTLIER -72.96 -30.36 63.78 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 176.918 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.576 ' HG3' ' HG2' ' A' ' 69' ' ' MET . 3.1 mm100 -77.49 -61.29 2.04 Favored 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 119.064 -1.054 . . . . 0.0 109.942 178.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.999 HG21 HG21 ' A' ' 50' ' ' ILE . 22.1 mm -59.06 -42.81 87.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.027 -1.046 . . . . 0.0 110.116 179.413 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.581 ' CA ' HG21 ' A' ' 39' ' ' ILE . . . -49.44 -53.35 20.69 Favored Glycine 0 N--CA 1.502 3.038 0 N-CA-C 110.014 -1.235 . . . . 0.0 110.014 179.203 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.426 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 11.0 pttm -104.05 24.79 10.84 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.257 -1.143 . . . . 0.0 110.898 179.507 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.588 ' HB ' ' HA ' ' A' ' 30' ' ' ILE . 9.9 p -64.42 -44.54 97.09 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 O-C-N 120.749 -1.219 . . . . 0.0 111.959 -178.441 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.46 ' N ' HG13 ' A' ' 33' ' ' VAL . 0.4 OUTLIER -179.58 -53.62 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.18 -0.95 . . . . 0.0 110.387 -179.37 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.511 ' O ' ' HA ' ' A' ' 52' ' ' TYR . . . -149.39 81.45 0.19 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.156 -1.578 . . . . 0.0 109.156 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.594 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 35.2 t -132.16 96.66 2.49 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-O 122.233 1.016 . . . . 0.0 108.81 179.457 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.911 ' HB2' HD12 ' A' ' 51' ' ' ILE . 64.6 m80 -66.36 -12.4 56.61 Favored 'General case' 0 N--CA 1.505 2.294 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.647 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.657 ' O ' HG22 ' A' ' 51' ' ' ILE . 6.4 t60 -170.4 122.88 0.66 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.412 -0.805 . . . . 0.0 109.242 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.602 HD13 ' O ' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -118.87 140.12 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.471 -0.768 . . . . 0.0 108.943 179.908 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.511 ' H ' HG22 ' A' ' 50' ' ' ILE . 1.2 ttpp -141.14 115.52 9.43 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.853 -1.154 . . . . 0.0 110.703 -179.194 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.628 ' CG2' ' HG2' ' A' ' 27' ' ' GLU . 90.8 t -108.05 161.19 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 CA-C-O 121.55 0.691 . . . . 0.0 110.769 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.694 ' HB3' ' HB3' ' A' ' 45' ' ' GLU . 0.1 OUTLIER -130.17 76.26 1.71 Allowed 'General case' 0 N--CA 1.485 1.278 0 O-C-N 121.368 -0.833 . . . . 0.0 110.517 -178.753 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.578 HD13 ' HB ' ' A' ' 23' ' ' VAL . 11.1 tp -34.43 -55.93 0.52 Allowed 'General case' 0 N--CA 1.503 2.18 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.498 ' O ' ' HD3' ' A' ' 46' ' ' LYS . 5.7 mp0 -85.12 -30.96 23.59 Favored 'General case' 0 N--CA 1.504 2.23 0 O-C-N 120.807 -1.183 . . . . 0.0 112.026 -178.557 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.694 ' HB3' ' HB3' ' A' ' 42' ' ' SER . 1.1 tt0 -76.31 -3.22 35.54 Favored 'General case' 0 C--N 1.296 -1.749 0 O-C-N 121.231 -0.918 . . . . 0.0 109.881 178.643 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.504 ' HG2' ' CD ' ' A' ' 15' ' ' GLU . 0.0 OUTLIER 52.5 52.73 13.54 Favored 'General case' 0 N--CA 1.504 2.263 0 O-C-N 121.275 -0.891 . . . . 0.0 111.587 179.428 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -158.84 148.71 19.29 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.81 -1.181 . . . . 0.0 110.936 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.679 ' HB3' ' CG2' ' A' ' 12' ' ' ILE . . . -132.05 127.87 37.06 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.607 -0.683 . . . . 0.0 109.536 179.12 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.489 ' HA ' ' HA ' ' A' ' 11' ' ' THR . 6.8 t -127.22 120.82 29.62 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.322 -0.861 . . . . 0.0 109.44 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.999 HG21 HG21 ' A' ' 30' ' ' ILE . 1.3 pp -136.48 167.2 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 121.185 -0.947 . . . . 0.0 111.094 -178.082 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.911 HD12 ' HB2' ' A' ' 37' ' ' HIS . 0.0 OUTLIER -109.47 153.05 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.367 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.76 ' N ' HD13 ' A' ' 51' ' ' ILE . 13.0 p90 -163.07 170.25 18.23 Favored 'General case' 0 C--N 1.296 -1.76 0 O-C-N 121.455 -0.778 . . . . 0.0 110.531 -178.191 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.626 ' HB3' ' HB3' ' A' ' 56' ' ' LEU . 5.7 t0 -82.17 117.77 69.57 Favored Pre-proline 0 C--N 1.293 -1.853 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 177.731 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.493 ' HD3' ' HB2' ' A' ' 8' ' ' ASN . 38.0 Cg_endo -64.07 -22.0 67.92 Favored 'Trans proline' 0 N--CA 1.491 1.36 0 O-C-N 123.428 1.225 . . . . 0.0 109.572 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.422 ' NZ ' ' OD1' ' A' ' 53' ' ' ASP . 3.3 ptpp? -84.62 -22.13 30.07 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.973 -0.454 . . . . 0.0 109.812 178.207 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.626 ' HB3' ' HB3' ' A' ' 53' ' ' ASP . 0.6 OUTLIER -107.81 -39.4 5.58 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.027 -1.046 . . . . 0.0 110.353 179.195 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 14.0 mm-40 -128.34 161.14 30.12 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.251 -0.906 . . . . 0.0 110.829 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.601 ' HB ' ' HD2' ' A' ' 59' ' ' PRO . 15.6 p -145.54 170.53 7.86 Favored Pre-proline 0 N--CA 1.503 2.211 0 O-C-N 121.324 -0.86 . . . . 0.0 110.326 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.601 ' HD2' ' HB ' ' A' ' 58' ' ' THR . 38.1 Cg_endo -64.0 -12.44 32.17 Favored 'Trans proline' 0 N--CA 1.49 1.296 0 O-C-N 123.289 1.152 . . . . 0.0 110.192 178.411 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.514 ' O ' ' HB3' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -88.3 -29.53 20.29 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.294 -0.879 . . . . 0.0 109.012 178.279 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.52 ' HA ' ' CD ' ' A' ' 64' ' ' GLU . 40.1 p -90.92 -24.78 20.07 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 177.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.772 HD22 HD11 ' A' ' 50' ' ' ILE . 34.1 mt -76.84 -29.29 55.83 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 177.203 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.616 ' HB2' HG21 ' A' ' 75' ' ' ILE . 12.3 tt0 -79.87 -30.15 40.18 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 177.379 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.52 ' CD ' ' HA ' ' A' ' 61' ' ' THR . 0.3 OUTLIER -78.53 -22.3 47.52 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.214 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -80.24 -27.26 38.75 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 176.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.825 HG13 HD13 ' A' ' 12' ' ' ILE . 8.7 mm -83.2 -36.06 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 176.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.466 ' HB2' ' HA ' ' A' ' 64' ' ' GLU . 61.8 m-20 -72.38 -32.21 66.22 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 177.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.427 ' HB2' ' O ' ' A' ' 64' ' ' GLU . 31.3 t70 -68.15 -36.68 80.05 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 177.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.576 ' HG2' ' HG3' ' A' ' 29' ' ' GLN . 0.0 OUTLIER -64.86 -47.58 77.4 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.477 -0.765 . . . . 0.0 109.942 178.513 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 119.75 47.87 0.35 Allowed Glycine 0 N--CA 1.502 3.075 0 C-N-CA 120.196 -1.002 . . . . 0.0 111.335 178.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.694 ' CE1' ' HB3' ' A' ' 22' ' ' CYS . 78.2 m-85 -137.4 143.38 41.88 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.229 -1.159 . . . . 0.0 109.563 179.329 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.671 ' O ' ' HA ' ' A' ' 14' ' ' VAL . 23.4 m-20 -55.1 110.74 0.72 Allowed 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.042 -1.036 . . . . 0.0 109.33 179.441 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.997 ' HB1' HD11 ' A' ' 12' ' ' ILE . . . -109.77 127.37 54.59 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.163 -0.961 . . . . 0.0 112.067 -178.109 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.581 ' HB ' ' HB2' ' A' ' 13' ' ' SER . 77.1 t -137.38 80.69 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 178.193 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.81 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . 40.8 pt -57.14 140.78 14.99 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 CA-C-O 122.373 1.083 . . . . 0.0 111.849 -178.067 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 5.0 m80 -115.13 36.16 4.02 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.166 178.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.43 ' OD1' ' HA ' ' A' ' 10' ' ' VAL . 0.7 OUTLIER -110.54 126.71 28.29 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.62 -0.675 . . . . 0.0 111.166 -179.421 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -79.63 -9.35 14.69 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 O-C-N 123.539 1.284 . . . . 0.0 110.09 178.059 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.613 ' HB2' ' HG3' ' A' ' 1' ' ' MET . 10.0 p-10 . . . . . 0 N--CA 1.487 1.414 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.238 -179.474 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 tpt . . . . . 0 N--CA 1.495 1.806 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 49.66 62.16 12.48 Favored Pre-proline 0 N--CA 1.499 2.016 0 O-C-N 121.96 -0.462 . . . . 0.0 111.274 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -70.83 -17.11 32.94 Favored 'Trans proline' 0 C--N 1.316 -1.175 0 O-C-N 123.564 1.297 . . . . 0.0 108.778 177.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.0 p -107.41 -18.33 13.89 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.789 -0.569 . . . . 0.0 109.998 178.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 3.0 mtt 55.29 43.62 28.78 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.352 -0.842 . . . . 0.0 110.883 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 98.08 -15.66 61.2 Favored Glycine 0 N--CA 1.501 2.999 0 C-N-CA 120.395 -0.907 . . . . 0.0 110.988 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.656 HG11 HD13 ' A' ' 51' ' ' ILE . 44.4 t -79.57 162.19 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 O-C-N 120.993 -1.298 . . . . 0.0 110.584 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.582 ' HB3' ' CZ ' ' A' ' 52' ' ' TYR . 0.8 OUTLIER -106.57 178.58 4.52 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.213 -0.93 . . . . 0.0 111.256 -179.303 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.689 ' HA ' ' HA ' ' A' ' 51' ' ' ILE . 9.4 t -141.96 131.89 24.45 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.307 -0.871 . . . . 0.0 111.371 179.352 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 1.036 HG21 ' HB3' ' A' ' 59' ' ' PRO . 0.9 OUTLIER -142.81 147.93 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 CA-C-O 121.944 0.878 . . . . 0.0 111.534 -179.137 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.64 ' HA ' ' HA ' ' A' ' 49' ' ' THR . 21.3 m -109.83 154.01 23.6 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.253 -0.904 . . . . 0.0 109.781 179.037 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.904 ' HA ' ' CG1' ' A' ' 75' ' ' ILE . 86.0 mt -134.16 110.92 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 122.251 -0.28 . . . . 0.0 111.744 -179.111 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.572 ' H ' HG23 ' A' ' 75' ' ' ILE . 7.2 p -83.05 121.3 26.85 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 119.746 -1.847 . . . . 0.0 107.095 177.385 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.12 126.15 73.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 O-C-N 121.187 -0.945 . . . . 0.0 110.214 -177.603 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.23 173.79 6.16 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.508 -0.745 . . . . 0.0 110.317 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.461 ' O ' ' C ' ' A' ' 17' ' ' MET . . . 88.48 -29.79 5.57 Favored Glycine 0 N--CA 1.499 2.853 0 C-N-CA 120.005 -1.093 . . . . 0.0 110.567 -179.201 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.679 ' HB3' ' HB2' ' A' ' 43' ' ' LEU . 28.2 mmm -28.13 97.49 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.657 0 CA-C-N 118.001 0.901 . . . . 0.0 111.403 -179.486 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.417 ' O ' ' HB3' ' A' ' 19' ' ' CYS . 66.6 p -73.82 -28.91 61.86 Favored 'General case' 0 N--CA 1.512 2.641 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -177.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.417 ' HB3' ' O ' ' A' ' 18' ' ' THR . 14.8 p 178.76 173.81 0.7 Allowed 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.251 -0.905 . . . . 0.0 110.192 -178.665 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.624 ' HA ' ' CD2' ' A' ' 43' ' ' LEU . 7.7 m120 -38.34 -36.65 0.24 Allowed 'General case' 0 N--CA 1.507 2.397 0 CA-C-O 121.062 0.458 . . . . 0.0 110.926 179.275 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.598 ' HA ' ' HE3' ' A' ' 24' ' ' TRP . 5.9 p -52.46 -23.98 7.1 Favored 'General case' 0 N--CA 1.507 2.38 0 CA-C-O 121.883 0.849 . . . . 0.0 110.931 178.492 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.414 ' HB3' ' CE1' ' A' ' 71' ' ' PHE . 74.0 m -88.2 -26.72 22.24 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.238 -0.914 . . . . 0.0 109.381 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.445 ' HB ' ' CD2' ' A' ' 43' ' ' LEU . 0.5 OUTLIER -79.41 -39.07 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 N-CA-C 105.955 -1.869 . . . . 0.0 105.955 176.339 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.618 ' CZ3' ' HB2' ' A' ' 20' ' ' ASN . 1.8 m0 -62.57 -32.25 73.2 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 118.82 -1.152 . . . . 0.0 108.033 176.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.473 ' CG2' ' SD ' ' A' ' 69' ' ' MET . 95.7 m -79.95 -32.43 39.95 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.787 -0.571 . . . . 0.0 112.304 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.828 HD12 HD13 ' A' ' 66' ' ' ILE . 18.9 mm -99.77 -22.47 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.242 0 O-C-N 120.785 -1.197 . . . . 0.0 111.297 -178.662 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.775 ' HA ' HD11 ' A' ' 39' ' ' ILE . 4.5 tt0 -85.78 -32.68 21.69 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 177.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.586 ' HB3' ' O ' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -80.27 -34.98 36.57 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 119.511 -0.876 . . . . 0.0 109.446 177.662 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.696 ' HG3' ' HB1' ' A' ' 65' ' ' ALA . 5.5 tp60 -67.9 -62.96 1.16 Allowed 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 119.358 -0.937 . . . . 0.0 110.103 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.509 ' CG2' HG13 ' A' ' 50' ' ' ILE . 16.6 mm -58.87 -41.33 82.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.314 -0.866 . . . . 0.0 110.656 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.782 ' CA ' HG21 ' A' ' 39' ' ' ILE . . . -55.71 -38.23 71.75 Favored Glycine 0 N--CA 1.498 2.807 0 O-C-N 121.368 -0.833 . . . . 0.0 111.223 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.73 26.55 7.12 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.973 -1.31 . . . . 0.0 111.806 -179.482 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.805 HG21 ' HB2' ' A' ' 65' ' ' ALA . 15.0 p -71.26 -41.23 74.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 120.778 -1.201 . . . . 0.0 111.214 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -162.22 -66.77 0.05 Allowed 'General case' 0 N--CA 1.501 2.084 0 O-C-N 120.643 -1.285 . . . . 0.0 111.471 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.467 ' O ' ' HA ' ' A' ' 52' ' ' TYR . . . -145.18 78.37 0.25 Allowed Glycine 0 N--CA 1.493 2.459 0 N-CA-C 108.804 -1.718 . . . . 0.0 108.804 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.898 HG22 HD11 ' A' ' 50' ' ' ILE . 20.8 t -126.2 89.68 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 CA-C-O 122.429 1.109 . . . . 0.0 108.583 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 1.009 ' HB2' HD11 ' A' ' 51' ' ' ILE . 50.0 m80 -60.94 -28.8 69.23 Favored 'General case' 0 C--N 1.286 -2.192 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.983 -179.561 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.628 ' HB2' HG12 ' A' ' 51' ' ' ILE . 41.5 m80 -141.89 125.63 16.97 Favored 'General case' 0 N--CA 1.506 2.331 0 O-C-N 121.038 -1.039 . . . . 0.0 109.637 178.459 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.838 ' C ' HD13 ' A' ' 39' ' ' ILE . 0.0 OUTLIER -133.96 140.19 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.187 -0.946 . . . . 0.0 109.408 -179.973 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.48 ' HD3' ' C ' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -146.0 121.34 10.26 Favored 'General case' 0 N--CA 1.507 2.39 0 O-C-N 120.537 -1.352 . . . . 0.0 111.084 178.947 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.528 HG21 HG22 ' A' ' 26' ' ' ILE . 82.0 t -112.6 161.63 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 CA-C-O 121.679 0.752 . . . . 0.0 110.976 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.405 ' HB3' ' HB2' ' A' ' 45' ' ' GLU . 1.7 m -142.67 77.26 1.57 Allowed 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.444 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.679 ' HB2' ' HB3' ' A' ' 17' ' ' MET . 0.5 OUTLIER -54.67 -30.34 55.14 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.493 -0.755 . . . . 0.0 111.636 -178.717 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.552 ' N ' ' HG ' ' A' ' 43' ' ' LEU . 15.1 mp0 -74.51 -50.0 19.88 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.959 -1.088 . . . . 0.0 109.597 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.405 ' HB2' ' HB3' ' A' ' 42' ' ' SER . 2.2 mp0 -79.52 5.99 11.55 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 177.325 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.497 ' HD3' ' CG ' ' A' ' 17' ' ' MET . 35.0 mmtp 46.53 64.96 1.32 Allowed 'General case' 0 N--CA 1.501 2.081 0 CA-C-O 121.5 0.667 . . . . 0.0 110.476 -179.352 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -165.55 174.33 10.01 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.019 -1.051 . . . . 0.0 110.439 -179.594 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -168.25 150.01 5.18 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.445 -0.785 . . . . 0.0 110.481 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.64 ' HA ' ' HA ' ' A' ' 11' ' ' THR . 0.4 OUTLIER -138.02 147.28 44.02 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.328 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.898 HD11 HG22 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -165.09 151.7 2.19 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 120.777 -1.202 . . . . 0.0 111.397 -178.083 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 1.009 HD11 ' HB2' ' A' ' 37' ' ' HIS . 2.3 pp -108.04 163.62 5.59 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 O-C-N 121.194 -0.941 . . . . 0.0 109.083 178.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.582 ' CZ ' ' HB3' ' A' ' 8' ' ' ASN . 13.2 p90 -162.31 158.87 24.78 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.089 -1.045 . . . . 0.0 112.033 -176.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.677 ' HB3' ' HB2' ' A' ' 56' ' ' LEU . 18.5 t0 -75.42 111.12 12.52 Favored Pre-proline 0 N--CA 1.498 1.932 0 O-C-N 121.645 -0.66 . . . . 0.0 110.101 179.6 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.515 ' HD3' ' HB2' ' A' ' 8' ' ' ASN . 40.5 Cg_endo -66.56 -37.17 23.14 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 O-C-N 123.731 1.385 . . . . 0.0 109.766 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.13 -19.01 64.78 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.599 -0.688 . . . . 0.0 109.654 178.266 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.677 ' HB2' ' HB3' ' A' ' 53' ' ' ASP . 0.4 OUTLIER -96.49 -48.19 5.65 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.388 -0.82 . . . . 0.0 109.438 178.92 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.401 ' O ' ' HA ' ' A' ' 54' ' ' PRO . 5.7 mm100 -153.56 -170.29 3.55 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.531 -0.731 . . . . 0.0 110.431 179.151 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.706 ' HB ' ' HD2' ' A' ' 59' ' ' PRO . 1.5 p -132.33 -176.3 0.55 Allowed Pre-proline 0 N--CA 1.502 2.131 0 O-C-N 120.861 -1.15 . . . . 0.0 110.109 -179.441 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 1.036 ' HB3' HG21 ' A' ' 10' ' ' VAL . 38.8 Cg_endo -68.83 -0.6 6.37 Favored 'Trans proline' 0 N--CA 1.488 1.201 0 O-C-N 123.308 1.162 . . . . 0.0 110.809 178.219 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.516 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 0.1 OUTLIER -77.8 -31.65 51.92 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 177.659 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.752 ' HA ' ' HB2' ' A' ' 64' ' ' GLU . 0.8 OUTLIER -77.88 -23.2 48.86 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 177.577 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.498 HD12 HG22 ' A' ' 61' ' ' THR . 10.9 mp -74.98 -27.52 60.19 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 175.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.401 ' O ' ' HB2' ' A' ' 67' ' ' ASP . 1.5 mm100 -86.4 -26.03 24.97 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 176.72 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.752 ' HB2' ' HA ' ' A' ' 61' ' ' THR . 30.8 mt-10 -73.03 -25.39 60.93 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 177.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.805 ' HB2' HG21 ' A' ' 33' ' ' VAL . . . -89.59 -24.63 21.65 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 178.586 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.828 HD13 HD12 ' A' ' 26' ' ' ILE . 14.6 mm -88.08 -36.97 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 178.486 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.401 ' HB2' ' O ' ' A' ' 63' ' ' GLN . 18.5 t70 -74.86 -27.77 60.39 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.335 -0.946 . . . . 0.0 108.632 178.123 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -76.52 -38.56 54.95 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.513 -0.742 . . . . 0.0 110.148 178.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.473 ' SD ' ' CG2' ' A' ' 25' ' ' THR . 3.5 mmt -67.64 -35.74 79.47 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.895 -1.128 . . . . 0.0 110.471 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 105.9 48.98 0.97 Allowed Glycine 0 N--CA 1.499 2.863 0 C-N-CA 120.099 -1.048 . . . . 0.0 110.707 178.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.664 ' CD2' HD11 ' A' ' 26' ' ' ILE . 55.0 m-85 -130.38 114.66 15.86 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.298 -1.119 . . . . 0.0 110.021 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -48.39 107.87 0.15 Allowed 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.553 -0.717 . . . . 0.0 110.684 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.641 ' HB2' HG21 ' A' ' 66' ' ' ILE . . . -111.23 164.58 12.73 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 122.068 0.937 . . . . 0.0 112.342 -178.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.787 ' C ' HG13 ' A' ' 75' ' ' ILE . 0.9 OUTLIER -168.91 103.72 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 179.618 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.904 ' CG1' ' HA ' ' A' ' 12' ' ' ILE . 0.2 OUTLIER -157.65 -137.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 C-N-CA 118.834 -1.146 . . . . 0.0 113.638 -174.759 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 52.6 t-80 -104.65 71.14 0.97 Allowed 'General case' 0 N--CA 1.499 1.995 0 O-C-N 120.856 -1.152 . . . . 0.0 111.062 -178.326 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -119.08 162.59 30.82 Favored Pre-proline 0 N--CA 1.493 1.695 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 178.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.703 ' HD3' ' HG2' ' A' ' 59' ' ' PRO . 49.5 Cg_endo -84.24 -57.49 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.313 0 O-C-N 123.098 1.051 . . . . 0.0 109.986 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 118.368 -0.825 . . . . 0.0 110.473 179.947 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 85' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.5 2.05 0 CA-C-O 120.894 0.378 . . . . 0.0 110.829 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 40.65 65.49 4.11 Favored Pre-proline 0 N--CA 1.504 2.237 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.505 ' O ' ' NZ ' ' A' ' 55' ' ' LYS . 43.5 Cg_endo -70.78 -17.6 32.82 Favored 'Trans proline' 0 C--N 1.313 -1.322 0 O-C-N 123.614 1.323 . . . . 0.0 109.64 177.554 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -138.66 -0.31 1.95 Allowed 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.32 -0.862 . . . . 0.0 111.989 179.359 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 46.51 28.32 0.74 Allowed 'General case' 0 N--CA 1.505 2.317 0 O-C-N 121.207 -0.933 . . . . 0.0 112.429 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.411 ' O ' ' HB ' ' A' ' 7' ' ' VAL . . . 91.76 3.65 68.29 Favored Glycine 0 N--CA 1.501 2.995 0 O-C-N 120.988 -1.07 . . . . 0.0 111.457 179.401 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 1.075 HG11 HD11 ' A' ' 51' ' ' ILE . 4.2 t 64.81 174.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.465 0 CA-C-N 118.625 1.213 . . . . 0.0 109.941 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.738 ' HB3' ' CZ ' ' A' ' 52' ' ' TYR . 1.0 OUTLIER -117.18 154.57 30.88 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.694 -1.254 . . . . 0.0 111.516 -179.232 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.626 ' HA ' ' HA ' ' A' ' 51' ' ' ILE . 14.7 t -118.98 146.51 44.94 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.336 -0.852 . . . . 0.0 110.012 178.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -140.6 133.95 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.347 -0.845 . . . . 0.0 111.186 -178.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.509 ' HA ' ' HA ' ' A' ' 49' ' ' THR . 51.7 m -109.69 116.81 32.41 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.524 0.678 . . . . 0.0 109.273 179.16 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 1.093 HG21 HD13 ' A' ' 66' ' ' ILE . 5.7 mt -108.43 145.12 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.379 -0.826 . . . . 0.0 110.914 -178.432 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.546 ' O ' ' HB1' ' A' ' 73' ' ' ALA . 0.8 OUTLIER -78.98 137.74 37.73 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.747 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.644 HG13 ' CE ' ' A' ' 17' ' ' MET . 1.2 t -129.09 111.26 22.43 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 O-C-N 120.947 -1.095 . . . . 0.0 111.888 -178.166 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -122.56 170.19 10.26 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.047 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.552 ' O ' HG23 ' A' ' 18' ' ' THR . . . 73.81 25.43 71.87 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 -178.54 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.688 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 29.7 mmt -66.22 -36.08 82.12 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.106 -1.232 . . . . 0.0 110.178 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.552 HG23 ' O ' ' A' ' 16' ' ' GLY . 1.0 OUTLIER 58.93 -42.84 0.07 Allowed 'General case' 0 N--CA 1.515 2.794 0 O-C-N 121.664 -0.648 . . . . 0.0 112.64 -179.708 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.529 ' N ' ' O ' ' A' ' 17' ' ' MET . 9.0 p 179.02 163.49 0.82 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.334 -0.854 . . . . 0.0 110.228 -178.578 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.579 ' HB2' ' CZ3' ' A' ' 24' ' ' TRP . 2.9 p30 -35.13 -36.71 0.06 Allowed 'General case' 0 N--CA 1.508 2.453 0 CA-C-O 120.947 0.403 . . . . 0.0 111.67 178.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.513 ' HA ' ' HE3' ' A' ' 24' ' ' TRP . 10.5 p -46.17 -30.67 2.05 Favored 'General case' 0 N--CA 1.504 2.258 0 CA-C-O 121.983 0.897 . . . . 0.0 110.912 178.667 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.688 ' SG ' ' O ' ' A' ' 17' ' ' MET . 69.6 m -90.3 -27.63 19.3 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.444 -0.785 . . . . 0.0 109.066 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.542 HG21 ' HB2' ' A' ' 43' ' ' LEU . 1.1 t -71.96 -37.65 61.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 175.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.634 ' O ' ' HB2' ' A' ' 28' ' ' GLN . 2.8 m0 -67.6 -32.14 72.67 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 119.142 -1.023 . . . . 0.0 108.488 177.133 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.6 ' O ' ' HB2' ' A' ' 29' ' ' GLN . 96.8 m -82.1 -23.98 35.41 Favored 'General case' 0 N--CA 1.505 2.285 0 C-N-CA 120.532 -0.467 . . . . 0.0 112.034 -179.435 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.739 HD11 ' CD2' ' A' ' 71' ' ' PHE . 1.5 mp -98.49 -22.35 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.31 0 O-C-N 120.868 -1.145 . . . . 0.0 110.126 -179.588 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.595 ' HA ' HD11 ' A' ' 39' ' ' ILE . 4.7 tt0 -83.1 -36.32 24.93 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 178.231 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.634 ' HB2' ' O ' ' A' ' 24' ' ' TRP . 1.2 mp0 -80.13 -33.84 38.24 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.725 -0.79 . . . . 0.0 109.81 178.355 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.6 ' HB2' ' O ' ' A' ' 25' ' ' THR . 5.2 mm100 -77.46 -61.42 2.0 Allowed 'General case' 0 N--CA 1.501 2.088 0 C-N-CA 118.32 -1.352 . . . . 0.0 110.694 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.75 ' CG2' HG21 ' A' ' 50' ' ' ILE . 38.0 mt -64.98 -36.9 78.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 120.776 -1.202 . . . . 0.0 109.989 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.495 ' CA ' HG21 ' A' ' 39' ' ' ILE . . . -58.36 -46.47 92.93 Favored Glycine 0 N--CA 1.499 2.857 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 178.732 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.08 29.99 7.29 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.459 -1.024 . . . . 0.0 110.864 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.476 ' HB ' ' HA ' ' A' ' 30' ' ' ILE . 8.4 p -64.29 -38.19 81.89 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 O-C-N 121.083 -1.011 . . . . 0.0 111.049 -179.651 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -175.39 -60.38 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.333 -0.854 . . . . 0.0 110.357 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.517 ' O ' ' HA ' ' A' ' 52' ' ' TYR . . . -148.47 83.48 0.18 Allowed Glycine 0 N--CA 1.489 2.204 0 N-CA-C 108.307 -1.917 . . . . 0.0 108.307 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.723 HG11 ' HB ' ' A' ' 39' ' ' ILE . 17.1 t -124.15 93.71 2.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 CA-C-O 122.503 1.144 . . . . 0.0 108.637 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.961 ' HB2' HD12 ' A' ' 51' ' ' ILE . 74.8 m80 -60.45 -18.53 51.83 Favored 'General case' 0 N--CA 1.503 2.209 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.676 -179.428 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.584 ' HB3' ' CG2' ' A' ' 51' ' ' ILE . 0.6 OUTLIER -158.92 129.49 5.99 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.791 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.989 ' HA ' HG22 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -129.94 128.79 65.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.565 -0.71 . . . . 0.0 109.392 -179.927 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.695 ' HB3' HG22 ' A' ' 49' ' ' THR . 0.0 OUTLIER -121.02 121.54 38.18 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.882 -1.136 . . . . 0.0 110.073 179.743 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.523 ' O ' ' NZ ' ' A' ' 40' ' ' LYS . 10.6 p -106.89 152.54 8.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 178.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.771 ' HB3' ' HB3' ' A' ' 45' ' ' GLU . 0.4 OUTLIER -136.57 76.51 1.6 Allowed 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.09 -1.006 . . . . 0.0 111.073 -177.74 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.542 ' HB2' HG21 ' A' ' 23' ' ' VAL . 11.7 tp -39.32 -57.19 1.42 Allowed 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.461 ' O ' ' NZ ' ' A' ' 46' ' ' LYS . 0.7 OUTLIER -94.57 -32.69 13.34 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.831 -1.168 . . . . 0.0 111.409 -179.799 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.771 ' HB3' ' HB3' ' A' ' 42' ' ' SER . 9.7 tt0 -66.61 -7.47 20.61 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.038 -1.039 . . . . 0.0 109.929 177.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.461 ' NZ ' ' O ' ' A' ' 44' ' ' GLU . 0.0 OUTLIER 55.77 69.36 0.74 Allowed 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.47 -0.768 . . . . 0.0 111.17 179.008 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -170.31 161.15 8.06 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.72 -1.238 . . . . 0.0 113.037 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.535 ' HB2' HG21 ' A' ' 14' ' ' VAL . . . -147.93 97.25 2.77 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 115.518 -0.765 . . . . 0.0 108.984 179.263 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.695 HG22 ' HB3' ' A' ' 40' ' ' LYS . 1.0 OUTLIER -109.74 133.79 52.73 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.783 -1.198 . . . . 0.0 110.254 -179.674 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.989 HG22 ' HA ' ' A' ' 39' ' ' ILE . 2.6 pp -146.63 177.63 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.511 -0.743 . . . . 0.0 111.146 -178.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 1.075 HD11 HG11 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -123.82 158.89 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 178.541 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.738 ' CZ ' ' HB3' ' A' ' 8' ' ' ASN . 14.8 p90 -163.95 153.7 14.58 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.235 -0.915 . . . . 0.0 111.089 -177.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.478 ' HB3' ' HG3' ' A' ' 55' ' ' LYS . 0.4 OUTLIER -79.69 117.74 68.82 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.277 -0.89 . . . . 0.0 109.49 178.892 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -67.63 57.61 0.73 Allowed 'Trans proline' 0 N--CA 1.494 1.529 0 O-C-N 123.929 1.489 . . . . 0.0 111.408 -178.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.505 ' NZ ' ' O ' ' A' ' 3' ' ' PRO . 0.0 OUTLIER -135.47 -66.25 0.57 Allowed 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 179.073 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -96.84 -8.99 29.6 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.472 -0.768 . . . . 0.0 109.285 177.297 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.66 146.5 50.85 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.512 -0.742 . . . . 0.0 109.947 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.609 ' HB ' ' HD2' ' A' ' 59' ' ' PRO . 78.3 p -142.66 169.08 11.53 Favored Pre-proline 0 N--CA 1.497 1.922 0 O-C-N 121.493 -0.754 . . . . 0.0 110.14 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.609 ' HD2' ' HB ' ' A' ' 58' ' ' THR . 39.3 Cg_endo -65.41 -19.18 61.34 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 O-C-N 123.328 1.172 . . . . 0.0 111.226 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 2.2 tptt -92.0 -30.51 16.03 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.291 -0.881 . . . . 0.0 109.791 179.014 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.709 ' HA ' ' HB2' ' A' ' 64' ' ' GLU . 6.0 p -79.2 -24.17 43.33 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 177.658 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.574 HD22 HD11 ' A' ' 50' ' ' ILE . 14.2 mt -72.97 -30.68 64.01 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 106.314 -1.735 . . . . 0.0 106.314 175.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.478 ' HG3' HD11 ' A' ' 75' ' ' ILE . 1.2 tt0 -82.36 -27.71 31.99 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 177.716 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.709 ' HB2' ' HA ' ' A' ' 61' ' ' THR . 10.3 mt-10 -82.09 -16.38 50.22 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 177.567 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -86.86 -27.22 23.6 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 177.058 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 1.093 HD13 HG21 ' A' ' 12' ' ' ILE . 26.2 mt -86.32 -38.52 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 177.527 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.478 ' HB2' ' O ' ' A' ' 63' ' ' GLN . 0.4 OUTLIER -66.27 -33.21 75.23 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 177.459 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.619 ' HB2' ' O ' ' A' ' 64' ' ' GLU . 2.6 t70 -79.37 -38.07 35.86 Favored 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 119.771 -0.772 . . . . 0.0 109.298 178.539 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.571 ' HE1' HG13 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -47.65 -59.77 3.04 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.555 -0.716 . . . . 0.0 110.018 179.153 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 123.3 51.26 0.21 Allowed Glycine 0 N--CA 1.497 2.735 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 179.249 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.739 ' CD2' HD11 ' A' ' 26' ' ' ILE . 10.9 m-85 -140.73 147.61 39.44 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.435 -1.038 . . . . 0.0 111.029 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -72.39 81.46 1.04 Allowed 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.576 0.703 . . . . 0.0 109.245 179.154 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.546 ' HB1' ' O ' ' A' ' 13' ' ' SER . . . -134.59 142.17 46.86 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.999 -1.063 . . . . 0.0 110.961 -179.116 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.837 ' O ' HG23 ' A' ' 12' ' ' ILE . 2.5 t -117.51 -134.7 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.211 -0.939 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 178.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.641 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . 0.1 OUTLIER -151.83 146.62 15.57 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.357 0 O-C-N 121.072 -1.018 . . . . 0.0 111.514 -179.912 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 -112.61 20.99 16.07 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 177.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.409 ' HB3' ' OD2' ' A' ' 79' ' ' ASP . 0.7 OUTLIER -109.29 139.17 20.8 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.833 -0.542 . . . . 0.0 110.108 -179.617 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.61 56.14 3.34 Favored 'Trans proline' 0 N--CA 1.493 1.48 0 O-C-N 123.585 1.308 . . . . 0.0 110.816 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.409 ' OD2' ' HB3' ' A' ' 77' ' ' ASN . 56.2 m-20 . . . . . 0 N--CA 1.491 1.592 0 O-C-N 121.356 -0.84 . . . . 0.0 110.836 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.3 tpt . . . . . 0 N--CA 1.498 1.939 0 CA-C-O 120.675 0.274 . . . . 0.0 110.738 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -117.39 80.57 12.87 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.12 -0.987 . . . . 0.0 111.461 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.494 ' HB2' ' HE2' ' A' ' 55' ' ' LYS . 46.9 Cg_endo -72.45 -13.03 27.63 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 O-C-N 123.814 1.428 . . . . 0.0 108.593 177.131 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.2 m -141.17 -22.49 0.76 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.721 -0.612 . . . . 0.0 111.981 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 55.55 56.55 6.14 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 120.821 -1.175 . . . . 0.0 110.357 -179.496 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 177.08 -52.81 0.1 Allowed Glycine 0 N--CA 1.501 3.022 0 N-CA-C 110.451 -1.06 . . . . 0.0 110.451 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 1.029 HG11 HD13 ' A' ' 51' ' ' ILE . 1.1 t 67.97 165.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.334 0 O-C-N 121.901 -0.764 . . . . 0.0 111.003 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.486 ' HB3' ' CZ ' ' A' ' 52' ' ' TYR . 2.5 m120 -112.17 -179.87 3.8 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.051 -1.031 . . . . 0.0 110.656 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.62 ' HA ' ' HA ' ' A' ' 51' ' ' ILE . 3.8 m -141.29 132.68 26.74 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.294 -0.879 . . . . 0.0 110.192 179.593 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.593 HG23 ' OH ' ' A' ' 52' ' ' TYR . 0.9 OUTLIER -130.99 135.82 59.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 CA-C-O 121.592 0.711 . . . . 0.0 111.953 -178.14 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.504 ' HA ' ' HA ' ' A' ' 49' ' ' THR . 27.5 m -115.3 118.94 34.68 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.066 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.761 HG12 HG22 ' A' ' 75' ' ' ILE . 64.9 mt -118.73 146.29 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.299 -0.876 . . . . 0.0 111.612 -178.01 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.867 ' CB ' HG13 ' A' ' 74' ' ' VAL . 0.9 OUTLIER -90.42 144.55 25.7 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 177.574 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.51 ' O ' ' HB3' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -141.55 126.38 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.82 -1.175 . . . . 0.0 110.824 -178.754 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.7 ' HB3' ' HB3' ' A' ' 72' ' ' ASP . 5.8 tp10 -108.95 165.42 11.59 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.418 -0.801 . . . . 0.0 110.247 179.209 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.71 -25.89 26.67 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 108.577 -1.809 . . . . 0.0 108.577 -177.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.501 ' HA ' ' CB ' ' A' ' 22' ' ' CYS . 51.2 mtm -73.87 102.7 4.15 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.253 -1.145 . . . . 0.0 109.888 179.344 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 14.9 t -106.59 9.41 31.41 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.532 -0.73 . . . . 0.0 111.367 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.436 ' O ' ' N ' ' A' ' 21' ' ' SER . 0.5 OUTLIER -178.99 139.64 0.16 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.183 -0.948 . . . . 0.0 109.295 179.822 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 1.024 ' HA ' HD21 ' A' ' 43' ' ' LEU . 7.8 m120 -23.08 -46.12 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.599 0 N-CA-C 112.719 0.636 . . . . 0.0 112.719 -179.269 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.554 ' HA ' ' HE3' ' A' ' 24' ' ' TRP . 3.0 p -47.66 -27.5 1.94 Allowed 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.391 -0.818 . . . . 0.0 111.518 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.631 ' HB3' ' CE1' ' A' ' 71' ' ' PHE . 60.2 m -87.04 -33.08 19.67 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.03 -1.044 . . . . 0.0 109.414 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.913 HG21 HD22 ' A' ' 43' ' ' LEU . 9.1 t -77.47 -39.44 27.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 177.398 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.554 ' HE3' ' HA ' ' A' ' 21' ' ' SER . 1.4 m0 -59.24 -36.97 76.41 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 176.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.455 ' O ' ' HB2' ' A' ' 29' ' ' GLN . 64.1 m -66.0 -34.5 78.25 Favored 'General case' 0 N--CA 1.501 2.086 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.006 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.588 HD11 ' CD2' ' A' ' 71' ' ' PHE . 1.4 mp -94.8 -29.61 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.241 0 O-C-N 121.261 -0.899 . . . . 0.0 110.03 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.733 ' HG3' ' CD1' ' A' ' 39' ' ' ILE . 2.6 tt0 -74.16 -35.64 64.05 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 178.639 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.522 ' HB2' ' O ' ' A' ' 24' ' ' TRP . 28.9 mt-30 -79.3 -34.15 42.67 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 119.146 -1.022 . . . . 0.0 108.99 177.639 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.664 ' HB3' ' SD ' ' A' ' 69' ' ' MET . 2.2 mm100 -73.04 -51.36 18.45 Favored 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 118.44 -1.304 . . . . 0.0 110.112 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.553 ' CG2' ' HB ' ' A' ' 39' ' ' ILE . 0.4 OUTLIER -57.41 -41.11 77.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 120.98 -1.075 . . . . 0.0 109.859 179.094 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.874 ' HA2' HG21 ' A' ' 39' ' ' ILE . . . -64.61 -26.52 70.99 Favored Glycine 0 N--CA 1.498 2.772 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 178.372 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.5 ' HB3' ' HE3' ' A' ' 32' ' ' LYS . 3.2 ttpp -116.7 26.7 9.66 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.566 -0.961 . . . . 0.0 110.678 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.562 HG21 ' HB1' ' A' ' 65' ' ' ALA . 8.1 p -87.41 -49.22 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 O-C-N 120.594 -1.316 . . . . 0.0 112.489 -178.793 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.503 ' N ' HG13 ' A' ' 33' ' ' VAL . 0.6 OUTLIER -169.66 -68.07 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.134 0 O-C-N 120.408 -1.433 . . . . 0.0 112.453 -179.581 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.606 ' HA3' HD11 ' A' ' 56' ' ' LEU . . . -142.74 73.17 0.37 Allowed Glycine 0 N--CA 1.496 2.676 0 C-N-CA 119.987 -1.102 . . . . 0.0 110.855 -178.725 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.928 ' CG1' HG22 ' A' ' 39' ' ' ILE . 61.5 t -127.57 89.2 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 CA-C-O 122.335 1.064 . . . . 0.0 108.564 178.218 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 1.009 ' HB2' HD11 ' A' ' 51' ' ' ILE . 36.3 m80 -61.6 -23.26 65.89 Favored 'General case' 0 N--CA 1.507 2.402 0 CA-C-N 115.388 -0.823 . . . . 0.0 110.72 -179.271 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.64 ' HB2' HG12 ' A' ' 51' ' ' ILE . 75.4 m80 -136.94 113.36 10.04 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.308 -0.87 . . . . 0.0 109.162 179.28 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.928 HG22 ' CG1' ' A' ' 36' ' ' VAL . 1.8 pp -114.28 136.42 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.286 -0.884 . . . . 0.0 109.637 -179.521 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.634 ' HA ' ' CE ' ' A' ' 40' ' ' LYS . 0.3 OUTLIER -150.58 122.91 8.39 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.168 -1.583 . . . . 0.0 112.408 -179.715 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.489 HG13 ' HB2' ' A' ' 48' ' ' ALA . 3.9 t -127.79 167.14 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.191 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.4 m -108.84 -101.04 0.38 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.87 -1.144 . . . . 0.0 110.168 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 1.024 HD21 ' HA ' ' A' ' 20' ' ' ASN . 0.1 OUTLIER -179.13 -92.41 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.308 0 O-C-N 121.069 -1.019 . . . . 0.0 109.683 179.411 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.49 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -76.73 -9.77 58.9 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.512 -1.368 . . . . 0.0 109.594 178.538 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -74.59 -11.87 60.31 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 177.108 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.51 ' HB3' ' O ' ' A' ' 14' ' ' VAL . 21.5 mmtt 51.5 56.13 8.36 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.623 -0.673 . . . . 0.0 111.295 179.037 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -154.08 152.13 30.11 Favored 'General case' 0 N--CA 1.504 2.235 0 O-C-N 120.587 -1.32 . . . . 0.0 112.274 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.489 ' HB2' HG13 ' A' ' 41' ' ' VAL . . . -142.36 134.91 28.05 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.251 0.548 . . . . 0.0 110.592 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.504 ' HA ' ' HA ' ' A' ' 11' ' ' THR . 5.8 t -128.67 134.41 48.5 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.377 -0.827 . . . . 0.0 109.408 179.021 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.48 ' CD1' HD22 ' A' ' 62' ' ' LEU . 0.1 OUTLIER -149.59 164.85 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.072 -1.018 . . . . 0.0 110.975 -179.014 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 1.029 HD13 HG11 ' A' ' 7' ' ' VAL . 1.7 pp -107.03 167.52 3.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 178.056 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.593 ' OH ' HG23 ' A' ' 10' ' ' VAL . 28.8 p90 -170.52 161.83 7.91 Favored 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 119.159 -1.017 . . . . 0.0 110.731 -178.187 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.436 ' O ' ' N ' ' A' ' 55' ' ' LYS . 0.9 OUTLIER -78.84 121.62 83.67 Favored Pre-proline 0 C--N 1.302 -1.492 0 C-N-CA 119.701 -0.799 . . . . 0.0 109.726 179.182 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.421 ' C ' ' HG2' ' A' ' 55' ' ' LYS . 38.7 Cg_endo -64.67 70.31 0.24 Allowed 'Trans proline' 0 N--CA 1.492 1.395 0 O-C-N 124.1 1.579 . . . . 0.0 109.728 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.494 ' HE2' ' HB2' ' A' ' 3' ' ' PRO . 3.2 ptpp? -172.24 -45.48 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.756 -0.59 . . . . 0.0 110.877 -178.748 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.606 HD11 ' HA3' ' A' ' 35' ' ' GLY . 1.8 pp -111.8 -21.65 11.53 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.093 -1.004 . . . . 0.0 111.837 -179.293 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.517 ' HB3' ' HB2' ' A' ' 52' ' ' TYR . 5.5 tp60 -125.85 133.76 51.85 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.818 -1.176 . . . . 0.0 110.025 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.777 ' C ' HD12 ' A' ' 62' ' ' LEU . 34.9 p -141.78 168.33 14.13 Favored Pre-proline 0 N--CA 1.504 2.239 0 O-C-N 121.111 -0.993 . . . . 0.0 109.988 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.612 ' HA ' ' HB2' ' A' ' 62' ' ' LEU . 37.8 Cg_endo -62.39 -20.45 70.4 Favored 'Trans proline' 0 N--CA 1.498 1.78 0 O-C-N 123.418 1.22 . . . . 0.0 111.877 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.425 ' NZ ' ' HB3' ' A' ' 64' ' ' GLU . 0.4 OUTLIER -81.4 -30.53 33.57 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.097 -1.002 . . . . 0.0 108.777 178.241 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.548 ' HA ' ' CD ' ' A' ' 64' ' ' GLU . 0.9 OUTLIER -90.3 -24.15 20.97 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 178.033 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.777 HD12 ' C ' ' A' ' 58' ' ' THR . 5.2 mt -74.11 -28.07 61.18 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 177.389 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.823 ' HB2' HG21 ' A' ' 75' ' ' ILE . 15.8 tt0 -84.08 -30.22 26.18 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 177.553 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.548 ' CD ' ' HA ' ' A' ' 61' ' ' THR . 1.5 pt-20 -81.05 -18.99 44.77 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.293 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.562 ' HB1' HG21 ' A' ' 33' ' ' VAL . . . -82.95 -28.76 29.61 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 175.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.711 HG22 ' HB2' ' A' ' 73' ' ' ALA . 51.5 mt -82.01 -38.77 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 177.136 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.46 ' HB2' ' HA ' ' A' ' 64' ' ' GLU . 1.2 m-20 -61.05 -28.54 69.14 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 176.607 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -71.05 -42.74 69.08 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.799 -0.563 . . . . 0.0 109.885 178.347 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.664 ' SD ' ' HB3' ' A' ' 29' ' ' GLN . 0.8 OUTLIER -54.73 -47.95 73.14 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.454 -0.779 . . . . 0.0 111.043 179.717 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 120.89 43.0 0.46 Allowed Glycine 0 N--CA 1.503 3.109 0 C-N-CA 120.069 -1.062 . . . . 0.0 110.586 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.631 ' CE1' ' HB3' ' A' ' 22' ' ' CYS . 61.8 m-85 -144.87 130.29 18.78 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.444 -1.033 . . . . 0.0 109.229 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.7 ' HB3' ' HB3' ' A' ' 15' ' ' GLU . 5.5 t70 -47.43 116.51 1.45 Allowed 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.525 -0.735 . . . . 0.0 110.005 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.711 ' HB2' HG22 ' A' ' 66' ' ' ILE . . . -109.43 150.17 28.48 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.382 -0.824 . . . . 0.0 111.554 -178.706 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.867 HG13 ' CB ' ' A' ' 13' ' ' SER . 1.0 OUTLIER -154.83 93.76 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 CA-C-O 122.559 1.171 . . . . 0.0 108.1 179.103 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.823 HG21 ' HB2' ' A' ' 63' ' ' GLN . 14.0 pt -69.62 150.73 10.17 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 CA-C-O 122.481 1.134 . . . . 0.0 112.455 -177.643 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 17.8 m-70 -109.93 14.95 22.91 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.147 178.412 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 30.0 m120 -133.38 140.13 36.14 Favored Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 121.018 -1.051 . . . . 0.0 110.302 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -79.33 -53.67 0.05 OUTLIER 'Trans proline' 0 C--N 1.315 -1.235 0 O-C-N 123.853 1.449 . . . . 0.0 110.527 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 118.439 -0.791 . . . . 0.0 110.603 -179.778 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 85' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.0 tpt . . . . . 0 N--CA 1.495 1.806 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.435 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 12.9 m-20 49.17 52.05 12.06 Favored Pre-proline 0 N--CA 1.503 2.203 0 O-C-N 121.756 -0.59 . . . . 0.0 111.563 179.599 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.435 ' CD ' ' N ' ' A' ' 2' ' ' ASP . 45.2 Cg_endo -72.03 -13.48 28.85 Favored 'Trans proline' 0 C--N 1.317 -1.087 0 O-C-N 123.483 1.254 . . . . 0.0 109.022 177.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.411 ' HB2' ' HB ' ' A' ' 7' ' ' VAL . 1.4 p -156.01 29.02 0.36 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.586 -0.696 . . . . 0.0 110.843 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -41.45 107.05 0.07 Allowed 'General case' 0 N--CA 1.505 2.282 0 O-C-N 121.41 -0.806 . . . . 0.0 110.426 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.549 ' O ' ' HD2' ' A' ' 54' ' ' PRO . . . 118.66 -24.67 8.39 Favored Glycine 0 N--CA 1.497 2.716 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 -179.018 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.411 ' HB ' ' HB2' ' A' ' 4' ' ' SER . 48.2 t -108.32 145.25 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 O-C-N 121.137 -1.213 . . . . 0.0 109.717 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.772 ' HB3' ' CZ ' ' A' ' 52' ' ' TYR . 1.0 OUTLIER -106.24 172.46 6.8 Favored 'General case' 0 N--CA 1.503 2.21 0 O-C-N 120.977 -1.077 . . . . 0.0 110.957 -179.789 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.499 ' HA ' ' HA ' ' A' ' 51' ' ' ILE . 6.8 t -130.52 131.04 44.89 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.352 -0.843 . . . . 0.0 110.27 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.941 HG11 HD13 ' A' ' 62' ' ' LEU . 0.5 OUTLIER -125.61 132.63 70.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.462 -0.774 . . . . 0.0 111.315 -178.411 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.587 ' HA ' ' HA ' ' A' ' 49' ' ' THR . 8.9 m -108.67 119.17 38.73 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.532 -0.73 . . . . 0.0 109.138 178.728 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.68 ' HA ' ' HA ' ' A' ' 75' ' ' ILE . 9.8 mt -110.93 122.13 64.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.294 -0.879 . . . . 0.0 110.9 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.675 ' HB2' ' CG1' ' A' ' 74' ' ' VAL . 0.7 OUTLIER -79.34 136.11 36.91 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 178.011 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.42 HG12 ' HB3' ' A' ' 71' ' ' PHE . 0.2 OUTLIER -131.27 130.14 63.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.17 -0.957 . . . . 0.0 110.987 -178.641 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -119.48 159.57 24.02 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.387 -0.82 . . . . 0.0 110.159 178.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.527 ' O ' HG23 ' A' ' 18' ' ' THR . . . 98.35 -31.14 8.36 Favored Glycine 0 N--CA 1.497 2.762 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 -179.145 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.58 ' SD ' ' HA ' ' A' ' 43' ' ' LEU . 8.0 ptp -62.43 122.63 16.2 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.171 -1.193 . . . . 0.0 110.302 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.527 HG23 ' O ' ' A' ' 16' ' ' GLY . 54.7 p -125.64 5.96 7.5 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.252 -0.905 . . . . 0.0 113.333 -178.073 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.484 ' O ' HD21 ' A' ' 43' ' ' LEU . 1.1 p -165.56 145.3 6.6 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.14 -1.6 . . . . 0.0 110.512 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.49 ' O ' HG12 ' A' ' 23' ' ' VAL . 28.9 m120 -25.8 -40.67 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.674 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -179.334 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.811 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 2.2 p -51.32 -19.75 1.42 Allowed 'General case' 0 N--CA 1.499 1.978 0 CA-C-O 122.294 1.045 . . . . 0.0 110.703 178.624 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.791 ' HB2' HD21 ' A' ' 43' ' ' LEU . 44.7 m -91.15 -20.87 21.53 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 119.32 -2.112 . . . . 0.0 109.221 179.002 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.775 ' HB ' HD22 ' A' ' 43' ' ' LEU . 0.3 OUTLIER -90.02 -35.51 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.411 -0.806 . . . . 0.0 108.868 178.531 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.811 ' CE3' ' HA ' ' A' ' 21' ' ' SER . 0.0 OUTLIER -78.96 -22.55 45.51 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 117.85 -1.54 . . . . 0.0 108.688 178.642 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.509 ' HB ' ' CZ3' ' A' ' 24' ' ' TRP . 1.3 t -86.18 -27.6 24.44 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 120.774 -1.204 . . . . 0.0 110.378 177.552 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.676 HD11 ' CD2' ' A' ' 71' ' ' PHE . 20.4 mm -90.77 -25.12 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.377 0 O-C-N 120.75 -1.218 . . . . 0.0 109.561 179.052 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.574 ' HA ' HD12 ' A' ' 39' ' ' ILE . 0.2 OUTLIER -81.24 -34.37 32.18 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 177.55 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.638 ' HB2' ' O ' ' A' ' 24' ' ' TRP . 0.9 OUTLIER -72.95 -33.01 65.63 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 177.413 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.482 ' O ' ' HB ' ' A' ' 33' ' ' VAL . 5.5 tp60 -70.88 -66.63 0.58 Allowed 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 120.045 -0.662 . . . . 0.0 110.527 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.844 HG21 HG21 ' A' ' 50' ' ' ILE . 84.1 mt -64.3 -45.7 95.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 O-C-N 121.245 -0.91 . . . . 0.0 110.35 -179.405 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.498 ' CA ' HG21 ' A' ' 39' ' ' ILE . . . -50.48 -34.44 27.02 Favored Glycine 0 N--CA 1.497 2.712 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 179.29 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 56.1 mtmt -126.71 29.9 5.61 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.008 -1.29 . . . . 0.0 111.865 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.508 HG13 ' N ' ' A' ' 34' ' ' ASN . 14.9 p -75.15 -49.83 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 O-C-N 120.633 -1.292 . . . . 0.0 111.541 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.508 ' N ' HG13 ' A' ' 33' ' ' VAL . 0.4 OUTLIER -178.47 -60.29 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.285 0 O-C-N 120.871 -1.143 . . . . 0.0 111.663 179.772 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.451 ' O ' ' HA ' ' A' ' 52' ' ' TYR . . . -122.94 67.71 0.48 Allowed Glycine 0 N--CA 1.495 2.586 0 C-N-CA 120.207 -0.997 . . . . 0.0 110.647 -178.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.88 HG22 HD13 ' A' ' 50' ' ' ILE . 50.4 t -136.57 92.4 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.487 -1.008 . . . . 0.0 108.585 178.511 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.793 ' N ' HD11 ' A' ' 51' ' ' ILE . 60.3 m80 -51.67 -29.27 17.39 Favored 'General case' 0 N--CA 1.512 2.667 0 CA-C-O 121.575 0.702 . . . . 0.0 109.709 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.69 ' ND1' HD12 ' A' ' 51' ' ' ILE . 0.1 OUTLIER -171.39 145.41 2.12 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 178.615 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.876 HG12 HG22 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -121.06 144.86 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.145 -0.972 . . . . 0.0 110.023 -178.689 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.594 ' HG3' HG22 ' A' ' 49' ' ' THR . 4.5 tptt -122.21 100.23 6.85 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.555 -1.341 . . . . 0.0 109.518 179.258 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.643 HG23 ' HB2' ' A' ' 48' ' ' ALA . 11.2 p -108.93 154.68 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 O-C-N 121.604 -0.685 . . . . 0.0 109.614 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.57 ' HB3' ' HB2' ' A' ' 45' ' ' GLU . 0.4 OUTLIER -139.93 79.31 1.71 Allowed 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.712 -0.618 . . . . 0.0 109.693 -179.834 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.791 HD21 ' HB2' ' A' ' 22' ' ' CYS . 1.8 tp -45.32 -32.66 2.1 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.595 -0.691 . . . . 0.0 110.994 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.5 mp0 -72.02 -51.74 20.33 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.151 -0.968 . . . . 0.0 109.97 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.57 ' HB2' ' HB3' ' A' ' 42' ' ' SER . 1.8 mp0 -73.43 1.42 9.79 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.619 -0.676 . . . . 0.0 109.747 177.592 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 51.38 56.16 8.35 Favored 'General case' 0 N--CA 1.506 2.349 0 O-C-N 121.367 -0.833 . . . . 0.0 111.713 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -171.22 158.84 5.6 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.893 -1.129 . . . . 0.0 110.38 179.162 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.643 ' HB2' HG23 ' A' ' 41' ' ' VAL . . . -144.49 137.43 26.89 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.967 -1.083 . . . . 0.0 111.85 -179.45 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.594 HG22 ' HG3' ' A' ' 40' ' ' LYS . 5.6 t -127.22 135.78 51.1 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.014 -1.054 . . . . 0.0 109.299 178.035 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.88 HD13 HG22 ' A' ' 36' ' ' VAL . 1.4 pp -145.03 167.62 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 O-C-N 121.08 -1.013 . . . . 0.0 111.036 -177.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.793 HD11 ' N ' ' A' ' 37' ' ' HIS . 0.0 OUTLIER -109.12 169.26 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 O-C-N 121.281 -0.887 . . . . 0.0 110.15 178.727 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.772 ' CZ ' ' HB3' ' A' ' 8' ' ' ASN . 15.4 p90 -170.43 159.73 7.14 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.54 -0.725 . . . . 0.0 110.672 -178.611 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.465 ' OD2' ' HB3' ' A' ' 56' ' ' LEU . 6.6 p-10 -79.26 117.37 66.63 Favored Pre-proline 0 C--N 1.3 -1.558 0 C-N-CA 119.631 -0.828 . . . . 0.0 109.425 179.037 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.549 ' HD2' ' O ' ' A' ' 6' ' ' GLY . 39.8 Cg_endo -68.54 66.2 1.15 Allowed 'Trans proline' 0 N--CA 1.487 1.115 0 O-C-N 123.516 1.272 . . . . 0.0 109.374 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.49 ' HG2' ' C ' ' A' ' 54' ' ' PRO . 0.0 OUTLIER -164.11 -55.3 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 -179.267 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.465 ' HB3' ' OD2' ' A' ' 53' ' ' ASP . 0.4 OUTLIER -98.55 -41.45 7.74 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.381 -0.824 . . . . 0.0 109.53 178.271 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.416 ' HB3' ' HB2' ' A' ' 52' ' ' TYR . 20.5 tp60 -104.14 140.38 37.88 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.026 -1.046 . . . . 0.0 111.036 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.72 ' HB ' ' HD2' ' A' ' 59' ' ' PRO . 29.9 p -140.75 171.55 7.49 Favored Pre-proline 0 N--CA 1.508 2.469 0 O-C-N 121.013 -1.055 . . . . 0.0 110.363 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.72 ' HD2' ' HB ' ' A' ' 58' ' ' THR . 38.5 Cg_endo -64.22 -20.24 66.75 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 O-C-N 123.455 1.24 . . . . 0.0 110.229 179.329 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.579 ' O ' ' HB3' ' A' ' 64' ' ' GLU . 1.4 tmtt? -77.02 -31.31 56.27 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 177.673 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.546 ' HA ' ' CD ' ' A' ' 64' ' ' GLU . 39.1 p -86.84 -25.41 24.54 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 177.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.941 HD13 HG11 ' A' ' 10' ' ' VAL . 20.3 mt -77.06 -26.6 53.73 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 176.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.438 ' HA ' HG22 ' A' ' 66' ' ' ILE . 1.3 tp60 -86.05 -24.56 26.31 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 177.34 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.579 ' HB3' ' O ' ' A' ' 60' ' ' LYS . 1.1 pt-20 -87.14 -15.39 38.54 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 177.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -90.05 -27.96 19.36 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 177.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.438 HG22 ' HA ' ' A' ' 63' ' ' GLN . 0.4 OUTLIER -86.41 -38.24 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.047 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -71.93 -29.74 64.61 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 177.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.435 ' HB2' ' O ' ' A' ' 64' ' ' GLU . 11.8 t70 -69.39 -41.55 76.31 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.413 -0.804 . . . . 0.0 109.181 177.68 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.29 -46.85 76.21 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.669 -0.645 . . . . 0.0 110.25 179.329 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 121.08 38.35 0.65 Allowed Glycine 0 N--CA 1.499 2.852 0 C-N-CA 120.043 -1.075 . . . . 0.0 110.856 179.293 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.676 ' CD2' HD11 ' A' ' 26' ' ' ILE . 59.9 m-85 -131.3 121.67 25.11 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.521 -0.988 . . . . 0.0 108.947 179.002 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -58.99 110.44 1.03 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.241 -0.912 . . . . 0.0 109.621 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.427 ' HA ' ' O ' ' A' ' 13' ' ' SER . . . -124.08 168.19 13.21 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 122.051 0.929 . . . . 0.0 112.029 -178.664 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.675 ' CG1' ' HB2' ' A' ' 13' ' ' SER . 2.7 p -149.2 91.75 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 178.685 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.68 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . 0.0 OUTLIER -51.74 143.49 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 CA-C-O 122.488 1.137 . . . . 0.0 112.157 -177.728 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -109.64 10.63 24.9 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.657 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -131.0 100.22 17.4 Favored Pre-proline 0 N--CA 1.496 1.872 0 O-C-N 121.331 -0.855 . . . . 0.0 110.642 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -83.59 46.38 2.05 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 O-C-N 123.586 1.309 . . . . 0.0 110.569 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.483 ' O ' ' HD3' ' A' ' 59' ' ' PRO . 5.5 m-20 . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.434 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.8 ttt . . . . . 0 N--CA 1.501 2.11 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.476 ' N ' ' HD3' ' A' ' 3' ' ' PRO . 1.9 m-20 46.64 53.04 12.82 Favored Pre-proline 0 N--CA 1.502 2.125 0 O-C-N 121.789 -0.57 . . . . 0.0 111.94 177.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.476 ' HD3' ' N ' ' A' ' 2' ' ' ASP . 51.9 Cg_endo -78.68 -8.59 15.87 Favored 'Trans proline' 0 C--N 1.318 -1.05 0 O-C-N 123.61 1.321 . . . . 0.0 109.286 177.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.41 ' O ' ' N ' ' A' ' 6' ' ' GLY . 0.7 OUTLIER -139.14 10.63 2.57 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.304 -0.872 . . . . 0.0 111.246 179.58 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.45 92.03 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.24 0 O-C-N 120.904 -1.123 . . . . 0.0 111.001 -179.627 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 4' ' ' SER . . . 116.73 -10.31 16.11 Favored Glycine 0 N--CA 1.5 2.92 0 O-C-N 121.204 -0.935 . . . . 0.0 111.704 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.64 ' HB ' HD11 ' A' ' 51' ' ' ILE . 26.7 m -131.13 165.84 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.351 0 CA-C-N 119.355 1.577 . . . . 0.0 111.23 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.511 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 8.1 m-20 -117.16 167.72 10.93 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.226 -0.921 . . . . 0.0 110.289 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.534 ' HA ' ' HA ' ' A' ' 51' ' ' ILE . 1.9 m -116.58 136.48 52.94 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.104 -0.997 . . . . 0.0 110.776 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.56 HG23 ' CE1' ' A' ' 52' ' ' TYR . 1.0 OUTLIER -126.58 120.71 56.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.415 -0.803 . . . . 0.0 111.459 -179.396 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.489 ' HA ' ' HA ' ' A' ' 49' ' ' THR . 24.2 m -111.75 104.74 13.1 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 177.59 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.604 ' HA ' ' HA ' ' A' ' 75' ' ' ILE . 72.6 mt -113.6 138.86 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.258 -0.901 . . . . 0.0 111.391 -178.152 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.747 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 0.7 OUTLIER -74.57 134.02 42.18 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 177.984 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.549 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 23.3 t -120.29 120.71 63.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 121.274 -0.891 . . . . 0.0 110.945 -178.117 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.606 ' CB ' ' HB3' ' A' ' 72' ' ' ASP . 1.7 tm-20 -109.22 -171.58 1.87 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.796 -0.565 . . . . 0.0 109.864 179.294 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.96 21.96 67.01 Favored Glycine 0 N--CA 1.497 2.712 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -178.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.497 ' CG ' ' HG ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -66.35 154.32 40.35 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.256 -1.144 . . . . 0.0 111.386 -179.494 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.41 ' O ' ' HB3' ' A' ' 19' ' ' CYS . 1.6 p -146.91 -41.15 0.19 Allowed 'General case' 0 N--CA 1.508 2.439 0 O-C-N 121.407 -0.808 . . . . 0.0 111.556 -179.273 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.541 ' O ' HD21 ' A' ' 43' ' ' LEU . 29.5 p -179.79 169.23 1.31 Allowed 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.523 -0.735 . . . . 0.0 109.923 -178.646 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.558 ' O ' HG12 ' A' ' 23' ' ' VAL . 13.2 t-20 -31.72 -36.88 0.02 OUTLIER 'General case' 0 N--CA 1.512 2.639 0 CA-C-O 121.149 0.5 . . . . 0.0 112.095 179.226 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.85 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 4.5 p -55.99 -17.3 6.4 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 122.187 0.994 . . . . 0.0 111.354 179.064 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.686 ' CB ' HD11 ' A' ' 43' ' ' LEU . 62.4 m -93.25 -28.83 16.01 Favored 'General case' 0 C--N 1.287 -2.131 0 O-C-N 119.602 -1.936 . . . . 0.0 110.841 -178.706 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.66 ' CA ' HD13 ' A' ' 43' ' ' LEU . 10.7 p -85.49 -32.64 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.351 -0.843 . . . . 0.0 109.167 178.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.85 ' CE3' ' HA ' ' A' ' 21' ' ' SER . 0.0 OUTLIER -83.37 -23.07 32.61 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 117.745 -1.582 . . . . 0.0 108.886 178.488 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.629 ' HB ' ' O ' ' A' ' 21' ' ' SER . 1.2 t -82.26 -26.64 33.01 Favored 'General case' 0 N--CA 1.507 2.39 0 C-N-CA 118.722 -1.191 . . . . 0.0 111.061 178.001 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.996 HD11 ' CD2' ' A' ' 71' ' ' PHE . 20.8 mt -96.47 -28.86 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 O-C-N 120.81 -1.181 . . . . 0.0 110.25 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.611 ' HA ' HD11 ' A' ' 39' ' ' ILE . 1.0 OUTLIER -74.54 -35.39 63.12 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 178.369 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.606 ' HB2' ' O ' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -80.86 -31.91 35.18 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 119.423 -0.911 . . . . 0.0 108.607 177.545 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.578 ' HB2' ' O ' ' A' ' 25' ' ' THR . 1.6 tm0? -73.06 -60.44 2.23 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.036 -1.04 . . . . 0.0 110.162 179.222 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.868 HG21 HG21 ' A' ' 50' ' ' ILE . 88.5 mt -59.34 -39.27 78.55 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 120.945 -1.097 . . . . 0.0 109.952 179.5 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.75 ' HA2' HG21 ' A' ' 39' ' ' ILE . . . -48.53 -46.44 29.72 Favored Glycine 0 N--CA 1.497 2.741 0 N-CA-C 110.219 -1.152 . . . . 0.0 110.219 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.491 ' HG3' ' O ' ' A' ' 28' ' ' GLN . 0.2 OUTLIER -130.9 40.99 3.42 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.572 -0.958 . . . . 0.0 110.88 179.526 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.519 ' HB ' ' O ' ' A' ' 29' ' ' GLN . 15.0 p -72.76 -40.35 61.04 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.298 0 O-C-N 121.143 -0.973 . . . . 0.0 111.151 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.4 ' N ' HG13 ' A' ' 33' ' ' VAL . 0.3 OUTLIER -171.04 -51.64 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.092 0 O-C-N 120.903 -1.123 . . . . 0.0 111.08 179.844 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -150.12 82.64 0.18 Allowed Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.901 HG22 HD13 ' A' ' 50' ' ' ILE . 54.0 t -139.43 100.89 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.293 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.993 ' HB2' HD12 ' A' ' 51' ' ' ILE . 67.5 m80 -70.09 -27.53 64.68 Favored 'General case' 0 C--N 1.289 -2.043 0 C-N-CA 120.288 -0.565 . . . . 0.0 110.155 -179.281 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.812 ' HB2' HG22 ' A' ' 51' ' ' ILE . 31.0 m80 -142.78 130.71 21.7 Favored 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.047 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.781 ' C ' HD13 ' A' ' 39' ' ' ILE . 0.0 OUTLIER -127.88 139.08 52.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.081 -1.012 . . . . 0.0 110.252 -179.282 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.538 ' H ' HG22 ' A' ' 50' ' ' ILE . 0.3 OUTLIER -148.31 106.21 3.71 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.165 -0.959 . . . . 0.0 110.227 179.232 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.682 HG21 ' CG2' ' A' ' 26' ' ' ILE . 1.1 p -107.28 170.17 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.619 -0.676 . . . . 0.0 109.411 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.699 ' HB3' ' HB2' ' A' ' 45' ' ' GLU . 2.2 m -152.4 86.02 1.27 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.074 -1.016 . . . . 0.0 111.013 -178.187 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.686 HD11 ' CB ' ' A' ' 22' ' ' CYS . 1.9 tp -46.13 -34.04 3.97 Favored 'General case' 0 N--CA 1.509 2.489 0 O-C-N 121.768 -0.583 . . . . 0.0 111.617 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.416 ' O ' ' NZ ' ' A' ' 46' ' ' LYS . 14.3 mm-40 -82.75 -41.94 18.59 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.464 -1.397 . . . . 0.0 110.93 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.699 ' HB2' ' HB3' ' A' ' 42' ' ' SER . 18.9 mt-10 -80.37 5.54 14.64 Favored 'General case' 0 N--CA 1.498 1.938 0 C-N-CA 119.762 -0.775 . . . . 0.0 109.76 177.717 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.549 ' HG3' ' O ' ' A' ' 14' ' ' VAL . 0.0 OUTLIER 42.48 51.38 4.81 Favored 'General case' 0 N--CA 1.506 2.332 0 O-C-N 121.647 -0.658 . . . . 0.0 111.226 179.866 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.452 ' ND2' ' HA ' ' A' ' 13' ' ' SER . 0.4 OUTLIER -154.45 157.06 37.87 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 120.696 -1.252 . . . . 0.0 111.975 -179.382 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.594 ' HB2' HG23 ' A' ' 41' ' ' VAL . . . -136.63 127.16 26.88 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.491 -0.756 . . . . 0.0 109.863 178.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.522 HG22 ' HD3' ' A' ' 40' ' ' LYS . 15.1 t -127.75 119.69 26.31 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.353 -0.842 . . . . 0.0 110.071 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.901 HD13 HG22 ' A' ' 36' ' ' VAL . 1.9 pp -141.88 176.44 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.28 -0.887 . . . . 0.0 111.086 -178.421 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.993 HD12 ' HB2' ' A' ' 37' ' ' HIS . 0.0 OUTLIER -117.9 150.49 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 177.014 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.599 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 19.6 p90 -154.09 171.69 18.72 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 119.796 -0.762 . . . . 0.0 111.082 -176.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.445 ' HA ' ' HD2' ' A' ' 54' ' ' PRO . 0.4 OUTLIER -86.0 115.77 63.13 Favored Pre-proline 0 C--N 1.3 -1.569 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.294 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.445 ' HD2' ' HA ' ' A' ' 53' ' ' ASP . 37.5 Cg_endo -60.17 -22.64 70.94 Favored 'Trans proline' 0 N--CA 1.493 1.457 0 O-C-N 123.587 1.309 . . . . 0.0 110.035 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.4 ptpp? -79.95 -8.98 59.63 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.729 -0.607 . . . . 0.0 110.471 178.14 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -131.44 -46.64 0.98 Allowed 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.073 -1.017 . . . . 0.0 110.826 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -110.87 154.8 23.52 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.175 -0.953 . . . . 0.0 110.277 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.777 ' HB ' ' HD2' ' A' ' 59' ' ' PRO . 12.2 p -143.46 176.07 2.5 Favored Pre-proline 0 N--CA 1.499 1.982 0 O-C-N 121.488 -0.758 . . . . 0.0 110.456 -179.45 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.777 ' HD2' ' HB ' ' A' ' 58' ' ' THR . 40.0 Cg_endo -65.26 -23.35 59.55 Favored 'Trans proline' 0 N--CA 1.497 1.717 0 O-C-N 123.317 1.167 . . . . 0.0 112.199 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.542 ' O ' ' HB3' ' A' ' 64' ' ' GLU . 4.7 mmtm -90.47 -29.39 17.97 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.092 -1.005 . . . . 0.0 110.188 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.411 ' OG1' ' N ' ' A' ' 58' ' ' THR . 8.3 p -82.27 -25.84 33.7 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 177.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.552 HD13 ' CB ' ' A' ' 10' ' ' VAL . 0.9 OUTLIER -77.03 -27.91 54.7 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 176.676 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -82.62 -24.5 33.81 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 177.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.542 ' HB3' ' O ' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -84.7 -19.47 32.72 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 177.575 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -79.49 -30.54 42.05 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 176.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.492 HD13 HG22 ' A' ' 14' ' ' VAL . 32.3 mt -79.53 -37.58 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 176.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.458 ' HB2' ' HA ' ' A' ' 64' ' ' GLU . 0.9 OUTLIER -70.79 -29.35 65.53 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 176.778 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -69.73 -47.59 62.54 Favored 'General case' 0 N--CA 1.501 2.1 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 177.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.553 ' HE3' ' HB2' ' A' ' 29' ' ' GLN . 0.0 OUTLIER -56.53 -36.43 69.22 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.584 -0.698 . . . . 0.0 109.777 179.252 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 120.28 34.99 0.9 Allowed Glycine 0 N--CA 1.494 2.544 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 179.141 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.996 ' CD2' HD11 ' A' ' 26' ' ' ILE . 95.0 m-85 -135.99 144.09 45.16 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.306 -1.114 . . . . 0.0 110.546 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.606 ' HB3' ' CB ' ' A' ' 15' ' ' GLU . 5.2 t70 -60.52 129.78 43.3 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.344 -0.847 . . . . 0.0 109.972 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -108.76 116.98 33.01 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.459 -0.775 . . . . 0.0 110.565 -179.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.747 ' HB ' ' HB2' ' A' ' 13' ' ' SER . 53.1 t -123.12 73.07 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 CA-C-O 122.138 0.971 . . . . 0.0 108.742 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.604 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . 38.1 mt -35.4 137.25 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 CA-C-O 121.827 0.822 . . . . 0.0 112.472 -178.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -117.18 2.19 12.58 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.861 -0.525 . . . . 0.0 110.707 178.259 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.442 ' OD1' ' HD2' ' A' ' 78' ' ' PRO . 31.5 t30 -125.62 147.46 58.35 Favored Pre-proline 0 N--CA 1.499 2.004 0 O-C-N 120.983 -1.073 . . . . 0.0 109.916 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.442 ' HD2' ' OD1' ' A' ' 77' ' ' ASN . 38.9 Cg_endo -66.61 -40.0 14.55 Favored 'Trans proline' 0 N--CA 1.493 1.489 0 O-C-N 123.382 1.201 . . . . 0.0 110.26 179.449 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.487 1.396 0 CA-C-O 118.47 -0.776 . . . . 0.0 109.501 178.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.502 2.133 0 CA-C-O 120.967 0.413 . . . . 0.0 110.233 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -127.96 65.24 68.12 Favored Pre-proline 0 N--CA 1.496 1.872 0 O-C-N 121.407 -0.808 . . . . 0.0 111.411 -179.017 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.35 -21.73 19.56 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 O-C-N 123.642 1.338 . . . . 0.0 108.988 177.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.44 ' HA ' ' CG2' ' A' ' 7' ' ' VAL . 1.9 p -175.2 29.48 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.779 -0.575 . . . . 0.0 111.424 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 37.5 mmm -52.93 -43.01 65.97 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.085 -1.009 . . . . 0.0 109.515 179.385 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -125.54 35.76 2.96 Favored Glycine 0 N--CA 1.496 2.693 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 178.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.638 HG11 ' CD1' ' A' ' 51' ' ' ILE . 9.1 t -118.06 168.14 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.589 -0.947 . . . . 0.0 110.041 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.494 ' HB3' ' CZ ' ' A' ' 52' ' ' TYR . 2.9 t-20 -115.24 169.88 8.8 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.058 -1.026 . . . . 0.0 110.92 -179.272 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.658 ' HA ' ' HA ' ' A' ' 51' ' ' ILE . 26.0 p -129.46 128.97 43.99 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.427 -0.796 . . . . 0.0 110.39 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.689 HG11 HD13 ' A' ' 62' ' ' LEU . 1.2 t -123.48 137.13 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 CA-C-O 121.632 0.73 . . . . 0.0 110.88 -178.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.522 ' HA ' ' HA ' ' A' ' 49' ' ' THR . 4.3 m -118.59 121.13 39.46 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.587 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.915 HG12 HD12 ' A' ' 75' ' ' ILE . 25.6 mt -110.56 118.45 57.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.365 -0.835 . . . . 0.0 111.549 -177.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.469 ' O ' ' HA ' ' A' ' 73' ' ' ALA . 1.1 m -71.89 114.8 10.37 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 177.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.621 ' HA ' ' O ' ' A' ' 72' ' ' ASP . 20.5 t -114.52 130.66 68.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.166 -0.959 . . . . 0.0 111.404 -177.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.69 ' HA ' ' HG2' ' A' ' 46' ' ' LYS . 2.6 mm-40 -112.54 -15.32 13.07 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.14 -0.975 . . . . 0.0 111.521 179.373 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -79.71 33.44 2.11 Favored Glycine 0 N--CA 1.499 2.866 0 O-C-N 120.845 -1.159 . . . . 0.0 111.493 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.667 ' HG3' ' HA ' ' A' ' 46' ' ' LYS . 32.6 mmt -77.25 75.99 3.8 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 120.682 -1.481 . . . . 0.0 109.486 178.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.442 HG23 ' H ' ' A' ' 18' ' ' THR . 17.4 p -52.76 -33.78 50.04 Favored 'General case' 0 N--CA 1.51 2.56 0 O-C-N 121.418 -0.802 . . . . 0.0 111.767 -179.017 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.515 ' O ' HD21 ' A' ' 43' ' ' LEU . 22.5 p 179.13 164.4 0.9 Allowed 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.61 ' HA ' ' HG ' ' A' ' 43' ' ' LEU . 17.4 m120 -38.58 -32.91 0.09 Allowed 'General case' 0 N--CA 1.509 2.51 0 CA-C-N 117.844 0.293 . . . . 0.0 111.475 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.531 ' HA ' ' HE3' ' A' ' 24' ' ' TRP . 5.0 p -52.09 -19.03 1.68 Allowed 'General case' 0 N--CA 1.507 2.406 0 O-C-N 121.095 -1.003 . . . . 0.0 111.208 177.652 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.661 ' HB3' ' CE1' ' A' ' 71' ' ' PHE . 84.6 m -88.92 -22.04 23.31 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.375 -0.828 . . . . 0.0 109.406 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.738 ' HB ' HD23 ' A' ' 43' ' ' LEU . 0.9 OUTLIER -80.56 -35.85 15.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 106.714 -1.588 . . . . 0.0 106.714 177.467 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.54 ' CZ3' ' CB ' ' A' ' 20' ' ' ASN . 4.2 m-90 -74.87 -30.7 61.4 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.028 -1.069 . . . . 0.0 109.188 178.188 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.512 ' O ' ' HB2' ' A' ' 29' ' ' GLN . 0.5 OUTLIER -80.73 -19.16 45.6 Favored 'General case' 0 N--CA 1.505 2.281 0 C-N-CA 119.701 -0.8 . . . . 0.0 110.849 179.232 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.47 ' O ' ' HB ' ' A' ' 30' ' ' ILE . 7.8 mm -100.15 -21.17 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 O-C-N 121.179 -0.95 . . . . 0.0 109.519 179.255 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.506 ' HB3' ' O ' ' A' ' 23' ' ' VAL . 0.1 OUTLIER -78.82 -36.16 43.04 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 177.309 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.44 ' HB2' ' O ' ' A' ' 24' ' ' TRP . 0.8 OUTLIER -81.06 -36.93 29.85 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 119.82 -0.752 . . . . 0.0 109.492 177.769 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.512 ' HB2' ' O ' ' A' ' 25' ' ' THR . 1.1 tm0? -74.1 -62.32 1.55 Allowed 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 118.94 -1.104 . . . . 0.0 110.257 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.47 ' HB ' ' O ' ' A' ' 26' ' ' ILE . 41.4 mm -61.39 -45.16 99.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.12 -0.988 . . . . 0.0 109.264 179.135 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -50.64 -35.78 30.77 Favored Glycine 0 N--CA 1.501 3.002 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 178.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.449 ' HA ' ' HD3' ' A' ' 32' ' ' LYS . 12.1 mmtm -128.25 34.57 4.54 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.145 -1.209 . . . . 0.0 110.565 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.487 ' HB ' ' O ' ' A' ' 29' ' ' GLN . 8.7 p -74.86 -41.53 46.67 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.017 -1.052 . . . . 0.0 111.799 -178.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.417 ' N ' HG13 ' A' ' 33' ' ' VAL . 6.2 t-20 -175.95 -54.86 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.113 0 O-C-N 120.903 -1.123 . . . . 0.0 111.08 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -144.09 80.12 0.24 Allowed Glycine 0 N--CA 1.494 2.56 0 N-CA-C 108.763 -1.735 . . . . 0.0 108.763 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.724 HG22 HD11 ' A' ' 50' ' ' ILE . 28.7 t -133.82 88.78 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 CA-C-O 122.265 1.031 . . . . 0.0 110.076 -179.404 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 1.024 ' HB2' HD11 ' A' ' 51' ' ' ILE . 43.4 m80 -67.16 -27.44 67.29 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.115 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.669 ' HB2' HG12 ' A' ' 51' ' ' ILE . 52.7 m80 -141.16 125.57 17.62 Favored 'General case' 0 N--CA 1.5 2.025 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.153 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.825 ' C ' HD13 ' A' ' 39' ' ' ILE . 0.0 OUTLIER -126.41 135.28 64.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.101 -0.999 . . . . 0.0 109.8 -179.537 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.493 ' NZ ' ' O ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -130.06 121.7 26.91 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.966 -1.083 . . . . 0.0 110.593 -179.868 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.686 HG11 ' HA ' ' A' ' 23' ' ' VAL . 2.0 t -109.21 163.51 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 178.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.642 ' HB3' ' HB2' ' A' ' 45' ' ' GLU . 0.6 OUTLIER -151.0 85.49 1.35 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.062 -1.023 . . . . 0.0 110.47 -178.864 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.738 HD23 ' HB ' ' A' ' 23' ' ' VAL . 0.2 OUTLIER -52.86 -58.02 8.32 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.713 -0.617 . . . . 0.0 111.372 -179.586 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.9 mp0 -69.69 -44.51 70.27 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.185 -0.947 . . . . 0.0 110.668 -179.166 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.642 ' HB2' ' HB3' ' A' ' 42' ' ' SER . 1.3 mt-10 -76.81 7.29 4.87 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 120.008 -0.677 . . . . 0.0 110.413 178.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.69 ' HG2' ' HA ' ' A' ' 15' ' ' GLU . 0.0 OUTLIER 36.6 66.8 0.37 Allowed 'General case' 0 N--CA 1.5 2.046 0 CA-C-O 121.544 0.688 . . . . 0.0 111.754 178.994 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -157.79 145.18 18.36 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 120.693 -1.254 . . . . 0.0 112.51 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.513 ' HB3' ' HB ' ' A' ' 12' ' ' ILE . . . -124.0 109.15 13.18 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.574 -0.703 . . . . 0.0 109.126 179.1 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.522 ' HA ' ' HA ' ' A' ' 11' ' ' THR . 0.8 OUTLIER -114.92 142.53 46.47 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.047 -1.033 . . . . 0.0 109.194 179.988 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.724 HD11 HG22 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -165.25 157.13 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 120.71 -1.244 . . . . 0.0 110.724 -178.92 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 1.024 HD11 ' HB2' ' A' ' 37' ' ' HIS . 1.6 pp -107.08 159.91 6.56 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 O-C-N 121.275 -0.891 . . . . 0.0 109.301 179.525 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.631 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 6.8 p90 -161.73 166.05 27.17 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.229 -0.919 . . . . 0.0 111.732 -176.013 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.31 113.05 17.31 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.651 -0.656 . . . . 0.0 110.63 179.638 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.49 ' HD3' ' N ' ' A' ' 8' ' ' ASN . 46.0 Cg_endo -70.25 67.16 2.04 Favored 'Trans proline' 0 N--CA 1.489 1.224 0 O-C-N 123.964 1.507 . . . . 0.0 109.039 179.221 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.54 -46.88 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 121.419 0.628 . . . . 0.0 109.425 -178.319 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.405 HD23 ' N ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -98.37 -25.57 14.77 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.603 -0.686 . . . . 0.0 109.997 179.357 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.415 ' HG3' ' N ' ' A' ' 58' ' ' THR . 2.3 tp60 -129.53 145.72 51.43 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.222 -0.924 . . . . 0.0 110.0 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.567 ' HB ' ' HD2' ' A' ' 59' ' ' PRO . 7.6 p -135.24 166.44 28.96 Favored Pre-proline 0 N--CA 1.504 2.272 0 O-C-N 121.045 -1.035 . . . . 0.0 110.783 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.567 ' HD2' ' HB ' ' A' ' 58' ' ' THR . 37.8 Cg_endo -62.06 -21.35 72.26 Favored 'Trans proline' 0 N--CA 1.493 1.499 0 O-C-N 123.957 1.504 . . . . 0.0 110.55 179.041 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.434 ' NZ ' ' OD1' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -76.83 -38.02 54.6 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 177.785 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.608 ' HA ' ' HB2' ' A' ' 64' ' ' GLU . 34.4 p -77.74 -27.21 50.4 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 177.241 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.689 HD13 HG11 ' A' ' 10' ' ' VAL . 17.6 mt -73.02 -27.45 61.78 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 176.566 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.696 ' HG2' HD13 ' A' ' 75' ' ' ILE . 9.1 mm100 -85.62 -19.02 31.62 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 177.302 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.608 ' HB2' ' HA ' ' A' ' 61' ' ' THR . 4.8 mt-10 -90.36 -18.37 25.64 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 177.614 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.423 ' HB1' HG21 ' A' ' 33' ' ' VAL . . . -87.8 -29.63 20.83 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 177.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.596 HG12 ' HB2' ' A' ' 73' ' ' ALA . 6.9 tp -80.54 -31.61 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 177.179 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.434 ' HB2' ' O ' ' A' ' 63' ' ' GLN . 15.2 t70 -72.22 -29.84 64.33 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 176.272 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -64.52 -48.96 73.15 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.939 -0.475 . . . . 0.0 110.294 179.033 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.415 ' HB3' ' HD2' ' A' ' 71' ' ' PHE . 5.1 tpt -67.82 -36.94 81.28 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.349 -0.845 . . . . 0.0 110.6 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 108.74 59.1 0.54 Allowed Glycine 0 N--CA 1.498 2.795 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 179.319 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.661 ' CE1' ' HB3' ' A' ' 22' ' ' CYS . 43.0 m-85 -139.17 122.04 16.58 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.516 -0.991 . . . . 0.0 110.379 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.621 ' O ' ' HA ' ' A' ' 14' ' ' VAL . 6.3 t70 -54.06 104.03 0.1 Allowed 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.546 -0.721 . . . . 0.0 109.186 179.077 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.78 ' HB1' ' CG2' ' A' ' 12' ' ' ILE . . . -116.73 147.12 42.3 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 122.129 0.966 . . . . 0.0 112.596 -177.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.432 ' N ' ' O ' ' A' ' 13' ' ' SER . 46.1 t -138.07 81.55 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 CA-C-O 122.011 0.91 . . . . 0.0 108.585 179.157 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.915 HD12 HG12 ' A' ' 12' ' ' ILE . 0.3 OUTLIER -49.83 152.47 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 CA-C-O 122.679 1.228 . . . . 0.0 112.789 -178.366 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 47.9 t-80 -108.98 11.59 25.81 Favored 'General case' 0 N--CA 1.498 1.962 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.172 179.453 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -130.77 141.02 40.45 Favored Pre-proline 0 N--CA 1.5 2.027 0 O-C-N 121.146 -0.971 . . . . 0.0 110.064 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -81.52 -58.54 0.03 OUTLIER 'Trans proline' 0 N--CA 1.489 1.208 0 O-C-N 123.806 1.424 . . . . 0.0 111.991 -179.244 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.434 ' OD1' ' NZ ' ' A' ' 60' ' ' LYS . 25.9 m-20 . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 117.894 -1.05 . . . . 0.0 110.609 -179.132 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.748 ' HB ' HD11 ' A' ' 51' ' ' ILE . 1.7 m . . . . . 0 N--CA 1.508 2.463 0 CA-C-O 120.924 0.392 . . . . 0.0 110.298 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.47 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 0.5 OUTLIER -135.8 165.99 24.32 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.957 -1.089 . . . . 0.0 111.034 -179.827 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.614 ' HA ' ' HA ' ' A' ' 51' ' ' ILE . 38.0 t -114.4 150.68 34.28 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.232 -0.917 . . . . 0.0 111.421 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.626 HG21 ' HB3' ' A' ' 59' ' ' PRO . 0.9 OUTLIER -144.17 130.22 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.783 -0.573 . . . . 0.0 110.559 -179.234 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.594 HG23 ' HB ' ' A' ' 49' ' ' THR . 90.2 m -109.22 122.25 46.92 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.538 0.685 . . . . 0.0 110.595 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 1.032 HG12 HG22 ' A' ' 75' ' ' ILE . 45.9 mt -109.61 121.61 62.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.568 -0.707 . . . . 0.0 111.239 -178.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.655 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 1.4 m -70.71 133.28 46.48 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 177.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.516 HG12 ' HG2' ' A' ' 17' ' ' MET . 2.1 t -127.03 161.06 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.11 -0.994 . . . . 0.0 111.083 -178.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.83 158.65 35.58 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.493 -0.754 . . . . 0.0 110.728 178.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 73.93 20.99 79.71 Favored Glycine 0 N--CA 1.497 2.706 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.768 ' HE2' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -128.87 28.93 5.29 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.891 -1.358 . . . . 0.0 110.806 -179.816 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.8 m -71.59 49.17 0.16 Allowed 'General case' 0 N--CA 1.501 2.114 0 O-C-N 120.918 -1.114 . . . . 0.0 111.243 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.487 ' O ' ' N ' ' A' ' 21' ' ' SER . 0.0 OUTLIER -150.56 118.55 6.27 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.879 -1.138 . . . . 0.0 108.896 178.844 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.488 ' O ' HG12 ' A' ' 23' ' ' VAL . 76.5 m-20 -14.97 -51.55 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.761 0 C-N-CA 123.742 0.817 . . . . 0.0 113.115 -178.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.864 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 3.7 p -52.1 -14.46 0.42 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.399 -0.813 . . . . 0.0 112.973 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.766 ' HB2' HD22 ' A' ' 43' ' ' LEU . 63.8 m -91.63 -24.77 19.44 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 119.121 -2.237 . . . . 0.0 110.65 -179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.843 HG23 HG13 ' A' ' 41' ' ' VAL . 1.6 p -87.8 -34.98 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.53 -0.731 . . . . 0.0 109.231 179.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.864 ' CE3' ' HA ' ' A' ' 21' ' ' SER . 0.0 OUTLIER -81.79 -22.67 37.0 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 117.687 -1.605 . . . . 0.0 109.094 178.828 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.687 HG23 ' HE2' ' A' ' 69' ' ' MET . 0.6 OUTLIER -87.6 -24.68 23.9 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 120.94 -1.1 . . . . 0.0 110.812 178.027 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.649 HD12 HD12 ' A' ' 66' ' ' ILE . 12.5 mm -92.78 -26.53 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.388 0 O-C-N 120.874 -1.142 . . . . 0.0 109.656 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.705 ' HG2' HD12 ' A' ' 39' ' ' ILE . 4.4 tm-20 -78.83 -40.22 33.37 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 177.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.423 ' HB2' ' O ' ' A' ' 24' ' ' TRP . 68.9 mm-40 -70.44 -33.79 71.73 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 119.361 -0.936 . . . . 0.0 109.287 178.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.532 ' HA ' ' OE1' ' A' ' 29' ' ' GLN . 4.3 tp60 -75.89 -62.16 1.68 Allowed 'General case' 0 N--CA 1.496 1.849 0 C-N-CA 119.61 -0.836 . . . . 0.0 110.586 179.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.861 HG21 HG21 ' A' ' 50' ' ' ILE . 51.1 mt -60.85 -50.5 80.26 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 O-C-N 120.994 -1.066 . . . . 0.0 109.841 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -47.73 -44.2 23.33 Favored Glycine 0 N--CA 1.5 2.917 0 N-CA-C 110.849 -0.901 . . . . 0.0 110.849 179.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.01 16.86 24.46 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.98 -1.306 . . . . 0.0 112.447 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.496 HG21 ' HB2' ' A' ' 65' ' ' ALA . 0.5 OUTLIER -65.79 -42.3 92.04 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.175 0 O-C-N 120.89 -1.131 . . . . 0.0 111.061 -179.908 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.428 ' N ' HG12 ' A' ' 33' ' ' VAL . 0.1 OUTLIER -163.04 -76.75 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.222 -0.924 . . . . 0.0 110.784 -179.747 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.549 ' O ' ' HA ' ' A' ' 52' ' ' TYR . . . -141.39 75.84 0.33 Allowed Glycine 0 N--CA 1.495 2.567 0 N-CA-C 108.758 -1.737 . . . . 0.0 108.758 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.84 HG22 HD13 ' A' ' 50' ' ' ILE . 41.1 t -103.04 91.43 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 CA-C-O 122.665 1.221 . . . . 0.0 108.128 179.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.94 ' HB2' HD12 ' A' ' 51' ' ' ILE . 63.2 m-70 -61.67 -14.27 29.82 Favored 'General case' 0 C--N 1.283 -2.325 0 CA-C-N 114.827 -1.079 . . . . 0.0 110.627 -179.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.567 ' HB3' ' CG2' ' A' ' 51' ' ' ILE . 6.8 t60 -170.83 121.1 0.56 Allowed 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.817 ' HB ' HG11 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -122.07 128.8 75.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.268 -0.895 . . . . 0.0 109.565 -179.438 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.481 ' HD3' HG22 ' A' ' 49' ' ' THR . 0.0 OUTLIER -125.19 99.83 6.26 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.599 -1.313 . . . . 0.0 111.445 -179.615 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.843 HG13 HG23 ' A' ' 23' ' ' VAL . 15.0 p -107.41 153.97 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 177.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.845 ' HB3' ' HB3' ' A' ' 45' ' ' GLU . 0.2 OUTLIER -153.15 94.33 1.82 Allowed 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.103 -0.998 . . . . 0.0 110.763 -178.057 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.768 ' HA ' ' HE2' ' A' ' 17' ' ' MET . 14.5 mt -46.83 -25.17 0.7 Allowed 'General case' 0 N--CA 1.508 2.436 0 O-C-N 121.923 -0.486 . . . . 0.0 112.016 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.574 ' HG2' ' N ' ' A' ' 45' ' ' GLU . 0.4 OUTLIER -96.92 -38.48 9.8 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 120.4 -1.437 . . . . 0.0 111.332 179.651 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.845 ' HB3' ' HB3' ' A' ' 42' ' ' SER . 0.2 OUTLIER -74.61 -4.2 35.72 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.202 -0.936 . . . . 0.0 108.802 177.476 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.9 mptt 56.66 34.88 25.28 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.271 -0.893 . . . . 0.0 112.961 177.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -148.19 151.32 35.32 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.534 -1.353 . . . . 0.0 112.071 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.437 ' HA ' ' HA ' ' A' ' 41' ' ' VAL . . . -130.84 103.28 6.48 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.594 ' HB ' HG23 ' A' ' 11' ' ' THR . 14.8 t -116.55 134.72 54.51 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.233 -0.917 . . . . 0.0 110.376 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.954 HD11 HD21 ' A' ' 62' ' ' LEU . 1.3 pp -144.85 -178.71 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-O 121.621 0.724 . . . . 0.0 110.785 -178.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.94 HD12 ' HB2' ' A' ' 37' ' ' HIS . 0.0 OUTLIER -121.59 145.38 28.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 177.918 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.744 ' N ' HD13 ' A' ' 51' ' ' ILE . 13.7 p90 -149.2 165.82 30.7 Favored 'General case' 0 C--N 1.296 -1.761 0 O-C-N 121.245 -0.909 . . . . 0.0 111.347 -177.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.447 ' HA ' HG12 ' A' ' 7' ' ' VAL . 0.3 OUTLIER -84.5 107.14 10.09 Favored Pre-proline 0 N--CA 1.49 1.539 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.701 179.924 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.547 ' HD2' ' HA ' ' A' ' 7' ' ' VAL . 48.2 Cg_endo -75.11 -9.12 20.48 Favored 'Trans proline' 0 C--N 1.319 -1.018 0 O-C-N 123.624 1.328 . . . . 0.0 109.75 178.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 8.8 mtmm -74.18 -35.97 64.01 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.5 pp -121.4 -17.16 7.68 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.523 -0.736 . . . . 0.0 111.44 179.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.517 ' O ' ' HA ' ' A' ' 54' ' ' PRO . 2.7 mm-40 -131.58 -179.39 5.35 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.796 -1.19 . . . . 0.0 110.484 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.542 ' OG1' ' HD2' ' A' ' 59' ' ' PRO . 0.5 OUTLIER -164.22 173.5 3.96 Favored Pre-proline 0 N--CA 1.497 1.914 0 O-C-N 120.874 -1.141 . . . . 0.0 110.01 -179.993 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.626 ' HB3' HG21 ' A' ' 10' ' ' VAL . 37.9 Cg_endo -62.78 8.32 0.13 Allowed 'Trans proline' 0 N--CA 1.502 1.972 0 C-N-CA 121.227 1.285 . . . . 0.0 113.258 -179.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.555 ' HG3' ' N ' ' A' ' 61' ' ' THR . 0.2 OUTLIER -90.68 -28.27 18.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.973 -1.08 . . . . 0.0 108.525 177.773 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.555 ' N ' ' HG3' ' A' ' 60' ' ' LYS . 0.8 OUTLIER -85.85 -27.69 24.91 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 177.953 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.954 HD21 HD11 ' A' ' 50' ' ' ILE . 4.5 mp -72.15 -27.62 62.72 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 176.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.483 ' O ' ' HB2' ' A' ' 67' ' ' ASP . 14.2 tp60 -86.65 -20.21 28.14 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 177.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.537 ' HB3' ' O ' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -91.28 -22.15 20.71 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.159 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.496 ' HB2' HG21 ' A' ' 33' ' ' VAL . . . -85.27 -27.66 25.85 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.676 HG12 ' HB2' ' A' ' 73' ' ' ALA . 2.1 tp -85.17 -32.73 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 177.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.483 ' HB2' ' O ' ' A' ' 63' ' ' GLN . 27.8 t70 -74.37 -32.28 62.68 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 177.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.407 ' HB3' ' O ' ' A' ' 64' ' ' GLU . 0.2 OUTLIER -70.5 -43.39 69.79 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.878 -0.514 . . . . 0.0 109.868 178.915 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.687 ' HE2' HG23 ' A' ' 25' ' ' THR . 23.6 mmm -59.86 -46.72 88.38 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.18 -0.95 . . . . 0.0 109.996 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 114.54 51.42 0.46 Allowed Glycine 0 N--CA 1.499 2.846 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.592 ' CD1' ' HB3' ' A' ' 17' ' ' MET . 75.1 m-85 -139.27 130.18 26.29 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.69 -0.888 . . . . 0.0 109.526 179.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.495 ' O ' ' HA ' ' A' ' 14' ' ' VAL . 1.7 m-20 -49.9 111.32 0.49 Allowed 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.433 -0.792 . . . . 0.0 110.045 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.676 ' HB2' HG12 ' A' ' 66' ' ' ILE . . . -109.77 127.26 54.52 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.185 -0.947 . . . . 0.0 111.582 -178.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.655 ' HB ' ' HB2' ' A' ' 13' ' ' SER . 75.5 t -131.67 76.4 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.487 -0.758 . . . . 0.0 109.071 178.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 1.032 HG22 HG12 ' A' ' 12' ' ' ILE . 33.3 pt . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 121.763 0.792 . . . . 0.0 110.861 -179.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 1.071 HG11 HD11 ' A' ' 51' ' ' ILE . 12.9 t . . . . . 0 N--CA 1.506 2.344 0 CA-C-O 121.45 0.643 . . . . 0.0 110.446 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.406 ' O ' HG12 ' A' ' 51' ' ' ILE . 9.8 m120 -124.6 166.3 16.35 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 120.785 -1.197 . . . . 0.0 111.306 -179.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.616 ' HA ' ' HA ' ' A' ' 51' ' ' ILE . 2.5 m -120.29 145.68 46.85 Favored 'General case' 0 N--CA 1.505 2.294 0 O-C-N 121.088 -1.007 . . . . 0.0 111.833 -179.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.457 HG21 ' HA ' ' A' ' 59' ' ' PRO . 1.0 OUTLIER -134.24 140.97 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.639 -0.663 . . . . 0.0 110.891 -179.29 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.604 ' HA ' ' HA ' ' A' ' 49' ' ' THR . 2.9 m -118.91 130.35 55.68 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.229 -0.919 . . . . 0.0 110.151 178.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.706 ' HA ' ' HA ' ' A' ' 75' ' ' ILE . 51.9 mt -122.74 133.02 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.363 -0.836 . . . . 0.0 111.553 -178.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.563 ' HB3' ' CG1' ' A' ' 74' ' ' VAL . 0.1 OUTLIER -87.75 117.2 26.42 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.071 -1.018 . . . . 0.0 108.703 178.129 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.568 HG13 ' O ' ' A' ' 14' ' ' VAL . 14.6 p -112.21 108.43 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 O-C-N 121.179 -0.951 . . . . 0.0 110.408 -178.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.577 ' HA ' ' HD2' ' A' ' 46' ' ' LYS . 0.1 OUTLIER -108.34 -32.11 7.58 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.052 -1.03 . . . . 0.0 112.008 -178.6 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -70.03 30.97 0.41 Allowed Glycine 0 N--CA 1.502 3.066 0 C-N-CA 120.423 -0.894 . . . . 0.0 112.255 -179.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.824 ' SD ' HD12 ' A' ' 43' ' ' LEU . 13.2 ptp -90.75 -173.21 3.64 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.474 -1.603 . . . . 0.0 109.799 178.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 16.9 p -147.22 -27.65 0.38 Allowed 'General case' 0 N--CA 1.514 2.745 0 O-C-N 121.248 -0.908 . . . . 0.0 112.283 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.434 ' CA ' HD11 ' A' ' 43' ' ' LEU . 19.5 p -179.7 176.44 0.78 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.109 -0.994 . . . . 0.0 108.55 -179.048 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.633 ' HB3' ' CZ3' ' A' ' 24' ' ' TRP . 4.3 m120 -43.31 -31.69 0.68 Allowed 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.773 -0.579 . . . . 0.0 110.618 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.546 ' HA ' ' HE3' ' A' ' 24' ' ' TRP . 3.7 p -54.12 -26.29 26.68 Favored 'General case' 0 N--CA 1.506 2.339 0 O-C-N 121.06 -1.025 . . . . 0.0 110.398 178.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.824 ' O ' HD12 ' A' ' 26' ' ' ILE . 80.7 m -91.49 -25.81 19.1 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.701 0.762 . . . . 0.0 108.977 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.685 HG21 ' HB2' ' A' ' 43' ' ' LEU . 12.0 t -79.47 -41.62 22.49 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 176.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.633 ' CZ3' ' HB3' ' A' ' 20' ' ' ASN . 2.1 m0 -60.79 -40.47 92.75 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 176.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.421 HG21 ' HE2' ' A' ' 71' ' ' PHE . 40.2 m -66.7 -31.05 71.47 Favored 'General case' 0 N--CA 1.502 2.127 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.608 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.824 HD12 ' O ' ' A' ' 22' ' ' CYS . 2.1 mt -99.07 -17.22 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.225 0 O-C-N 121.142 -0.974 . . . . 0.0 110.902 -179.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.691 ' HG3' HD12 ' A' ' 39' ' ' ILE . 1.1 tt0 -87.67 -31.66 19.63 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 177.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.495 ' HB3' ' O ' ' A' ' 24' ' ' TRP . 1.1 tm0? -80.41 -39.49 28.22 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 178.016 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.423 ' HB2' ' SD ' ' A' ' 69' ' ' MET . 7.2 mm100 -70.6 -60.02 2.5 Favored 'General case' 0 N--CA 1.502 2.154 0 C-N-CA 119.251 -0.98 . . . . 0.0 110.352 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.485 ' HB ' HG13 ' A' ' 39' ' ' ILE . 45.4 mm -60.58 -42.38 91.37 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.113 -0.992 . . . . 0.0 110.497 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -51.73 -45.93 54.6 Favored Glycine 0 N--CA 1.5 2.961 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.4 mttt -114.98 27.53 9.34 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.331 -1.099 . . . . 0.0 111.494 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.471 HG13 ' N ' ' A' ' 34' ' ' ASN . 12.2 p -66.46 -43.26 91.09 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 O-C-N 120.887 -1.133 . . . . 0.0 111.449 -179.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.528 ' HB3' ' HG2' ' A' ' 57' ' ' GLN . 0.7 OUTLIER -178.86 -52.13 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.109 -0.995 . . . . 0.0 110.777 179.847 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.419 ' HA3' HD23 ' A' ' 56' ' ' LEU . . . -148.24 81.74 0.2 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -179.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.856 HG22 HD11 ' A' ' 50' ' ' ILE . 38.8 t -133.07 97.4 2.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 1.031 ' HB2' HD12 ' A' ' 51' ' ' ILE . 59.5 m-70 -72.1 -29.28 63.94 Favored 'General case' 0 C--N 1.289 -2.063 0 C-N-CA 120.043 -0.663 . . . . 0.0 109.818 -179.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.718 ' HB2' HG22 ' A' ' 51' ' ' ILE . 24.7 m-70 -144.57 117.23 8.66 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.786 ' HB ' HG11 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -117.79 126.02 74.52 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 179.391 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.625 ' HB3' HG22 ' A' ' 49' ' ' THR . 2.1 tmtm? -126.52 119.54 27.39 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.616 -1.303 . . . . 0.0 111.01 -179.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.492 ' O ' ' NZ ' ' A' ' 40' ' ' LYS . 47.0 t -107.29 170.77 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 178.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.698 ' HB3' ' HB2' ' A' ' 45' ' ' GLU . 0.6 OUTLIER -149.82 85.25 1.42 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.683 -1.261 . . . . 0.0 110.67 -179.51 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.824 HD12 ' SD ' ' A' ' 17' ' ' MET . 20.0 tp -42.53 -43.1 3.58 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.2 mp0 -82.92 -44.24 15.58 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.154 -0.966 . . . . 0.0 111.771 -178.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.698 ' HB2' ' HB3' ' A' ' 42' ' ' SER . 5.8 mt-10 -80.03 8.94 6.09 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.195 -0.941 . . . . 0.0 110.344 179.133 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.577 ' HD2' ' HA ' ' A' ' 15' ' ' GLU . 8.1 mmtp 37.15 59.47 1.11 Allowed 'General case' 0 N--CA 1.504 2.253 0 CA-C-O 121.528 0.68 . . . . 0.0 110.967 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.425 ' HA ' ' H ' ' A' ' 14' ' ' VAL . 12.5 t-20 -159.08 149.08 19.14 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.031 -1.043 . . . . 0.0 111.202 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.532 ' HA ' ' O ' ' A' ' 40' ' ' LYS . . . -139.41 122.31 16.62 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.4 -0.813 . . . . 0.0 110.745 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.625 HG22 ' HB3' ' A' ' 40' ' ' LYS . 6.9 t -113.59 151.93 31.01 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.302 -0.874 . . . . 0.0 109.539 178.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.856 HD11 HG22 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -160.13 157.23 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.026 -1.046 . . . . 0.0 111.954 -177.932 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 1.071 HD11 HG11 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -109.89 152.85 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.587 -0.696 . . . . 0.0 109.27 178.378 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.556 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 33.9 p90 -158.04 160.16 37.11 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.899 -0.72 . . . . 0.0 111.874 -177.056 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.431 ' HA ' ' HD2' ' A' ' 54' ' ' PRO . 5.1 t0 -86.61 120.32 71.86 Favored Pre-proline 0 N--CA 1.492 1.669 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 177.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.431 ' HD2' ' HA ' ' A' ' 53' ' ' ASP . 36.7 Cg_endo -59.23 -29.68 91.0 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 O-C-N 123.633 1.333 . . . . 0.0 109.73 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.38 -19.18 65.38 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.855 -0.528 . . . . 0.0 110.681 178.174 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.477 HD21 ' C ' ' A' ' 34' ' ' ASN . 0.4 OUTLIER -124.65 -36.82 2.55 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.096 -1.003 . . . . 0.0 111.441 -179.173 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.528 ' HG2' ' HB3' ' A' ' 34' ' ' ASN . 3.4 mm-40 -130.15 155.05 46.85 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.054 -1.029 . . . . 0.0 110.399 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.627 ' HB ' ' HD2' ' A' ' 59' ' ' PRO . 4.7 p -136.61 172.97 6.09 Favored Pre-proline 0 N--CA 1.5 2.074 0 O-C-N 121.004 -1.06 . . . . 0.0 109.807 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.627 ' HD2' ' HB ' ' A' ' 58' ' ' THR . 42.9 Cg_endo -68.45 -14.36 39.73 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 O-C-N 123.326 1.171 . . . . 0.0 110.896 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.8 -38.37 13.03 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.322 -0.861 . . . . 0.0 109.352 179.042 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.602 ' HA ' ' HB2' ' A' ' 64' ' ' GLU . 0.3 OUTLIER -73.14 -27.01 61.43 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.237 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.498 ' CD2' HD12 ' A' ' 50' ' ' ILE . 16.3 mt -72.18 -28.39 63.18 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 176.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -83.43 -32.24 26.19 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 177.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.602 ' HB2' ' HA ' ' A' ' 61' ' ' THR . 0.1 OUTLIER -71.58 -20.08 62.05 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 177.402 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -90.02 -25.18 20.97 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 177.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.532 ' HA ' ' HE3' ' A' ' 69' ' ' MET . 0.4 OUTLIER -88.62 -39.49 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 178.042 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -68.87 -29.62 67.96 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 177.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.45 -44.01 59.05 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.552 -0.717 . . . . 0.0 109.881 178.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.556 ' SD ' HG13 ' A' ' 26' ' ' ILE . 28.7 mtm -51.69 -49.82 61.66 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.455 -0.778 . . . . 0.0 110.52 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 111.47 55.24 0.5 Allowed Glycine 0 N--CA 1.498 2.797 0 C-N-CA 119.542 -1.313 . . . . 0.0 110.096 179.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.65 ' CD2' HD11 ' A' ' 26' ' ' ILE . 25.4 m-85 -135.89 124.37 23.51 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.637 -0.92 . . . . 0.0 109.357 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -56.62 92.98 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.513 -0.742 . . . . 0.0 109.513 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.487 ' HA ' ' O ' ' A' ' 13' ' ' SER . . . -120.56 178.27 4.74 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 122.188 0.994 . . . . 0.0 112.13 -178.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.563 ' CG1' ' HB3' ' A' ' 13' ' ' SER . 3.6 p -159.26 91.68 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 179.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.706 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . 25.1 pt . . . . . 0 C--N 1.302 -1.462 0 CA-C-O 122.362 1.077 . . . . 0.0 111.772 -178.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.543 HG11 HD13 ' A' ' 51' ' ' ILE . 4.8 t . . . . . 0 N--CA 1.499 2.002 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.601 ' HB3' ' CZ ' ' A' ' 52' ' ' TYR . 0.9 OUTLIER -116.35 163.92 15.31 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.89 -1.131 . . . . 0.0 110.392 179.816 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.675 ' HA ' ' HA ' ' A' ' 51' ' ' ILE . 47.5 p -129.37 143.5 50.87 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.237 -0.915 . . . . 0.0 111.247 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.895 HG21 ' HB3' ' A' ' 59' ' ' PRO . 0.9 OUTLIER -142.26 142.26 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 CA-C-O 121.674 0.75 . . . . 0.0 110.806 -179.553 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.625 ' HA ' ' HA ' ' A' ' 49' ' ' THR . 20.7 m -106.47 145.99 31.11 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.946 ' HA ' HG12 ' A' ' 75' ' ' ILE . 23.3 mm -126.42 116.13 44.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -177.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.57 ' H ' ' CG2' ' A' ' 75' ' ' ILE . 1.4 t -82.91 111.25 18.62 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 176.089 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' A' ' 72' ' ' ASP . 9.8 p -108.91 135.06 48.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 O-C-N 121.538 -0.726 . . . . 0.0 112.325 -176.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -116.57 174.3 6.15 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.455 -0.778 . . . . 0.0 110.348 179.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 81.91 -7.73 62.02 Favored Glycine 0 N--CA 1.499 2.889 0 C-N-CA 120.483 -0.865 . . . . 0.0 111.164 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.592 ' HG2' ' HB3' ' A' ' 22' ' ' CYS . 12.4 mtm -82.46 112.09 19.08 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.76 -1.436 . . . . 0.0 111.041 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.4 t -139.56 25.14 2.42 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.07 -1.019 . . . . 0.0 111.984 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.77 ' C ' HD21 ' A' ' 43' ' ' LEU . 0.4 OUTLIER -170.07 139.33 1.81 Allowed 'General case' 0 N--CA 1.5 2.073 0 O-C-N 120.991 -1.068 . . . . 0.0 109.075 178.978 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.573 ' HA ' ' CD2' ' A' ' 43' ' ' LEU . 22.6 m120 -23.09 -45.44 0.01 OUTLIER 'General case' 0 N--CA 1.518 2.958 0 CA-C-O 121.453 0.644 . . . . 0.0 112.585 -178.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.884 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 1.5 p -56.46 -14.13 2.81 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 1.102 ' HB2' HD11 ' A' ' 43' ' ' LEU . 71.8 m -92.91 -26.83 17.43 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 119.808 -1.808 . . . . 0.0 111.678 -178.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.87 HG12 HD22 ' A' ' 43' ' ' LEU . 7.9 p -88.92 -34.73 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.119 -0.988 . . . . 0.0 108.706 178.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.884 ' CE3' ' HA ' ' A' ' 21' ' ' SER . 0.0 OUTLIER -79.98 -23.59 41.49 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 117.634 -1.626 . . . . 0.0 108.964 178.495 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.597 ' HB ' ' CZ3' ' A' ' 24' ' ' TRP . 1.7 t -84.46 -27.41 27.51 Favored 'General case' 0 N--CA 1.506 2.346 0 O-C-N 120.679 -1.263 . . . . 0.0 110.352 178.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.934 HD11 ' CD2' ' A' ' 71' ' ' PHE . 17.8 mm -89.48 -29.91 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 O-C-N 121.142 -0.973 . . . . 0.0 109.532 179.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.635 ' HG3' ' CG2' ' A' ' 39' ' ' ILE . 9.8 tt0 -81.31 -32.66 33.02 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 178.287 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.567 ' HB2' ' O ' ' A' ' 24' ' ' TRP . 0.9 OUTLIER -80.45 -26.5 38.29 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.281 177.872 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.436 ' O ' ' HB ' ' A' ' 33' ' ' VAL . 4.1 tp60 -71.43 -65.44 0.75 Allowed 'General case' 0 N--CA 1.497 1.92 0 C-N-CA 119.238 -0.985 . . . . 0.0 108.824 179.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.686 HG22 HD11 ' A' ' 39' ' ' ILE . 18.2 mm -59.51 -52.02 65.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.237 -0.915 . . . . 0.0 110.258 179.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -49.18 -39.75 27.94 Favored Glycine 0 N--CA 1.502 3.061 0 N-CA-C 110.404 -1.079 . . . . 0.0 110.404 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.15 26.39 10.51 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.232 -1.158 . . . . 0.0 111.047 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.642 HG12 ' O ' ' A' ' 30' ' ' ILE . 11.1 p -74.36 -46.81 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 120.455 -1.403 . . . . 0.0 111.331 -179.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.454 ' N ' HG13 ' A' ' 33' ' ' VAL . 1.0 OUTLIER -173.46 -32.14 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.33 0 O-C-N 120.907 -1.12 . . . . 0.0 111.633 179.259 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.498 ' O ' ' HA ' ' A' ' 52' ' ' TYR . . . -168.97 85.37 0.09 OUTLIER Glycine 0 N--CA 1.496 2.695 0 C-N-CA 119.873 -1.156 . . . . 0.0 110.509 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.878 HG11 ' CD1' ' A' ' 39' ' ' ILE . 42.8 t -130.38 90.34 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 CA-C-O 122.512 1.148 . . . . 0.0 109.307 178.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.964 ' HB2' HD11 ' A' ' 51' ' ' ILE . 42.1 m-70 -65.88 -13.46 59.68 Favored 'General case' 0 C--N 1.286 -2.153 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.926 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.8 ' CD2' HG23 ' A' ' 51' ' ' ILE . 0.2 OUTLIER -152.22 128.52 10.56 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 120.759 -1.213 . . . . 0.0 110.381 179.385 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.878 ' CD1' HG11 ' A' ' 36' ' ' VAL 0.293 2.0 mm -121.19 139.26 48.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.857 -177.906 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.917 ' HB3' HG22 ' A' ' 49' ' ' THR . 0.0 OUTLIER -142.1 83.17 1.83 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.556 -1.34 . . . . 0.0 109.685 176.621 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.727 HG22 ' HB1' ' A' ' 48' ' ' ALA . 17.2 t -107.33 155.94 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.068 -1.02 . . . . 0.0 109.272 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.793 ' HB2' ' HB3' ' A' ' 45' ' ' GLU . 41.5 m -152.33 91.07 1.55 Allowed 'General case' 0 C--N 1.308 -1.21 0 O-C-N 121.112 -0.992 . . . . 0.0 110.1 -178.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 1.102 HD11 ' HB2' ' A' ' 22' ' ' CYS . 6.9 tp -30.77 -53.38 0.19 Allowed 'General case' 0 N--CA 1.508 2.474 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -179.285 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.618 ' HA ' ' NZ ' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -78.5 -37.13 43.96 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.687 -1.258 . . . . 0.0 112.241 -178.81 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.793 ' HB3' ' HB2' ' A' ' 42' ' ' SER . 27.5 tt0 -59.48 -15.37 17.16 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 119.617 -0.833 . . . . 0.0 109.274 177.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.618 ' NZ ' ' HA ' ' A' ' 44' ' ' GLU . 0.1 OUTLIER 53.71 52.83 12.4 Favored 'General case' 0 N--CA 1.503 2.209 0 CA-C-O 121.816 0.817 . . . . 0.0 109.812 -179.813 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.504 ' ND2' ' HA ' ' A' ' 13' ' ' SER . 0.2 OUTLIER -170.75 159.37 6.44 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.579 -0.701 . . . . 0.0 109.716 179.905 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.727 ' HB1' HG22 ' A' ' 41' ' ' VAL . . . -150.7 116.85 5.63 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.302 -0.874 . . . . 0.0 109.492 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.917 HG22 ' HB3' ' A' ' 40' ' ' LYS . 4.8 t -110.13 127.38 54.86 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 120.843 -1.161 . . . . 0.0 109.069 179.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 1.08 HD11 HD21 ' A' ' 62' ' ' LEU . 1.8 pp -140.5 164.04 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.43 -0.793 . . . . 0.0 110.567 -177.155 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.964 HD11 ' HB2' ' A' ' 37' ' ' HIS . 1.5 pp -113.61 172.54 3.4 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 O-C-N 120.936 -1.103 . . . . 0.0 109.734 178.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.649 ' N ' HD12 ' A' ' 51' ' ' ILE . 11.0 p90 -163.3 167.36 21.98 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.343 -0.848 . . . . 0.0 110.963 -178.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.423 ' HB3' ' HB2' ' A' ' 56' ' ' LEU . 1.2 t0 -88.17 121.74 70.28 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.456 -0.778 . . . . 0.0 110.458 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.404 ' HD3' ' N ' ' A' ' 8' ' ' ASN . 38.4 Cg_endo -64.92 -29.58 57.87 Favored 'Trans proline' 0 N--CA 1.488 1.185 0 O-C-N 123.804 1.423 . . . . 0.0 108.784 178.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.1 ptpp? -77.62 -6.48 53.94 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.854 -0.529 . . . . 0.0 110.627 178.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.54 HD23 ' HG2' ' A' ' 57' ' ' GLN . 1.6 tt -117.13 -46.97 2.69 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.089 -1.007 . . . . 0.0 111.16 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.54 ' HG2' HD23 ' A' ' 56' ' ' LEU . 21.1 mm-40 -148.87 -174.05 4.52 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.077 -1.014 . . . . 0.0 110.951 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.6 ' HB ' ' HD2' ' A' ' 59' ' ' PRO . 1.1 p -144.07 176.82 2.05 Favored Pre-proline 0 N--CA 1.499 1.98 0 O-C-N 121.086 -1.009 . . . . 0.0 109.715 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.895 ' HB3' HG21 ' A' ' 10' ' ' VAL . 40.6 Cg_endo -68.29 -7.04 18.93 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 O-C-N 123.529 1.279 . . . . 0.0 110.791 178.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.86 -38.16 58.24 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.092 -1.005 . . . . 0.0 109.333 178.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.7 ' HA ' ' HB2' ' A' ' 64' ' ' GLU . 0.2 OUTLIER -90.74 -19.66 23.27 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 177.832 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 1.08 HD21 HD11 ' A' ' 50' ' ' ILE . 0.1 OUTLIER -71.17 -34.02 70.54 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 176.831 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -81.51 -30.82 33.11 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 176.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.7 ' HB2' ' HA ' ' A' ' 61' ' ' THR . 3.2 mt-10 -73.98 -17.98 60.93 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 176.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.447 ' CB ' HG21 ' A' ' 33' ' ' VAL . . . -86.94 -24.71 24.67 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 106.835 -1.542 . . . . 0.0 106.835 176.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.863 HG21 ' HB2' ' A' ' 73' ' ' ALA . 0.8 OUTLIER -86.57 -41.94 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 177.519 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.82 -31.83 72.91 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 177.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -75.19 -38.73 60.68 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.51 -0.744 . . . . 0.0 109.701 178.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.755 ' HG3' HD13 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -53.81 -46.61 71.17 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.54 -0.725 . . . . 0.0 111.396 179.86 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 119.0 35.06 0.98 Allowed Glycine 0 N--CA 1.501 3.028 0 C-N-CA 120.143 -1.027 . . . . 0.0 110.828 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.934 ' CD2' HD11 ' A' ' 26' ' ' ILE . 96.8 m-85 -140.5 136.61 33.11 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.284 -1.127 . . . . 0.0 109.62 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.448 ' O ' ' HA ' ' A' ' 14' ' ' VAL . 0.5 OUTLIER -57.04 135.02 56.3 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.359 -0.838 . . . . 0.0 111.233 -179.282 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.863 ' HB2' HG21 ' A' ' 66' ' ' ILE . . . -122.45 140.63 52.51 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.367 -0.833 . . . . 0.0 111.748 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.772 ' C ' HG13 ' A' ' 75' ' ' ILE . 4.4 t -155.7 99.02 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 178.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.946 HG12 ' HA ' ' A' ' 12' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.629 0 C-N-CA 118.567 -1.253 . . . . 0.0 113.742 -174.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.483 HG21 HD11 ' A' ' 51' ' ' ILE . 3.3 m . . . . . 0 N--CA 1.501 2.096 0 CA-C-O 121.152 0.501 . . . . 0.0 110.165 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.732 ' HB3' ' CZ ' ' A' ' 52' ' ' TYR . 1.9 t30 -129.79 161.8 29.91 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.276 -0.89 . . . . 0.0 110.368 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.554 ' HA ' ' HA ' ' A' ' 51' ' ' ILE . 0.3 OUTLIER -119.99 128.7 53.8 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.382 -0.824 . . . . 0.0 109.351 179.069 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.576 HG23 ' OH ' ' A' ' 52' ' ' TYR . 1.0 OUTLIER -121.14 133.75 66.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.384 -0.822 . . . . 0.0 112.061 -178.222 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.489 ' HA ' ' HA ' ' A' ' 49' ' ' THR . 19.0 m -114.68 121.27 42.86 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.997 HD11 ' HB1' ' A' ' 73' ' ' ALA . 13.1 tt -118.43 132.35 68.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 CA-C-O 121.831 0.824 . . . . 0.0 111.348 -179.072 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.581 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 49.1 m -77.17 121.75 24.05 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 178.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.671 ' HA ' ' O ' ' A' ' 72' ' ' ASP . 0.2 OUTLIER -126.43 121.49 58.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.271 -0.893 . . . . 0.0 111.65 -178.055 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.504 ' CD ' ' HG2' ' A' ' 46' ' ' LYS . 10.2 tp10 -109.49 158.07 18.34 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.457 -0.777 . . . . 0.0 110.559 179.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.51 10.09 59.56 Favored Glycine 0 N--CA 1.498 2.778 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 179.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.585 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 20.4 mmt -45.31 -41.47 8.77 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.026 -1.279 . . . . 0.0 110.46 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 40.1 m 61.51 -48.5 0.14 Allowed 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.841 -0.537 . . . . 0.0 112.249 178.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.517 ' N ' ' O ' ' A' ' 17' ' ' MET . 14.0 p -170.42 152.14 3.92 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.11 -0.994 . . . . 0.0 111.163 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.56 ' N ' HD21 ' A' ' 43' ' ' LEU . 3.2 p30 -29.28 -40.97 0.02 OUTLIER 'General case' 0 N--CA 1.511 2.589 0 C-N-CA 123.103 0.561 . . . . 0.0 112.431 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.539 ' HA ' ' HE3' ' A' ' 24' ' ' TRP . 4.2 p -48.28 -23.91 1.03 Allowed 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.257 -0.902 . . . . 0.0 111.374 179.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.694 ' HB3' ' CE1' ' A' ' 71' ' ' PHE . 68.9 m -89.59 -21.11 23.0 Favored 'General case' 0 N--CA 1.503 2.175 0 O-C-N 121.124 -0.985 . . . . 0.0 109.78 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.578 ' HB ' HD13 ' A' ' 43' ' ' LEU . 1.0 OUTLIER -85.74 -38.29 12.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 176.096 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.539 ' HE3' ' HA ' ' A' ' 21' ' ' SER . 4.2 m0 -64.0 -32.57 74.16 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 119.098 -1.041 . . . . 0.0 108.844 177.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.46 ' O ' ' HB2' ' A' ' 29' ' ' GLN . 0.6 OUTLIER -83.84 -24.68 30.83 Favored 'General case' 0 N--CA 1.505 2.28 0 C-N-CA 119.812 -0.755 . . . . 0.0 111.345 179.868 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.64 HD12 HD13 ' A' ' 66' ' ' ILE . 11.8 mm -91.88 -33.35 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 O-C-N 121.122 -0.986 . . . . 0.0 110.075 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.628 ' HG2' ' CG2' ' A' ' 41' ' ' VAL . 15.3 mt-10 -78.18 -34.78 49.38 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 178.153 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.509 ' HB2' ' O ' ' A' ' 24' ' ' TRP . 0.7 OUTLIER -72.96 -30.36 63.78 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 176.918 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.576 ' HG3' ' HG2' ' A' ' 69' ' ' MET . 3.1 mm100 -77.49 -61.29 2.04 Favored 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 119.064 -1.054 . . . . 0.0 109.942 178.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.999 HG21 HG21 ' A' ' 50' ' ' ILE . 22.1 mm -59.06 -42.81 87.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.027 -1.046 . . . . 0.0 110.116 179.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.581 ' CA ' HG21 ' A' ' 39' ' ' ILE . . . -49.44 -53.35 20.69 Favored Glycine 0 N--CA 1.502 3.038 0 N-CA-C 110.014 -1.235 . . . . 0.0 110.014 179.203 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.426 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 11.0 pttm -104.05 24.79 10.84 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.257 -1.143 . . . . 0.0 110.898 179.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.588 ' HB ' ' HA ' ' A' ' 30' ' ' ILE . 9.9 p -64.42 -44.54 97.09 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 O-C-N 120.749 -1.219 . . . . 0.0 111.959 -178.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.46 ' N ' HG13 ' A' ' 33' ' ' VAL . 0.4 OUTLIER -179.58 -53.62 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.18 -0.95 . . . . 0.0 110.387 -179.37 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.511 ' O ' ' HA ' ' A' ' 52' ' ' TYR . . . -149.39 81.45 0.19 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.156 -1.578 . . . . 0.0 109.156 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.594 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 35.2 t -132.16 96.66 2.49 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-O 122.233 1.016 . . . . 0.0 108.81 179.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.911 ' HB2' HD12 ' A' ' 51' ' ' ILE . 58.2 m-70 -66.36 -12.4 56.61 Favored 'General case' 0 N--CA 1.505 2.294 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.647 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.657 ' O ' HG22 ' A' ' 51' ' ' ILE . 6.4 t60 -170.4 122.88 0.66 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.412 -0.805 . . . . 0.0 109.242 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.602 HD13 ' O ' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -118.87 140.12 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.471 -0.768 . . . . 0.0 108.943 179.908 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.511 ' H ' HG22 ' A' ' 50' ' ' ILE . 1.2 ttpp -141.14 115.52 9.43 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.853 -1.154 . . . . 0.0 110.703 -179.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.628 ' CG2' ' HG2' ' A' ' 27' ' ' GLU . 90.8 t -108.05 161.19 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 CA-C-O 121.55 0.691 . . . . 0.0 110.769 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.694 ' HB3' ' HB3' ' A' ' 45' ' ' GLU . 0.1 OUTLIER -130.17 76.26 1.71 Allowed 'General case' 0 N--CA 1.485 1.278 0 O-C-N 121.368 -0.833 . . . . 0.0 110.517 -178.753 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.578 HD13 ' HB ' ' A' ' 23' ' ' VAL . 11.1 tp -34.43 -55.93 0.52 Allowed 'General case' 0 N--CA 1.503 2.18 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.498 ' O ' ' HD3' ' A' ' 46' ' ' LYS . 5.7 mp0 -85.12 -30.96 23.59 Favored 'General case' 0 N--CA 1.504 2.23 0 O-C-N 120.807 -1.183 . . . . 0.0 112.026 -178.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.694 ' HB3' ' HB3' ' A' ' 42' ' ' SER . 1.1 tt0 -76.31 -3.22 35.54 Favored 'General case' 0 C--N 1.296 -1.749 0 O-C-N 121.231 -0.918 . . . . 0.0 109.881 178.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.504 ' HG2' ' CD ' ' A' ' 15' ' ' GLU . 0.0 OUTLIER 52.5 52.73 13.54 Favored 'General case' 0 N--CA 1.504 2.263 0 O-C-N 121.275 -0.891 . . . . 0.0 111.587 179.428 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -158.84 148.71 19.29 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.81 -1.181 . . . . 0.0 110.936 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.679 ' HB3' ' CG2' ' A' ' 12' ' ' ILE . . . -132.05 127.87 37.06 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.607 -0.683 . . . . 0.0 109.536 179.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.489 ' HA ' ' HA ' ' A' ' 11' ' ' THR . 6.8 t -127.22 120.82 29.62 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.322 -0.861 . . . . 0.0 109.44 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.999 HG21 HG21 ' A' ' 30' ' ' ILE . 1.3 pp -136.48 167.2 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 121.185 -0.947 . . . . 0.0 111.094 -178.082 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.911 HD12 ' HB2' ' A' ' 37' ' ' HIS . 0.0 OUTLIER -109.47 153.05 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.367 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.76 ' N ' HD13 ' A' ' 51' ' ' ILE . 13.0 p90 -163.07 170.25 18.23 Favored 'General case' 0 C--N 1.296 -1.76 0 O-C-N 121.455 -0.778 . . . . 0.0 110.531 -178.191 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.626 ' HB3' ' HB3' ' A' ' 56' ' ' LEU . 5.7 t0 -82.17 117.77 69.57 Favored Pre-proline 0 C--N 1.293 -1.853 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 177.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.493 ' HD3' ' HB2' ' A' ' 8' ' ' ASN . 38.0 Cg_endo -64.07 -22.0 67.92 Favored 'Trans proline' 0 N--CA 1.491 1.36 0 O-C-N 123.428 1.225 . . . . 0.0 109.572 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.422 ' NZ ' ' OD1' ' A' ' 53' ' ' ASP . 3.3 ptpp? -84.62 -22.13 30.07 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.973 -0.454 . . . . 0.0 109.812 178.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.626 ' HB3' ' HB3' ' A' ' 53' ' ' ASP . 0.6 OUTLIER -107.81 -39.4 5.58 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.027 -1.046 . . . . 0.0 110.353 179.195 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 14.0 mm-40 -128.34 161.14 30.12 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.251 -0.906 . . . . 0.0 110.829 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.601 ' HB ' ' HD2' ' A' ' 59' ' ' PRO . 15.6 p -145.54 170.53 7.86 Favored Pre-proline 0 N--CA 1.503 2.211 0 O-C-N 121.324 -0.86 . . . . 0.0 110.326 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.601 ' HD2' ' HB ' ' A' ' 58' ' ' THR . 38.1 Cg_endo -64.0 -12.44 32.17 Favored 'Trans proline' 0 N--CA 1.49 1.296 0 O-C-N 123.289 1.152 . . . . 0.0 110.192 178.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.514 ' O ' ' HB3' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -88.3 -29.53 20.29 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.294 -0.879 . . . . 0.0 109.012 178.279 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.52 ' HA ' ' CD ' ' A' ' 64' ' ' GLU . 40.1 p -90.92 -24.78 20.07 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 177.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.772 HD22 HD11 ' A' ' 50' ' ' ILE . 34.1 mt -76.84 -29.29 55.83 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 177.203 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.616 ' HB2' HG21 ' A' ' 75' ' ' ILE . 12.3 tt0 -79.87 -30.15 40.18 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 177.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.52 ' CD ' ' HA ' ' A' ' 61' ' ' THR . 0.3 OUTLIER -78.53 -22.3 47.52 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.214 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -80.24 -27.26 38.75 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 176.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.825 HG13 HD13 ' A' ' 12' ' ' ILE . 8.7 mm -83.2 -36.06 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 176.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.466 ' HB2' ' HA ' ' A' ' 64' ' ' GLU . 61.8 m-20 -72.38 -32.21 66.22 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 177.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.427 ' HB2' ' O ' ' A' ' 64' ' ' GLU . 31.3 t70 -68.15 -36.68 80.05 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 177.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.576 ' HG2' ' HG3' ' A' ' 29' ' ' GLN . 0.0 OUTLIER -64.86 -47.58 77.4 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.477 -0.765 . . . . 0.0 109.942 178.513 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 119.75 47.87 0.35 Allowed Glycine 0 N--CA 1.502 3.075 0 C-N-CA 120.196 -1.002 . . . . 0.0 111.335 178.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.694 ' CE1' ' HB3' ' A' ' 22' ' ' CYS . 78.2 m-85 -137.4 143.38 41.88 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.229 -1.159 . . . . 0.0 109.563 179.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.671 ' O ' ' HA ' ' A' ' 14' ' ' VAL . 23.4 m-20 -55.1 110.74 0.72 Allowed 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.042 -1.036 . . . . 0.0 109.33 179.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.997 ' HB1' HD11 ' A' ' 12' ' ' ILE . . . -109.77 127.37 54.59 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.163 -0.961 . . . . 0.0 112.067 -178.109 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.581 ' HB ' ' HB2' ' A' ' 13' ' ' SER . 77.1 t -137.38 80.69 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 178.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.81 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . 40.8 pt . . . . . 0 C--N 1.308 -1.224 0 CA-C-O 122.373 1.083 . . . . 0.0 111.849 -178.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.656 HG11 HD13 ' A' ' 51' ' ' ILE . 44.4 t . . . . . 0 N--CA 1.503 2.202 0 CA-C-O 120.978 0.418 . . . . 0.0 110.584 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.582 ' HB3' ' CZ ' ' A' ' 52' ' ' TYR . 0.8 OUTLIER -106.57 178.58 4.52 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.213 -0.93 . . . . 0.0 111.256 -179.303 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.689 ' HA ' ' HA ' ' A' ' 51' ' ' ILE . 9.4 t -141.96 131.89 24.45 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.307 -0.871 . . . . 0.0 111.371 179.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 1.036 HG21 ' HB3' ' A' ' 59' ' ' PRO . 0.9 OUTLIER -142.81 147.93 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 CA-C-O 121.944 0.878 . . . . 0.0 111.534 -179.137 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.64 ' HA ' ' HA ' ' A' ' 49' ' ' THR . 21.3 m -109.83 154.01 23.6 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.253 -0.904 . . . . 0.0 109.781 179.037 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.904 ' HA ' ' CG1' ' A' ' 75' ' ' ILE . 86.0 mt -134.16 110.92 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 122.251 -0.28 . . . . 0.0 111.744 -179.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.572 ' H ' HG23 ' A' ' 75' ' ' ILE . 7.2 p -83.05 121.3 26.85 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 119.746 -1.847 . . . . 0.0 107.095 177.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.12 126.15 73.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 O-C-N 121.187 -0.945 . . . . 0.0 110.214 -177.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.23 173.79 6.16 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.508 -0.745 . . . . 0.0 110.317 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.461 ' O ' ' C ' ' A' ' 17' ' ' MET . . . 88.48 -29.79 5.57 Favored Glycine 0 N--CA 1.499 2.853 0 C-N-CA 120.005 -1.093 . . . . 0.0 110.567 -179.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.679 ' HB3' ' HB2' ' A' ' 43' ' ' LEU . 28.2 mmm -28.13 97.49 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.657 0 CA-C-N 118.001 0.901 . . . . 0.0 111.403 -179.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.417 ' O ' ' HB3' ' A' ' 19' ' ' CYS . 66.6 p -73.82 -28.91 61.86 Favored 'General case' 0 N--CA 1.512 2.641 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -177.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.417 ' HB3' ' O ' ' A' ' 18' ' ' THR . 14.8 p 178.76 173.81 0.7 Allowed 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.251 -0.905 . . . . 0.0 110.192 -178.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.624 ' HA ' ' CD2' ' A' ' 43' ' ' LEU . 7.7 m120 -38.34 -36.65 0.24 Allowed 'General case' 0 N--CA 1.507 2.397 0 CA-C-O 121.062 0.458 . . . . 0.0 110.926 179.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.598 ' HA ' ' HE3' ' A' ' 24' ' ' TRP . 5.9 p -52.46 -23.98 7.1 Favored 'General case' 0 N--CA 1.507 2.38 0 CA-C-O 121.883 0.849 . . . . 0.0 110.931 178.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.414 ' HB3' ' CE1' ' A' ' 71' ' ' PHE . 74.0 m -88.2 -26.72 22.24 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.238 -0.914 . . . . 0.0 109.381 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.445 ' HB ' ' CD2' ' A' ' 43' ' ' LEU . 0.5 OUTLIER -79.41 -39.07 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 N-CA-C 105.955 -1.869 . . . . 0.0 105.955 176.339 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.618 ' CZ3' ' HB2' ' A' ' 20' ' ' ASN . 1.8 m0 -62.57 -32.25 73.2 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 118.82 -1.152 . . . . 0.0 108.033 176.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.473 ' CG2' ' SD ' ' A' ' 69' ' ' MET . 95.7 m -79.95 -32.43 39.95 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.787 -0.571 . . . . 0.0 112.304 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.828 HD12 HD13 ' A' ' 66' ' ' ILE . 18.9 mm -99.77 -22.47 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.242 0 O-C-N 120.785 -1.197 . . . . 0.0 111.297 -178.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.775 ' HA ' HD11 ' A' ' 39' ' ' ILE . 4.5 tt0 -85.78 -32.68 21.69 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 177.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.586 ' HB3' ' O ' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -80.27 -34.98 36.57 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 119.511 -0.876 . . . . 0.0 109.446 177.662 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.696 ' HG3' ' HB1' ' A' ' 65' ' ' ALA . 5.5 tp60 -67.9 -62.96 1.16 Allowed 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 119.358 -0.937 . . . . 0.0 110.103 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.509 ' CG2' HG13 ' A' ' 50' ' ' ILE . 16.6 mm -58.87 -41.33 82.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.314 -0.866 . . . . 0.0 110.656 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.782 ' CA ' HG21 ' A' ' 39' ' ' ILE . . . -55.71 -38.23 71.75 Favored Glycine 0 N--CA 1.498 2.807 0 O-C-N 121.368 -0.833 . . . . 0.0 111.223 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.73 26.55 7.12 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.973 -1.31 . . . . 0.0 111.806 -179.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.805 HG21 ' HB2' ' A' ' 65' ' ' ALA . 15.0 p -71.26 -41.23 74.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 120.778 -1.201 . . . . 0.0 111.214 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 16.6 t30 -162.22 -66.77 0.05 Allowed 'General case' 0 N--CA 1.501 2.084 0 O-C-N 120.643 -1.285 . . . . 0.0 111.471 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.467 ' O ' ' HA ' ' A' ' 52' ' ' TYR . . . -145.18 78.37 0.25 Allowed Glycine 0 N--CA 1.493 2.459 0 N-CA-C 108.804 -1.718 . . . . 0.0 108.804 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.898 HG22 HD11 ' A' ' 50' ' ' ILE . 20.8 t -126.2 89.68 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 CA-C-O 122.429 1.109 . . . . 0.0 108.583 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 1.009 ' HB2' HD11 ' A' ' 51' ' ' ILE . 41.7 m-70 -60.94 -28.8 69.23 Favored 'General case' 0 C--N 1.286 -2.192 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.983 -179.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.628 ' HB2' HG12 ' A' ' 51' ' ' ILE . 37.3 m-70 -141.89 125.63 16.97 Favored 'General case' 0 N--CA 1.506 2.331 0 O-C-N 121.038 -1.039 . . . . 0.0 109.637 178.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.838 ' C ' HD13 ' A' ' 39' ' ' ILE . 0.0 OUTLIER -133.96 140.19 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.187 -0.946 . . . . 0.0 109.408 -179.973 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.48 ' HD3' ' C ' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -146.0 121.34 10.26 Favored 'General case' 0 N--CA 1.507 2.39 0 O-C-N 120.537 -1.352 . . . . 0.0 111.084 178.947 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.528 HG21 HG22 ' A' ' 26' ' ' ILE . 82.0 t -112.6 161.63 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 CA-C-O 121.679 0.752 . . . . 0.0 110.976 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.405 ' HB3' ' HB2' ' A' ' 45' ' ' GLU . 1.7 m -142.67 77.26 1.57 Allowed 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.679 ' HB2' ' HB3' ' A' ' 17' ' ' MET . 0.5 OUTLIER -54.67 -30.34 55.14 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.493 -0.755 . . . . 0.0 111.636 -178.717 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.552 ' N ' ' HG ' ' A' ' 43' ' ' LEU . 15.1 mp0 -74.51 -50.0 19.88 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.959 -1.088 . . . . 0.0 109.597 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.405 ' HB2' ' HB3' ' A' ' 42' ' ' SER . 2.2 mp0 -79.52 5.99 11.55 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 177.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.497 ' HD3' ' CG ' ' A' ' 17' ' ' MET . 35.0 mmtp 46.53 64.96 1.32 Allowed 'General case' 0 N--CA 1.501 2.081 0 CA-C-O 121.5 0.667 . . . . 0.0 110.476 -179.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -165.55 174.33 10.01 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.019 -1.051 . . . . 0.0 110.439 -179.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -168.25 150.01 5.18 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.445 -0.785 . . . . 0.0 110.481 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.64 ' HA ' ' HA ' ' A' ' 11' ' ' THR . 0.4 OUTLIER -138.02 147.28 44.02 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.328 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.898 HD11 HG22 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -165.09 151.7 2.19 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 120.777 -1.202 . . . . 0.0 111.397 -178.083 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 1.009 HD11 ' HB2' ' A' ' 37' ' ' HIS . 2.3 pp -108.04 163.62 5.59 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 O-C-N 121.194 -0.941 . . . . 0.0 109.083 178.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.582 ' CZ ' ' HB3' ' A' ' 8' ' ' ASN . 13.2 p90 -162.31 158.87 24.78 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.089 -1.045 . . . . 0.0 112.033 -176.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.677 ' HB3' ' HB2' ' A' ' 56' ' ' LEU . 18.5 t0 -75.42 111.12 12.52 Favored Pre-proline 0 N--CA 1.498 1.932 0 O-C-N 121.645 -0.66 . . . . 0.0 110.101 179.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.515 ' HD3' ' HB2' ' A' ' 8' ' ' ASN . 40.5 Cg_endo -66.56 -37.17 23.14 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 O-C-N 123.731 1.385 . . . . 0.0 109.766 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.13 -19.01 64.78 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.599 -0.688 . . . . 0.0 109.654 178.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.677 ' HB2' ' HB3' ' A' ' 53' ' ' ASP . 0.4 OUTLIER -96.49 -48.19 5.65 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.388 -0.82 . . . . 0.0 109.438 178.92 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.401 ' O ' ' HA ' ' A' ' 54' ' ' PRO . 5.7 mm100 -153.56 -170.29 3.55 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.531 -0.731 . . . . 0.0 110.431 179.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.706 ' HB ' ' HD2' ' A' ' 59' ' ' PRO . 1.5 p -132.33 -176.3 0.55 Allowed Pre-proline 0 N--CA 1.502 2.131 0 O-C-N 120.861 -1.15 . . . . 0.0 110.109 -179.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 1.036 ' HB3' HG21 ' A' ' 10' ' ' VAL . 38.8 Cg_endo -68.83 -0.6 6.37 Favored 'Trans proline' 0 N--CA 1.488 1.201 0 O-C-N 123.308 1.162 . . . . 0.0 110.809 178.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.516 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 0.1 OUTLIER -77.8 -31.65 51.92 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 177.659 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.752 ' HA ' ' HB2' ' A' ' 64' ' ' GLU . 0.8 OUTLIER -77.88 -23.2 48.86 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 177.577 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.498 HD12 HG22 ' A' ' 61' ' ' THR . 10.9 mp -74.98 -27.52 60.19 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 175.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.401 ' O ' ' HB2' ' A' ' 67' ' ' ASP . 1.5 mm100 -86.4 -26.03 24.97 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 176.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.752 ' HB2' ' HA ' ' A' ' 61' ' ' THR . 30.8 mt-10 -73.03 -25.39 60.93 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 177.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.805 ' HB2' HG21 ' A' ' 33' ' ' VAL . . . -89.59 -24.63 21.65 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 178.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.828 HD13 HD12 ' A' ' 26' ' ' ILE . 14.6 mm -88.08 -36.97 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 178.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.401 ' HB2' ' O ' ' A' ' 63' ' ' GLN . 18.5 t70 -74.86 -27.77 60.39 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.335 -0.946 . . . . 0.0 108.632 178.123 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -76.52 -38.56 54.95 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.513 -0.742 . . . . 0.0 110.148 178.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.473 ' SD ' ' CG2' ' A' ' 25' ' ' THR . 3.5 mmt -67.64 -35.74 79.47 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.895 -1.128 . . . . 0.0 110.471 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 105.9 48.98 0.97 Allowed Glycine 0 N--CA 1.499 2.863 0 C-N-CA 120.099 -1.048 . . . . 0.0 110.707 178.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.664 ' CD2' HD11 ' A' ' 26' ' ' ILE . 55.0 m-85 -130.38 114.66 15.86 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.298 -1.119 . . . . 0.0 110.021 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -48.39 107.87 0.15 Allowed 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.553 -0.717 . . . . 0.0 110.684 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.641 ' HB2' HG21 ' A' ' 66' ' ' ILE . . . -111.23 164.58 12.73 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 122.068 0.937 . . . . 0.0 112.342 -178.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.787 ' C ' HG13 ' A' ' 75' ' ' ILE . 0.9 OUTLIER -168.91 103.72 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 179.618 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.904 ' CG1' ' HA ' ' A' ' 12' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.649 0 C-N-CA 118.834 -1.146 . . . . 0.0 113.638 -174.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 1.075 HG11 HD11 ' A' ' 51' ' ' ILE . 4.2 t . . . . . 0 N--CA 1.508 2.465 0 CA-C-O 121.014 0.435 . . . . 0.0 109.941 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.738 ' HB3' ' CZ ' ' A' ' 52' ' ' TYR . 1.0 OUTLIER -117.18 154.57 30.88 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.694 -1.254 . . . . 0.0 111.516 -179.232 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.626 ' HA ' ' HA ' ' A' ' 51' ' ' ILE . 14.7 t -118.98 146.51 44.94 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.336 -0.852 . . . . 0.0 110.012 178.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -140.6 133.95 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.347 -0.845 . . . . 0.0 111.186 -178.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.509 ' HA ' ' HA ' ' A' ' 49' ' ' THR . 51.7 m -109.69 116.81 32.41 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.524 0.678 . . . . 0.0 109.273 179.16 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 1.093 HG21 HD13 ' A' ' 66' ' ' ILE . 5.7 mt -108.43 145.12 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.379 -0.826 . . . . 0.0 110.914 -178.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.546 ' O ' ' HB1' ' A' ' 73' ' ' ALA . 0.8 OUTLIER -78.98 137.74 37.73 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.747 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.644 HG13 ' CE ' ' A' ' 17' ' ' MET . 1.2 t -129.09 111.26 22.43 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 O-C-N 120.947 -1.095 . . . . 0.0 111.888 -178.166 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -122.56 170.19 10.26 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.552 ' O ' HG23 ' A' ' 18' ' ' THR . . . 73.81 25.43 71.87 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 -178.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.688 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 29.7 mmt -66.22 -36.08 82.12 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.106 -1.232 . . . . 0.0 110.178 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.552 HG23 ' O ' ' A' ' 16' ' ' GLY . 1.0 OUTLIER 58.93 -42.84 0.07 Allowed 'General case' 0 N--CA 1.515 2.794 0 O-C-N 121.664 -0.648 . . . . 0.0 112.64 -179.708 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.529 ' N ' ' O ' ' A' ' 17' ' ' MET . 9.0 p 179.02 163.49 0.82 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.334 -0.854 . . . . 0.0 110.228 -178.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.579 ' HB2' ' CZ3' ' A' ' 24' ' ' TRP . 2.9 p30 -35.13 -36.71 0.06 Allowed 'General case' 0 N--CA 1.508 2.453 0 CA-C-O 120.947 0.403 . . . . 0.0 111.67 178.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.513 ' HA ' ' HE3' ' A' ' 24' ' ' TRP . 10.5 p -46.17 -30.67 2.05 Favored 'General case' 0 N--CA 1.504 2.258 0 CA-C-O 121.983 0.897 . . . . 0.0 110.912 178.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.688 ' SG ' ' O ' ' A' ' 17' ' ' MET . 69.6 m -90.3 -27.63 19.3 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.444 -0.785 . . . . 0.0 109.066 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.542 HG21 ' HB2' ' A' ' 43' ' ' LEU . 1.1 t -71.96 -37.65 61.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 175.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.634 ' O ' ' HB2' ' A' ' 28' ' ' GLN . 2.8 m0 -67.6 -32.14 72.67 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 119.142 -1.023 . . . . 0.0 108.488 177.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.6 ' O ' ' HB2' ' A' ' 29' ' ' GLN . 96.8 m -82.1 -23.98 35.41 Favored 'General case' 0 N--CA 1.505 2.285 0 C-N-CA 120.532 -0.467 . . . . 0.0 112.034 -179.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.739 HD11 ' CD2' ' A' ' 71' ' ' PHE . 1.5 mp -98.49 -22.35 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.31 0 O-C-N 120.868 -1.145 . . . . 0.0 110.126 -179.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.595 ' HA ' HD11 ' A' ' 39' ' ' ILE . 4.7 tt0 -83.1 -36.32 24.93 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 178.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.634 ' HB2' ' O ' ' A' ' 24' ' ' TRP . 1.2 mp0 -80.13 -33.84 38.24 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.725 -0.79 . . . . 0.0 109.81 178.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.6 ' HB2' ' O ' ' A' ' 25' ' ' THR . 5.2 mm100 -77.46 -61.42 2.0 Allowed 'General case' 0 N--CA 1.501 2.088 0 C-N-CA 118.32 -1.352 . . . . 0.0 110.694 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.75 ' CG2' HG21 ' A' ' 50' ' ' ILE . 38.0 mt -64.98 -36.9 78.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 120.776 -1.202 . . . . 0.0 109.989 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.495 ' CA ' HG21 ' A' ' 39' ' ' ILE . . . -58.36 -46.47 92.93 Favored Glycine 0 N--CA 1.499 2.857 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 178.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.08 29.99 7.29 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.459 -1.024 . . . . 0.0 110.864 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.476 ' HB ' ' HA ' ' A' ' 30' ' ' ILE . 8.4 p -64.29 -38.19 81.89 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 O-C-N 121.083 -1.011 . . . . 0.0 111.049 -179.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -175.39 -60.38 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.333 -0.854 . . . . 0.0 110.357 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.517 ' O ' ' HA ' ' A' ' 52' ' ' TYR . . . -148.47 83.48 0.18 Allowed Glycine 0 N--CA 1.489 2.204 0 N-CA-C 108.307 -1.917 . . . . 0.0 108.307 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.723 HG11 ' HB ' ' A' ' 39' ' ' ILE . 17.1 t -124.15 93.71 2.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 CA-C-O 122.503 1.144 . . . . 0.0 108.637 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.961 ' HB2' HD12 ' A' ' 51' ' ' ILE . 68.2 m-70 -60.45 -18.53 51.83 Favored 'General case' 0 N--CA 1.503 2.209 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.676 -179.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.584 ' HB3' ' CG2' ' A' ' 51' ' ' ILE . 1.0 OUTLIER -158.92 129.49 5.99 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.791 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.989 ' HA ' HG22 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -129.94 128.79 65.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.565 -0.71 . . . . 0.0 109.392 -179.927 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.695 ' HB3' HG22 ' A' ' 49' ' ' THR . 0.0 OUTLIER -121.02 121.54 38.18 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.882 -1.136 . . . . 0.0 110.073 179.743 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.523 ' O ' ' NZ ' ' A' ' 40' ' ' LYS . 10.6 p -106.89 152.54 8.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 178.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.771 ' HB3' ' HB3' ' A' ' 45' ' ' GLU . 0.4 OUTLIER -136.57 76.51 1.6 Allowed 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.09 -1.006 . . . . 0.0 111.073 -177.74 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.542 ' HB2' HG21 ' A' ' 23' ' ' VAL . 11.7 tp -39.32 -57.19 1.42 Allowed 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.461 ' O ' ' NZ ' ' A' ' 46' ' ' LYS . 0.7 OUTLIER -94.57 -32.69 13.34 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.831 -1.168 . . . . 0.0 111.409 -179.799 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.771 ' HB3' ' HB3' ' A' ' 42' ' ' SER . 9.7 tt0 -66.61 -7.47 20.61 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.038 -1.039 . . . . 0.0 109.929 177.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.461 ' NZ ' ' O ' ' A' ' 44' ' ' GLU . 0.0 OUTLIER 55.77 69.36 0.74 Allowed 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.47 -0.768 . . . . 0.0 111.17 179.008 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -170.31 161.15 8.06 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.72 -1.238 . . . . 0.0 113.037 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.535 ' HB2' HG21 ' A' ' 14' ' ' VAL . . . -147.93 97.25 2.77 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 115.518 -0.765 . . . . 0.0 108.984 179.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.695 HG22 ' HB3' ' A' ' 40' ' ' LYS . 1.0 OUTLIER -109.74 133.79 52.73 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.783 -1.198 . . . . 0.0 110.254 -179.674 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.989 HG22 ' HA ' ' A' ' 39' ' ' ILE . 2.6 pp -146.63 177.63 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.511 -0.743 . . . . 0.0 111.146 -178.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 1.075 HD11 HG11 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -123.82 158.89 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 178.541 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.738 ' CZ ' ' HB3' ' A' ' 8' ' ' ASN . 14.8 p90 -163.95 153.7 14.58 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.235 -0.915 . . . . 0.0 111.089 -177.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.478 ' HB3' ' HG3' ' A' ' 55' ' ' LYS . 0.4 OUTLIER -79.69 117.74 68.82 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.277 -0.89 . . . . 0.0 109.49 178.892 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -67.63 57.61 0.73 Allowed 'Trans proline' 0 N--CA 1.494 1.529 0 O-C-N 123.929 1.489 . . . . 0.0 111.408 -178.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.478 ' HG3' ' HB3' ' A' ' 53' ' ' ASP . 0.0 OUTLIER -135.47 -66.25 0.57 Allowed 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 179.073 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -96.84 -8.99 29.6 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.472 -0.768 . . . . 0.0 109.285 177.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.66 146.5 50.85 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.512 -0.742 . . . . 0.0 109.947 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.609 ' HB ' ' HD2' ' A' ' 59' ' ' PRO . 78.3 p -142.66 169.08 11.53 Favored Pre-proline 0 N--CA 1.497 1.922 0 O-C-N 121.493 -0.754 . . . . 0.0 110.14 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.609 ' HD2' ' HB ' ' A' ' 58' ' ' THR . 39.3 Cg_endo -65.41 -19.18 61.34 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 O-C-N 123.328 1.172 . . . . 0.0 111.226 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 2.2 tptt -92.0 -30.51 16.03 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.291 -0.881 . . . . 0.0 109.791 179.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.709 ' HA ' ' HB2' ' A' ' 64' ' ' GLU . 6.0 p -79.2 -24.17 43.33 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 177.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.574 HD22 HD11 ' A' ' 50' ' ' ILE . 14.2 mt -72.97 -30.68 64.01 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 106.314 -1.735 . . . . 0.0 106.314 175.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.478 ' HG3' HD11 ' A' ' 75' ' ' ILE . 1.2 tt0 -82.36 -27.71 31.99 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 177.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.709 ' HB2' ' HA ' ' A' ' 61' ' ' THR . 10.3 mt-10 -82.09 -16.38 50.22 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 177.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -86.86 -27.22 23.6 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 177.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 1.093 HD13 HG21 ' A' ' 12' ' ' ILE . 26.2 mt -86.32 -38.52 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 177.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.478 ' HB2' ' O ' ' A' ' 63' ' ' GLN . 0.4 OUTLIER -66.27 -33.21 75.23 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 177.459 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.619 ' HB2' ' O ' ' A' ' 64' ' ' GLU . 2.6 t70 -79.37 -38.07 35.86 Favored 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 119.771 -0.772 . . . . 0.0 109.298 178.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.571 ' HE1' HG13 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -47.65 -59.77 3.04 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.555 -0.716 . . . . 0.0 110.018 179.153 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 123.3 51.26 0.21 Allowed Glycine 0 N--CA 1.497 2.735 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 179.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.739 ' CD2' HD11 ' A' ' 26' ' ' ILE . 10.9 m-85 -140.73 147.61 39.44 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.435 -1.038 . . . . 0.0 111.029 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -72.39 81.46 1.04 Allowed 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.576 0.703 . . . . 0.0 109.245 179.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.546 ' HB1' ' O ' ' A' ' 13' ' ' SER . . . -134.59 142.17 46.86 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.999 -1.063 . . . . 0.0 110.961 -179.116 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.837 ' O ' HG23 ' A' ' 12' ' ' ILE . 2.5 t -117.51 -134.7 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.211 -0.939 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 178.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.641 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--N 1.282 -2.357 0 O-C-N 121.072 -1.018 . . . . 0.0 111.514 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 1.029 HG11 HD13 ' A' ' 51' ' ' ILE . 1.1 t . . . . . 0 N--CA 1.506 2.334 0 CA-C-O 121.533 0.683 . . . . 0.0 111.003 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.486 ' HB3' ' CZ ' ' A' ' 52' ' ' TYR . 2.5 m120 -112.17 -179.87 3.8 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.051 -1.031 . . . . 0.0 110.656 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.62 ' HA ' ' HA ' ' A' ' 51' ' ' ILE . 3.8 m -141.29 132.68 26.74 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.294 -0.879 . . . . 0.0 110.192 179.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.593 HG23 ' OH ' ' A' ' 52' ' ' TYR . 0.9 OUTLIER -130.99 135.82 59.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 CA-C-O 121.592 0.711 . . . . 0.0 111.953 -178.14 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.504 ' HA ' ' HA ' ' A' ' 49' ' ' THR . 27.5 m -115.3 118.94 34.68 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.066 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.761 HG12 HG22 ' A' ' 75' ' ' ILE . 64.9 mt -118.73 146.29 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.299 -0.876 . . . . 0.0 111.612 -178.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.867 ' CB ' HG13 ' A' ' 74' ' ' VAL . 0.9 OUTLIER -90.42 144.55 25.7 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 177.574 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.51 ' O ' ' HB3' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -141.55 126.38 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.82 -1.175 . . . . 0.0 110.824 -178.754 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.7 ' HB3' ' HB3' ' A' ' 72' ' ' ASP . 5.8 tp10 -108.95 165.42 11.59 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.418 -0.801 . . . . 0.0 110.247 179.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.71 -25.89 26.67 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 108.577 -1.809 . . . . 0.0 108.577 -177.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.501 ' HA ' ' CB ' ' A' ' 22' ' ' CYS . 51.2 mtm -73.87 102.7 4.15 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.253 -1.145 . . . . 0.0 109.888 179.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 14.9 t -106.59 9.41 31.41 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.532 -0.73 . . . . 0.0 111.367 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.436 ' O ' ' N ' ' A' ' 21' ' ' SER . 0.5 OUTLIER -178.99 139.64 0.16 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.183 -0.948 . . . . 0.0 109.295 179.822 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 1.024 ' HA ' HD21 ' A' ' 43' ' ' LEU . 7.8 m120 -23.08 -46.12 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.599 0 N-CA-C 112.719 0.636 . . . . 0.0 112.719 -179.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.554 ' HA ' ' HE3' ' A' ' 24' ' ' TRP . 3.0 p -47.66 -27.5 1.94 Allowed 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.391 -0.818 . . . . 0.0 111.518 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.631 ' HB3' ' CE1' ' A' ' 71' ' ' PHE . 60.2 m -87.04 -33.08 19.67 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.03 -1.044 . . . . 0.0 109.414 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.913 HG21 HD22 ' A' ' 43' ' ' LEU . 9.1 t -77.47 -39.44 27.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 177.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.554 ' HE3' ' HA ' ' A' ' 21' ' ' SER . 1.4 m0 -59.24 -36.97 76.41 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 176.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.455 ' O ' ' HB2' ' A' ' 29' ' ' GLN . 64.1 m -66.0 -34.5 78.25 Favored 'General case' 0 N--CA 1.501 2.086 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.006 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.588 HD11 ' CD2' ' A' ' 71' ' ' PHE . 1.4 mp -94.8 -29.61 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.241 0 O-C-N 121.261 -0.899 . . . . 0.0 110.03 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.733 ' HG3' ' CD1' ' A' ' 39' ' ' ILE . 2.6 tt0 -74.16 -35.64 64.05 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 178.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.522 ' HB2' ' O ' ' A' ' 24' ' ' TRP . 28.9 mt-30 -79.3 -34.15 42.67 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 119.146 -1.022 . . . . 0.0 108.99 177.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.664 ' HB3' ' SD ' ' A' ' 69' ' ' MET . 2.2 mm100 -73.04 -51.36 18.45 Favored 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 118.44 -1.304 . . . . 0.0 110.112 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.553 ' CG2' ' HB ' ' A' ' 39' ' ' ILE . 0.4 OUTLIER -57.41 -41.11 77.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 120.98 -1.075 . . . . 0.0 109.859 179.094 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.874 ' HA2' HG21 ' A' ' 39' ' ' ILE . . . -64.61 -26.52 70.99 Favored Glycine 0 N--CA 1.498 2.772 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 178.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.5 ' HB3' ' HE3' ' A' ' 32' ' ' LYS . 3.2 ttpp -116.7 26.7 9.66 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.566 -0.961 . . . . 0.0 110.678 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.562 HG21 ' HB1' ' A' ' 65' ' ' ALA . 8.1 p -87.41 -49.22 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 O-C-N 120.594 -1.316 . . . . 0.0 112.489 -178.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.503 ' N ' HG13 ' A' ' 33' ' ' VAL . 0.6 OUTLIER -169.66 -68.07 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.134 0 O-C-N 120.408 -1.433 . . . . 0.0 112.453 -179.581 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.606 ' HA3' HD11 ' A' ' 56' ' ' LEU . . . -142.74 73.17 0.37 Allowed Glycine 0 N--CA 1.496 2.676 0 C-N-CA 119.987 -1.102 . . . . 0.0 110.855 -178.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.928 ' CG1' HG22 ' A' ' 39' ' ' ILE . 61.5 t -127.57 89.2 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 CA-C-O 122.335 1.064 . . . . 0.0 108.564 178.218 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 1.009 ' HB2' HD11 ' A' ' 51' ' ' ILE . 38.9 m-70 -61.6 -23.26 65.89 Favored 'General case' 0 N--CA 1.507 2.402 0 CA-C-N 115.388 -0.823 . . . . 0.0 110.72 -179.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.64 ' HB2' HG12 ' A' ' 51' ' ' ILE . 65.8 m-70 -136.94 113.36 10.04 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.308 -0.87 . . . . 0.0 109.162 179.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.928 HG22 ' CG1' ' A' ' 36' ' ' VAL . 1.8 pp -114.28 136.42 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.286 -0.884 . . . . 0.0 109.637 -179.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.634 ' HA ' ' CE ' ' A' ' 40' ' ' LYS . 0.3 OUTLIER -150.58 122.91 8.39 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.168 -1.583 . . . . 0.0 112.408 -179.715 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.489 HG13 ' HB2' ' A' ' 48' ' ' ALA . 3.9 t -127.79 167.14 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.4 m -108.84 -101.04 0.38 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.87 -1.144 . . . . 0.0 110.168 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 1.024 HD21 ' HA ' ' A' ' 20' ' ' ASN . 0.1 OUTLIER -179.13 -92.41 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.308 0 O-C-N 121.069 -1.019 . . . . 0.0 109.683 179.411 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.49 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -76.73 -9.77 58.9 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.512 -1.368 . . . . 0.0 109.594 178.538 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -74.59 -11.87 60.31 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 177.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.51 ' HB3' ' O ' ' A' ' 14' ' ' VAL . 21.5 mmtt 51.5 56.13 8.36 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.623 -0.673 . . . . 0.0 111.295 179.037 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.417 ' ND2' ' OG ' ' A' ' 13' ' ' SER . 0.3 OUTLIER -154.08 152.13 30.11 Favored 'General case' 0 N--CA 1.504 2.235 0 O-C-N 120.587 -1.32 . . . . 0.0 112.274 179.854 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.489 ' HB2' HG13 ' A' ' 41' ' ' VAL . . . -142.36 134.91 28.05 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.251 0.548 . . . . 0.0 110.592 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.504 ' HA ' ' HA ' ' A' ' 11' ' ' THR . 5.8 t -128.67 134.41 48.5 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.377 -0.827 . . . . 0.0 109.408 179.021 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.48 ' CD1' HD22 ' A' ' 62' ' ' LEU . 0.1 OUTLIER -149.59 164.85 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.072 -1.018 . . . . 0.0 110.975 -179.014 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 1.029 HD13 HG11 ' A' ' 7' ' ' VAL . 1.7 pp -107.03 167.52 3.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 178.056 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.593 ' OH ' HG23 ' A' ' 10' ' ' VAL . 28.8 p90 -170.52 161.83 7.91 Favored 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 119.159 -1.017 . . . . 0.0 110.731 -178.187 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.436 ' O ' ' N ' ' A' ' 55' ' ' LYS . 0.9 OUTLIER -78.84 121.62 83.67 Favored Pre-proline 0 C--N 1.302 -1.492 0 C-N-CA 119.701 -0.799 . . . . 0.0 109.726 179.182 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.421 ' C ' ' HG2' ' A' ' 55' ' ' LYS . 38.7 Cg_endo -64.67 70.31 0.24 Allowed 'Trans proline' 0 N--CA 1.492 1.395 0 O-C-N 124.1 1.579 . . . . 0.0 109.728 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.436 ' N ' ' O ' ' A' ' 53' ' ' ASP . 3.2 ptpp? -172.24 -45.48 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.756 -0.59 . . . . 0.0 110.877 -178.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.606 HD11 ' HA3' ' A' ' 35' ' ' GLY . 1.8 pp -111.8 -21.65 11.53 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.093 -1.004 . . . . 0.0 111.837 -179.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.517 ' HB3' ' HB2' ' A' ' 52' ' ' TYR . 5.5 tp60 -125.85 133.76 51.85 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.818 -1.176 . . . . 0.0 110.025 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.777 ' C ' HD12 ' A' ' 62' ' ' LEU . 34.9 p -141.78 168.33 14.13 Favored Pre-proline 0 N--CA 1.504 2.239 0 O-C-N 121.111 -0.993 . . . . 0.0 109.988 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.612 ' HA ' ' HB2' ' A' ' 62' ' ' LEU . 37.8 Cg_endo -62.39 -20.45 70.4 Favored 'Trans proline' 0 N--CA 1.498 1.78 0 O-C-N 123.418 1.22 . . . . 0.0 111.877 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.425 ' NZ ' ' HB3' ' A' ' 64' ' ' GLU . 0.4 OUTLIER -81.4 -30.53 33.57 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.097 -1.002 . . . . 0.0 108.777 178.241 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.548 ' HA ' ' CD ' ' A' ' 64' ' ' GLU . 0.9 OUTLIER -90.3 -24.15 20.97 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 178.033 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.777 HD12 ' C ' ' A' ' 58' ' ' THR . 5.2 mt -74.11 -28.07 61.18 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 177.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.823 ' HB2' HG21 ' A' ' 75' ' ' ILE . 15.8 tt0 -84.08 -30.22 26.18 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 177.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.548 ' CD ' ' HA ' ' A' ' 61' ' ' THR . 1.5 pt-20 -81.05 -18.99 44.77 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.562 ' HB1' HG21 ' A' ' 33' ' ' VAL . . . -82.95 -28.76 29.61 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 175.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.711 HG22 ' HB2' ' A' ' 73' ' ' ALA . 51.5 mt -82.01 -38.77 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 177.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.46 ' HB2' ' HA ' ' A' ' 64' ' ' GLU . 1.2 m-20 -61.05 -28.54 69.14 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 176.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -71.05 -42.74 69.08 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.799 -0.563 . . . . 0.0 109.885 178.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.664 ' SD ' ' HB3' ' A' ' 29' ' ' GLN . 0.8 OUTLIER -54.73 -47.95 73.14 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.454 -0.779 . . . . 0.0 111.043 179.717 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 120.89 43.0 0.46 Allowed Glycine 0 N--CA 1.503 3.109 0 C-N-CA 120.069 -1.062 . . . . 0.0 110.586 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.631 ' CE1' ' HB3' ' A' ' 22' ' ' CYS . 61.8 m-85 -144.87 130.29 18.78 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.444 -1.033 . . . . 0.0 109.229 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.7 ' HB3' ' HB3' ' A' ' 15' ' ' GLU . 5.5 t70 -47.43 116.51 1.45 Allowed 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.525 -0.735 . . . . 0.0 110.005 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.711 ' HB2' HG22 ' A' ' 66' ' ' ILE . . . -109.43 150.17 28.48 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.382 -0.824 . . . . 0.0 111.554 -178.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.867 HG13 ' CB ' ' A' ' 13' ' ' SER . 1.0 OUTLIER -154.83 93.76 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 CA-C-O 122.559 1.171 . . . . 0.0 108.1 179.103 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.823 HG21 ' HB2' ' A' ' 63' ' ' GLN . 14.0 pt . . . . . 0 C--N 1.296 -1.744 0 CA-C-O 122.481 1.134 . . . . 0.0 112.455 -177.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 48.2 t . . . . . 0 N--CA 1.5 2.05 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.772 ' HB3' ' CZ ' ' A' ' 52' ' ' TYR . 1.0 OUTLIER -106.24 172.46 6.8 Favored 'General case' 0 N--CA 1.503 2.21 0 O-C-N 120.977 -1.077 . . . . 0.0 110.957 -179.789 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.499 ' HA ' ' HA ' ' A' ' 51' ' ' ILE . 6.8 t -130.52 131.04 44.89 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.352 -0.843 . . . . 0.0 110.27 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.941 HG11 HD13 ' A' ' 62' ' ' LEU . 0.5 OUTLIER -125.61 132.63 70.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.462 -0.774 . . . . 0.0 111.315 -178.411 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.587 ' HA ' ' HA ' ' A' ' 49' ' ' THR . 8.9 m -108.67 119.17 38.73 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.532 -0.73 . . . . 0.0 109.138 178.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.68 ' HA ' ' HA ' ' A' ' 75' ' ' ILE . 9.8 mt -110.93 122.13 64.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.294 -0.879 . . . . 0.0 110.9 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.675 ' HB2' ' CG1' ' A' ' 74' ' ' VAL . 0.7 OUTLIER -79.34 136.11 36.91 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 178.011 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.42 HG12 ' HB3' ' A' ' 71' ' ' PHE . 0.2 OUTLIER -131.27 130.14 63.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.17 -0.957 . . . . 0.0 110.987 -178.641 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -119.48 159.57 24.02 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.387 -0.82 . . . . 0.0 110.159 178.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.527 ' O ' HG23 ' A' ' 18' ' ' THR . . . 98.35 -31.14 8.36 Favored Glycine 0 N--CA 1.497 2.762 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 -179.145 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.58 ' SD ' ' HA ' ' A' ' 43' ' ' LEU . 8.0 ptp -62.43 122.63 16.2 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.171 -1.193 . . . . 0.0 110.302 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.527 HG23 ' O ' ' A' ' 16' ' ' GLY . 54.7 p -125.64 5.96 7.5 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.252 -0.905 . . . . 0.0 113.333 -178.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.484 ' O ' HD21 ' A' ' 43' ' ' LEU . 1.1 p -165.56 145.3 6.6 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.14 -1.6 . . . . 0.0 110.512 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.49 ' O ' HG12 ' A' ' 23' ' ' VAL . 28.9 m120 -25.8 -40.67 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.674 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -179.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.811 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 2.2 p -51.32 -19.75 1.42 Allowed 'General case' 0 N--CA 1.499 1.978 0 CA-C-O 122.294 1.045 . . . . 0.0 110.703 178.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.791 ' HB2' HD21 ' A' ' 43' ' ' LEU . 44.7 m -91.15 -20.87 21.53 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 119.32 -2.112 . . . . 0.0 109.221 179.002 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.775 ' HB ' HD22 ' A' ' 43' ' ' LEU . 0.3 OUTLIER -90.02 -35.51 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.411 -0.806 . . . . 0.0 108.868 178.531 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.811 ' CE3' ' HA ' ' A' ' 21' ' ' SER . 0.0 OUTLIER -78.96 -22.55 45.51 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 117.85 -1.54 . . . . 0.0 108.688 178.642 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.509 ' HB ' ' CZ3' ' A' ' 24' ' ' TRP . 1.3 t -86.18 -27.6 24.44 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 120.774 -1.204 . . . . 0.0 110.378 177.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.676 HD11 ' CD2' ' A' ' 71' ' ' PHE . 20.4 mm -90.77 -25.12 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.377 0 O-C-N 120.75 -1.218 . . . . 0.0 109.561 179.052 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.574 ' HA ' HD12 ' A' ' 39' ' ' ILE . 0.2 OUTLIER -81.24 -34.37 32.18 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 177.55 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.638 ' HB2' ' O ' ' A' ' 24' ' ' TRP . 0.9 OUTLIER -72.95 -33.01 65.63 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 177.413 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.482 ' O ' ' HB ' ' A' ' 33' ' ' VAL . 5.5 tp60 -70.88 -66.63 0.58 Allowed 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 120.045 -0.662 . . . . 0.0 110.527 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.844 HG21 HG21 ' A' ' 50' ' ' ILE . 84.1 mt -64.3 -45.7 95.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 O-C-N 121.245 -0.91 . . . . 0.0 110.35 -179.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.498 ' CA ' HG21 ' A' ' 39' ' ' ILE . . . -50.48 -34.44 27.02 Favored Glycine 0 N--CA 1.497 2.712 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 179.29 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 56.1 mtmt -126.71 29.9 5.61 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.008 -1.29 . . . . 0.0 111.865 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.508 HG13 ' N ' ' A' ' 34' ' ' ASN . 14.9 p -75.15 -49.83 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 O-C-N 120.633 -1.292 . . . . 0.0 111.541 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.508 ' N ' HG13 ' A' ' 33' ' ' VAL . 0.4 OUTLIER -178.47 -60.29 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.285 0 O-C-N 120.871 -1.143 . . . . 0.0 111.663 179.772 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.451 ' O ' ' HA ' ' A' ' 52' ' ' TYR . . . -122.94 67.71 0.48 Allowed Glycine 0 N--CA 1.495 2.586 0 C-N-CA 120.207 -0.997 . . . . 0.0 110.647 -178.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.88 HG22 HD13 ' A' ' 50' ' ' ILE . 50.4 t -136.57 92.4 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.487 -1.008 . . . . 0.0 108.585 178.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.793 ' N ' HD11 ' A' ' 51' ' ' ILE . 50.3 m-70 -51.67 -29.27 17.39 Favored 'General case' 0 N--CA 1.512 2.667 0 CA-C-O 121.575 0.702 . . . . 0.0 109.709 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.89 ' CD2' HD12 ' A' ' 51' ' ' ILE . 0.2 OUTLIER -171.39 145.41 2.12 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 178.615 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.876 HG12 HG22 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -121.06 144.86 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.145 -0.972 . . . . 0.0 110.023 -178.689 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.594 ' HG3' HG22 ' A' ' 49' ' ' THR . 4.5 tptt -122.21 100.23 6.85 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.555 -1.341 . . . . 0.0 109.518 179.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.643 HG23 ' HB2' ' A' ' 48' ' ' ALA . 11.2 p -108.93 154.68 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 O-C-N 121.604 -0.685 . . . . 0.0 109.614 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.57 ' HB3' ' HB2' ' A' ' 45' ' ' GLU . 0.4 OUTLIER -139.93 79.31 1.71 Allowed 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.712 -0.618 . . . . 0.0 109.693 -179.834 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.791 HD21 ' HB2' ' A' ' 22' ' ' CYS . 1.8 tp -45.32 -32.66 2.1 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.595 -0.691 . . . . 0.0 110.994 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.5 mp0 -72.02 -51.74 20.33 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.151 -0.968 . . . . 0.0 109.97 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.57 ' HB2' ' HB3' ' A' ' 42' ' ' SER . 1.8 mp0 -73.43 1.42 9.79 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.619 -0.676 . . . . 0.0 109.747 177.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 51.38 56.16 8.35 Favored 'General case' 0 N--CA 1.506 2.349 0 O-C-N 121.367 -0.833 . . . . 0.0 111.713 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -171.22 158.84 5.6 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.893 -1.129 . . . . 0.0 110.38 179.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.643 ' HB2' HG23 ' A' ' 41' ' ' VAL . . . -144.49 137.43 26.89 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.967 -1.083 . . . . 0.0 111.85 -179.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.594 HG22 ' HG3' ' A' ' 40' ' ' LYS . 5.6 t -127.22 135.78 51.1 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.014 -1.054 . . . . 0.0 109.299 178.035 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.88 HD13 HG22 ' A' ' 36' ' ' VAL . 1.4 pp -145.03 167.62 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 O-C-N 121.08 -1.013 . . . . 0.0 111.036 -177.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.89 HD12 ' CD2' ' A' ' 38' ' ' HIS . 0.0 OUTLIER -109.12 169.26 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 O-C-N 121.281 -0.887 . . . . 0.0 110.15 178.727 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.772 ' CZ ' ' HB3' ' A' ' 8' ' ' ASN . 15.4 p90 -170.43 159.73 7.14 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.54 -0.725 . . . . 0.0 110.672 -178.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.465 ' OD2' ' HB3' ' A' ' 56' ' ' LEU . 6.6 p-10 -79.26 117.37 66.63 Favored Pre-proline 0 C--N 1.3 -1.558 0 C-N-CA 119.631 -0.828 . . . . 0.0 109.425 179.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.49 ' C ' ' HG2' ' A' ' 55' ' ' LYS . 39.8 Cg_endo -68.54 66.2 1.15 Allowed 'Trans proline' 0 N--CA 1.487 1.115 0 O-C-N 123.516 1.272 . . . . 0.0 109.374 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.49 ' HG2' ' C ' ' A' ' 54' ' ' PRO . 0.0 OUTLIER -164.11 -55.3 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 -179.267 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.465 ' HB3' ' OD2' ' A' ' 53' ' ' ASP . 0.4 OUTLIER -98.55 -41.45 7.74 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.381 -0.824 . . . . 0.0 109.53 178.271 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.416 ' HB3' ' HB2' ' A' ' 52' ' ' TYR . 20.5 tp60 -104.14 140.38 37.88 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.026 -1.046 . . . . 0.0 111.036 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.72 ' HB ' ' HD2' ' A' ' 59' ' ' PRO . 29.9 p -140.75 171.55 7.49 Favored Pre-proline 0 N--CA 1.508 2.469 0 O-C-N 121.013 -1.055 . . . . 0.0 110.363 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.72 ' HD2' ' HB ' ' A' ' 58' ' ' THR . 38.5 Cg_endo -64.22 -20.24 66.75 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 O-C-N 123.455 1.24 . . . . 0.0 110.229 179.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.579 ' O ' ' HB3' ' A' ' 64' ' ' GLU . 1.4 tmtt? -77.02 -31.31 56.27 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 177.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.546 ' HA ' ' CD ' ' A' ' 64' ' ' GLU . 39.1 p -86.84 -25.41 24.54 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 177.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.941 HD13 HG11 ' A' ' 10' ' ' VAL . 20.3 mt -77.06 -26.6 53.73 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 176.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.438 ' HA ' HG22 ' A' ' 66' ' ' ILE . 1.3 tp60 -86.05 -24.56 26.31 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 177.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.579 ' HB3' ' O ' ' A' ' 60' ' ' LYS . 1.1 pt-20 -87.14 -15.39 38.54 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 177.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -90.05 -27.96 19.36 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 177.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.438 HG22 ' HA ' ' A' ' 63' ' ' GLN . 0.4 OUTLIER -86.41 -38.24 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.047 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -71.93 -29.74 64.61 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 177.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.435 ' HB2' ' O ' ' A' ' 64' ' ' GLU . 11.8 t70 -69.39 -41.55 76.31 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.413 -0.804 . . . . 0.0 109.181 177.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.29 -46.85 76.21 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.669 -0.645 . . . . 0.0 110.25 179.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 121.08 38.35 0.65 Allowed Glycine 0 N--CA 1.499 2.852 0 C-N-CA 120.043 -1.075 . . . . 0.0 110.856 179.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.676 ' CD2' HD11 ' A' ' 26' ' ' ILE . 59.9 m-85 -131.3 121.67 25.11 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.521 -0.988 . . . . 0.0 108.947 179.002 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -58.99 110.44 1.03 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.241 -0.912 . . . . 0.0 109.621 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.427 ' HA ' ' O ' ' A' ' 13' ' ' SER . . . -124.08 168.19 13.21 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 122.051 0.929 . . . . 0.0 112.029 -178.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.675 ' CG1' ' HB2' ' A' ' 13' ' ' SER . 2.7 p -149.2 91.75 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 178.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.68 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 122.488 1.137 . . . . 0.0 112.157 -177.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.64 ' HB ' HD11 ' A' ' 51' ' ' ILE . 26.7 m . . . . . 0 N--CA 1.506 2.351 0 CA-C-O 121.348 0.594 . . . . 0.0 111.23 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.511 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 0.8 OUTLIER -117.16 167.72 10.93 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.226 -0.921 . . . . 0.0 110.289 179.802 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.534 ' HA ' ' HA ' ' A' ' 51' ' ' ILE . 1.9 m -116.58 136.48 52.94 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.104 -0.997 . . . . 0.0 110.776 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.56 HG23 ' CE1' ' A' ' 52' ' ' TYR . 1.0 OUTLIER -126.58 120.71 56.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.415 -0.803 . . . . 0.0 111.459 -179.396 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.489 ' HA ' ' HA ' ' A' ' 49' ' ' THR . 24.2 m -111.75 104.74 13.1 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 177.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.604 ' HA ' ' HA ' ' A' ' 75' ' ' ILE . 72.6 mt -113.6 138.86 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.258 -0.901 . . . . 0.0 111.391 -178.152 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.747 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 0.7 OUTLIER -74.57 134.02 42.18 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 177.984 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.549 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 23.3 t -120.29 120.71 63.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 121.274 -0.891 . . . . 0.0 110.945 -178.117 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.606 ' CB ' ' HB3' ' A' ' 72' ' ' ASP . 1.7 tm-20 -109.22 -171.58 1.87 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.796 -0.565 . . . . 0.0 109.864 179.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.96 21.96 67.01 Favored Glycine 0 N--CA 1.497 2.712 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -178.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.497 ' CG ' ' HG ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -66.35 154.32 40.35 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.256 -1.144 . . . . 0.0 111.386 -179.494 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.41 ' O ' ' HB3' ' A' ' 19' ' ' CYS . 1.6 p -146.91 -41.15 0.19 Allowed 'General case' 0 N--CA 1.508 2.439 0 O-C-N 121.407 -0.808 . . . . 0.0 111.556 -179.273 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.541 ' O ' HD21 ' A' ' 43' ' ' LEU . 29.5 p -179.79 169.23 1.31 Allowed 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.523 -0.735 . . . . 0.0 109.923 -178.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.558 ' O ' HG12 ' A' ' 23' ' ' VAL . 13.2 t-20 -31.72 -36.88 0.02 OUTLIER 'General case' 0 N--CA 1.512 2.639 0 CA-C-O 121.149 0.5 . . . . 0.0 112.095 179.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.85 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 4.5 p -55.99 -17.3 6.4 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 122.187 0.994 . . . . 0.0 111.354 179.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.686 ' CB ' HD11 ' A' ' 43' ' ' LEU . 62.4 m -93.25 -28.83 16.01 Favored 'General case' 0 C--N 1.287 -2.131 0 O-C-N 119.602 -1.936 . . . . 0.0 110.841 -178.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.66 ' CA ' HD13 ' A' ' 43' ' ' LEU . 10.7 p -85.49 -32.64 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.351 -0.843 . . . . 0.0 109.167 178.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.85 ' CE3' ' HA ' ' A' ' 21' ' ' SER . 0.0 OUTLIER -83.37 -23.07 32.61 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 117.745 -1.582 . . . . 0.0 108.886 178.488 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.629 ' HB ' ' O ' ' A' ' 21' ' ' SER . 1.2 t -82.26 -26.64 33.01 Favored 'General case' 0 N--CA 1.507 2.39 0 C-N-CA 118.722 -1.191 . . . . 0.0 111.061 178.001 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.996 HD11 ' CD2' ' A' ' 71' ' ' PHE . 20.8 mt -96.47 -28.86 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 O-C-N 120.81 -1.181 . . . . 0.0 110.25 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.611 ' HA ' HD11 ' A' ' 39' ' ' ILE . 1.0 OUTLIER -74.54 -35.39 63.12 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 178.369 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.606 ' HB2' ' O ' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -80.86 -31.91 35.18 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 119.423 -0.911 . . . . 0.0 108.607 177.545 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.578 ' HB2' ' O ' ' A' ' 25' ' ' THR . 1.6 tm0? -73.06 -60.44 2.23 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.036 -1.04 . . . . 0.0 110.162 179.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.868 HG21 HG21 ' A' ' 50' ' ' ILE . 88.5 mt -59.34 -39.27 78.55 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 120.945 -1.097 . . . . 0.0 109.952 179.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.75 ' HA2' HG21 ' A' ' 39' ' ' ILE . . . -48.53 -46.44 29.72 Favored Glycine 0 N--CA 1.497 2.741 0 N-CA-C 110.219 -1.152 . . . . 0.0 110.219 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.491 ' HG3' ' O ' ' A' ' 28' ' ' GLN . 0.2 OUTLIER -130.9 40.99 3.42 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.572 -0.958 . . . . 0.0 110.88 179.526 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.519 ' HB ' ' O ' ' A' ' 29' ' ' GLN . 15.0 p -72.76 -40.35 61.04 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.298 0 O-C-N 121.143 -0.973 . . . . 0.0 111.151 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.4 ' N ' HG13 ' A' ' 33' ' ' VAL . 0.3 OUTLIER -171.04 -51.64 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.092 0 O-C-N 120.903 -1.123 . . . . 0.0 111.08 179.844 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -150.12 82.64 0.18 Allowed Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.901 HG22 HD13 ' A' ' 50' ' ' ILE . 54.0 t -139.43 100.89 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.993 ' HB2' HD12 ' A' ' 51' ' ' ILE . 67.6 m-70 -70.09 -27.53 64.68 Favored 'General case' 0 C--N 1.289 -2.043 0 C-N-CA 120.288 -0.565 . . . . 0.0 110.155 -179.281 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.812 ' HB2' HG22 ' A' ' 51' ' ' ILE . 23.8 m-70 -142.78 130.71 21.7 Favored 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.047 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.781 ' C ' HD13 ' A' ' 39' ' ' ILE . 0.0 OUTLIER -127.88 139.08 52.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.081 -1.012 . . . . 0.0 110.252 -179.282 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.538 ' H ' HG22 ' A' ' 50' ' ' ILE . 0.3 OUTLIER -148.31 106.21 3.71 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.165 -0.959 . . . . 0.0 110.227 179.232 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.682 HG21 ' CG2' ' A' ' 26' ' ' ILE . 1.1 p -107.28 170.17 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.619 -0.676 . . . . 0.0 109.411 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.699 ' HB3' ' HB2' ' A' ' 45' ' ' GLU . 2.2 m -152.4 86.02 1.27 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.074 -1.016 . . . . 0.0 111.013 -178.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.686 HD11 ' CB ' ' A' ' 22' ' ' CYS . 1.9 tp -46.13 -34.04 3.97 Favored 'General case' 0 N--CA 1.509 2.489 0 O-C-N 121.768 -0.583 . . . . 0.0 111.617 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.416 ' O ' ' NZ ' ' A' ' 46' ' ' LYS . 14.3 mm-40 -82.75 -41.94 18.59 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.464 -1.397 . . . . 0.0 110.93 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.699 ' HB2' ' HB3' ' A' ' 42' ' ' SER . 18.9 mt-10 -80.37 5.54 14.64 Favored 'General case' 0 N--CA 1.498 1.938 0 C-N-CA 119.762 -0.775 . . . . 0.0 109.76 177.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.549 ' HG3' ' O ' ' A' ' 14' ' ' VAL . 0.0 OUTLIER 42.48 51.38 4.81 Favored 'General case' 0 N--CA 1.506 2.332 0 O-C-N 121.647 -0.658 . . . . 0.0 111.226 179.866 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.452 ' ND2' ' HA ' ' A' ' 13' ' ' SER . 0.4 OUTLIER -154.45 157.06 37.87 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 120.696 -1.252 . . . . 0.0 111.975 -179.382 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.594 ' HB2' HG23 ' A' ' 41' ' ' VAL . . . -136.63 127.16 26.88 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.491 -0.756 . . . . 0.0 109.863 178.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.522 HG22 ' HD3' ' A' ' 40' ' ' LYS . 15.1 t -127.75 119.69 26.31 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.353 -0.842 . . . . 0.0 110.071 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.901 HD13 HG22 ' A' ' 36' ' ' VAL . 1.9 pp -141.88 176.44 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.28 -0.887 . . . . 0.0 111.086 -178.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.993 HD12 ' HB2' ' A' ' 37' ' ' HIS . 0.0 OUTLIER -117.9 150.49 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 177.014 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.599 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 19.6 p90 -154.09 171.69 18.72 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 119.796 -0.762 . . . . 0.0 111.082 -176.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.445 ' HA ' ' HD2' ' A' ' 54' ' ' PRO . 0.4 OUTLIER -86.0 115.77 63.13 Favored Pre-proline 0 C--N 1.3 -1.569 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.294 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.445 ' HD2' ' HA ' ' A' ' 53' ' ' ASP . 37.5 Cg_endo -60.17 -22.64 70.94 Favored 'Trans proline' 0 N--CA 1.493 1.457 0 O-C-N 123.587 1.309 . . . . 0.0 110.035 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.4 ptpp? -79.95 -8.98 59.63 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.729 -0.607 . . . . 0.0 110.471 178.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -131.44 -46.64 0.98 Allowed 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.073 -1.017 . . . . 0.0 110.826 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -110.87 154.8 23.52 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.175 -0.953 . . . . 0.0 110.277 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.777 ' HB ' ' HD2' ' A' ' 59' ' ' PRO . 12.2 p -143.46 176.07 2.5 Favored Pre-proline 0 N--CA 1.499 1.982 0 O-C-N 121.488 -0.758 . . . . 0.0 110.456 -179.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.777 ' HD2' ' HB ' ' A' ' 58' ' ' THR . 40.0 Cg_endo -65.26 -23.35 59.55 Favored 'Trans proline' 0 N--CA 1.497 1.717 0 O-C-N 123.317 1.167 . . . . 0.0 112.199 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.542 ' O ' ' HB3' ' A' ' 64' ' ' GLU . 4.7 mmtm -90.47 -29.39 17.97 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.092 -1.005 . . . . 0.0 110.188 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.411 ' OG1' ' N ' ' A' ' 58' ' ' THR . 8.3 p -82.27 -25.84 33.7 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 177.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.552 HD13 ' CB ' ' A' ' 10' ' ' VAL . 0.9 OUTLIER -77.03 -27.91 54.7 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 176.676 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -82.62 -24.5 33.81 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 177.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.542 ' HB3' ' O ' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -84.7 -19.47 32.72 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 177.575 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -79.49 -30.54 42.05 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 176.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.492 HD13 HG22 ' A' ' 14' ' ' VAL . 32.3 mt -79.53 -37.58 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 176.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.458 ' HB2' ' HA ' ' A' ' 64' ' ' GLU . 0.9 OUTLIER -70.79 -29.35 65.53 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 176.778 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -69.73 -47.59 62.54 Favored 'General case' 0 N--CA 1.501 2.1 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 177.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.553 ' HE3' ' HB2' ' A' ' 29' ' ' GLN . 0.0 OUTLIER -56.53 -36.43 69.22 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.584 -0.698 . . . . 0.0 109.777 179.252 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 120.28 34.99 0.9 Allowed Glycine 0 N--CA 1.494 2.544 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 179.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.996 ' CD2' HD11 ' A' ' 26' ' ' ILE . 95.0 m-85 -135.99 144.09 45.16 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.306 -1.114 . . . . 0.0 110.546 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.606 ' HB3' ' CB ' ' A' ' 15' ' ' GLU . 5.2 t70 -60.52 129.78 43.3 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.344 -0.847 . . . . 0.0 109.972 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -108.76 116.98 33.01 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.459 -0.775 . . . . 0.0 110.565 -179.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.747 ' HB ' ' HB2' ' A' ' 13' ' ' SER . 53.1 t -123.12 73.07 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 CA-C-O 122.138 0.971 . . . . 0.0 108.742 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.604 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . 38.1 mt . . . . . 0 N--CA 1.499 1.985 0 CA-C-O 121.827 0.822 . . . . 0.0 112.472 -178.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.638 HG11 ' CD1' ' A' ' 51' ' ' ILE . 9.1 t . . . . . 0 N--CA 1.499 1.987 0 CA-C-O 121.077 0.465 . . . . 0.0 110.041 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.494 ' HB3' ' CZ ' ' A' ' 52' ' ' TYR . 2.9 t-20 -115.24 169.88 8.8 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.058 -1.026 . . . . 0.0 110.92 -179.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.658 ' HA ' ' HA ' ' A' ' 51' ' ' ILE . 26.0 p -129.46 128.97 43.99 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.427 -0.796 . . . . 0.0 110.39 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.689 HG11 HD13 ' A' ' 62' ' ' LEU . 1.2 t -123.48 137.13 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 CA-C-O 121.632 0.73 . . . . 0.0 110.88 -178.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.522 ' HA ' ' HA ' ' A' ' 49' ' ' THR . 4.3 m -118.59 121.13 39.46 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.915 HG12 HD12 ' A' ' 75' ' ' ILE . 25.6 mt -110.56 118.45 57.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.365 -0.835 . . . . 0.0 111.549 -177.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.469 ' O ' ' HA ' ' A' ' 73' ' ' ALA . 1.1 m -71.89 114.8 10.37 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 177.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.621 ' HA ' ' O ' ' A' ' 72' ' ' ASP . 20.5 t -114.52 130.66 68.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.166 -0.959 . . . . 0.0 111.404 -177.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.69 ' HA ' ' HG2' ' A' ' 46' ' ' LYS . 2.6 mm-40 -112.54 -15.32 13.07 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.14 -0.975 . . . . 0.0 111.521 179.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -79.71 33.44 2.11 Favored Glycine 0 N--CA 1.499 2.866 0 O-C-N 120.845 -1.159 . . . . 0.0 111.493 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.667 ' HG3' ' HA ' ' A' ' 46' ' ' LYS . 32.6 mmt -77.25 75.99 3.8 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 120.682 -1.481 . . . . 0.0 109.486 178.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.442 HG23 ' H ' ' A' ' 18' ' ' THR . 17.4 p -52.76 -33.78 50.04 Favored 'General case' 0 N--CA 1.51 2.56 0 O-C-N 121.418 -0.802 . . . . 0.0 111.767 -179.017 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.515 ' O ' HD21 ' A' ' 43' ' ' LEU . 22.5 p 179.13 164.4 0.9 Allowed 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.61 ' HA ' ' HG ' ' A' ' 43' ' ' LEU . 17.4 m120 -38.58 -32.91 0.09 Allowed 'General case' 0 N--CA 1.509 2.51 0 CA-C-N 117.844 0.293 . . . . 0.0 111.475 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.531 ' HA ' ' HE3' ' A' ' 24' ' ' TRP . 5.0 p -52.09 -19.03 1.68 Allowed 'General case' 0 N--CA 1.507 2.406 0 O-C-N 121.095 -1.003 . . . . 0.0 111.208 177.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.661 ' HB3' ' CE1' ' A' ' 71' ' ' PHE . 84.6 m -88.92 -22.04 23.31 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.375 -0.828 . . . . 0.0 109.406 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.738 ' HB ' HD23 ' A' ' 43' ' ' LEU . 0.9 OUTLIER -80.56 -35.85 15.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 106.714 -1.588 . . . . 0.0 106.714 177.467 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.54 ' CZ3' ' CB ' ' A' ' 20' ' ' ASN . 4.2 m-90 -74.87 -30.7 61.4 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.028 -1.069 . . . . 0.0 109.188 178.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.512 ' O ' ' HB2' ' A' ' 29' ' ' GLN . 0.5 OUTLIER -80.73 -19.16 45.6 Favored 'General case' 0 N--CA 1.505 2.281 0 C-N-CA 119.701 -0.8 . . . . 0.0 110.849 179.232 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.47 ' O ' ' HB ' ' A' ' 30' ' ' ILE . 7.8 mm -100.15 -21.17 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 O-C-N 121.179 -0.95 . . . . 0.0 109.519 179.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.506 ' HB3' ' O ' ' A' ' 23' ' ' VAL . 0.1 OUTLIER -78.82 -36.16 43.04 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 177.309 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.44 ' HB2' ' O ' ' A' ' 24' ' ' TRP . 0.8 OUTLIER -81.06 -36.93 29.85 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 119.82 -0.752 . . . . 0.0 109.492 177.769 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.512 ' HB2' ' O ' ' A' ' 25' ' ' THR . 1.1 tm0? -74.1 -62.32 1.55 Allowed 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 118.94 -1.104 . . . . 0.0 110.257 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.47 ' HB ' ' O ' ' A' ' 26' ' ' ILE . 41.4 mm -61.39 -45.16 99.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.12 -0.988 . . . . 0.0 109.264 179.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -50.64 -35.78 30.77 Favored Glycine 0 N--CA 1.501 3.002 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 178.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.449 ' HA ' ' HD3' ' A' ' 32' ' ' LYS . 12.1 mmtm -128.25 34.57 4.54 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.145 -1.209 . . . . 0.0 110.565 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.487 ' HB ' ' O ' ' A' ' 29' ' ' GLN . 8.7 p -74.86 -41.53 46.67 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.017 -1.052 . . . . 0.0 111.799 -178.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.417 ' N ' HG13 ' A' ' 33' ' ' VAL . 6.2 t-20 -175.95 -54.86 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.113 0 O-C-N 120.903 -1.123 . . . . 0.0 111.08 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -144.09 80.12 0.24 Allowed Glycine 0 N--CA 1.494 2.56 0 N-CA-C 108.763 -1.735 . . . . 0.0 108.763 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.724 HG22 HD11 ' A' ' 50' ' ' ILE . 28.7 t -133.82 88.78 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 CA-C-O 122.265 1.031 . . . . 0.0 110.076 -179.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 1.024 ' HB2' HD11 ' A' ' 51' ' ' ILE . 33.1 m-70 -67.16 -27.44 67.29 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.669 ' HB2' HG12 ' A' ' 51' ' ' ILE . 42.0 m-70 -141.16 125.57 17.62 Favored 'General case' 0 N--CA 1.5 2.025 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.153 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.825 ' C ' HD13 ' A' ' 39' ' ' ILE . 0.0 OUTLIER -126.41 135.28 64.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.101 -0.999 . . . . 0.0 109.8 -179.537 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.493 ' NZ ' ' O ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -130.06 121.7 26.91 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.966 -1.083 . . . . 0.0 110.593 -179.868 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.686 HG11 ' HA ' ' A' ' 23' ' ' VAL . 2.0 t -109.21 163.51 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 178.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.642 ' HB3' ' HB2' ' A' ' 45' ' ' GLU . 0.6 OUTLIER -151.0 85.49 1.35 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.062 -1.023 . . . . 0.0 110.47 -178.864 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.738 HD23 ' HB ' ' A' ' 23' ' ' VAL . 0.2 OUTLIER -52.86 -58.02 8.32 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.713 -0.617 . . . . 0.0 111.372 -179.586 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.9 mp0 -69.69 -44.51 70.27 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.185 -0.947 . . . . 0.0 110.668 -179.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.642 ' HB2' ' HB3' ' A' ' 42' ' ' SER . 1.3 mt-10 -76.81 7.29 4.87 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 120.008 -0.677 . . . . 0.0 110.413 178.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.69 ' HG2' ' HA ' ' A' ' 15' ' ' GLU . 0.0 OUTLIER 36.6 66.8 0.37 Allowed 'General case' 0 N--CA 1.5 2.046 0 CA-C-O 121.544 0.688 . . . . 0.0 111.754 178.994 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -157.79 145.18 18.36 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 120.693 -1.254 . . . . 0.0 112.51 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.513 ' HB3' ' HB ' ' A' ' 12' ' ' ILE . . . -124.0 109.15 13.18 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.574 -0.703 . . . . 0.0 109.126 179.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.522 ' HA ' ' HA ' ' A' ' 11' ' ' THR . 0.8 OUTLIER -114.92 142.53 46.47 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.047 -1.033 . . . . 0.0 109.194 179.988 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.724 HD11 HG22 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -165.25 157.13 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 120.71 -1.244 . . . . 0.0 110.724 -178.92 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 1.024 HD11 ' HB2' ' A' ' 37' ' ' HIS . 1.6 pp -107.08 159.91 6.56 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 O-C-N 121.275 -0.891 . . . . 0.0 109.301 179.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.631 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 6.8 p90 -161.73 166.05 27.17 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.229 -0.919 . . . . 0.0 111.732 -176.013 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.31 113.05 17.31 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.651 -0.656 . . . . 0.0 110.63 179.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.49 ' HD3' ' N ' ' A' ' 8' ' ' ASN . 46.0 Cg_endo -70.25 67.16 2.04 Favored 'Trans proline' 0 N--CA 1.489 1.224 0 O-C-N 123.964 1.507 . . . . 0.0 109.039 179.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.54 -46.88 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 121.419 0.628 . . . . 0.0 109.425 -178.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.405 HD23 ' N ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -98.37 -25.57 14.77 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.603 -0.686 . . . . 0.0 109.997 179.357 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.415 ' HG3' ' N ' ' A' ' 58' ' ' THR . 2.3 tp60 -129.53 145.72 51.43 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.222 -0.924 . . . . 0.0 110.0 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.567 ' HB ' ' HD2' ' A' ' 59' ' ' PRO . 7.6 p -135.24 166.44 28.96 Favored Pre-proline 0 N--CA 1.504 2.272 0 O-C-N 121.045 -1.035 . . . . 0.0 110.783 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.567 ' HD2' ' HB ' ' A' ' 58' ' ' THR . 37.8 Cg_endo -62.06 -21.35 72.26 Favored 'Trans proline' 0 N--CA 1.493 1.499 0 O-C-N 123.957 1.504 . . . . 0.0 110.55 179.041 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.83 -38.02 54.6 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 177.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.608 ' HA ' ' HB2' ' A' ' 64' ' ' GLU . 34.4 p -77.74 -27.21 50.4 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 177.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.689 HD13 HG11 ' A' ' 10' ' ' VAL . 17.6 mt -73.02 -27.45 61.78 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 176.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.696 ' HG2' HD13 ' A' ' 75' ' ' ILE . 9.1 mm100 -85.62 -19.02 31.62 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 177.302 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.608 ' HB2' ' HA ' ' A' ' 61' ' ' THR . 4.8 mt-10 -90.36 -18.37 25.64 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 177.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.423 ' HB1' HG21 ' A' ' 33' ' ' VAL . . . -87.8 -29.63 20.83 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 177.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.596 HG12 ' HB2' ' A' ' 73' ' ' ALA . 6.9 tp -80.54 -31.61 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 177.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.434 ' HB2' ' O ' ' A' ' 63' ' ' GLN . 15.2 t70 -72.22 -29.84 64.33 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 176.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -64.52 -48.96 73.15 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.939 -0.475 . . . . 0.0 110.294 179.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.415 ' HB3' ' HD2' ' A' ' 71' ' ' PHE . 5.1 tpt -67.82 -36.94 81.28 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.349 -0.845 . . . . 0.0 110.6 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 108.74 59.1 0.54 Allowed Glycine 0 N--CA 1.498 2.795 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 179.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.661 ' CE1' ' HB3' ' A' ' 22' ' ' CYS . 43.0 m-85 -139.17 122.04 16.58 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.516 -0.991 . . . . 0.0 110.379 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.621 ' O ' ' HA ' ' A' ' 14' ' ' VAL . 6.3 t70 -54.06 104.03 0.1 Allowed 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.546 -0.721 . . . . 0.0 109.186 179.077 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.78 ' HB1' ' CG2' ' A' ' 12' ' ' ILE . . . -116.73 147.12 42.3 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 122.129 0.966 . . . . 0.0 112.596 -177.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.432 ' N ' ' O ' ' A' ' 13' ' ' SER . 46.1 t -138.07 81.55 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 CA-C-O 122.011 0.91 . . . . 0.0 108.585 179.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.915 HD12 HG12 ' A' ' 12' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.485 0 CA-C-O 122.679 1.228 . . . . 0.0 112.789 -178.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.499 1.984 0 CA-C-O 120.863 0.363 . . . . 0.0 110.382 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -120.68 72.74 22.0 Favored Pre-proline 0 N--CA 1.498 1.958 0 O-C-N 121.496 -0.753 . . . . 0.0 111.118 -179.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -70.84 -19.87 30.43 Favored 'Trans proline' 0 C--N 1.314 -1.276 0 N-CA-C 108.396 -1.425 . . . . 0.0 108.396 177.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.583 ' HA ' ' CG2' ' A' ' 7' ' ' VAL . 2.6 m -177.43 40.67 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.7 -0.625 . . . . 0.0 109.379 179.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -39.24 -40.74 0.79 Allowed 'General case' 0 N--CA 1.506 2.342 0 O-C-N 121.646 -0.659 . . . . 0.0 112.343 -179.058 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -141.98 47.33 0.84 Allowed Glycine 0 N--CA 1.498 2.78 0 C-N-CA 119.781 -1.2 . . . . 0.0 111.197 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.748 ' HB ' HD11 ' A' ' 51' ' ' ILE . 1.7 m -141.18 176.81 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.463 0 CA-C-N 118.179 0.99 . . . . 0.0 110.298 178.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.47 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 0.5 OUTLIER -135.8 165.99 24.32 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.957 -1.089 . . . . 0.0 111.034 -179.827 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.614 ' HA ' ' HA ' ' A' ' 51' ' ' ILE . 38.0 t -114.4 150.68 34.28 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.232 -0.917 . . . . 0.0 111.421 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.626 HG21 ' HB3' ' A' ' 59' ' ' PRO . 0.9 OUTLIER -144.17 130.22 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.783 -0.573 . . . . 0.0 110.559 -179.234 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.594 HG23 ' HB ' ' A' ' 49' ' ' THR . 90.2 m -109.22 122.25 46.92 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.538 0.685 . . . . 0.0 110.595 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 1.032 HG12 HG22 ' A' ' 75' ' ' ILE . 45.9 mt -109.61 121.61 62.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.568 -0.707 . . . . 0.0 111.239 -178.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.655 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 1.4 m -70.71 133.28 46.48 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 177.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.516 HG12 ' HG2' ' A' ' 17' ' ' MET . 2.1 t -127.03 161.06 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.11 -0.994 . . . . 0.0 111.083 -178.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.83 158.65 35.58 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.493 -0.754 . . . . 0.0 110.728 178.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 73.93 20.99 79.71 Favored Glycine 0 N--CA 1.497 2.706 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.768 ' HE2' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -128.87 28.93 5.29 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.891 -1.358 . . . . 0.0 110.806 -179.816 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.8 m -71.59 49.17 0.16 Allowed 'General case' 0 N--CA 1.501 2.114 0 O-C-N 120.918 -1.114 . . . . 0.0 111.243 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.487 ' O ' ' N ' ' A' ' 21' ' ' SER . 0.0 OUTLIER -150.56 118.55 6.27 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.879 -1.138 . . . . 0.0 108.896 178.844 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.488 ' O ' HG12 ' A' ' 23' ' ' VAL . 76.5 m-20 -14.97 -51.55 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.761 0 C-N-CA 123.742 0.817 . . . . 0.0 113.115 -178.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.864 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 3.7 p -52.1 -14.46 0.42 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.399 -0.813 . . . . 0.0 112.973 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.766 ' HB2' HD22 ' A' ' 43' ' ' LEU . 63.8 m -91.63 -24.77 19.44 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 119.121 -2.237 . . . . 0.0 110.65 -179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.843 HG23 HG13 ' A' ' 41' ' ' VAL . 1.6 p -87.8 -34.98 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.53 -0.731 . . . . 0.0 109.231 179.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.864 ' CE3' ' HA ' ' A' ' 21' ' ' SER . 0.0 OUTLIER -81.79 -22.67 37.0 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 117.687 -1.605 . . . . 0.0 109.094 178.828 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.687 HG23 ' HE2' ' A' ' 69' ' ' MET . 0.6 OUTLIER -87.6 -24.68 23.9 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 120.94 -1.1 . . . . 0.0 110.812 178.027 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.649 HD12 HD12 ' A' ' 66' ' ' ILE . 12.5 mm -92.78 -26.53 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.388 0 O-C-N 120.874 -1.142 . . . . 0.0 109.656 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.705 ' HG2' HD12 ' A' ' 39' ' ' ILE . 4.4 tm-20 -78.83 -40.22 33.37 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 177.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.423 ' HB2' ' O ' ' A' ' 24' ' ' TRP . 68.9 mm-40 -70.44 -33.79 71.73 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 119.361 -0.936 . . . . 0.0 109.287 178.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.532 ' HA ' ' OE1' ' A' ' 29' ' ' GLN . 4.3 tp60 -75.89 -62.16 1.68 Allowed 'General case' 0 N--CA 1.496 1.849 0 C-N-CA 119.61 -0.836 . . . . 0.0 110.586 179.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.861 HG21 HG21 ' A' ' 50' ' ' ILE . 51.1 mt -60.85 -50.5 80.26 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 O-C-N 120.994 -1.066 . . . . 0.0 109.841 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -47.73 -44.2 23.33 Favored Glycine 0 N--CA 1.5 2.917 0 N-CA-C 110.849 -0.901 . . . . 0.0 110.849 179.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.01 16.86 24.46 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.98 -1.306 . . . . 0.0 112.447 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.496 HG21 ' HB2' ' A' ' 65' ' ' ALA . 0.5 OUTLIER -65.79 -42.3 92.04 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.175 0 O-C-N 120.89 -1.131 . . . . 0.0 111.061 -179.908 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.428 ' N ' HG12 ' A' ' 33' ' ' VAL . 0.1 OUTLIER -163.04 -76.75 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.222 -0.924 . . . . 0.0 110.784 -179.747 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.549 ' O ' ' HA ' ' A' ' 52' ' ' TYR . . . -141.39 75.84 0.33 Allowed Glycine 0 N--CA 1.495 2.567 0 N-CA-C 108.758 -1.737 . . . . 0.0 108.758 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.84 HG22 HD13 ' A' ' 50' ' ' ILE . 41.1 t -103.04 91.43 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 CA-C-O 122.665 1.221 . . . . 0.0 108.128 179.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.94 ' HB2' HD12 ' A' ' 51' ' ' ILE . 63.2 m-70 -61.67 -14.27 29.82 Favored 'General case' 0 C--N 1.283 -2.325 0 CA-C-N 114.827 -1.079 . . . . 0.0 110.627 -179.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.567 ' HB3' ' CG2' ' A' ' 51' ' ' ILE . 6.8 t60 -170.83 121.1 0.56 Allowed 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.817 ' HB ' HG11 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -122.07 128.8 75.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.268 -0.895 . . . . 0.0 109.565 -179.438 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.481 ' HD3' HG22 ' A' ' 49' ' ' THR . 0.0 OUTLIER -125.19 99.83 6.26 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.599 -1.313 . . . . 0.0 111.445 -179.615 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.843 HG13 HG23 ' A' ' 23' ' ' VAL . 15.0 p -107.41 153.97 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 177.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.845 ' HB3' ' HB3' ' A' ' 45' ' ' GLU . 0.2 OUTLIER -153.15 94.33 1.82 Allowed 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.103 -0.998 . . . . 0.0 110.763 -178.057 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.768 ' HA ' ' HE2' ' A' ' 17' ' ' MET . 14.5 mt -46.83 -25.17 0.7 Allowed 'General case' 0 N--CA 1.508 2.436 0 O-C-N 121.923 -0.486 . . . . 0.0 112.016 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.574 ' HG2' ' N ' ' A' ' 45' ' ' GLU . 0.4 OUTLIER -96.92 -38.48 9.8 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 120.4 -1.437 . . . . 0.0 111.332 179.651 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.845 ' HB3' ' HB3' ' A' ' 42' ' ' SER . 0.2 OUTLIER -74.61 -4.2 35.72 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.202 -0.936 . . . . 0.0 108.802 177.476 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.9 mptt 56.66 34.88 25.28 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.271 -0.893 . . . . 0.0 112.961 177.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -148.19 151.32 35.32 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.534 -1.353 . . . . 0.0 112.071 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.437 ' HA ' ' HA ' ' A' ' 41' ' ' VAL . . . -130.84 103.28 6.48 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.594 ' HB ' HG23 ' A' ' 11' ' ' THR . 14.8 t -116.55 134.72 54.51 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.233 -0.917 . . . . 0.0 110.376 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.954 HD11 HD21 ' A' ' 62' ' ' LEU . 1.3 pp -144.85 -178.71 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-O 121.621 0.724 . . . . 0.0 110.785 -178.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.94 HD12 ' HB2' ' A' ' 37' ' ' HIS . 0.0 OUTLIER -121.59 145.38 28.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 177.918 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.744 ' N ' HD13 ' A' ' 51' ' ' ILE . 13.7 p90 -149.2 165.82 30.7 Favored 'General case' 0 C--N 1.296 -1.761 0 O-C-N 121.245 -0.909 . . . . 0.0 111.347 -177.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.447 ' HA ' HG12 ' A' ' 7' ' ' VAL . 0.3 OUTLIER -84.5 107.14 10.09 Favored Pre-proline 0 N--CA 1.49 1.539 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.701 179.924 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.547 ' HD2' ' HA ' ' A' ' 7' ' ' VAL . 48.2 Cg_endo -75.11 -9.12 20.48 Favored 'Trans proline' 0 C--N 1.319 -1.018 0 O-C-N 123.624 1.328 . . . . 0.0 109.75 178.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 8.8 mtmm -74.18 -35.97 64.01 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.5 pp -121.4 -17.16 7.68 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.523 -0.736 . . . . 0.0 111.44 179.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.517 ' O ' ' HA ' ' A' ' 54' ' ' PRO . 2.7 mm-40 -131.58 -179.39 5.35 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.796 -1.19 . . . . 0.0 110.484 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.542 ' OG1' ' HD2' ' A' ' 59' ' ' PRO . 0.5 OUTLIER -164.22 173.5 3.96 Favored Pre-proline 0 N--CA 1.497 1.914 0 O-C-N 120.874 -1.141 . . . . 0.0 110.01 -179.993 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.626 ' HB3' HG21 ' A' ' 10' ' ' VAL . 37.9 Cg_endo -62.78 8.32 0.13 Allowed 'Trans proline' 0 N--CA 1.502 1.972 0 C-N-CA 121.227 1.285 . . . . 0.0 113.258 -179.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.555 ' HG3' ' N ' ' A' ' 61' ' ' THR . 0.2 OUTLIER -90.68 -28.27 18.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.973 -1.08 . . . . 0.0 108.525 177.773 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.555 ' N ' ' HG3' ' A' ' 60' ' ' LYS . 0.8 OUTLIER -85.85 -27.69 24.91 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 177.953 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.954 HD21 HD11 ' A' ' 50' ' ' ILE . 4.5 mp -72.15 -27.62 62.72 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 176.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.483 ' O ' ' HB2' ' A' ' 67' ' ' ASP . 14.2 tp60 -86.65 -20.21 28.14 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 177.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.537 ' HB3' ' O ' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -91.28 -22.15 20.71 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.159 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.496 ' HB2' HG21 ' A' ' 33' ' ' VAL . . . -85.27 -27.66 25.85 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.676 HG12 ' HB2' ' A' ' 73' ' ' ALA . 2.1 tp -85.17 -32.73 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 177.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.483 ' HB2' ' O ' ' A' ' 63' ' ' GLN . 27.8 t70 -74.37 -32.28 62.68 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 177.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.407 ' HB3' ' O ' ' A' ' 64' ' ' GLU . 0.2 OUTLIER -70.5 -43.39 69.79 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.878 -0.514 . . . . 0.0 109.868 178.915 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.687 ' HE2' HG23 ' A' ' 25' ' ' THR . 23.6 mmm -59.86 -46.72 88.38 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.18 -0.95 . . . . 0.0 109.996 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 114.54 51.42 0.46 Allowed Glycine 0 N--CA 1.499 2.846 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.592 ' CD1' ' HB3' ' A' ' 17' ' ' MET . 75.1 m-85 -139.27 130.18 26.29 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.69 -0.888 . . . . 0.0 109.526 179.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.495 ' O ' ' HA ' ' A' ' 14' ' ' VAL . 1.7 m-20 -49.9 111.32 0.49 Allowed 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.433 -0.792 . . . . 0.0 110.045 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.676 ' HB2' HG12 ' A' ' 66' ' ' ILE . . . -109.77 127.26 54.52 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.185 -0.947 . . . . 0.0 111.582 -178.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.655 ' HB ' ' HB2' ' A' ' 13' ' ' SER . 75.5 t -131.67 76.4 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.487 -0.758 . . . . 0.0 109.071 178.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 1.032 HG22 HG12 ' A' ' 12' ' ' ILE . 33.3 pt -58.73 138.38 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 CA-C-O 121.763 0.792 . . . . 0.0 110.861 -179.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.45 ' O ' ' ND1' ' A' ' 76' ' ' HIS . 13.3 p80 -130.14 45.06 2.87 Favored 'General case' 0 N--CA 1.5 2.064 0 CA-C-O 121.459 0.647 . . . . 0.0 110.824 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.53 ' HB3' ' HD3' ' A' ' 78' ' ' PRO . 0.3 OUTLIER -109.93 -66.2 0.03 OUTLIER Pre-proline 0 N--CA 1.496 1.863 0 O-C-N 121.228 -0.92 . . . . 0.0 111.095 179.997 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.53 ' HD3' ' HB3' ' A' ' 77' ' ' ASN . 44.5 Cg_endo -75.0 -28.54 9.07 Favored 'Trans proline' 0 N--CA 1.488 1.152 0 O-C-N 123.113 1.06 . . . . 0.0 110.78 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 . . . . . 0 N--CA 1.486 1.334 0 CA-C-O 118.372 -0.823 . . . . 0.0 110.471 -179.764 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.795 0 CA-C-O 120.821 0.344 . . . . 0.0 110.18 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 47.24 66.93 4.99 Favored Pre-proline 0 N--CA 1.504 2.253 0 O-C-N 121.822 -0.549 . . . . 0.0 111.87 179.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -71.25 -17.46 31.07 Favored 'Trans proline' 0 C--N 1.313 -1.333 0 O-C-N 123.463 1.244 . . . . 0.0 109.114 177.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 95.3 p -135.95 -2.49 2.34 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.49 -0.757 . . . . 0.0 111.599 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 1.4 mtm 48.98 33.19 4.37 Favored 'General case' 0 N--CA 1.504 2.26 0 O-C-N 121.238 -0.913 . . . . 0.0 111.187 -179.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.507 ' O ' ' HB ' ' A' ' 7' ' ' VAL . . . 64.76 28.42 73.32 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 1.071 HG11 HD11 ' A' ' 51' ' ' ILE . 12.9 t 69.08 158.4 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.344 0 CA-C-N 117.778 0.789 . . . . 0.0 110.446 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.406 ' O ' HG12 ' A' ' 51' ' ' ILE . 9.8 m120 -124.6 166.3 16.35 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 120.785 -1.197 . . . . 0.0 111.306 -179.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.616 ' HA ' ' HA ' ' A' ' 51' ' ' ILE . 2.5 m -120.29 145.68 46.85 Favored 'General case' 0 N--CA 1.505 2.294 0 O-C-N 121.088 -1.007 . . . . 0.0 111.833 -179.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.457 HG21 ' HA ' ' A' ' 59' ' ' PRO . 1.0 OUTLIER -134.24 140.97 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.639 -0.663 . . . . 0.0 110.891 -179.29 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.604 ' HA ' ' HA ' ' A' ' 49' ' ' THR . 2.9 m -118.91 130.35 55.68 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.229 -0.919 . . . . 0.0 110.151 178.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.706 ' HA ' ' HA ' ' A' ' 75' ' ' ILE . 51.9 mt -122.74 133.02 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.363 -0.836 . . . . 0.0 111.553 -178.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.563 ' HB3' ' CG1' ' A' ' 74' ' ' VAL . 0.1 OUTLIER -87.75 117.2 26.42 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.071 -1.018 . . . . 0.0 108.703 178.129 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.568 HG13 ' O ' ' A' ' 14' ' ' VAL . 14.6 p -112.21 108.43 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 O-C-N 121.179 -0.951 . . . . 0.0 110.408 -178.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.577 ' HA ' ' HD2' ' A' ' 46' ' ' LYS . 0.1 OUTLIER -108.34 -32.11 7.58 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.052 -1.03 . . . . 0.0 112.008 -178.6 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -70.03 30.97 0.41 Allowed Glycine 0 N--CA 1.502 3.066 0 C-N-CA 120.423 -0.894 . . . . 0.0 112.255 -179.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.824 ' SD ' HD12 ' A' ' 43' ' ' LEU . 13.2 ptp -90.75 -173.21 3.64 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.474 -1.603 . . . . 0.0 109.799 178.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 16.9 p -147.22 -27.65 0.38 Allowed 'General case' 0 N--CA 1.514 2.745 0 O-C-N 121.248 -0.908 . . . . 0.0 112.283 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.434 ' CA ' HD11 ' A' ' 43' ' ' LEU . 19.5 p -179.7 176.44 0.78 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.109 -0.994 . . . . 0.0 108.55 -179.048 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.633 ' HB3' ' CZ3' ' A' ' 24' ' ' TRP . 4.3 m120 -43.31 -31.69 0.68 Allowed 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.773 -0.579 . . . . 0.0 110.618 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.546 ' HA ' ' HE3' ' A' ' 24' ' ' TRP . 3.7 p -54.12 -26.29 26.68 Favored 'General case' 0 N--CA 1.506 2.339 0 O-C-N 121.06 -1.025 . . . . 0.0 110.398 178.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.824 ' O ' HD12 ' A' ' 26' ' ' ILE . 80.7 m -91.49 -25.81 19.1 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.701 0.762 . . . . 0.0 108.977 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.685 HG21 ' HB2' ' A' ' 43' ' ' LEU . 12.0 t -79.47 -41.62 22.49 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 176.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.633 ' CZ3' ' HB3' ' A' ' 20' ' ' ASN . 2.1 m0 -60.79 -40.47 92.75 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 176.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.421 HG21 ' HE2' ' A' ' 71' ' ' PHE . 40.2 m -66.7 -31.05 71.47 Favored 'General case' 0 N--CA 1.502 2.127 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.608 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.824 HD12 ' O ' ' A' ' 22' ' ' CYS . 2.1 mt -99.07 -17.22 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.225 0 O-C-N 121.142 -0.974 . . . . 0.0 110.902 -179.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.691 ' HG3' HD12 ' A' ' 39' ' ' ILE . 1.1 tt0 -87.67 -31.66 19.63 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 177.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.495 ' HB3' ' O ' ' A' ' 24' ' ' TRP . 1.1 tm0? -80.41 -39.49 28.22 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 178.016 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.423 ' HB2' ' SD ' ' A' ' 69' ' ' MET . 7.2 mm100 -70.6 -60.02 2.5 Favored 'General case' 0 N--CA 1.502 2.154 0 C-N-CA 119.251 -0.98 . . . . 0.0 110.352 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.485 ' HB ' HG13 ' A' ' 39' ' ' ILE . 45.4 mm -60.58 -42.38 91.37 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.113 -0.992 . . . . 0.0 110.497 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -51.73 -45.93 54.6 Favored Glycine 0 N--CA 1.5 2.961 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.4 mttt -114.98 27.53 9.34 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.331 -1.099 . . . . 0.0 111.494 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.471 HG13 ' N ' ' A' ' 34' ' ' ASN . 12.2 p -66.46 -43.26 91.09 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 O-C-N 120.887 -1.133 . . . . 0.0 111.449 -179.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.528 ' HB3' ' HG2' ' A' ' 57' ' ' GLN . 0.7 OUTLIER -178.86 -52.13 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.109 -0.995 . . . . 0.0 110.777 179.847 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.419 ' HA3' HD23 ' A' ' 56' ' ' LEU . . . -148.24 81.74 0.2 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -179.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.856 HG22 HD11 ' A' ' 50' ' ' ILE . 38.8 t -133.07 97.4 2.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 1.031 ' HB2' HD12 ' A' ' 51' ' ' ILE . 59.5 m-70 -72.1 -29.28 63.94 Favored 'General case' 0 C--N 1.289 -2.063 0 C-N-CA 120.043 -0.663 . . . . 0.0 109.818 -179.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.718 ' HB2' HG22 ' A' ' 51' ' ' ILE . 24.7 m-70 -144.57 117.23 8.66 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.786 ' HB ' HG11 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -117.79 126.02 74.52 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 179.391 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.625 ' HB3' HG22 ' A' ' 49' ' ' THR . 2.1 tmtm? -126.52 119.54 27.39 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.616 -1.303 . . . . 0.0 111.01 -179.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.492 ' O ' ' NZ ' ' A' ' 40' ' ' LYS . 47.0 t -107.29 170.77 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 178.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.698 ' HB3' ' HB2' ' A' ' 45' ' ' GLU . 0.6 OUTLIER -149.82 85.25 1.42 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.683 -1.261 . . . . 0.0 110.67 -179.51 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.824 HD12 ' SD ' ' A' ' 17' ' ' MET . 20.0 tp -42.53 -43.1 3.58 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.2 mp0 -82.92 -44.24 15.58 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.154 -0.966 . . . . 0.0 111.771 -178.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.698 ' HB2' ' HB3' ' A' ' 42' ' ' SER . 5.8 mt-10 -80.03 8.94 6.09 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.195 -0.941 . . . . 0.0 110.344 179.133 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.577 ' HD2' ' HA ' ' A' ' 15' ' ' GLU . 8.1 mmtp 37.15 59.47 1.11 Allowed 'General case' 0 N--CA 1.504 2.253 0 CA-C-O 121.528 0.68 . . . . 0.0 110.967 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.425 ' HA ' ' H ' ' A' ' 14' ' ' VAL . 12.5 t-20 -159.08 149.08 19.14 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.031 -1.043 . . . . 0.0 111.202 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.532 ' HA ' ' O ' ' A' ' 40' ' ' LYS . . . -139.41 122.31 16.62 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.4 -0.813 . . . . 0.0 110.745 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.625 HG22 ' HB3' ' A' ' 40' ' ' LYS . 6.9 t -113.59 151.93 31.01 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.302 -0.874 . . . . 0.0 109.539 178.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.856 HD11 HG22 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -160.13 157.23 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.026 -1.046 . . . . 0.0 111.954 -177.932 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 1.071 HD11 HG11 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -109.89 152.85 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.587 -0.696 . . . . 0.0 109.27 178.378 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.556 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 33.9 p90 -158.04 160.16 37.11 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.899 -0.72 . . . . 0.0 111.874 -177.056 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.431 ' HA ' ' HD2' ' A' ' 54' ' ' PRO . 5.1 t0 -86.61 120.32 71.86 Favored Pre-proline 0 N--CA 1.492 1.669 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 177.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.431 ' HD2' ' HA ' ' A' ' 53' ' ' ASP . 36.7 Cg_endo -59.23 -29.68 91.0 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 O-C-N 123.633 1.333 . . . . 0.0 109.73 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.38 -19.18 65.38 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.855 -0.528 . . . . 0.0 110.681 178.174 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.477 HD21 ' C ' ' A' ' 34' ' ' ASN . 0.4 OUTLIER -124.65 -36.82 2.55 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.096 -1.003 . . . . 0.0 111.441 -179.173 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.528 ' HG2' ' HB3' ' A' ' 34' ' ' ASN . 3.4 mm-40 -130.15 155.05 46.85 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.054 -1.029 . . . . 0.0 110.399 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.627 ' HB ' ' HD2' ' A' ' 59' ' ' PRO . 4.7 p -136.61 172.97 6.09 Favored Pre-proline 0 N--CA 1.5 2.074 0 O-C-N 121.004 -1.06 . . . . 0.0 109.807 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.627 ' HD2' ' HB ' ' A' ' 58' ' ' THR . 42.9 Cg_endo -68.45 -14.36 39.73 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 O-C-N 123.326 1.171 . . . . 0.0 110.896 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.8 -38.37 13.03 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.322 -0.861 . . . . 0.0 109.352 179.042 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.602 ' HA ' ' HB2' ' A' ' 64' ' ' GLU . 0.3 OUTLIER -73.14 -27.01 61.43 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.237 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.498 ' CD2' HD12 ' A' ' 50' ' ' ILE . 16.3 mt -72.18 -28.39 63.18 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 176.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -83.43 -32.24 26.19 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 177.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.602 ' HB2' ' HA ' ' A' ' 61' ' ' THR . 0.1 OUTLIER -71.58 -20.08 62.05 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 177.402 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -90.02 -25.18 20.97 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 177.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.532 ' HA ' ' HE3' ' A' ' 69' ' ' MET . 0.4 OUTLIER -88.62 -39.49 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 178.042 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -68.87 -29.62 67.96 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 177.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.45 -44.01 59.05 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.552 -0.717 . . . . 0.0 109.881 178.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.556 ' SD ' HG13 ' A' ' 26' ' ' ILE . 28.7 mtm -51.69 -49.82 61.66 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.455 -0.778 . . . . 0.0 110.52 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 111.47 55.24 0.5 Allowed Glycine 0 N--CA 1.498 2.797 0 C-N-CA 119.542 -1.313 . . . . 0.0 110.096 179.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.65 ' CD2' HD11 ' A' ' 26' ' ' ILE . 25.4 m-85 -135.89 124.37 23.51 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.637 -0.92 . . . . 0.0 109.357 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -56.62 92.98 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.513 -0.742 . . . . 0.0 109.513 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.487 ' HA ' ' O ' ' A' ' 13' ' ' SER . . . -120.56 178.27 4.74 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 122.188 0.994 . . . . 0.0 112.13 -178.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.563 ' CG1' ' HB3' ' A' ' 13' ' ' SER . 3.6 p -159.26 91.68 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 179.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.706 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . 25.1 pt -57.15 153.18 2.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 CA-C-O 122.362 1.077 . . . . 0.0 111.772 -178.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -109.81 31.86 5.51 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.215 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -130.9 88.98 44.22 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 121.444 -0.785 . . . . 0.0 110.269 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -77.44 61.09 7.29 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 O-C-N 123.475 1.25 . . . . 0.0 110.467 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.582 ' HB2' ' HG3' ' A' ' 59' ' ' PRO . 7.2 m-20 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 117.826 -1.083 . . . . 0.0 110.131 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpp? . . . . . 0 N--CA 1.503 2.202 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 49.92 67.37 4.48 Favored Pre-proline 0 N--CA 1.496 1.865 0 O-C-N 121.797 -0.564 . . . . 0.0 111.555 178.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -70.07 -17.04 36.42 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 O-C-N 123.936 1.492 . . . . 0.0 109.057 177.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 89.7 p -126.4 -12.6 6.18 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.53 -0.731 . . . . 0.0 111.283 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 1.8 ttp 55.05 23.05 4.86 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.157 -0.964 . . . . 0.0 111.022 -179.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 85.69 6.96 82.37 Favored Glycine 0 N--CA 1.5 2.931 0 O-C-N 121.032 -1.043 . . . . 0.0 111.071 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.543 HG11 HD13 ' A' ' 51' ' ' ILE . 4.8 t -121.93 160.71 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.057 -1.261 . . . . 0.0 109.935 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.601 ' HB3' ' CZ ' ' A' ' 52' ' ' TYR . 0.9 OUTLIER -116.35 163.92 15.31 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.89 -1.131 . . . . 0.0 110.392 179.816 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.675 ' HA ' ' HA ' ' A' ' 51' ' ' ILE . 47.5 p -129.37 143.5 50.87 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.237 -0.915 . . . . 0.0 111.247 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.895 HG21 ' HB3' ' A' ' 59' ' ' PRO . 0.9 OUTLIER -142.26 142.26 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 CA-C-O 121.674 0.75 . . . . 0.0 110.806 -179.553 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.625 ' HA ' ' HA ' ' A' ' 49' ' ' THR . 20.7 m -106.47 145.99 31.11 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.946 ' HA ' HG12 ' A' ' 75' ' ' ILE . 23.3 mm -126.42 116.13 44.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -177.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.57 ' H ' ' CG2' ' A' ' 75' ' ' ILE . 1.4 t -82.91 111.25 18.62 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 176.089 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' A' ' 72' ' ' ASP . 9.8 p -108.91 135.06 48.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 O-C-N 121.538 -0.726 . . . . 0.0 112.325 -176.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -116.57 174.3 6.15 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.455 -0.778 . . . . 0.0 110.348 179.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 81.91 -7.73 62.02 Favored Glycine 0 N--CA 1.499 2.889 0 C-N-CA 120.483 -0.865 . . . . 0.0 111.164 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.592 ' HG2' ' HB3' ' A' ' 22' ' ' CYS . 12.4 mtm -82.46 112.09 19.08 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.76 -1.436 . . . . 0.0 111.041 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.4 t -139.56 25.14 2.42 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.07 -1.019 . . . . 0.0 111.984 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.77 ' C ' HD21 ' A' ' 43' ' ' LEU . 0.4 OUTLIER -170.07 139.33 1.81 Allowed 'General case' 0 N--CA 1.5 2.073 0 O-C-N 120.991 -1.068 . . . . 0.0 109.075 178.978 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.573 ' HA ' ' CD2' ' A' ' 43' ' ' LEU . 22.6 m120 -23.09 -45.44 0.01 OUTLIER 'General case' 0 N--CA 1.518 2.958 0 CA-C-O 121.453 0.644 . . . . 0.0 112.585 -178.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.884 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 1.5 p -56.46 -14.13 2.81 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 1.102 ' HB2' HD11 ' A' ' 43' ' ' LEU . 71.8 m -92.91 -26.83 17.43 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 119.808 -1.808 . . . . 0.0 111.678 -178.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.87 HG12 HD22 ' A' ' 43' ' ' LEU . 7.9 p -88.92 -34.73 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.119 -0.988 . . . . 0.0 108.706 178.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.884 ' CE3' ' HA ' ' A' ' 21' ' ' SER . 0.0 OUTLIER -79.98 -23.59 41.49 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 117.634 -1.626 . . . . 0.0 108.964 178.495 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.597 ' HB ' ' CZ3' ' A' ' 24' ' ' TRP . 1.7 t -84.46 -27.41 27.51 Favored 'General case' 0 N--CA 1.506 2.346 0 O-C-N 120.679 -1.263 . . . . 0.0 110.352 178.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.934 HD11 ' CD2' ' A' ' 71' ' ' PHE . 17.8 mm -89.48 -29.91 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 O-C-N 121.142 -0.973 . . . . 0.0 109.532 179.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.635 ' HG3' ' CG2' ' A' ' 39' ' ' ILE . 9.8 tt0 -81.31 -32.66 33.02 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 178.287 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.567 ' HB2' ' O ' ' A' ' 24' ' ' TRP . 0.9 OUTLIER -80.45 -26.5 38.29 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.281 177.872 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.436 ' O ' ' HB ' ' A' ' 33' ' ' VAL . 4.1 tp60 -71.43 -65.44 0.75 Allowed 'General case' 0 N--CA 1.497 1.92 0 C-N-CA 119.238 -0.985 . . . . 0.0 108.824 179.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.686 HG22 HD11 ' A' ' 39' ' ' ILE . 18.2 mm -59.51 -52.02 65.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.237 -0.915 . . . . 0.0 110.258 179.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -49.18 -39.75 27.94 Favored Glycine 0 N--CA 1.502 3.061 0 N-CA-C 110.404 -1.079 . . . . 0.0 110.404 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.15 26.39 10.51 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.232 -1.158 . . . . 0.0 111.047 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.642 HG12 ' O ' ' A' ' 30' ' ' ILE . 11.1 p -74.36 -46.81 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 120.455 -1.403 . . . . 0.0 111.331 -179.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.454 ' N ' HG13 ' A' ' 33' ' ' VAL . 1.0 OUTLIER -173.46 -32.14 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.33 0 O-C-N 120.907 -1.12 . . . . 0.0 111.633 179.259 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.498 ' O ' ' HA ' ' A' ' 52' ' ' TYR . . . -168.97 85.37 0.09 OUTLIER Glycine 0 N--CA 1.496 2.695 0 C-N-CA 119.873 -1.156 . . . . 0.0 110.509 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.878 HG11 ' CD1' ' A' ' 39' ' ' ILE . 42.8 t -130.38 90.34 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 CA-C-O 122.512 1.148 . . . . 0.0 109.307 178.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.964 ' HB2' HD11 ' A' ' 51' ' ' ILE . 42.1 m-70 -65.88 -13.46 59.68 Favored 'General case' 0 C--N 1.286 -2.153 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.926 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.8 ' CD2' HG23 ' A' ' 51' ' ' ILE . 0.2 OUTLIER -152.22 128.52 10.56 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 120.759 -1.213 . . . . 0.0 110.381 179.385 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.878 ' CD1' HG11 ' A' ' 36' ' ' VAL 0.293 2.0 mm -121.19 139.26 48.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.857 -177.906 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.917 ' HB3' HG22 ' A' ' 49' ' ' THR . 0.0 OUTLIER -142.1 83.17 1.83 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.556 -1.34 . . . . 0.0 109.685 176.621 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.727 HG22 ' HB1' ' A' ' 48' ' ' ALA . 17.2 t -107.33 155.94 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.068 -1.02 . . . . 0.0 109.272 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.793 ' HB2' ' HB3' ' A' ' 45' ' ' GLU . 41.5 m -152.33 91.07 1.55 Allowed 'General case' 0 C--N 1.308 -1.21 0 O-C-N 121.112 -0.992 . . . . 0.0 110.1 -178.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 1.102 HD11 ' HB2' ' A' ' 22' ' ' CYS . 6.9 tp -30.77 -53.38 0.19 Allowed 'General case' 0 N--CA 1.508 2.474 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -179.285 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.618 ' HA ' ' NZ ' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -78.5 -37.13 43.96 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.687 -1.258 . . . . 0.0 112.241 -178.81 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.793 ' HB3' ' HB2' ' A' ' 42' ' ' SER . 27.5 tt0 -59.48 -15.37 17.16 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 119.617 -0.833 . . . . 0.0 109.274 177.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.618 ' NZ ' ' HA ' ' A' ' 44' ' ' GLU . 0.1 OUTLIER 53.71 52.83 12.4 Favored 'General case' 0 N--CA 1.503 2.209 0 CA-C-O 121.816 0.817 . . . . 0.0 109.812 -179.813 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.504 ' ND2' ' HA ' ' A' ' 13' ' ' SER . 0.2 OUTLIER -170.75 159.37 6.44 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.579 -0.701 . . . . 0.0 109.716 179.905 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.727 ' HB1' HG22 ' A' ' 41' ' ' VAL . . . -150.7 116.85 5.63 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.302 -0.874 . . . . 0.0 109.492 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.917 HG22 ' HB3' ' A' ' 40' ' ' LYS . 4.8 t -110.13 127.38 54.86 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 120.843 -1.161 . . . . 0.0 109.069 179.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 1.08 HD11 HD21 ' A' ' 62' ' ' LEU . 1.8 pp -140.5 164.04 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.43 -0.793 . . . . 0.0 110.567 -177.155 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.964 HD11 ' HB2' ' A' ' 37' ' ' HIS . 1.5 pp -113.61 172.54 3.4 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 O-C-N 120.936 -1.103 . . . . 0.0 109.734 178.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.649 ' N ' HD12 ' A' ' 51' ' ' ILE . 11.0 p90 -163.3 167.36 21.98 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.343 -0.848 . . . . 0.0 110.963 -178.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.423 ' HB3' ' HB2' ' A' ' 56' ' ' LEU . 1.2 t0 -88.17 121.74 70.28 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.456 -0.778 . . . . 0.0 110.458 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.404 ' HD3' ' N ' ' A' ' 8' ' ' ASN . 38.4 Cg_endo -64.92 -29.58 57.87 Favored 'Trans proline' 0 N--CA 1.488 1.185 0 O-C-N 123.804 1.423 . . . . 0.0 108.784 178.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.1 ptpp? -77.62 -6.48 53.94 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.854 -0.529 . . . . 0.0 110.627 178.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.54 HD23 ' HG2' ' A' ' 57' ' ' GLN . 1.6 tt -117.13 -46.97 2.69 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.089 -1.007 . . . . 0.0 111.16 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.54 ' HG2' HD23 ' A' ' 56' ' ' LEU . 21.1 mm-40 -148.87 -174.05 4.52 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.077 -1.014 . . . . 0.0 110.951 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.6 ' HB ' ' HD2' ' A' ' 59' ' ' PRO . 1.1 p -144.07 176.82 2.05 Favored Pre-proline 0 N--CA 1.499 1.98 0 O-C-N 121.086 -1.009 . . . . 0.0 109.715 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.895 ' HB3' HG21 ' A' ' 10' ' ' VAL . 40.6 Cg_endo -68.29 -7.04 18.93 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 O-C-N 123.529 1.279 . . . . 0.0 110.791 178.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.86 -38.16 58.24 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.092 -1.005 . . . . 0.0 109.333 178.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.7 ' HA ' ' HB2' ' A' ' 64' ' ' GLU . 0.2 OUTLIER -90.74 -19.66 23.27 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 177.832 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 1.08 HD21 HD11 ' A' ' 50' ' ' ILE . 0.1 OUTLIER -71.17 -34.02 70.54 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 176.831 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -81.51 -30.82 33.11 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 176.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.7 ' HB2' ' HA ' ' A' ' 61' ' ' THR . 3.2 mt-10 -73.98 -17.98 60.93 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 176.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.447 ' CB ' HG21 ' A' ' 33' ' ' VAL . . . -86.94 -24.71 24.67 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 106.835 -1.542 . . . . 0.0 106.835 176.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.863 HG21 ' HB2' ' A' ' 73' ' ' ALA . 0.8 OUTLIER -86.57 -41.94 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 177.519 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.82 -31.83 72.91 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 177.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -75.19 -38.73 60.68 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.51 -0.744 . . . . 0.0 109.701 178.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.755 ' HG3' HD13 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -53.81 -46.61 71.17 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.54 -0.725 . . . . 0.0 111.396 179.86 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 119.0 35.06 0.98 Allowed Glycine 0 N--CA 1.501 3.028 0 C-N-CA 120.143 -1.027 . . . . 0.0 110.828 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.934 ' CD2' HD11 ' A' ' 26' ' ' ILE . 96.8 m-85 -140.5 136.61 33.11 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.284 -1.127 . . . . 0.0 109.62 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.448 ' O ' ' HA ' ' A' ' 14' ' ' VAL . 0.5 OUTLIER -57.04 135.02 56.3 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.359 -0.838 . . . . 0.0 111.233 -179.282 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.863 ' HB2' HG21 ' A' ' 66' ' ' ILE . . . -122.45 140.63 52.51 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.367 -0.833 . . . . 0.0 111.748 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.772 ' C ' HG13 ' A' ' 75' ' ' ILE . 4.4 t -155.7 99.02 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 178.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.946 HG12 ' HA ' ' A' ' 12' ' ' ILE . 0.2 OUTLIER -156.39 -135.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 C-N-CA 118.567 -1.253 . . . . 0.0 113.742 -174.869 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.441 ' H ' ' HB ' ' A' ' 75' ' ' ILE . 52.9 t-80 -103.7 53.52 0.75 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.932 -1.105 . . . . 0.0 109.496 -178.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.668 ' HA ' ' HB2' ' A' ' 59' ' ' PRO . 8.2 m120 -123.1 145.81 47.09 Favored Pre-proline 0 N--CA 1.493 1.72 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.306 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.619 ' HD3' ' HG2' ' A' ' 59' ' ' PRO . 42.2 Cg_endo -70.02 -61.44 0.06 OUTLIER 'Trans proline' 0 C--N 1.312 -1.344 0 O-C-N 123.286 1.15 . . . . 0.0 111.592 -179.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.4 p30 . . . . . 0 N--CA 1.491 1.623 0 O-C-N 121.321 -0.862 . . . . 0.0 110.577 -179.68 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.613 ' HG3' ' HB2' ' A' ' 79' ' ' ASP . 34.1 mtt . . . . . 0 N--CA 1.498 1.963 0 CA-C-O 121.075 0.464 . . . . 0.0 110.383 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.585 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 1.0 OUTLIER -137.38 38.25 0.36 Allowed Pre-proline 0 N--CA 1.497 1.923 0 O-C-N 121.28 -0.887 . . . . 0.0 112.096 -179.235 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' A' ' 2' ' ' ASP . 53.7 Cg_endo -77.37 -5.37 15.58 Favored 'Trans proline' 0 C--N 1.321 -0.893 0 N-CA-C 109.492 -1.003 . . . . 0.0 109.492 177.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.484 ' HB3' HG23 ' A' ' 7' ' ' VAL . 0.5 OUTLIER -142.27 9.06 1.85 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.219 -0.925 . . . . 0.0 111.515 -179.864 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.412 ' HB2' ' O ' ' A' ' 4' ' ' SER . 0.3 OUTLIER 62.79 -61.28 0.13 Allowed 'General case' 0 N--CA 1.51 2.535 0 O-C-N 121.323 -0.861 . . . . 0.0 112.233 179.397 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 4' ' ' SER . . . -88.93 -36.2 7.87 Favored Glycine 0 N--CA 1.502 3.08 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 -179.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.484 HG23 ' HB3' ' A' ' 4' ' ' SER . 3.3 m -129.0 -170.33 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 O-C-N 121.574 -0.956 . . . . 0.0 110.165 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.732 ' HB3' ' CZ ' ' A' ' 52' ' ' TYR . 1.9 t30 -129.79 161.8 29.91 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.276 -0.89 . . . . 0.0 110.368 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.554 ' HA ' ' HA ' ' A' ' 51' ' ' ILE . 0.3 OUTLIER -119.99 128.7 53.8 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.382 -0.824 . . . . 0.0 109.351 179.069 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.576 HG23 ' OH ' ' A' ' 52' ' ' TYR . 1.0 OUTLIER -121.14 133.75 66.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.384 -0.822 . . . . 0.0 112.061 -178.222 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.489 ' HA ' ' HA ' ' A' ' 49' ' ' THR . 19.0 m -114.68 121.27 42.86 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.997 HD11 ' HB1' ' A' ' 73' ' ' ALA . 13.1 tt -118.43 132.35 68.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 CA-C-O 121.831 0.824 . . . . 0.0 111.348 -179.072 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.581 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 49.1 m -77.17 121.75 24.05 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 178.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.671 ' HA ' ' O ' ' A' ' 72' ' ' ASP . 0.2 OUTLIER -126.43 121.49 58.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.271 -0.893 . . . . 0.0 111.65 -178.055 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.504 ' CD ' ' HG2' ' A' ' 46' ' ' LYS . 10.2 tp10 -109.49 158.07 18.34 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.457 -0.777 . . . . 0.0 110.559 179.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.51 10.09 59.56 Favored Glycine 0 N--CA 1.498 2.778 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 179.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.585 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 20.4 mmt -45.31 -41.47 8.77 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.026 -1.279 . . . . 0.0 110.46 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 40.1 m 61.51 -48.5 0.14 Allowed 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.841 -0.537 . . . . 0.0 112.249 178.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.517 ' N ' ' O ' ' A' ' 17' ' ' MET . 14.0 p -170.42 152.14 3.92 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.11 -0.994 . . . . 0.0 111.163 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.56 ' N ' HD21 ' A' ' 43' ' ' LEU . 3.2 p30 -29.28 -40.97 0.02 OUTLIER 'General case' 0 N--CA 1.511 2.589 0 C-N-CA 123.103 0.561 . . . . 0.0 112.431 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.539 ' HA ' ' HE3' ' A' ' 24' ' ' TRP . 4.2 p -48.28 -23.91 1.03 Allowed 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.257 -0.902 . . . . 0.0 111.374 179.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.694 ' HB3' ' CE1' ' A' ' 71' ' ' PHE . 68.9 m -89.59 -21.11 23.0 Favored 'General case' 0 N--CA 1.503 2.175 0 O-C-N 121.124 -0.985 . . . . 0.0 109.78 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.578 ' HB ' HD13 ' A' ' 43' ' ' LEU . 1.0 OUTLIER -85.74 -38.29 12.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 176.096 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.539 ' HE3' ' HA ' ' A' ' 21' ' ' SER . 4.2 m0 -64.0 -32.57 74.16 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 119.098 -1.041 . . . . 0.0 108.844 177.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.46 ' O ' ' HB2' ' A' ' 29' ' ' GLN . 0.6 OUTLIER -83.84 -24.68 30.83 Favored 'General case' 0 N--CA 1.505 2.28 0 C-N-CA 119.812 -0.755 . . . . 0.0 111.345 179.868 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.64 HD12 HD13 ' A' ' 66' ' ' ILE . 11.8 mm -91.88 -33.35 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 O-C-N 121.122 -0.986 . . . . 0.0 110.075 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.628 ' HG2' ' CG2' ' A' ' 41' ' ' VAL . 15.3 mt-10 -78.18 -34.78 49.38 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 178.153 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.509 ' HB2' ' O ' ' A' ' 24' ' ' TRP . 0.7 OUTLIER -72.96 -30.36 63.78 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 176.918 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.576 ' HG3' ' HG2' ' A' ' 69' ' ' MET . 3.1 mm100 -77.49 -61.29 2.04 Favored 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 119.064 -1.054 . . . . 0.0 109.942 178.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.999 HG21 HG21 ' A' ' 50' ' ' ILE . 22.1 mm -59.06 -42.81 87.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.027 -1.046 . . . . 0.0 110.116 179.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.581 ' CA ' HG21 ' A' ' 39' ' ' ILE . . . -49.44 -53.35 20.69 Favored Glycine 0 N--CA 1.502 3.038 0 N-CA-C 110.014 -1.235 . . . . 0.0 110.014 179.203 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.426 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 11.0 pttm -104.05 24.79 10.84 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.257 -1.143 . . . . 0.0 110.898 179.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.588 ' HB ' ' HA ' ' A' ' 30' ' ' ILE . 9.9 p -64.42 -44.54 97.09 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 O-C-N 120.749 -1.219 . . . . 0.0 111.959 -178.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.46 ' N ' HG13 ' A' ' 33' ' ' VAL . 0.4 OUTLIER -179.58 -53.62 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.18 -0.95 . . . . 0.0 110.387 -179.37 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.511 ' O ' ' HA ' ' A' ' 52' ' ' TYR . . . -149.39 81.45 0.19 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.156 -1.578 . . . . 0.0 109.156 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.594 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 35.2 t -132.16 96.66 2.49 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-O 122.233 1.016 . . . . 0.0 108.81 179.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.911 ' HB2' HD12 ' A' ' 51' ' ' ILE . 58.2 m-70 -66.36 -12.4 56.61 Favored 'General case' 0 N--CA 1.505 2.294 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.647 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.657 ' O ' HG22 ' A' ' 51' ' ' ILE . 6.4 t60 -170.4 122.88 0.66 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.412 -0.805 . . . . 0.0 109.242 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.602 HD13 ' O ' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -118.87 140.12 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.471 -0.768 . . . . 0.0 108.943 179.908 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.511 ' H ' HG22 ' A' ' 50' ' ' ILE . 1.2 ttpp -141.14 115.52 9.43 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.853 -1.154 . . . . 0.0 110.703 -179.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.628 ' CG2' ' HG2' ' A' ' 27' ' ' GLU . 90.8 t -108.05 161.19 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 CA-C-O 121.55 0.691 . . . . 0.0 110.769 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.694 ' HB3' ' HB3' ' A' ' 45' ' ' GLU . 0.1 OUTLIER -130.17 76.26 1.71 Allowed 'General case' 0 N--CA 1.485 1.278 0 O-C-N 121.368 -0.833 . . . . 0.0 110.517 -178.753 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.578 HD13 ' HB ' ' A' ' 23' ' ' VAL . 11.1 tp -34.43 -55.93 0.52 Allowed 'General case' 0 N--CA 1.503 2.18 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.498 ' O ' ' HD3' ' A' ' 46' ' ' LYS . 5.7 mp0 -85.12 -30.96 23.59 Favored 'General case' 0 N--CA 1.504 2.23 0 O-C-N 120.807 -1.183 . . . . 0.0 112.026 -178.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.694 ' HB3' ' HB3' ' A' ' 42' ' ' SER . 1.1 tt0 -76.31 -3.22 35.54 Favored 'General case' 0 C--N 1.296 -1.749 0 O-C-N 121.231 -0.918 . . . . 0.0 109.881 178.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.504 ' HG2' ' CD ' ' A' ' 15' ' ' GLU . 0.0 OUTLIER 52.5 52.73 13.54 Favored 'General case' 0 N--CA 1.504 2.263 0 O-C-N 121.275 -0.891 . . . . 0.0 111.587 179.428 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -158.84 148.71 19.29 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.81 -1.181 . . . . 0.0 110.936 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.679 ' HB3' ' CG2' ' A' ' 12' ' ' ILE . . . -132.05 127.87 37.06 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.607 -0.683 . . . . 0.0 109.536 179.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.489 ' HA ' ' HA ' ' A' ' 11' ' ' THR . 6.8 t -127.22 120.82 29.62 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.322 -0.861 . . . . 0.0 109.44 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.999 HG21 HG21 ' A' ' 30' ' ' ILE . 1.3 pp -136.48 167.2 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 121.185 -0.947 . . . . 0.0 111.094 -178.082 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.911 HD12 ' HB2' ' A' ' 37' ' ' HIS . 0.0 OUTLIER -109.47 153.05 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.367 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.76 ' N ' HD13 ' A' ' 51' ' ' ILE . 13.0 p90 -163.07 170.25 18.23 Favored 'General case' 0 C--N 1.296 -1.76 0 O-C-N 121.455 -0.778 . . . . 0.0 110.531 -178.191 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.626 ' HB3' ' HB3' ' A' ' 56' ' ' LEU . 5.7 t0 -82.17 117.77 69.57 Favored Pre-proline 0 C--N 1.293 -1.853 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 177.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.493 ' HD3' ' HB2' ' A' ' 8' ' ' ASN . 38.0 Cg_endo -64.07 -22.0 67.92 Favored 'Trans proline' 0 N--CA 1.491 1.36 0 O-C-N 123.428 1.225 . . . . 0.0 109.572 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.422 ' NZ ' ' OD1' ' A' ' 53' ' ' ASP . 3.3 ptpp? -84.62 -22.13 30.07 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.973 -0.454 . . . . 0.0 109.812 178.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.626 ' HB3' ' HB3' ' A' ' 53' ' ' ASP . 0.6 OUTLIER -107.81 -39.4 5.58 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.027 -1.046 . . . . 0.0 110.353 179.195 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 14.0 mm-40 -128.34 161.14 30.12 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.251 -0.906 . . . . 0.0 110.829 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.601 ' HB ' ' HD2' ' A' ' 59' ' ' PRO . 15.6 p -145.54 170.53 7.86 Favored Pre-proline 0 N--CA 1.503 2.211 0 O-C-N 121.324 -0.86 . . . . 0.0 110.326 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.601 ' HD2' ' HB ' ' A' ' 58' ' ' THR . 38.1 Cg_endo -64.0 -12.44 32.17 Favored 'Trans proline' 0 N--CA 1.49 1.296 0 O-C-N 123.289 1.152 . . . . 0.0 110.192 178.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.514 ' O ' ' HB3' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -88.3 -29.53 20.29 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.294 -0.879 . . . . 0.0 109.012 178.279 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.52 ' HA ' ' CD ' ' A' ' 64' ' ' GLU . 40.1 p -90.92 -24.78 20.07 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 177.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.772 HD22 HD11 ' A' ' 50' ' ' ILE . 34.1 mt -76.84 -29.29 55.83 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 177.203 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.616 ' HB2' HG21 ' A' ' 75' ' ' ILE . 12.3 tt0 -79.87 -30.15 40.18 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 177.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.52 ' CD ' ' HA ' ' A' ' 61' ' ' THR . 0.3 OUTLIER -78.53 -22.3 47.52 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.214 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -80.24 -27.26 38.75 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 176.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.825 HG13 HD13 ' A' ' 12' ' ' ILE . 8.7 mm -83.2 -36.06 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 176.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.466 ' HB2' ' HA ' ' A' ' 64' ' ' GLU . 61.8 m-20 -72.38 -32.21 66.22 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 177.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.427 ' HB2' ' O ' ' A' ' 64' ' ' GLU . 31.3 t70 -68.15 -36.68 80.05 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 177.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.576 ' HG2' ' HG3' ' A' ' 29' ' ' GLN . 0.0 OUTLIER -64.86 -47.58 77.4 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.477 -0.765 . . . . 0.0 109.942 178.513 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 119.75 47.87 0.35 Allowed Glycine 0 N--CA 1.502 3.075 0 C-N-CA 120.196 -1.002 . . . . 0.0 111.335 178.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.694 ' CE1' ' HB3' ' A' ' 22' ' ' CYS . 78.2 m-85 -137.4 143.38 41.88 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.229 -1.159 . . . . 0.0 109.563 179.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.671 ' O ' ' HA ' ' A' ' 14' ' ' VAL . 23.4 m-20 -55.1 110.74 0.72 Allowed 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.042 -1.036 . . . . 0.0 109.33 179.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.997 ' HB1' HD11 ' A' ' 12' ' ' ILE . . . -109.77 127.37 54.59 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.163 -0.961 . . . . 0.0 112.067 -178.109 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.581 ' HB ' ' HB2' ' A' ' 13' ' ' SER . 77.1 t -137.38 80.69 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 178.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.81 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . 40.8 pt -57.14 140.78 14.99 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 CA-C-O 122.373 1.083 . . . . 0.0 111.849 -178.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 5.0 m80 -115.13 36.16 4.02 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.166 178.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.43 ' OD1' ' HA ' ' A' ' 10' ' ' VAL . 0.7 OUTLIER -110.54 126.71 28.29 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.62 -0.675 . . . . 0.0 111.166 -179.421 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -79.63 -9.35 14.69 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 O-C-N 123.539 1.284 . . . . 0.0 110.09 178.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.613 ' HB2' ' HG3' ' A' ' 1' ' ' MET . 10.0 p-10 . . . . . 0 N--CA 1.487 1.414 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.238 -179.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 tpt . . . . . 0 N--CA 1.495 1.806 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 49.66 62.16 12.48 Favored Pre-proline 0 N--CA 1.499 2.016 0 O-C-N 121.96 -0.462 . . . . 0.0 111.274 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -70.83 -17.11 32.94 Favored 'Trans proline' 0 C--N 1.316 -1.175 0 O-C-N 123.564 1.297 . . . . 0.0 108.778 177.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.0 p -107.41 -18.33 13.89 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.789 -0.569 . . . . 0.0 109.998 178.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 3.0 mtt 55.29 43.62 28.78 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.352 -0.842 . . . . 0.0 110.883 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 98.08 -15.66 61.2 Favored Glycine 0 N--CA 1.501 2.999 0 C-N-CA 120.395 -0.907 . . . . 0.0 110.988 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.656 HG11 HD13 ' A' ' 51' ' ' ILE . 44.4 t -79.57 162.19 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 O-C-N 120.993 -1.298 . . . . 0.0 110.584 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.582 ' HB3' ' CZ ' ' A' ' 52' ' ' TYR . 0.8 OUTLIER -106.57 178.58 4.52 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.213 -0.93 . . . . 0.0 111.256 -179.303 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.689 ' HA ' ' HA ' ' A' ' 51' ' ' ILE . 9.4 t -141.96 131.89 24.45 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.307 -0.871 . . . . 0.0 111.371 179.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 1.036 HG21 ' HB3' ' A' ' 59' ' ' PRO . 0.9 OUTLIER -142.81 147.93 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 CA-C-O 121.944 0.878 . . . . 0.0 111.534 -179.137 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.64 ' HA ' ' HA ' ' A' ' 49' ' ' THR . 21.3 m -109.83 154.01 23.6 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.253 -0.904 . . . . 0.0 109.781 179.037 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.904 ' HA ' ' CG1' ' A' ' 75' ' ' ILE . 86.0 mt -134.16 110.92 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 122.251 -0.28 . . . . 0.0 111.744 -179.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.572 ' H ' HG23 ' A' ' 75' ' ' ILE . 7.2 p -83.05 121.3 26.85 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 119.746 -1.847 . . . . 0.0 107.095 177.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.12 126.15 73.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 O-C-N 121.187 -0.945 . . . . 0.0 110.214 -177.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.23 173.79 6.16 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.508 -0.745 . . . . 0.0 110.317 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.461 ' O ' ' C ' ' A' ' 17' ' ' MET . . . 88.48 -29.79 5.57 Favored Glycine 0 N--CA 1.499 2.853 0 C-N-CA 120.005 -1.093 . . . . 0.0 110.567 -179.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.679 ' HB3' ' HB2' ' A' ' 43' ' ' LEU . 28.2 mmm -28.13 97.49 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.657 0 CA-C-N 118.001 0.901 . . . . 0.0 111.403 -179.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.417 ' O ' ' HB3' ' A' ' 19' ' ' CYS . 66.6 p -73.82 -28.91 61.86 Favored 'General case' 0 N--CA 1.512 2.641 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -177.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.417 ' HB3' ' O ' ' A' ' 18' ' ' THR . 14.8 p 178.76 173.81 0.7 Allowed 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.251 -0.905 . . . . 0.0 110.192 -178.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.624 ' HA ' ' CD2' ' A' ' 43' ' ' LEU . 7.7 m120 -38.34 -36.65 0.24 Allowed 'General case' 0 N--CA 1.507 2.397 0 CA-C-O 121.062 0.458 . . . . 0.0 110.926 179.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.598 ' HA ' ' HE3' ' A' ' 24' ' ' TRP . 5.9 p -52.46 -23.98 7.1 Favored 'General case' 0 N--CA 1.507 2.38 0 CA-C-O 121.883 0.849 . . . . 0.0 110.931 178.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.414 ' HB3' ' CE1' ' A' ' 71' ' ' PHE . 74.0 m -88.2 -26.72 22.24 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.238 -0.914 . . . . 0.0 109.381 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.445 ' HB ' ' CD2' ' A' ' 43' ' ' LEU . 0.5 OUTLIER -79.41 -39.07 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 N-CA-C 105.955 -1.869 . . . . 0.0 105.955 176.339 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.618 ' CZ3' ' HB2' ' A' ' 20' ' ' ASN . 1.8 m0 -62.57 -32.25 73.2 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 118.82 -1.152 . . . . 0.0 108.033 176.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.473 ' CG2' ' SD ' ' A' ' 69' ' ' MET . 95.7 m -79.95 -32.43 39.95 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.787 -0.571 . . . . 0.0 112.304 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.828 HD12 HD13 ' A' ' 66' ' ' ILE . 18.9 mm -99.77 -22.47 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.242 0 O-C-N 120.785 -1.197 . . . . 0.0 111.297 -178.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.775 ' HA ' HD11 ' A' ' 39' ' ' ILE . 4.5 tt0 -85.78 -32.68 21.69 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 177.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.586 ' HB3' ' O ' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -80.27 -34.98 36.57 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 119.511 -0.876 . . . . 0.0 109.446 177.662 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.696 ' HG3' ' HB1' ' A' ' 65' ' ' ALA . 5.5 tp60 -67.9 -62.96 1.16 Allowed 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 119.358 -0.937 . . . . 0.0 110.103 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.509 ' CG2' HG13 ' A' ' 50' ' ' ILE . 16.6 mm -58.87 -41.33 82.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.314 -0.866 . . . . 0.0 110.656 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.782 ' CA ' HG21 ' A' ' 39' ' ' ILE . . . -55.71 -38.23 71.75 Favored Glycine 0 N--CA 1.498 2.807 0 O-C-N 121.368 -0.833 . . . . 0.0 111.223 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.73 26.55 7.12 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.973 -1.31 . . . . 0.0 111.806 -179.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.805 HG21 ' HB2' ' A' ' 65' ' ' ALA . 15.0 p -71.26 -41.23 74.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 120.778 -1.201 . . . . 0.0 111.214 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 16.6 t30 -162.22 -66.77 0.05 Allowed 'General case' 0 N--CA 1.501 2.084 0 O-C-N 120.643 -1.285 . . . . 0.0 111.471 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.467 ' O ' ' HA ' ' A' ' 52' ' ' TYR . . . -145.18 78.37 0.25 Allowed Glycine 0 N--CA 1.493 2.459 0 N-CA-C 108.804 -1.718 . . . . 0.0 108.804 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.898 HG22 HD11 ' A' ' 50' ' ' ILE . 20.8 t -126.2 89.68 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 CA-C-O 122.429 1.109 . . . . 0.0 108.583 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 1.009 ' HB2' HD11 ' A' ' 51' ' ' ILE . 41.7 m-70 -60.94 -28.8 69.23 Favored 'General case' 0 C--N 1.286 -2.192 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.983 -179.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.628 ' HB2' HG12 ' A' ' 51' ' ' ILE . 37.3 m-70 -141.89 125.63 16.97 Favored 'General case' 0 N--CA 1.506 2.331 0 O-C-N 121.038 -1.039 . . . . 0.0 109.637 178.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.838 ' C ' HD13 ' A' ' 39' ' ' ILE . 0.0 OUTLIER -133.96 140.19 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.187 -0.946 . . . . 0.0 109.408 -179.973 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.48 ' HD3' ' C ' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -146.0 121.34 10.26 Favored 'General case' 0 N--CA 1.507 2.39 0 O-C-N 120.537 -1.352 . . . . 0.0 111.084 178.947 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.528 HG21 HG22 ' A' ' 26' ' ' ILE . 82.0 t -112.6 161.63 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 CA-C-O 121.679 0.752 . . . . 0.0 110.976 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.405 ' HB3' ' HB2' ' A' ' 45' ' ' GLU . 1.7 m -142.67 77.26 1.57 Allowed 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.679 ' HB2' ' HB3' ' A' ' 17' ' ' MET . 0.5 OUTLIER -54.67 -30.34 55.14 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.493 -0.755 . . . . 0.0 111.636 -178.717 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.552 ' N ' ' HG ' ' A' ' 43' ' ' LEU . 15.1 mp0 -74.51 -50.0 19.88 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.959 -1.088 . . . . 0.0 109.597 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.405 ' HB2' ' HB3' ' A' ' 42' ' ' SER . 2.2 mp0 -79.52 5.99 11.55 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 177.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.497 ' HD3' ' CG ' ' A' ' 17' ' ' MET . 35.0 mmtp 46.53 64.96 1.32 Allowed 'General case' 0 N--CA 1.501 2.081 0 CA-C-O 121.5 0.667 . . . . 0.0 110.476 -179.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -165.55 174.33 10.01 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.019 -1.051 . . . . 0.0 110.439 -179.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -168.25 150.01 5.18 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.445 -0.785 . . . . 0.0 110.481 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.64 ' HA ' ' HA ' ' A' ' 11' ' ' THR . 0.4 OUTLIER -138.02 147.28 44.02 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.328 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.898 HD11 HG22 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -165.09 151.7 2.19 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 120.777 -1.202 . . . . 0.0 111.397 -178.083 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 1.009 HD11 ' HB2' ' A' ' 37' ' ' HIS . 2.3 pp -108.04 163.62 5.59 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 O-C-N 121.194 -0.941 . . . . 0.0 109.083 178.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.582 ' CZ ' ' HB3' ' A' ' 8' ' ' ASN . 13.2 p90 -162.31 158.87 24.78 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.089 -1.045 . . . . 0.0 112.033 -176.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.677 ' HB3' ' HB2' ' A' ' 56' ' ' LEU . 18.5 t0 -75.42 111.12 12.52 Favored Pre-proline 0 N--CA 1.498 1.932 0 O-C-N 121.645 -0.66 . . . . 0.0 110.101 179.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.515 ' HD3' ' HB2' ' A' ' 8' ' ' ASN . 40.5 Cg_endo -66.56 -37.17 23.14 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 O-C-N 123.731 1.385 . . . . 0.0 109.766 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.13 -19.01 64.78 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.599 -0.688 . . . . 0.0 109.654 178.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.677 ' HB2' ' HB3' ' A' ' 53' ' ' ASP . 0.4 OUTLIER -96.49 -48.19 5.65 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.388 -0.82 . . . . 0.0 109.438 178.92 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.401 ' O ' ' HA ' ' A' ' 54' ' ' PRO . 5.7 mm100 -153.56 -170.29 3.55 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.531 -0.731 . . . . 0.0 110.431 179.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.706 ' HB ' ' HD2' ' A' ' 59' ' ' PRO . 1.5 p -132.33 -176.3 0.55 Allowed Pre-proline 0 N--CA 1.502 2.131 0 O-C-N 120.861 -1.15 . . . . 0.0 110.109 -179.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 1.036 ' HB3' HG21 ' A' ' 10' ' ' VAL . 38.8 Cg_endo -68.83 -0.6 6.37 Favored 'Trans proline' 0 N--CA 1.488 1.201 0 O-C-N 123.308 1.162 . . . . 0.0 110.809 178.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.516 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 0.1 OUTLIER -77.8 -31.65 51.92 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 177.659 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.752 ' HA ' ' HB2' ' A' ' 64' ' ' GLU . 0.8 OUTLIER -77.88 -23.2 48.86 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 177.577 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.498 HD12 HG22 ' A' ' 61' ' ' THR . 10.9 mp -74.98 -27.52 60.19 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 175.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.401 ' O ' ' HB2' ' A' ' 67' ' ' ASP . 1.5 mm100 -86.4 -26.03 24.97 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 176.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.752 ' HB2' ' HA ' ' A' ' 61' ' ' THR . 30.8 mt-10 -73.03 -25.39 60.93 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 177.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.805 ' HB2' HG21 ' A' ' 33' ' ' VAL . . . -89.59 -24.63 21.65 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 178.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.828 HD13 HD12 ' A' ' 26' ' ' ILE . 14.6 mm -88.08 -36.97 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 178.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.401 ' HB2' ' O ' ' A' ' 63' ' ' GLN . 18.5 t70 -74.86 -27.77 60.39 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.335 -0.946 . . . . 0.0 108.632 178.123 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -76.52 -38.56 54.95 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.513 -0.742 . . . . 0.0 110.148 178.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.473 ' SD ' ' CG2' ' A' ' 25' ' ' THR . 3.5 mmt -67.64 -35.74 79.47 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.895 -1.128 . . . . 0.0 110.471 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 105.9 48.98 0.97 Allowed Glycine 0 N--CA 1.499 2.863 0 C-N-CA 120.099 -1.048 . . . . 0.0 110.707 178.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.664 ' CD2' HD11 ' A' ' 26' ' ' ILE . 55.0 m-85 -130.38 114.66 15.86 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.298 -1.119 . . . . 0.0 110.021 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -48.39 107.87 0.15 Allowed 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.553 -0.717 . . . . 0.0 110.684 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.641 ' HB2' HG21 ' A' ' 66' ' ' ILE . . . -111.23 164.58 12.73 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 122.068 0.937 . . . . 0.0 112.342 -178.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.787 ' C ' HG13 ' A' ' 75' ' ' ILE . 0.9 OUTLIER -168.91 103.72 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 179.618 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.904 ' CG1' ' HA ' ' A' ' 12' ' ' ILE . 0.2 OUTLIER -157.65 -137.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 C-N-CA 118.834 -1.146 . . . . 0.0 113.638 -174.759 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 52.6 t-80 -104.65 71.14 0.97 Allowed 'General case' 0 N--CA 1.499 1.995 0 O-C-N 120.856 -1.152 . . . . 0.0 111.062 -178.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -119.08 162.59 30.82 Favored Pre-proline 0 N--CA 1.493 1.695 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 178.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.703 ' HD3' ' HG2' ' A' ' 59' ' ' PRO . 49.5 Cg_endo -84.24 -57.49 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.313 0 O-C-N 123.098 1.051 . . . . 0.0 109.986 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 118.368 -0.825 . . . . 0.0 110.473 179.947 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.5 2.05 0 CA-C-O 120.894 0.378 . . . . 0.0 110.829 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 40.65 65.49 4.11 Favored Pre-proline 0 N--CA 1.504 2.237 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.505 ' O ' ' NZ ' ' A' ' 55' ' ' LYS . 43.5 Cg_endo -70.78 -17.6 32.82 Favored 'Trans proline' 0 C--N 1.313 -1.322 0 O-C-N 123.614 1.323 . . . . 0.0 109.64 177.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -138.66 -0.31 1.95 Allowed 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.32 -0.862 . . . . 0.0 111.989 179.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 46.51 28.32 0.74 Allowed 'General case' 0 N--CA 1.505 2.317 0 O-C-N 121.207 -0.933 . . . . 0.0 112.429 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.411 ' O ' ' HB ' ' A' ' 7' ' ' VAL . . . 91.76 3.65 68.29 Favored Glycine 0 N--CA 1.501 2.995 0 O-C-N 120.988 -1.07 . . . . 0.0 111.457 179.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 1.075 HG11 HD11 ' A' ' 51' ' ' ILE . 4.2 t 64.81 174.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.465 0 CA-C-N 118.625 1.213 . . . . 0.0 109.941 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.738 ' HB3' ' CZ ' ' A' ' 52' ' ' TYR . 1.0 OUTLIER -117.18 154.57 30.88 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.694 -1.254 . . . . 0.0 111.516 -179.232 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.626 ' HA ' ' HA ' ' A' ' 51' ' ' ILE . 14.7 t -118.98 146.51 44.94 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.336 -0.852 . . . . 0.0 110.012 178.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -140.6 133.95 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.347 -0.845 . . . . 0.0 111.186 -178.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.509 ' HA ' ' HA ' ' A' ' 49' ' ' THR . 51.7 m -109.69 116.81 32.41 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.524 0.678 . . . . 0.0 109.273 179.16 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 1.093 HG21 HD13 ' A' ' 66' ' ' ILE . 5.7 mt -108.43 145.12 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.379 -0.826 . . . . 0.0 110.914 -178.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.546 ' O ' ' HB1' ' A' ' 73' ' ' ALA . 0.8 OUTLIER -78.98 137.74 37.73 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.747 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.644 HG13 ' CE ' ' A' ' 17' ' ' MET . 1.2 t -129.09 111.26 22.43 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 O-C-N 120.947 -1.095 . . . . 0.0 111.888 -178.166 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -122.56 170.19 10.26 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.552 ' O ' HG23 ' A' ' 18' ' ' THR . . . 73.81 25.43 71.87 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 -178.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.688 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 29.7 mmt -66.22 -36.08 82.12 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.106 -1.232 . . . . 0.0 110.178 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.552 HG23 ' O ' ' A' ' 16' ' ' GLY . 1.0 OUTLIER 58.93 -42.84 0.07 Allowed 'General case' 0 N--CA 1.515 2.794 0 O-C-N 121.664 -0.648 . . . . 0.0 112.64 -179.708 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.529 ' N ' ' O ' ' A' ' 17' ' ' MET . 9.0 p 179.02 163.49 0.82 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.334 -0.854 . . . . 0.0 110.228 -178.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.579 ' HB2' ' CZ3' ' A' ' 24' ' ' TRP . 2.9 p30 -35.13 -36.71 0.06 Allowed 'General case' 0 N--CA 1.508 2.453 0 CA-C-O 120.947 0.403 . . . . 0.0 111.67 178.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.513 ' HA ' ' HE3' ' A' ' 24' ' ' TRP . 10.5 p -46.17 -30.67 2.05 Favored 'General case' 0 N--CA 1.504 2.258 0 CA-C-O 121.983 0.897 . . . . 0.0 110.912 178.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.688 ' SG ' ' O ' ' A' ' 17' ' ' MET . 69.6 m -90.3 -27.63 19.3 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.444 -0.785 . . . . 0.0 109.066 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.542 HG21 ' HB2' ' A' ' 43' ' ' LEU . 1.1 t -71.96 -37.65 61.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 175.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.634 ' O ' ' HB2' ' A' ' 28' ' ' GLN . 2.8 m0 -67.6 -32.14 72.67 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 119.142 -1.023 . . . . 0.0 108.488 177.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.6 ' O ' ' HB2' ' A' ' 29' ' ' GLN . 96.8 m -82.1 -23.98 35.41 Favored 'General case' 0 N--CA 1.505 2.285 0 C-N-CA 120.532 -0.467 . . . . 0.0 112.034 -179.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.739 HD11 ' CD2' ' A' ' 71' ' ' PHE . 1.5 mp -98.49 -22.35 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.31 0 O-C-N 120.868 -1.145 . . . . 0.0 110.126 -179.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.595 ' HA ' HD11 ' A' ' 39' ' ' ILE . 4.7 tt0 -83.1 -36.32 24.93 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 178.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.634 ' HB2' ' O ' ' A' ' 24' ' ' TRP . 1.2 mp0 -80.13 -33.84 38.24 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.725 -0.79 . . . . 0.0 109.81 178.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.6 ' HB2' ' O ' ' A' ' 25' ' ' THR . 5.2 mm100 -77.46 -61.42 2.0 Allowed 'General case' 0 N--CA 1.501 2.088 0 C-N-CA 118.32 -1.352 . . . . 0.0 110.694 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.75 ' CG2' HG21 ' A' ' 50' ' ' ILE . 38.0 mt -64.98 -36.9 78.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 120.776 -1.202 . . . . 0.0 109.989 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.495 ' CA ' HG21 ' A' ' 39' ' ' ILE . . . -58.36 -46.47 92.93 Favored Glycine 0 N--CA 1.499 2.857 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 178.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.08 29.99 7.29 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.459 -1.024 . . . . 0.0 110.864 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.476 ' HB ' ' HA ' ' A' ' 30' ' ' ILE . 8.4 p -64.29 -38.19 81.89 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 O-C-N 121.083 -1.011 . . . . 0.0 111.049 -179.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -175.39 -60.38 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.333 -0.854 . . . . 0.0 110.357 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.517 ' O ' ' HA ' ' A' ' 52' ' ' TYR . . . -148.47 83.48 0.18 Allowed Glycine 0 N--CA 1.489 2.204 0 N-CA-C 108.307 -1.917 . . . . 0.0 108.307 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.723 HG11 ' HB ' ' A' ' 39' ' ' ILE . 17.1 t -124.15 93.71 2.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 CA-C-O 122.503 1.144 . . . . 0.0 108.637 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.961 ' HB2' HD12 ' A' ' 51' ' ' ILE . 68.2 m-70 -60.45 -18.53 51.83 Favored 'General case' 0 N--CA 1.503 2.209 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.676 -179.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.584 ' HB3' ' CG2' ' A' ' 51' ' ' ILE . 1.0 OUTLIER -158.92 129.49 5.99 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.791 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.989 ' HA ' HG22 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -129.94 128.79 65.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.565 -0.71 . . . . 0.0 109.392 -179.927 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.695 ' HB3' HG22 ' A' ' 49' ' ' THR . 0.0 OUTLIER -121.02 121.54 38.18 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.882 -1.136 . . . . 0.0 110.073 179.743 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.523 ' O ' ' NZ ' ' A' ' 40' ' ' LYS . 10.6 p -106.89 152.54 8.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 178.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.771 ' HB3' ' HB3' ' A' ' 45' ' ' GLU . 0.4 OUTLIER -136.57 76.51 1.6 Allowed 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.09 -1.006 . . . . 0.0 111.073 -177.74 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.542 ' HB2' HG21 ' A' ' 23' ' ' VAL . 11.7 tp -39.32 -57.19 1.42 Allowed 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.461 ' O ' ' NZ ' ' A' ' 46' ' ' LYS . 0.7 OUTLIER -94.57 -32.69 13.34 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.831 -1.168 . . . . 0.0 111.409 -179.799 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.771 ' HB3' ' HB3' ' A' ' 42' ' ' SER . 9.7 tt0 -66.61 -7.47 20.61 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.038 -1.039 . . . . 0.0 109.929 177.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.461 ' NZ ' ' O ' ' A' ' 44' ' ' GLU . 0.0 OUTLIER 55.77 69.36 0.74 Allowed 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.47 -0.768 . . . . 0.0 111.17 179.008 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -170.31 161.15 8.06 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.72 -1.238 . . . . 0.0 113.037 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.535 ' HB2' HG21 ' A' ' 14' ' ' VAL . . . -147.93 97.25 2.77 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 115.518 -0.765 . . . . 0.0 108.984 179.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.695 HG22 ' HB3' ' A' ' 40' ' ' LYS . 1.0 OUTLIER -109.74 133.79 52.73 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.783 -1.198 . . . . 0.0 110.254 -179.674 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.989 HG22 ' HA ' ' A' ' 39' ' ' ILE . 2.6 pp -146.63 177.63 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.511 -0.743 . . . . 0.0 111.146 -178.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 1.075 HD11 HG11 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -123.82 158.89 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 178.541 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.738 ' CZ ' ' HB3' ' A' ' 8' ' ' ASN . 14.8 p90 -163.95 153.7 14.58 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.235 -0.915 . . . . 0.0 111.089 -177.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.478 ' HB3' ' HG3' ' A' ' 55' ' ' LYS . 0.4 OUTLIER -79.69 117.74 68.82 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.277 -0.89 . . . . 0.0 109.49 178.892 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -67.63 57.61 0.73 Allowed 'Trans proline' 0 N--CA 1.494 1.529 0 O-C-N 123.929 1.489 . . . . 0.0 111.408 -178.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.505 ' NZ ' ' O ' ' A' ' 3' ' ' PRO . 0.0 OUTLIER -135.47 -66.25 0.57 Allowed 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 179.073 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -96.84 -8.99 29.6 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.472 -0.768 . . . . 0.0 109.285 177.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.66 146.5 50.85 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.512 -0.742 . . . . 0.0 109.947 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.609 ' HB ' ' HD2' ' A' ' 59' ' ' PRO . 78.3 p -142.66 169.08 11.53 Favored Pre-proline 0 N--CA 1.497 1.922 0 O-C-N 121.493 -0.754 . . . . 0.0 110.14 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.609 ' HD2' ' HB ' ' A' ' 58' ' ' THR . 39.3 Cg_endo -65.41 -19.18 61.34 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 O-C-N 123.328 1.172 . . . . 0.0 111.226 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 2.2 tptt -92.0 -30.51 16.03 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.291 -0.881 . . . . 0.0 109.791 179.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.709 ' HA ' ' HB2' ' A' ' 64' ' ' GLU . 6.0 p -79.2 -24.17 43.33 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 177.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.574 HD22 HD11 ' A' ' 50' ' ' ILE . 14.2 mt -72.97 -30.68 64.01 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 106.314 -1.735 . . . . 0.0 106.314 175.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.478 ' HG3' HD11 ' A' ' 75' ' ' ILE . 1.2 tt0 -82.36 -27.71 31.99 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 177.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.709 ' HB2' ' HA ' ' A' ' 61' ' ' THR . 10.3 mt-10 -82.09 -16.38 50.22 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 177.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -86.86 -27.22 23.6 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 177.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 1.093 HD13 HG21 ' A' ' 12' ' ' ILE . 26.2 mt -86.32 -38.52 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 177.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.478 ' HB2' ' O ' ' A' ' 63' ' ' GLN . 0.4 OUTLIER -66.27 -33.21 75.23 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 177.459 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.619 ' HB2' ' O ' ' A' ' 64' ' ' GLU . 2.6 t70 -79.37 -38.07 35.86 Favored 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 119.771 -0.772 . . . . 0.0 109.298 178.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.571 ' HE1' HG13 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -47.65 -59.77 3.04 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.555 -0.716 . . . . 0.0 110.018 179.153 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 123.3 51.26 0.21 Allowed Glycine 0 N--CA 1.497 2.735 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 179.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.739 ' CD2' HD11 ' A' ' 26' ' ' ILE . 10.9 m-85 -140.73 147.61 39.44 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.435 -1.038 . . . . 0.0 111.029 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -72.39 81.46 1.04 Allowed 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.576 0.703 . . . . 0.0 109.245 179.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.546 ' HB1' ' O ' ' A' ' 13' ' ' SER . . . -134.59 142.17 46.86 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.999 -1.063 . . . . 0.0 110.961 -179.116 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.837 ' O ' HG23 ' A' ' 12' ' ' ILE . 2.5 t -117.51 -134.7 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.211 -0.939 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 178.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.641 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . 0.1 OUTLIER -151.83 146.62 15.57 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.357 0 O-C-N 121.072 -1.018 . . . . 0.0 111.514 -179.912 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 -112.61 20.99 16.07 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 177.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.409 ' HB3' ' OD2' ' A' ' 79' ' ' ASP . 0.7 OUTLIER -109.29 139.17 20.8 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.833 -0.542 . . . . 0.0 110.108 -179.617 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.61 56.14 3.34 Favored 'Trans proline' 0 N--CA 1.493 1.48 0 O-C-N 123.585 1.308 . . . . 0.0 110.816 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.409 ' OD2' ' HB3' ' A' ' 77' ' ' ASN . 56.2 m-20 . . . . . 0 N--CA 1.491 1.592 0 O-C-N 121.356 -0.84 . . . . 0.0 110.836 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.3 tpt . . . . . 0 N--CA 1.498 1.939 0 CA-C-O 120.675 0.274 . . . . 0.0 110.738 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -117.39 80.57 12.87 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.12 -0.987 . . . . 0.0 111.461 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.494 ' HB2' ' HE2' ' A' ' 55' ' ' LYS . 46.9 Cg_endo -72.45 -13.03 27.63 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 O-C-N 123.814 1.428 . . . . 0.0 108.593 177.131 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.2 m -141.17 -22.49 0.76 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.721 -0.612 . . . . 0.0 111.981 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 55.55 56.55 6.14 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 120.821 -1.175 . . . . 0.0 110.357 -179.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 177.08 -52.81 0.1 Allowed Glycine 0 N--CA 1.501 3.022 0 N-CA-C 110.451 -1.06 . . . . 0.0 110.451 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 1.029 HG11 HD13 ' A' ' 51' ' ' ILE . 1.1 t 67.97 165.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.334 0 O-C-N 121.901 -0.764 . . . . 0.0 111.003 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.486 ' HB3' ' CZ ' ' A' ' 52' ' ' TYR . 2.5 m120 -112.17 -179.87 3.8 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.051 -1.031 . . . . 0.0 110.656 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.62 ' HA ' ' HA ' ' A' ' 51' ' ' ILE . 3.8 m -141.29 132.68 26.74 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.294 -0.879 . . . . 0.0 110.192 179.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.593 HG23 ' OH ' ' A' ' 52' ' ' TYR . 0.9 OUTLIER -130.99 135.82 59.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 CA-C-O 121.592 0.711 . . . . 0.0 111.953 -178.14 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.504 ' HA ' ' HA ' ' A' ' 49' ' ' THR . 27.5 m -115.3 118.94 34.68 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.066 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.761 HG12 HG22 ' A' ' 75' ' ' ILE . 64.9 mt -118.73 146.29 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.299 -0.876 . . . . 0.0 111.612 -178.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.867 ' CB ' HG13 ' A' ' 74' ' ' VAL . 0.9 OUTLIER -90.42 144.55 25.7 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 177.574 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.51 ' O ' ' HB3' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -141.55 126.38 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.82 -1.175 . . . . 0.0 110.824 -178.754 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.7 ' HB3' ' HB3' ' A' ' 72' ' ' ASP . 5.8 tp10 -108.95 165.42 11.59 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.418 -0.801 . . . . 0.0 110.247 179.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.71 -25.89 26.67 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 108.577 -1.809 . . . . 0.0 108.577 -177.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.501 ' HA ' ' CB ' ' A' ' 22' ' ' CYS . 51.2 mtm -73.87 102.7 4.15 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.253 -1.145 . . . . 0.0 109.888 179.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 14.9 t -106.59 9.41 31.41 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.532 -0.73 . . . . 0.0 111.367 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.436 ' O ' ' N ' ' A' ' 21' ' ' SER . 0.5 OUTLIER -178.99 139.64 0.16 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.183 -0.948 . . . . 0.0 109.295 179.822 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 1.024 ' HA ' HD21 ' A' ' 43' ' ' LEU . 7.8 m120 -23.08 -46.12 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.599 0 N-CA-C 112.719 0.636 . . . . 0.0 112.719 -179.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.554 ' HA ' ' HE3' ' A' ' 24' ' ' TRP . 3.0 p -47.66 -27.5 1.94 Allowed 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.391 -0.818 . . . . 0.0 111.518 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.631 ' HB3' ' CE1' ' A' ' 71' ' ' PHE . 60.2 m -87.04 -33.08 19.67 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.03 -1.044 . . . . 0.0 109.414 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.913 HG21 HD22 ' A' ' 43' ' ' LEU . 9.1 t -77.47 -39.44 27.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 177.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.554 ' HE3' ' HA ' ' A' ' 21' ' ' SER . 1.4 m0 -59.24 -36.97 76.41 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 176.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.455 ' O ' ' HB2' ' A' ' 29' ' ' GLN . 64.1 m -66.0 -34.5 78.25 Favored 'General case' 0 N--CA 1.501 2.086 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.006 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.588 HD11 ' CD2' ' A' ' 71' ' ' PHE . 1.4 mp -94.8 -29.61 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.241 0 O-C-N 121.261 -0.899 . . . . 0.0 110.03 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.733 ' HG3' ' CD1' ' A' ' 39' ' ' ILE . 2.6 tt0 -74.16 -35.64 64.05 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 178.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.522 ' HB2' ' O ' ' A' ' 24' ' ' TRP . 28.9 mt-30 -79.3 -34.15 42.67 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 119.146 -1.022 . . . . 0.0 108.99 177.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.664 ' HB3' ' SD ' ' A' ' 69' ' ' MET . 2.2 mm100 -73.04 -51.36 18.45 Favored 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 118.44 -1.304 . . . . 0.0 110.112 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.553 ' CG2' ' HB ' ' A' ' 39' ' ' ILE . 0.4 OUTLIER -57.41 -41.11 77.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 120.98 -1.075 . . . . 0.0 109.859 179.094 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.874 ' HA2' HG21 ' A' ' 39' ' ' ILE . . . -64.61 -26.52 70.99 Favored Glycine 0 N--CA 1.498 2.772 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 178.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.5 ' HB3' ' HE3' ' A' ' 32' ' ' LYS . 3.2 ttpp -116.7 26.7 9.66 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.566 -0.961 . . . . 0.0 110.678 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.562 HG21 ' HB1' ' A' ' 65' ' ' ALA . 8.1 p -87.41 -49.22 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 O-C-N 120.594 -1.316 . . . . 0.0 112.489 -178.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.503 ' N ' HG13 ' A' ' 33' ' ' VAL . 0.6 OUTLIER -169.66 -68.07 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.134 0 O-C-N 120.408 -1.433 . . . . 0.0 112.453 -179.581 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.606 ' HA3' HD11 ' A' ' 56' ' ' LEU . . . -142.74 73.17 0.37 Allowed Glycine 0 N--CA 1.496 2.676 0 C-N-CA 119.987 -1.102 . . . . 0.0 110.855 -178.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.928 ' CG1' HG22 ' A' ' 39' ' ' ILE . 61.5 t -127.57 89.2 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 CA-C-O 122.335 1.064 . . . . 0.0 108.564 178.218 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 1.009 ' HB2' HD11 ' A' ' 51' ' ' ILE . 38.9 m-70 -61.6 -23.26 65.89 Favored 'General case' 0 N--CA 1.507 2.402 0 CA-C-N 115.388 -0.823 . . . . 0.0 110.72 -179.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.64 ' HB2' HG12 ' A' ' 51' ' ' ILE . 65.8 m-70 -136.94 113.36 10.04 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.308 -0.87 . . . . 0.0 109.162 179.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.928 HG22 ' CG1' ' A' ' 36' ' ' VAL . 1.8 pp -114.28 136.42 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.286 -0.884 . . . . 0.0 109.637 -179.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.634 ' HA ' ' CE ' ' A' ' 40' ' ' LYS . 0.3 OUTLIER -150.58 122.91 8.39 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.168 -1.583 . . . . 0.0 112.408 -179.715 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.489 HG13 ' HB2' ' A' ' 48' ' ' ALA . 3.9 t -127.79 167.14 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.4 m -108.84 -101.04 0.38 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.87 -1.144 . . . . 0.0 110.168 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 1.024 HD21 ' HA ' ' A' ' 20' ' ' ASN . 0.1 OUTLIER -179.13 -92.41 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.308 0 O-C-N 121.069 -1.019 . . . . 0.0 109.683 179.411 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.49 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -76.73 -9.77 58.9 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.512 -1.368 . . . . 0.0 109.594 178.538 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -74.59 -11.87 60.31 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 177.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.51 ' HB3' ' O ' ' A' ' 14' ' ' VAL . 21.5 mmtt 51.5 56.13 8.36 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.623 -0.673 . . . . 0.0 111.295 179.037 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.417 ' ND2' ' OG ' ' A' ' 13' ' ' SER . 0.3 OUTLIER -154.08 152.13 30.11 Favored 'General case' 0 N--CA 1.504 2.235 0 O-C-N 120.587 -1.32 . . . . 0.0 112.274 179.854 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.489 ' HB2' HG13 ' A' ' 41' ' ' VAL . . . -142.36 134.91 28.05 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.251 0.548 . . . . 0.0 110.592 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.504 ' HA ' ' HA ' ' A' ' 11' ' ' THR . 5.8 t -128.67 134.41 48.5 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.377 -0.827 . . . . 0.0 109.408 179.021 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.48 ' CD1' HD22 ' A' ' 62' ' ' LEU . 0.1 OUTLIER -149.59 164.85 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.072 -1.018 . . . . 0.0 110.975 -179.014 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 1.029 HD13 HG11 ' A' ' 7' ' ' VAL . 1.7 pp -107.03 167.52 3.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 178.056 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.593 ' OH ' HG23 ' A' ' 10' ' ' VAL . 28.8 p90 -170.52 161.83 7.91 Favored 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 119.159 -1.017 . . . . 0.0 110.731 -178.187 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.436 ' O ' ' N ' ' A' ' 55' ' ' LYS . 0.9 OUTLIER -78.84 121.62 83.67 Favored Pre-proline 0 C--N 1.302 -1.492 0 C-N-CA 119.701 -0.799 . . . . 0.0 109.726 179.182 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.421 ' C ' ' HG2' ' A' ' 55' ' ' LYS . 38.7 Cg_endo -64.67 70.31 0.24 Allowed 'Trans proline' 0 N--CA 1.492 1.395 0 O-C-N 124.1 1.579 . . . . 0.0 109.728 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.494 ' HE2' ' HB2' ' A' ' 3' ' ' PRO . 3.2 ptpp? -172.24 -45.48 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.756 -0.59 . . . . 0.0 110.877 -178.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.606 HD11 ' HA3' ' A' ' 35' ' ' GLY . 1.8 pp -111.8 -21.65 11.53 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.093 -1.004 . . . . 0.0 111.837 -179.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.517 ' HB3' ' HB2' ' A' ' 52' ' ' TYR . 5.5 tp60 -125.85 133.76 51.85 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.818 -1.176 . . . . 0.0 110.025 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.777 ' C ' HD12 ' A' ' 62' ' ' LEU . 34.9 p -141.78 168.33 14.13 Favored Pre-proline 0 N--CA 1.504 2.239 0 O-C-N 121.111 -0.993 . . . . 0.0 109.988 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.612 ' HA ' ' HB2' ' A' ' 62' ' ' LEU . 37.8 Cg_endo -62.39 -20.45 70.4 Favored 'Trans proline' 0 N--CA 1.498 1.78 0 O-C-N 123.418 1.22 . . . . 0.0 111.877 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.425 ' NZ ' ' HB3' ' A' ' 64' ' ' GLU . 0.4 OUTLIER -81.4 -30.53 33.57 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.097 -1.002 . . . . 0.0 108.777 178.241 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.548 ' HA ' ' CD ' ' A' ' 64' ' ' GLU . 0.9 OUTLIER -90.3 -24.15 20.97 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 178.033 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.777 HD12 ' C ' ' A' ' 58' ' ' THR . 5.2 mt -74.11 -28.07 61.18 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 177.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.823 ' HB2' HG21 ' A' ' 75' ' ' ILE . 15.8 tt0 -84.08 -30.22 26.18 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 177.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.548 ' CD ' ' HA ' ' A' ' 61' ' ' THR . 1.5 pt-20 -81.05 -18.99 44.77 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.562 ' HB1' HG21 ' A' ' 33' ' ' VAL . . . -82.95 -28.76 29.61 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 175.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.711 HG22 ' HB2' ' A' ' 73' ' ' ALA . 51.5 mt -82.01 -38.77 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 177.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.46 ' HB2' ' HA ' ' A' ' 64' ' ' GLU . 1.2 m-20 -61.05 -28.54 69.14 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 176.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -71.05 -42.74 69.08 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.799 -0.563 . . . . 0.0 109.885 178.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.664 ' SD ' ' HB3' ' A' ' 29' ' ' GLN . 0.8 OUTLIER -54.73 -47.95 73.14 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.454 -0.779 . . . . 0.0 111.043 179.717 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 120.89 43.0 0.46 Allowed Glycine 0 N--CA 1.503 3.109 0 C-N-CA 120.069 -1.062 . . . . 0.0 110.586 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.631 ' CE1' ' HB3' ' A' ' 22' ' ' CYS . 61.8 m-85 -144.87 130.29 18.78 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.444 -1.033 . . . . 0.0 109.229 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.7 ' HB3' ' HB3' ' A' ' 15' ' ' GLU . 5.5 t70 -47.43 116.51 1.45 Allowed 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.525 -0.735 . . . . 0.0 110.005 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.711 ' HB2' HG22 ' A' ' 66' ' ' ILE . . . -109.43 150.17 28.48 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.382 -0.824 . . . . 0.0 111.554 -178.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.867 HG13 ' CB ' ' A' ' 13' ' ' SER . 1.0 OUTLIER -154.83 93.76 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 CA-C-O 122.559 1.171 . . . . 0.0 108.1 179.103 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.823 HG21 ' HB2' ' A' ' 63' ' ' GLN . 14.0 pt -69.62 150.73 10.17 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 CA-C-O 122.481 1.134 . . . . 0.0 112.455 -177.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 17.8 m-70 -109.93 14.95 22.91 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.147 178.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 30.0 m120 -133.38 140.13 36.14 Favored Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 121.018 -1.051 . . . . 0.0 110.302 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -79.33 -53.67 0.05 OUTLIER 'Trans proline' 0 C--N 1.315 -1.235 0 O-C-N 123.853 1.449 . . . . 0.0 110.527 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 118.439 -0.791 . . . . 0.0 110.603 -179.778 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.0 tpt . . . . . 0 N--CA 1.495 1.806 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.435 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 12.9 m-20 49.17 52.05 12.06 Favored Pre-proline 0 N--CA 1.503 2.203 0 O-C-N 121.756 -0.59 . . . . 0.0 111.563 179.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.435 ' CD ' ' N ' ' A' ' 2' ' ' ASP . 45.2 Cg_endo -72.03 -13.48 28.85 Favored 'Trans proline' 0 C--N 1.317 -1.087 0 O-C-N 123.483 1.254 . . . . 0.0 109.022 177.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.411 ' HB2' ' HB ' ' A' ' 7' ' ' VAL . 1.4 p -156.01 29.02 0.36 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.586 -0.696 . . . . 0.0 110.843 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -41.45 107.05 0.07 Allowed 'General case' 0 N--CA 1.505 2.282 0 O-C-N 121.41 -0.806 . . . . 0.0 110.426 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.549 ' O ' ' HD2' ' A' ' 54' ' ' PRO . . . 118.66 -24.67 8.39 Favored Glycine 0 N--CA 1.497 2.716 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 -179.018 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.411 ' HB ' ' HB2' ' A' ' 4' ' ' SER . 48.2 t -108.32 145.25 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 O-C-N 121.137 -1.213 . . . . 0.0 109.717 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.772 ' HB3' ' CZ ' ' A' ' 52' ' ' TYR . 1.0 OUTLIER -106.24 172.46 6.8 Favored 'General case' 0 N--CA 1.503 2.21 0 O-C-N 120.977 -1.077 . . . . 0.0 110.957 -179.789 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.499 ' HA ' ' HA ' ' A' ' 51' ' ' ILE . 6.8 t -130.52 131.04 44.89 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.352 -0.843 . . . . 0.0 110.27 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.941 HG11 HD13 ' A' ' 62' ' ' LEU . 0.5 OUTLIER -125.61 132.63 70.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.462 -0.774 . . . . 0.0 111.315 -178.411 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.587 ' HA ' ' HA ' ' A' ' 49' ' ' THR . 8.9 m -108.67 119.17 38.73 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.532 -0.73 . . . . 0.0 109.138 178.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.68 ' HA ' ' HA ' ' A' ' 75' ' ' ILE . 9.8 mt -110.93 122.13 64.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.294 -0.879 . . . . 0.0 110.9 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.675 ' HB2' ' CG1' ' A' ' 74' ' ' VAL . 0.7 OUTLIER -79.34 136.11 36.91 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 178.011 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.42 HG12 ' HB3' ' A' ' 71' ' ' PHE . 0.2 OUTLIER -131.27 130.14 63.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.17 -0.957 . . . . 0.0 110.987 -178.641 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -119.48 159.57 24.02 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.387 -0.82 . . . . 0.0 110.159 178.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.527 ' O ' HG23 ' A' ' 18' ' ' THR . . . 98.35 -31.14 8.36 Favored Glycine 0 N--CA 1.497 2.762 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 -179.145 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.58 ' SD ' ' HA ' ' A' ' 43' ' ' LEU . 8.0 ptp -62.43 122.63 16.2 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.171 -1.193 . . . . 0.0 110.302 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.527 HG23 ' O ' ' A' ' 16' ' ' GLY . 54.7 p -125.64 5.96 7.5 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.252 -0.905 . . . . 0.0 113.333 -178.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.484 ' O ' HD21 ' A' ' 43' ' ' LEU . 1.1 p -165.56 145.3 6.6 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.14 -1.6 . . . . 0.0 110.512 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.49 ' O ' HG12 ' A' ' 23' ' ' VAL . 28.9 m120 -25.8 -40.67 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.674 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -179.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.811 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 2.2 p -51.32 -19.75 1.42 Allowed 'General case' 0 N--CA 1.499 1.978 0 CA-C-O 122.294 1.045 . . . . 0.0 110.703 178.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.791 ' HB2' HD21 ' A' ' 43' ' ' LEU . 44.7 m -91.15 -20.87 21.53 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 119.32 -2.112 . . . . 0.0 109.221 179.002 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.775 ' HB ' HD22 ' A' ' 43' ' ' LEU . 0.3 OUTLIER -90.02 -35.51 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.411 -0.806 . . . . 0.0 108.868 178.531 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.811 ' CE3' ' HA ' ' A' ' 21' ' ' SER . 0.0 OUTLIER -78.96 -22.55 45.51 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 117.85 -1.54 . . . . 0.0 108.688 178.642 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.509 ' HB ' ' CZ3' ' A' ' 24' ' ' TRP . 1.3 t -86.18 -27.6 24.44 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 120.774 -1.204 . . . . 0.0 110.378 177.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.676 HD11 ' CD2' ' A' ' 71' ' ' PHE . 20.4 mm -90.77 -25.12 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.377 0 O-C-N 120.75 -1.218 . . . . 0.0 109.561 179.052 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.574 ' HA ' HD12 ' A' ' 39' ' ' ILE . 0.2 OUTLIER -81.24 -34.37 32.18 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 177.55 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.638 ' HB2' ' O ' ' A' ' 24' ' ' TRP . 0.9 OUTLIER -72.95 -33.01 65.63 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 177.413 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.482 ' O ' ' HB ' ' A' ' 33' ' ' VAL . 5.5 tp60 -70.88 -66.63 0.58 Allowed 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 120.045 -0.662 . . . . 0.0 110.527 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.844 HG21 HG21 ' A' ' 50' ' ' ILE . 84.1 mt -64.3 -45.7 95.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 O-C-N 121.245 -0.91 . . . . 0.0 110.35 -179.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.498 ' CA ' HG21 ' A' ' 39' ' ' ILE . . . -50.48 -34.44 27.02 Favored Glycine 0 N--CA 1.497 2.712 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 179.29 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 56.1 mtmt -126.71 29.9 5.61 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.008 -1.29 . . . . 0.0 111.865 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.508 HG13 ' N ' ' A' ' 34' ' ' ASN . 14.9 p -75.15 -49.83 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 O-C-N 120.633 -1.292 . . . . 0.0 111.541 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.508 ' N ' HG13 ' A' ' 33' ' ' VAL . 0.4 OUTLIER -178.47 -60.29 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.285 0 O-C-N 120.871 -1.143 . . . . 0.0 111.663 179.772 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.451 ' O ' ' HA ' ' A' ' 52' ' ' TYR . . . -122.94 67.71 0.48 Allowed Glycine 0 N--CA 1.495 2.586 0 C-N-CA 120.207 -0.997 . . . . 0.0 110.647 -178.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.88 HG22 HD13 ' A' ' 50' ' ' ILE . 50.4 t -136.57 92.4 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.487 -1.008 . . . . 0.0 108.585 178.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.793 ' N ' HD11 ' A' ' 51' ' ' ILE . 50.3 m-70 -51.67 -29.27 17.39 Favored 'General case' 0 N--CA 1.512 2.667 0 CA-C-O 121.575 0.702 . . . . 0.0 109.709 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.89 ' CD2' HD12 ' A' ' 51' ' ' ILE . 0.2 OUTLIER -171.39 145.41 2.12 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 178.615 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.876 HG12 HG22 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -121.06 144.86 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.145 -0.972 . . . . 0.0 110.023 -178.689 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.594 ' HG3' HG22 ' A' ' 49' ' ' THR . 4.5 tptt -122.21 100.23 6.85 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.555 -1.341 . . . . 0.0 109.518 179.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.643 HG23 ' HB2' ' A' ' 48' ' ' ALA . 11.2 p -108.93 154.68 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 O-C-N 121.604 -0.685 . . . . 0.0 109.614 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.57 ' HB3' ' HB2' ' A' ' 45' ' ' GLU . 0.4 OUTLIER -139.93 79.31 1.71 Allowed 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.712 -0.618 . . . . 0.0 109.693 -179.834 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.791 HD21 ' HB2' ' A' ' 22' ' ' CYS . 1.8 tp -45.32 -32.66 2.1 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.595 -0.691 . . . . 0.0 110.994 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.5 mp0 -72.02 -51.74 20.33 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.151 -0.968 . . . . 0.0 109.97 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.57 ' HB2' ' HB3' ' A' ' 42' ' ' SER . 1.8 mp0 -73.43 1.42 9.79 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.619 -0.676 . . . . 0.0 109.747 177.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 51.38 56.16 8.35 Favored 'General case' 0 N--CA 1.506 2.349 0 O-C-N 121.367 -0.833 . . . . 0.0 111.713 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -171.22 158.84 5.6 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.893 -1.129 . . . . 0.0 110.38 179.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.643 ' HB2' HG23 ' A' ' 41' ' ' VAL . . . -144.49 137.43 26.89 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.967 -1.083 . . . . 0.0 111.85 -179.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.594 HG22 ' HG3' ' A' ' 40' ' ' LYS . 5.6 t -127.22 135.78 51.1 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.014 -1.054 . . . . 0.0 109.299 178.035 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.88 HD13 HG22 ' A' ' 36' ' ' VAL . 1.4 pp -145.03 167.62 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 O-C-N 121.08 -1.013 . . . . 0.0 111.036 -177.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.89 HD12 ' CD2' ' A' ' 38' ' ' HIS . 0.0 OUTLIER -109.12 169.26 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 O-C-N 121.281 -0.887 . . . . 0.0 110.15 178.727 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.772 ' CZ ' ' HB3' ' A' ' 8' ' ' ASN . 15.4 p90 -170.43 159.73 7.14 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.54 -0.725 . . . . 0.0 110.672 -178.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.465 ' OD2' ' HB3' ' A' ' 56' ' ' LEU . 6.6 p-10 -79.26 117.37 66.63 Favored Pre-proline 0 C--N 1.3 -1.558 0 C-N-CA 119.631 -0.828 . . . . 0.0 109.425 179.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.549 ' HD2' ' O ' ' A' ' 6' ' ' GLY . 39.8 Cg_endo -68.54 66.2 1.15 Allowed 'Trans proline' 0 N--CA 1.487 1.115 0 O-C-N 123.516 1.272 . . . . 0.0 109.374 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.49 ' HG2' ' C ' ' A' ' 54' ' ' PRO . 0.0 OUTLIER -164.11 -55.3 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 -179.267 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.465 ' HB3' ' OD2' ' A' ' 53' ' ' ASP . 0.4 OUTLIER -98.55 -41.45 7.74 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.381 -0.824 . . . . 0.0 109.53 178.271 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.416 ' HB3' ' HB2' ' A' ' 52' ' ' TYR . 20.5 tp60 -104.14 140.38 37.88 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.026 -1.046 . . . . 0.0 111.036 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.72 ' HB ' ' HD2' ' A' ' 59' ' ' PRO . 29.9 p -140.75 171.55 7.49 Favored Pre-proline 0 N--CA 1.508 2.469 0 O-C-N 121.013 -1.055 . . . . 0.0 110.363 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.72 ' HD2' ' HB ' ' A' ' 58' ' ' THR . 38.5 Cg_endo -64.22 -20.24 66.75 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 O-C-N 123.455 1.24 . . . . 0.0 110.229 179.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.579 ' O ' ' HB3' ' A' ' 64' ' ' GLU . 1.4 tmtt? -77.02 -31.31 56.27 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 177.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.546 ' HA ' ' CD ' ' A' ' 64' ' ' GLU . 39.1 p -86.84 -25.41 24.54 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 177.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.941 HD13 HG11 ' A' ' 10' ' ' VAL . 20.3 mt -77.06 -26.6 53.73 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 176.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.438 ' HA ' HG22 ' A' ' 66' ' ' ILE . 1.3 tp60 -86.05 -24.56 26.31 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 177.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.579 ' HB3' ' O ' ' A' ' 60' ' ' LYS . 1.1 pt-20 -87.14 -15.39 38.54 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 177.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -90.05 -27.96 19.36 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 177.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.438 HG22 ' HA ' ' A' ' 63' ' ' GLN . 0.4 OUTLIER -86.41 -38.24 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.047 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -71.93 -29.74 64.61 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 177.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.435 ' HB2' ' O ' ' A' ' 64' ' ' GLU . 11.8 t70 -69.39 -41.55 76.31 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.413 -0.804 . . . . 0.0 109.181 177.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.29 -46.85 76.21 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.669 -0.645 . . . . 0.0 110.25 179.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 121.08 38.35 0.65 Allowed Glycine 0 N--CA 1.499 2.852 0 C-N-CA 120.043 -1.075 . . . . 0.0 110.856 179.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.676 ' CD2' HD11 ' A' ' 26' ' ' ILE . 59.9 m-85 -131.3 121.67 25.11 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.521 -0.988 . . . . 0.0 108.947 179.002 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -58.99 110.44 1.03 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.241 -0.912 . . . . 0.0 109.621 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.427 ' HA ' ' O ' ' A' ' 13' ' ' SER . . . -124.08 168.19 13.21 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 122.051 0.929 . . . . 0.0 112.029 -178.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.675 ' CG1' ' HB2' ' A' ' 13' ' ' SER . 2.7 p -149.2 91.75 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 178.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.68 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . 0.0 OUTLIER -51.74 143.49 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 CA-C-O 122.488 1.137 . . . . 0.0 112.157 -177.728 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -109.64 10.63 24.9 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.657 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -131.0 100.22 17.4 Favored Pre-proline 0 N--CA 1.496 1.872 0 O-C-N 121.331 -0.855 . . . . 0.0 110.642 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -83.59 46.38 2.05 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 O-C-N 123.586 1.309 . . . . 0.0 110.569 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.483 ' O ' ' HD3' ' A' ' 59' ' ' PRO . 5.5 m-20 . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.434 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.8 ttt . . . . . 0 N--CA 1.501 2.11 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.476 ' N ' ' HD3' ' A' ' 3' ' ' PRO . 1.9 m-20 46.64 53.04 12.82 Favored Pre-proline 0 N--CA 1.502 2.125 0 O-C-N 121.789 -0.57 . . . . 0.0 111.94 177.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.476 ' HD3' ' N ' ' A' ' 2' ' ' ASP . 51.9 Cg_endo -78.68 -8.59 15.87 Favored 'Trans proline' 0 C--N 1.318 -1.05 0 O-C-N 123.61 1.321 . . . . 0.0 109.286 177.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.41 ' O ' ' N ' ' A' ' 6' ' ' GLY . 0.7 OUTLIER -139.14 10.63 2.57 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.304 -0.872 . . . . 0.0 111.246 179.58 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.45 92.03 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.24 0 O-C-N 120.904 -1.123 . . . . 0.0 111.001 -179.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 4' ' ' SER . . . 116.73 -10.31 16.11 Favored Glycine 0 N--CA 1.5 2.92 0 O-C-N 121.204 -0.935 . . . . 0.0 111.704 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.64 ' HB ' HD11 ' A' ' 51' ' ' ILE . 26.7 m -131.13 165.84 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.351 0 CA-C-N 119.355 1.577 . . . . 0.0 111.23 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.511 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 0.8 OUTLIER -117.16 167.72 10.93 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.226 -0.921 . . . . 0.0 110.289 179.802 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.534 ' HA ' ' HA ' ' A' ' 51' ' ' ILE . 1.9 m -116.58 136.48 52.94 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.104 -0.997 . . . . 0.0 110.776 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.56 HG23 ' CE1' ' A' ' 52' ' ' TYR . 1.0 OUTLIER -126.58 120.71 56.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.415 -0.803 . . . . 0.0 111.459 -179.396 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.489 ' HA ' ' HA ' ' A' ' 49' ' ' THR . 24.2 m -111.75 104.74 13.1 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 177.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.604 ' HA ' ' HA ' ' A' ' 75' ' ' ILE . 72.6 mt -113.6 138.86 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.258 -0.901 . . . . 0.0 111.391 -178.152 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.747 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . 0.7 OUTLIER -74.57 134.02 42.18 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 177.984 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.549 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 23.3 t -120.29 120.71 63.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 121.274 -0.891 . . . . 0.0 110.945 -178.117 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.606 ' CB ' ' HB3' ' A' ' 72' ' ' ASP . 1.7 tm-20 -109.22 -171.58 1.87 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.796 -0.565 . . . . 0.0 109.864 179.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.96 21.96 67.01 Favored Glycine 0 N--CA 1.497 2.712 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -178.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.497 ' CG ' ' HG ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -66.35 154.32 40.35 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.256 -1.144 . . . . 0.0 111.386 -179.494 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.41 ' O ' ' HB3' ' A' ' 19' ' ' CYS . 1.6 p -146.91 -41.15 0.19 Allowed 'General case' 0 N--CA 1.508 2.439 0 O-C-N 121.407 -0.808 . . . . 0.0 111.556 -179.273 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.541 ' O ' HD21 ' A' ' 43' ' ' LEU . 29.5 p -179.79 169.23 1.31 Allowed 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.523 -0.735 . . . . 0.0 109.923 -178.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.558 ' O ' HG12 ' A' ' 23' ' ' VAL . 13.2 t-20 -31.72 -36.88 0.02 OUTLIER 'General case' 0 N--CA 1.512 2.639 0 CA-C-O 121.149 0.5 . . . . 0.0 112.095 179.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.85 ' HA ' ' CE3' ' A' ' 24' ' ' TRP . 4.5 p -55.99 -17.3 6.4 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 122.187 0.994 . . . . 0.0 111.354 179.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.686 ' CB ' HD11 ' A' ' 43' ' ' LEU . 62.4 m -93.25 -28.83 16.01 Favored 'General case' 0 C--N 1.287 -2.131 0 O-C-N 119.602 -1.936 . . . . 0.0 110.841 -178.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.66 ' CA ' HD13 ' A' ' 43' ' ' LEU . 10.7 p -85.49 -32.64 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.351 -0.843 . . . . 0.0 109.167 178.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.85 ' CE3' ' HA ' ' A' ' 21' ' ' SER . 0.0 OUTLIER -83.37 -23.07 32.61 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 117.745 -1.582 . . . . 0.0 108.886 178.488 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.629 ' HB ' ' O ' ' A' ' 21' ' ' SER . 1.2 t -82.26 -26.64 33.01 Favored 'General case' 0 N--CA 1.507 2.39 0 C-N-CA 118.722 -1.191 . . . . 0.0 111.061 178.001 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.996 HD11 ' CD2' ' A' ' 71' ' ' PHE . 20.8 mt -96.47 -28.86 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 O-C-N 120.81 -1.181 . . . . 0.0 110.25 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.611 ' HA ' HD11 ' A' ' 39' ' ' ILE . 1.0 OUTLIER -74.54 -35.39 63.12 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 178.369 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.606 ' HB2' ' O ' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -80.86 -31.91 35.18 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 119.423 -0.911 . . . . 0.0 108.607 177.545 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.578 ' HB2' ' O ' ' A' ' 25' ' ' THR . 1.6 tm0? -73.06 -60.44 2.23 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.036 -1.04 . . . . 0.0 110.162 179.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.868 HG21 HG21 ' A' ' 50' ' ' ILE . 88.5 mt -59.34 -39.27 78.55 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 120.945 -1.097 . . . . 0.0 109.952 179.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.75 ' HA2' HG21 ' A' ' 39' ' ' ILE . . . -48.53 -46.44 29.72 Favored Glycine 0 N--CA 1.497 2.741 0 N-CA-C 110.219 -1.152 . . . . 0.0 110.219 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.491 ' HG3' ' O ' ' A' ' 28' ' ' GLN . 0.2 OUTLIER -130.9 40.99 3.42 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.572 -0.958 . . . . 0.0 110.88 179.526 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.519 ' HB ' ' O ' ' A' ' 29' ' ' GLN . 15.0 p -72.76 -40.35 61.04 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.298 0 O-C-N 121.143 -0.973 . . . . 0.0 111.151 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.4 ' N ' HG13 ' A' ' 33' ' ' VAL . 0.3 OUTLIER -171.04 -51.64 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.092 0 O-C-N 120.903 -1.123 . . . . 0.0 111.08 179.844 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -150.12 82.64 0.18 Allowed Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.901 HG22 HD13 ' A' ' 50' ' ' ILE . 54.0 t -139.43 100.89 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.993 ' HB2' HD12 ' A' ' 51' ' ' ILE . 67.6 m-70 -70.09 -27.53 64.68 Favored 'General case' 0 C--N 1.289 -2.043 0 C-N-CA 120.288 -0.565 . . . . 0.0 110.155 -179.281 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.812 ' HB2' HG22 ' A' ' 51' ' ' ILE . 23.8 m-70 -142.78 130.71 21.7 Favored 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.047 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.781 ' C ' HD13 ' A' ' 39' ' ' ILE . 0.0 OUTLIER -127.88 139.08 52.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.081 -1.012 . . . . 0.0 110.252 -179.282 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.538 ' H ' HG22 ' A' ' 50' ' ' ILE . 0.3 OUTLIER -148.31 106.21 3.71 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.165 -0.959 . . . . 0.0 110.227 179.232 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.682 HG21 ' CG2' ' A' ' 26' ' ' ILE . 1.1 p -107.28 170.17 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.619 -0.676 . . . . 0.0 109.411 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.699 ' HB3' ' HB2' ' A' ' 45' ' ' GLU . 2.2 m -152.4 86.02 1.27 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.074 -1.016 . . . . 0.0 111.013 -178.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.686 HD11 ' CB ' ' A' ' 22' ' ' CYS . 1.9 tp -46.13 -34.04 3.97 Favored 'General case' 0 N--CA 1.509 2.489 0 O-C-N 121.768 -0.583 . . . . 0.0 111.617 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.416 ' O ' ' NZ ' ' A' ' 46' ' ' LYS . 14.3 mm-40 -82.75 -41.94 18.59 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.464 -1.397 . . . . 0.0 110.93 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.699 ' HB2' ' HB3' ' A' ' 42' ' ' SER . 18.9 mt-10 -80.37 5.54 14.64 Favored 'General case' 0 N--CA 1.498 1.938 0 C-N-CA 119.762 -0.775 . . . . 0.0 109.76 177.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.549 ' HG3' ' O ' ' A' ' 14' ' ' VAL . 0.0 OUTLIER 42.48 51.38 4.81 Favored 'General case' 0 N--CA 1.506 2.332 0 O-C-N 121.647 -0.658 . . . . 0.0 111.226 179.866 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.452 ' ND2' ' HA ' ' A' ' 13' ' ' SER . 0.4 OUTLIER -154.45 157.06 37.87 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 120.696 -1.252 . . . . 0.0 111.975 -179.382 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.594 ' HB2' HG23 ' A' ' 41' ' ' VAL . . . -136.63 127.16 26.88 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.491 -0.756 . . . . 0.0 109.863 178.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.522 HG22 ' HD3' ' A' ' 40' ' ' LYS . 15.1 t -127.75 119.69 26.31 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.353 -0.842 . . . . 0.0 110.071 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.901 HD13 HG22 ' A' ' 36' ' ' VAL . 1.9 pp -141.88 176.44 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.28 -0.887 . . . . 0.0 111.086 -178.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.993 HD12 ' HB2' ' A' ' 37' ' ' HIS . 0.0 OUTLIER -117.9 150.49 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 177.014 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.599 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 19.6 p90 -154.09 171.69 18.72 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 119.796 -0.762 . . . . 0.0 111.082 -176.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.445 ' HA ' ' HD2' ' A' ' 54' ' ' PRO . 0.4 OUTLIER -86.0 115.77 63.13 Favored Pre-proline 0 C--N 1.3 -1.569 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.294 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.445 ' HD2' ' HA ' ' A' ' 53' ' ' ASP . 37.5 Cg_endo -60.17 -22.64 70.94 Favored 'Trans proline' 0 N--CA 1.493 1.457 0 O-C-N 123.587 1.309 . . . . 0.0 110.035 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.4 ptpp? -79.95 -8.98 59.63 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.729 -0.607 . . . . 0.0 110.471 178.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -131.44 -46.64 0.98 Allowed 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.073 -1.017 . . . . 0.0 110.826 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -110.87 154.8 23.52 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.175 -0.953 . . . . 0.0 110.277 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.777 ' HB ' ' HD2' ' A' ' 59' ' ' PRO . 12.2 p -143.46 176.07 2.5 Favored Pre-proline 0 N--CA 1.499 1.982 0 O-C-N 121.488 -0.758 . . . . 0.0 110.456 -179.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.777 ' HD2' ' HB ' ' A' ' 58' ' ' THR . 40.0 Cg_endo -65.26 -23.35 59.55 Favored 'Trans proline' 0 N--CA 1.497 1.717 0 O-C-N 123.317 1.167 . . . . 0.0 112.199 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.542 ' O ' ' HB3' ' A' ' 64' ' ' GLU . 4.7 mmtm -90.47 -29.39 17.97 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.092 -1.005 . . . . 0.0 110.188 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.411 ' OG1' ' N ' ' A' ' 58' ' ' THR . 8.3 p -82.27 -25.84 33.7 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 177.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.552 HD13 ' CB ' ' A' ' 10' ' ' VAL . 0.9 OUTLIER -77.03 -27.91 54.7 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 176.676 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -82.62 -24.5 33.81 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 177.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.542 ' HB3' ' O ' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -84.7 -19.47 32.72 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 177.575 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -79.49 -30.54 42.05 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 176.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.492 HD13 HG22 ' A' ' 14' ' ' VAL . 32.3 mt -79.53 -37.58 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 176.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.458 ' HB2' ' HA ' ' A' ' 64' ' ' GLU . 0.9 OUTLIER -70.79 -29.35 65.53 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 176.778 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -69.73 -47.59 62.54 Favored 'General case' 0 N--CA 1.501 2.1 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 177.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.553 ' HE3' ' HB2' ' A' ' 29' ' ' GLN . 0.0 OUTLIER -56.53 -36.43 69.22 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.584 -0.698 . . . . 0.0 109.777 179.252 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 120.28 34.99 0.9 Allowed Glycine 0 N--CA 1.494 2.544 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 179.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.996 ' CD2' HD11 ' A' ' 26' ' ' ILE . 95.0 m-85 -135.99 144.09 45.16 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.306 -1.114 . . . . 0.0 110.546 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.606 ' HB3' ' CB ' ' A' ' 15' ' ' GLU . 5.2 t70 -60.52 129.78 43.3 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.344 -0.847 . . . . 0.0 109.972 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -108.76 116.98 33.01 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.459 -0.775 . . . . 0.0 110.565 -179.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.747 ' HB ' ' HB2' ' A' ' 13' ' ' SER . 53.1 t -123.12 73.07 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 CA-C-O 122.138 0.971 . . . . 0.0 108.742 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.604 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . 38.1 mt -35.4 137.25 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 CA-C-O 121.827 0.822 . . . . 0.0 112.472 -178.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -117.18 2.19 12.58 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.861 -0.525 . . . . 0.0 110.707 178.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.442 ' OD1' ' HD2' ' A' ' 78' ' ' PRO . 31.5 t30 -125.62 147.46 58.35 Favored Pre-proline 0 N--CA 1.499 2.004 0 O-C-N 120.983 -1.073 . . . . 0.0 109.916 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.442 ' HD2' ' OD1' ' A' ' 77' ' ' ASN . 38.9 Cg_endo -66.61 -40.0 14.55 Favored 'Trans proline' 0 N--CA 1.493 1.489 0 O-C-N 123.382 1.201 . . . . 0.0 110.26 179.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.487 1.396 0 CA-C-O 118.47 -0.776 . . . . 0.0 109.501 178.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.502 2.133 0 CA-C-O 120.967 0.413 . . . . 0.0 110.233 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -127.96 65.24 68.12 Favored Pre-proline 0 N--CA 1.496 1.872 0 O-C-N 121.407 -0.808 . . . . 0.0 111.411 -179.017 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.35 -21.73 19.56 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 O-C-N 123.642 1.338 . . . . 0.0 108.988 177.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.44 ' HA ' ' CG2' ' A' ' 7' ' ' VAL . 1.9 p -175.2 29.48 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.779 -0.575 . . . . 0.0 111.424 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 37.5 mmm -52.93 -43.01 65.97 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.085 -1.009 . . . . 0.0 109.515 179.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -125.54 35.76 2.96 Favored Glycine 0 N--CA 1.496 2.693 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 178.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.638 HG11 ' CD1' ' A' ' 51' ' ' ILE . 9.1 t -118.06 168.14 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.589 -0.947 . . . . 0.0 110.041 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.494 ' HB3' ' CZ ' ' A' ' 52' ' ' TYR . 2.9 t-20 -115.24 169.88 8.8 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.058 -1.026 . . . . 0.0 110.92 -179.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.658 ' HA ' ' HA ' ' A' ' 51' ' ' ILE . 26.0 p -129.46 128.97 43.99 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.427 -0.796 . . . . 0.0 110.39 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.689 HG11 HD13 ' A' ' 62' ' ' LEU . 1.2 t -123.48 137.13 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 CA-C-O 121.632 0.73 . . . . 0.0 110.88 -178.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.522 ' HA ' ' HA ' ' A' ' 49' ' ' THR . 4.3 m -118.59 121.13 39.46 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.915 HG12 HD12 ' A' ' 75' ' ' ILE . 25.6 mt -110.56 118.45 57.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.365 -0.835 . . . . 0.0 111.549 -177.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.469 ' O ' ' HA ' ' A' ' 73' ' ' ALA . 1.1 m -71.89 114.8 10.37 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 177.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.621 ' HA ' ' O ' ' A' ' 72' ' ' ASP . 20.5 t -114.52 130.66 68.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.166 -0.959 . . . . 0.0 111.404 -177.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.69 ' HA ' ' HG2' ' A' ' 46' ' ' LYS . 2.6 mm-40 -112.54 -15.32 13.07 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.14 -0.975 . . . . 0.0 111.521 179.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -79.71 33.44 2.11 Favored Glycine 0 N--CA 1.499 2.866 0 O-C-N 120.845 -1.159 . . . . 0.0 111.493 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.667 ' HG3' ' HA ' ' A' ' 46' ' ' LYS . 32.6 mmt -77.25 75.99 3.8 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 120.682 -1.481 . . . . 0.0 109.486 178.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.442 HG23 ' H ' ' A' ' 18' ' ' THR . 17.4 p -52.76 -33.78 50.04 Favored 'General case' 0 N--CA 1.51 2.56 0 O-C-N 121.418 -0.802 . . . . 0.0 111.767 -179.017 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.515 ' O ' HD21 ' A' ' 43' ' ' LEU . 22.5 p 179.13 164.4 0.9 Allowed 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.61 ' HA ' ' HG ' ' A' ' 43' ' ' LEU . 17.4 m120 -38.58 -32.91 0.09 Allowed 'General case' 0 N--CA 1.509 2.51 0 CA-C-N 117.844 0.293 . . . . 0.0 111.475 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.531 ' HA ' ' HE3' ' A' ' 24' ' ' TRP . 5.0 p -52.09 -19.03 1.68 Allowed 'General case' 0 N--CA 1.507 2.406 0 O-C-N 121.095 -1.003 . . . . 0.0 111.208 177.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.661 ' HB3' ' CE1' ' A' ' 71' ' ' PHE . 84.6 m -88.92 -22.04 23.31 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.375 -0.828 . . . . 0.0 109.406 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.738 ' HB ' HD23 ' A' ' 43' ' ' LEU . 0.9 OUTLIER -80.56 -35.85 15.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 106.714 -1.588 . . . . 0.0 106.714 177.467 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.54 ' CZ3' ' CB ' ' A' ' 20' ' ' ASN . 4.2 m-90 -74.87 -30.7 61.4 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.028 -1.069 . . . . 0.0 109.188 178.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.512 ' O ' ' HB2' ' A' ' 29' ' ' GLN . 0.5 OUTLIER -80.73 -19.16 45.6 Favored 'General case' 0 N--CA 1.505 2.281 0 C-N-CA 119.701 -0.8 . . . . 0.0 110.849 179.232 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.47 ' O ' ' HB ' ' A' ' 30' ' ' ILE . 7.8 mm -100.15 -21.17 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 O-C-N 121.179 -0.95 . . . . 0.0 109.519 179.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.506 ' HB3' ' O ' ' A' ' 23' ' ' VAL . 0.1 OUTLIER -78.82 -36.16 43.04 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 177.309 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.44 ' HB2' ' O ' ' A' ' 24' ' ' TRP . 0.8 OUTLIER -81.06 -36.93 29.85 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 119.82 -0.752 . . . . 0.0 109.492 177.769 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.512 ' HB2' ' O ' ' A' ' 25' ' ' THR . 1.1 tm0? -74.1 -62.32 1.55 Allowed 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 118.94 -1.104 . . . . 0.0 110.257 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.47 ' HB ' ' O ' ' A' ' 26' ' ' ILE . 41.4 mm -61.39 -45.16 99.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.12 -0.988 . . . . 0.0 109.264 179.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -50.64 -35.78 30.77 Favored Glycine 0 N--CA 1.501 3.002 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 178.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.449 ' HA ' ' HD3' ' A' ' 32' ' ' LYS . 12.1 mmtm -128.25 34.57 4.54 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.145 -1.209 . . . . 0.0 110.565 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.487 ' HB ' ' O ' ' A' ' 29' ' ' GLN . 8.7 p -74.86 -41.53 46.67 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.017 -1.052 . . . . 0.0 111.799 -178.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.417 ' N ' HG13 ' A' ' 33' ' ' VAL . 6.2 t-20 -175.95 -54.86 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.113 0 O-C-N 120.903 -1.123 . . . . 0.0 111.08 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -144.09 80.12 0.24 Allowed Glycine 0 N--CA 1.494 2.56 0 N-CA-C 108.763 -1.735 . . . . 0.0 108.763 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.724 HG22 HD11 ' A' ' 50' ' ' ILE . 28.7 t -133.82 88.78 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 CA-C-O 122.265 1.031 . . . . 0.0 110.076 -179.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 1.024 ' HB2' HD11 ' A' ' 51' ' ' ILE . 33.1 m-70 -67.16 -27.44 67.29 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.669 ' HB2' HG12 ' A' ' 51' ' ' ILE . 42.0 m-70 -141.16 125.57 17.62 Favored 'General case' 0 N--CA 1.5 2.025 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.153 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.825 ' C ' HD13 ' A' ' 39' ' ' ILE . 0.0 OUTLIER -126.41 135.28 64.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.101 -0.999 . . . . 0.0 109.8 -179.537 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.493 ' NZ ' ' O ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -130.06 121.7 26.91 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.966 -1.083 . . . . 0.0 110.593 -179.868 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.686 HG11 ' HA ' ' A' ' 23' ' ' VAL . 2.0 t -109.21 163.51 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 178.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.642 ' HB3' ' HB2' ' A' ' 45' ' ' GLU . 0.6 OUTLIER -151.0 85.49 1.35 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.062 -1.023 . . . . 0.0 110.47 -178.864 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.738 HD23 ' HB ' ' A' ' 23' ' ' VAL . 0.2 OUTLIER -52.86 -58.02 8.32 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.713 -0.617 . . . . 0.0 111.372 -179.586 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.9 mp0 -69.69 -44.51 70.27 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.185 -0.947 . . . . 0.0 110.668 -179.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.642 ' HB2' ' HB3' ' A' ' 42' ' ' SER . 1.3 mt-10 -76.81 7.29 4.87 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 120.008 -0.677 . . . . 0.0 110.413 178.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.69 ' HG2' ' HA ' ' A' ' 15' ' ' GLU . 0.0 OUTLIER 36.6 66.8 0.37 Allowed 'General case' 0 N--CA 1.5 2.046 0 CA-C-O 121.544 0.688 . . . . 0.0 111.754 178.994 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -157.79 145.18 18.36 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 120.693 -1.254 . . . . 0.0 112.51 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.513 ' HB3' ' HB ' ' A' ' 12' ' ' ILE . . . -124.0 109.15 13.18 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.574 -0.703 . . . . 0.0 109.126 179.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.522 ' HA ' ' HA ' ' A' ' 11' ' ' THR . 0.8 OUTLIER -114.92 142.53 46.47 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.047 -1.033 . . . . 0.0 109.194 179.988 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.724 HD11 HG22 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -165.25 157.13 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 120.71 -1.244 . . . . 0.0 110.724 -178.92 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 1.024 HD11 ' HB2' ' A' ' 37' ' ' HIS . 1.6 pp -107.08 159.91 6.56 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 O-C-N 121.275 -0.891 . . . . 0.0 109.301 179.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.631 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 6.8 p90 -161.73 166.05 27.17 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.229 -0.919 . . . . 0.0 111.732 -176.013 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.31 113.05 17.31 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.651 -0.656 . . . . 0.0 110.63 179.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.49 ' HD3' ' N ' ' A' ' 8' ' ' ASN . 46.0 Cg_endo -70.25 67.16 2.04 Favored 'Trans proline' 0 N--CA 1.489 1.224 0 O-C-N 123.964 1.507 . . . . 0.0 109.039 179.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.54 -46.88 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 121.419 0.628 . . . . 0.0 109.425 -178.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.405 HD23 ' N ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -98.37 -25.57 14.77 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.603 -0.686 . . . . 0.0 109.997 179.357 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.415 ' HG3' ' N ' ' A' ' 58' ' ' THR . 2.3 tp60 -129.53 145.72 51.43 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.222 -0.924 . . . . 0.0 110.0 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.567 ' HB ' ' HD2' ' A' ' 59' ' ' PRO . 7.6 p -135.24 166.44 28.96 Favored Pre-proline 0 N--CA 1.504 2.272 0 O-C-N 121.045 -1.035 . . . . 0.0 110.783 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.567 ' HD2' ' HB ' ' A' ' 58' ' ' THR . 37.8 Cg_endo -62.06 -21.35 72.26 Favored 'Trans proline' 0 N--CA 1.493 1.499 0 O-C-N 123.957 1.504 . . . . 0.0 110.55 179.041 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.434 ' NZ ' ' OD1' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -76.83 -38.02 54.6 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 177.785 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.608 ' HA ' ' HB2' ' A' ' 64' ' ' GLU . 34.4 p -77.74 -27.21 50.4 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 177.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.689 HD13 HG11 ' A' ' 10' ' ' VAL . 17.6 mt -73.02 -27.45 61.78 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 176.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.696 ' HG2' HD13 ' A' ' 75' ' ' ILE . 9.1 mm100 -85.62 -19.02 31.62 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 177.302 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.608 ' HB2' ' HA ' ' A' ' 61' ' ' THR . 4.8 mt-10 -90.36 -18.37 25.64 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 177.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.423 ' HB1' HG21 ' A' ' 33' ' ' VAL . . . -87.8 -29.63 20.83 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 177.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.596 HG12 ' HB2' ' A' ' 73' ' ' ALA . 6.9 tp -80.54 -31.61 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 177.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.434 ' HB2' ' O ' ' A' ' 63' ' ' GLN . 15.2 t70 -72.22 -29.84 64.33 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 176.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -64.52 -48.96 73.15 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.939 -0.475 . . . . 0.0 110.294 179.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.415 ' HB3' ' HD2' ' A' ' 71' ' ' PHE . 5.1 tpt -67.82 -36.94 81.28 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.349 -0.845 . . . . 0.0 110.6 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 108.74 59.1 0.54 Allowed Glycine 0 N--CA 1.498 2.795 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 179.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.661 ' CE1' ' HB3' ' A' ' 22' ' ' CYS . 43.0 m-85 -139.17 122.04 16.58 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.516 -0.991 . . . . 0.0 110.379 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.621 ' O ' ' HA ' ' A' ' 14' ' ' VAL . 6.3 t70 -54.06 104.03 0.1 Allowed 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.546 -0.721 . . . . 0.0 109.186 179.077 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.78 ' HB1' ' CG2' ' A' ' 12' ' ' ILE . . . -116.73 147.12 42.3 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 122.129 0.966 . . . . 0.0 112.596 -177.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.432 ' N ' ' O ' ' A' ' 13' ' ' SER . 46.1 t -138.07 81.55 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 CA-C-O 122.011 0.91 . . . . 0.0 108.585 179.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.915 HD12 HG12 ' A' ' 12' ' ' ILE . 0.3 OUTLIER -49.83 152.47 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 CA-C-O 122.679 1.228 . . . . 0.0 112.789 -178.366 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 47.9 t-80 -108.98 11.59 25.81 Favored 'General case' 0 N--CA 1.498 1.962 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.172 179.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -130.77 141.02 40.45 Favored Pre-proline 0 N--CA 1.5 2.027 0 O-C-N 121.146 -0.971 . . . . 0.0 110.064 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -81.52 -58.54 0.03 OUTLIER 'Trans proline' 0 N--CA 1.489 1.208 0 O-C-N 123.806 1.424 . . . . 0.0 111.991 -179.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.434 ' OD1' ' NZ ' ' A' ' 60' ' ' LYS . 25.9 m-20 . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 117.894 -1.05 . . . . 0.0 110.609 -179.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_